<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 2 5 0 0 0 0 0 0 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 9 6 1 1 1 1 1;}
@font-face
	{font-family:MingLiU;
	panose-1:2 2 5 9 0 0 0 0 0 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;}
@font-face
	{font-family:Mangal;
	panose-1:2 4 5 3 5 2 3 3 2 2;}
@font-face
	{font-family:Latha;
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;}
@font-face
	{font-family:Vrinda;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Raavi;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Shruti;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:Tunga;
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:3 8 6 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.55pt;
	margin-left:189.75pt;
	text-align:justify;
	text-justify:inter-ideograph;
	text-indent:-.5pt;
	line-height:103%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.55pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.5pt;
	font-family:"Times New Roman",serif;
	color:black;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:normal;
	font-style:italic;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:normal;
	font-style:italic;}
h5
	{mso-style-link:"Heading 5 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:38.45pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.55pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:9.5pt;
	font-family:"Times New Roman",serif;
	color:black;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-link:"Heading 8 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:43.05pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-link:"Heading 9 Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:11.4pt;
	margin-left:38.45pt;
	text-indent:-.5pt;
	line-height:103%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
p.footnotedescription, li.footnotedescription, div.footnotedescription
	{mso-style-name:"footnote description";
	mso-style-link:"footnote description Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:42.55pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	color:black;}
span.footnotedescriptionChar
	{mso-style-name:"footnote description Char";
	mso-style-link:"footnote description";
	font-family:"Times New Roman",serif;
	color:black;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-link:"Heading 9";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-link:"Heading 8";
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Times New Roman",serif;
	color:black;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Times New Roman",serif;
	color:black;
	font-style:italic;}
span.footnotemark
	{mso-style-name:"footnote mark";
	font-family:"Times New Roman",serif;
	color:black;
	vertical-align:super;}
span.msoIns
	{mso-style-name:"";
	text-decoration:underline;
	color:teal;}
span.msoDel
	{mso-style-name:"";
	text-decoration:line-through;
	color:red;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
 /* Page Definitions */
 @page WordSection1
	{size:595.2pt 842.0pt;
	margin:61.5pt 65.0pt 35.65pt 28.4pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=NL>

<div class=WordSection1>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:43.2pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span style='font-family:"Arial",sans-serif'> </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:27.0pt;margin-left:43.2pt;text-align:left;text-indent:0cm;
line-height:107%'><img width=107 height=72 src="IA_files/image001.gif"
align=left hspace=12><span lang=EN-US style='font-family:"Arial",sans-serif'>EUROPEAN
COMMISSION </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:15.0pt;margin-left:122.5pt;text-align:left;text-indent:0cm;
line-height:107%'><span lang=EN-US style='font-family:"Arial",sans-serif'> </span></p>

<p class=MsoNormal align=center style='margin-bottom:0cm;margin-bottom:.0001pt;
text-align:center;line-height:107%'><span lang=EN-US>Brussels, 31.1.2012  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
27.1pt;margin-left:298.75pt'><span lang=EN-US>SEC(2011) 1547 final </span></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:24.95pt;margin-left:98.7pt;text-align:center;text-indent:0cm;
line-height:107%'><i><span lang=EN-US style='font-size:16.0pt;line-height:107%'> </span></i></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:.1pt;
margin-bottom:16.8pt;margin-left:38.6pt;text-align:center;line-height:107%'><b><span
lang=EN-US>COMMISSION STAFF WORKING PAPER </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:16.8pt;margin-left:38.6pt;text-align:center;line-height:107%'><b><span
lang=EN-US>IMPACT ASSESSMENT </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:38.05pt;text-align:center;text-indent:0cm;
line-height:107%'><b><i><span lang=EN-US>Accompanying the document </span></i></b></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:56.3pt;text-align:left;line-height:103%'><b><span
lang=EN-US>PROPOSAL FOR A DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE
COUNCIL   </span></b></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:8.5pt;
margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:right;
text-indent:0cm;line-height:107%'><b><span lang=EN-US>amending Directives
2000/60/EC and 2008/105/EC as regards priority substances in the </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:.05pt;
margin-bottom:0cm;margin-left:38.6pt;margin-bottom:.0001pt;text-align:center;
line-height:107%'><b><span lang=EN-US>field of water policy </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:41.05pt;margin-bottom:.0001pt;text-align:center;
text-indent:0cm;line-height:107%'><b><span lang=EN-US> </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:16.55pt;margin-left:41.05pt;text-align:center;text-indent:0cm;
line-height:107%'><b><span lang=EN-US> </span></b></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:151.25pt;
margin-bottom:0cm;margin-left:189.75pt;margin-bottom:.0001pt;text-align:center;
line-height:107%'><span lang=EN-US>{COM(2011) 876 final} </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:294.5pt;margin-left:0cm;text-align:left;text-indent:0cm;
line-height:110%'><span lang=EN-US style='font-size:11.0pt;line-height:110%;
font-family:"Calibri",sans-serif'>                                                                                              </span><span
lang=EN-US>{SEC(2011) 1546 final}                                                         </span></p>

<p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
style='font-size:24.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'><b><span lang=EN-US>Disclaimer:</span></b><span
lang=EN-US> This impact assessment commits only the Commission's services
involved in its preparation and does not prejudge the final form of any
decision to be taken by the Commission.<br clear=all style='page-break-before:
always'>
</span></p>

<p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:13.0pt;margin-left:36.75pt;text-align:center;text-indent:0cm;
line-height:107%'><b><span style='font-size:14.0pt;line-height:107%'>TABLE OF
CONTENTS </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Procedural issues and consultation of interested
parties.............................................. </span>6 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Overview......................................................................................................................
6 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Impact Assessment Steering Group
(IASG)................................................................ </span>6
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Expertise for the technical
process...............................................................................
</span>6 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Stakeholder
consultation..............................................................................................
7 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>1.4.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Stakeholders and nature of consultation
...................................................................... </span>7
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>1.4.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Consultation outputs
....................................................................................................
8 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>1.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>The Impact Assessment Board.....................................................................................
8 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Problem
definition........................................................................................................
9 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Introduction: policy
context/background.....................................................................
9 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>What is the issue or problem requiring
action?.......................................................... </span>11 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>General points
............................................................................................................
11 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.2.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Summary of main issues/problems
............................................................................ </span>11
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.2.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>New information on risks to environment and
human health.................................... </span>12 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>2.2.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Specific difficulties with ubiquitous
persistent, bioaccumulative and toxic (PBT) </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>chemicals....................................................................................................................
15 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.2.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Knowledge base.........................................................................................................
16 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>What are the underlying drivers of the
problem?....................................................... </span>18 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Who is affected by the problems identified, in
what ways and to what extent?........ </span>19 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>How would the problem evolve, all things being
equal?........................................... </span>19 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.5.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>New information on risks to environment and
human health.................................... </span>19 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>2.5.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Specific difficulties with ubiquitous
persistent, bioaccumulative and toxic chemicals23 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>2.5.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Knowledge
base.........................................................................................................
23 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>2.6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Does the EU have the right to act?.............................................................................
</span>24 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Objectives...................................................................................................................
24 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Policy options.............................................................................................................
25 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>4.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Overview....................................................................................................................
25 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>4.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Policy options in relation to the substances
............................................................... </span>25 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Introduction................................................................................................................
25 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>4.2.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>The options A1, A2 and A3
(a)-(c)............................................................................
26 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>4.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Policy options in relation to the specific
difficulties with ubiquitous PBTs.............. </span>27 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.3.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Option B1: No
change................................................................................................
28 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.3.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B2a presentation: Allow separate
presentation of ubiquitous PBTs.............. </span>28 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.3.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B2b presentation: Take ubiquitous PBTs
out of chemical status .................. </span>28 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>4.3.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B3a choice of matrix: Leave flexibility
but link the choice to requirements of </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>Directive
2009/90/EC
................................................................................................
28 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.3.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B3b choice of matrix: Fix the preferred
matrix for each substance............... </span>29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>4.3.6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B4a monitoring: Introduce reduced
monitoring obligations for ubiquitous </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'><span
lang=EN-US>PBTs if certain specified conditions are
met.............................................................. </span>29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>4.3.7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option B4b monitoring: Introduce reduced
monitoring obligations for ubiquitous </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>PBTs
(unconditional).................................................................................................
29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>4.4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Policy options in relation to improving the
knowledge base..................................... </span>29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.4.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Option C1: No change................................................................................................
29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.4.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Options C2 and C3: Establishment of a watch
list..................................................... </span>29 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.4.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option C2: Establish a watch list without legal
obligation........................................ </span>30 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.1pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>4.4.4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Option C3: Establish a watch list with legal
obligation............................................. </span>30 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts and comparison of the
options................................................... </span>30 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Introduction................................................................................................................
30 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of the substance options
............................................................ </span>31 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.2.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>General considerations as regards costs and
benefits of the substance options......... </span>31 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.2.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Uncertainties in the analysis of the substance
options............................................... </span>35 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.2.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option A2: Change EQS
and/or status of existing PS.......... </span>36 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.2.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option A3a: Existing-PS
changes plus Annex III substances41 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.95pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.2.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option A3b: Existing-PS
changes plus Annex III substances plus other new substances excluding
pharmaceuticals .............................................. </span>43 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.95pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.2.6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option A3c: Existing-PS
changes plus Annex III substances plus other new substances including
pharmaceuticals............................................... </span>46 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Comparison of the substance
options.........................................................................
</span>50 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.4.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of options in relation to
the ubiquitous PBTs............................ </span>52 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.4.1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B2a on
presentation: Give more flexibility on </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>presentation................................................................................................................
52 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.4.2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B2b on
presentation: Take ubiquitous PBTs out of </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>chemical
status...........................................................................................................
52 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.4.3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B3a on choice of
matrix: Leave flexibility but link the </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'><span
lang=EN-US>choice to requirements of Directive
2009/90/EC....................................................... 53 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.4.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B3b on choice of
matrix: Fix the preferred matrix for </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>each
substance............................................................................................................
53 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.95pt;margin-left:84.4pt;text-indent:-42.55pt'><span lang=EN-US
style='line-height:103%'>5.4.5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B4a on monitoring:
Introduce reduced monitoring obligations for ubiquitous PBTs if certain
specified conditions are met................... 54 </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.95pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.4.6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option B4b on monitoring:
Introduce reduced monitoring obligations for ubiquitous PBTs (unconditional).......................................................
</span>54 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.5.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Comparison of options in relation to the
ubiquitous PBTs........................................ </span>55 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.6.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of options to improve the
knowledge base................................ </span>56 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.6.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option C2: Establish a
watch list without legal obligation... </span>56 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.6.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Analysis of impacts of Option C3: Establish a
watch list with legal obligation........ </span>56 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.35pt;text-indent:-42.5pt'><span style='line-height:103%'>5.7.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Comparison of the options to improve the
knowledge base...................................... </span>57 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:84.35pt;text-indent:-42.5pt'><span lang=EN-US
style='line-height:103%'>5.8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cumulative impacts, interactions across the
various options and significant </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:8.95pt;margin-left:.5pt;text-align:right;line-height:110%'>distributional
effects...................................................................................................
57 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.8.1.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Interactions and cumulative
impacts..........................................................................
57 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.15pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.8.2.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Cumulative impacts of the package of preferred
options........................................... </span>59 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.7pt;margin-left:84.4pt;text-indent:-42.55pt'><span style='line-height:103%'>5.8.3.<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Distributional effects of the package of
preferred options......................................... </span>60 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:84.4pt;text-indent:-42.55pt;line-height:164%'><span
style='line-height:164%'>5.8.4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Approach to translating the options into a
legislative proposal................................. </span>63 6. Monitoring
and
evaluation.........................................................................................
63 </p>

<h5 style='margin-left:42.3pt'>ANNEXES </h5>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX I: Glossary / List of
acronyms </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX II: Summary of the
prioritisation process and the establishment of EQS </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX III: Background and details
regarding ubiquitous PBTs and knowledge base (watch list) options </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX IV: Approach to the
assessment of impacts </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX V: Substance factsheets </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>ANNEX VI: Description of the main policies
affecting the baseline and interactions with the </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>WFD </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX VII: List of stakeholders
involved in the consultation  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>ANNEX VIII: References </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> <br clear=all
style='page-break-before:always'>
</span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>1.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>P</span><span lang=EN-US>ROCEDURAL
ISSUES AND CONSULTATION OF INTERESTED PARTIES</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%'> </span></h1>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><b><span
lang=EN-US style='font-style:normal'>1.1.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Overview </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The Commission proposal which
this Impact Assessment concerns addresses the control of pollution of surface
water bodies by Priority Substances (PS) - chemicals presenting a significant
risk to or via the aquatic environment at EU level - . The Water Framework
Directive (WFD) 2000/60/EC</span><a href="#_ftn1" name="_ftnref1" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[1]</span></sup></sup></a><span lang=EN-US> (Article 16(4))
requires that the list of PS be reviewed at least every four years. Technical
work on the review began in 2007.  It aimed to identify substances that should
be added to the list through a prioritisation exercise, to set environmental
quality standards (EQS)</span><a href="#_ftn2" name="_ftnref2" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[2]</span></sup></sup></a><span lang=EN-US> for them, and to
review the EQS for and status of the existing PS.  As the technical work was in
its final stages in 2010, work on the impact assessment began with the
commencement of a study by the consultancy Entec</span><a href="#_ftn3"
name="_ftnref3" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[3]</span></sup></sup></a><span
lang=EN-US>.  The consultant drafted individual substance impacts reports
taking into account the conclusions of the technical work</span><a href="#_ftn4"
name="_ftnref4" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[4]</span></sup></sup></a><span
lang=EN-US>, and these were drawn upon for a large part of this Impact
Assessment Report. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the course of reviewing the PS
list, possible improvements in the functioning of the Environmental Quality
Standards Directive (EQSD) 2008/105/EC</span><a href="#_ftn5" name="_ftnref5"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[5]</span></sup></sup></a><span
lang=EN-US> were identified, and a possible mechanism for improving the
identification of additional PS in future reviews, and these are included as
separate sets of options. The preferred option is therefore a package of
options. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The roadmap for the assessment
was drafted in March and finalised in October 2010. </span></p>

<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:17.5pt;margin-left:
0cm;text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>1.2.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Impact Assessment Steering Group (IASG) </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Meetings of the IASG were held in
February 2010, March, April and May 2011, with a fifth and final meeting on 18
May 2011.  The following DGs attended one or more of the meetings: the
Secretariat General (SG), AGRI, ENTR, JRC, MARE, REGIO, RTD, and SANCO. DG ENTR
and DG SANCO also attended meetings of the working groups doing the technical
work and contributing to the impact assessment study (see section 1.3). </span></p>

<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:17.5pt;margin-left:
0cm;text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>1.3.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Expertise for the technical process </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'><span lang=EN-US>The technical
work for the review, i.e. principally the prioritisation and EQS setting, was
led by DG ENV and the JRC and carried out by a range of experts.  These
included members of the Chemical Aspects Working Group E under the WFD Common
Implementation Strategy (CIS)</span><a href="#_ftn6" name="_ftnref6" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[6]</span></sup></sup></a><span lang=EN-US>, in particular two
sub-groups of WG E, and the consultancy INERIS (with input from the Institute
of Water, IoW).  The membership of WG E and the two sub-groups consists of
Commission DGs, Member States (MS) and stakeholder organisations including a
range of European industry associations (AESGP, AISE, Business Europe, CEFIC,
CEPI, CONCAWE, COPA-COGECA, ECPA, EFPIA, EUCETSA, EUDA, EUREAU, EURELECTRIC,
EUROFER, EUROMETAUX, EUROMINES) and NGOs (EEB, </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Greenpeace, OSPAR , WWF).  Annex
VII gives the full names and sectors. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>WG E contributed significantly to
the review by supporting the collection of data (including monitoring and
hazard data), the prioritisation process for identifying new substances, the
update of the Technical Guidance Document on EQS setting, and the derivation of
EQS.  The two sub-groups of WG E that carried out much of the work were the
Expert Group on the Technical Guidance Document EQS (EG-EQS), and the Sub-Group
on Review of Priority Substances (SG-R), both chaired by the JRC.  The WG E
industry stakeholder groups involved their most relevant member companies,
generally represented by technical experts, in the sub-group discussions,
particularly as the selection procedure reached its final stages and EQS were
developed. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.7pt;margin-left:42.35pt'><span lang=EN-US>The draft EQS were submitted to
the Scientific Committee on Health and Environmental Risks (SCHER)</span><a
href="#_ftn7" name="_ftnref7" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[7]</span></sup></sup></a><span
lang=EN-US> for its opinion.  </span></p>

<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:17.75pt;margin-left:
0cm;text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>1.4.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Stakeholder consultation </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>1.4.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Stakeholders and nature of consultation </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The members of WG E  i.e. all MS
and the most relevant stakeholder organisations - were kept informed of the
progress on the technical work in the sub-groups throughout the review process.
They contributed information to that process and provided information to the
consultancy Entec for the impact assessment study.  They were consulted twice
on the methodology and twice on the draft substance impacts reports. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.85pt;margin-left:42.35pt'><span lang=EN-US>The penultimate drafts of the
substance impacts reports were also sent to additional selected stakeholders in
a targeted stakeholder consultation, to cover organisations (see Annex VII) not
already (fully) represented on WG E.  In view of the wide range of
organisations/sectors already involved in WG E, their involvement throughout
the process, and the technical nature of the review, it was judged appropriate
to target additional consultation to selected additional organisations rather
than to conduct a full public consultation. Other DGs were asked to propose
organisations whose interests might require additional representation, and
those targeted included groups representing the fishing/aquaculture and
transportation industries, medical professionals and users/consumers. Output
from a public internet consultation would likely have been of a very general
nature, and unlikely to add to the feedback already gathered by other means.
For example, in the Flash Eurobarometer on water in 2009, 75% of EU citizens
identified chemical pollution of water as a threat to the water environment, a
higher proportion than for any other threat. In the 2011 Environment
Eurobarometer</span><a href="#_ftn8" name="_ftnref8" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[8]</span></sup></sup></a><span lang=EN-US> water pollution was
most frequently identified as one of the top five environmental concerns. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>1.4.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Consultation outputs </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The involvement of WG E and its
sub-groups in the technical process from its inception allowed the represented
MS and organisations to inform the selection of new PS and the EQS setting, for
example by highlighting substances of concern or relevant toxicity studies. The
general view of MS and stakeholders in WG E is that the results of the
technical work have a sound scientific basis despite some differences of
opinion between industry and MS experts  as for example highlighted to the
SCHER for its consideration. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The development of the options
was informed by discussion on issues including the appropriateness of setting
sediment and biota standards, and the difficulty for MS of dealing with
&quot;ubiquitous PBTs&quot;.  Some stakeholder views on specific options are
mentioned in the relevant sections.  The need to interface effectively with
other legislation (see Annex VI) was emphasised. </span></p>

<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:17.5pt;margin-left:
0cm;text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>1.5.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>The Impact Assessment Board  </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This Impact Assessment Report was
discussed by the Impact Assessment Board on 22 June 2011, leading to a positive
opinion with comments. The Board commented in its overall assessment that the
findings of the IA should be presented more clearly.  For this reason, the
material in the report has been substantially reorganised and supplemented, to
some extent using information from the existing annexes.  The overview (section
1.1) makes clearer what the options cover; the policy context (section 2.1)
elaborates on the current assessment of the River Basin Management Plans; the
baseline has been more clearly presented (see point 2 below); the introductory
parts of section 5.2 explain in more detail the analysis of costs and benefits
of the substance options and the uncertainties involved; and specific reference
is made to SMEs. Finally, the preferred policy package is compared to the
baseline in section 5.8.2. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The Board provided five main
groups of recommendations.  These have been acted upon as follows: </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>(1) Better present the scale of the problem and the
experience with implementation of the</span></u><span lang=EN-US
style='font-style:normal'> <u>relevant provisions of the WFD</u> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Risks to health and the
environment from the candidate substances, and current levels of use and
production, have been summarised in a new table in section 2.2.3.  This section
also explains the prioritisation process in more detail.  The participation of
interested businesses is elaborated in section 1.3, and additional references
to stakeholder views on individual substances have been made in section 5.
Information on substitutes has been included in the (adapted) tables in section
5.2.  Preliminary information on the use by MS of provisions for exemptions in
the WFD is presented in section 2.1. </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>(2) Provide a more coherent baseline scenario and
clearly explain the role of other existing</span></u><span lang=EN-US
style='font-style:normal'> <u>policy instruments</u> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The section on the baseline
(2.5.1) has been expanded to explain better how other legislation including
REACH and the Biocidal Products Directive could affect the baseline, and
influences on the baseline in the substance options are summarised in the tables
in section 5.2. Other references to the relationship between the WFD and REACH
are made in sections 2.1 and 4.2.1.  The numbers of MS that have set national
standards for the candidate PS are now given in the table in section 2.2.3 (the
details can still be found in Annex VI) and comment is made on the likelihood
that other MS would follow. The information on exemptions in section 2.1
distinguishes between applications on the basis of disproportionate costs and
those on other grounds. </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>(3) Present expected costs and benefits in a more
systematic and transparent way</span></u><span lang=EN-US style='font-style:
normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The report attempts to be more
explicit about the cost estimates (separately for business and public
authorities), the uncertainties around them and the process for collecting and
validating them (sections 5.2.1, 5.2.2 and the adapted tables and text on the
individual substance options in section 5.2). The issue of disproportionate
costs, including the relevance of socio-economic assessment under other
legislation, is addressed in sections 5.2.1.2 and 5.3. The benefits of the
proposal have been brought out more clearly by stressing the contribution made
by the WFD to providing monitoring data in sections 2.5.1 and 5.2, by
summarising the risks posed by the candidate substances in section 2.2.3, and
by clarifying what is already included in the baseline (particularly in the
tables in section 5.2). </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>(4) Assess impacts on SMEs</span></u><span
lang=EN-US style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The implications of the substance
options for SMEs are indicated in section 5.2.1.2 and the sections in 5.2
analysing the individual substance options (especially the adapted tables). The
compliance strategies of MS are mentioned in section 5.3, and reference to the
likelihood of MS exempting SMEs on grounds of disproportionate costs is made in
section 5.2.1.2. </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>(5) Include a clear overview of costs and benefits of
the retained policy package</span></u><span lang=EN-US style='font-style:normal'>
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The report explains better in
section 4.2.1 how measures could be triggered by the proposal, and stresses in
sections 2.5.1 and 5.2 the value of the monitoring data delivered under the
WFD. Comparison of the options with the baseline has been made more consistent.
The benefits and costs of the preferred package of options are summarised in
section 5.8.2, and the section on distributional impacts elaborates on several
points, including the possible impact of high production and use coinciding in
particular MS. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Additional technical comments by
the Board have been addressed throughout the report. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
25.65pt;margin-left:42.35pt'><span lang=EN-US>The Board's request that the
absence of a public internet consultation be better explained has been
addressed in section 1.4.1.  The views of stakeholders have been more
extensively incorporated in the report.  The Executive Summary has been
complemented with a summary of the costs and benefits of the preferred package
of options. </span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>2.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>P</span><span lang=EN-US>ROBLEM
DEFINITION</span><span lang=EN-US style='font-size:12.0pt;line-height:107%'> </span></h1>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><b><span
lang=EN-US style='font-style:normal'>2.1.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Introduction: policy context/background </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The WFD acknowledges the
existence of considerable pressures on the aquatic environment, including that
from chemical pollution, and the need for sustainable water management.  Its 
environmental objectives include the achievement of good chemical and
ecological status for surface and groundwater bodies, and the prevention of
deterioration.  The Directive is implemented at the level of river basin
districts (RBDs).  MS were required to adopt by 2009 a River Basin Management
Plan (RBMP) based <i>inter alia </i>on a pressures and impact analysis and the
results of monitoring, and a programme of measures for each district.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>To meet good chemical status,
water bodies must meet the EQS set for the PS. The current 33 PS include a
range of industrial chemicals, pesticides and metals/metal compounds. Some PS
are identified as Priority Hazardous Substances (PHS) because of their
persistence, bioaccumulation and/or toxicity or equivalent level of concern,
criteria consistent with the criteria for Substances of Very High Concern
(SVHCs) under REACH. MS are required to monitor the PS in surface water bodies,
and to report exceedances of the EQS.  The objective of good ecological status
requires that for chemicals identified as substances of concern at
local/river-basin/national level but not as PS at EU level, standards have to
be set at national level. These chemicals are known as River Basin Specific
Pollutants (RBSPs). The WFD requires the adoption of measures to control the
discharges, emissions and losses of PS and PHS to the aquatic environment 
progressive reduction in the case of PS, cessation or phasing out in the case
of PHS. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The WFD (Article 16(4)) requires
the Commission to review the list of PS at least every four years, and the EQSD
(Article 8) requires the Commission to report the outcome of its first review
to the European Parliament in 2011.  As part of the review, the Commission has
to consider inter alia the substances in Annex III of the Directive for
possible inclusion in the list.  It is also required to identify, if
appropriate, new PS or PHS, and to set EQS for surface water, sediment or biota</span><a
href="#_ftn9" name="_ftnref9" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[9]</span></sup></sup></a><span
lang=EN-US> as appropriate, and to review the existing PS.  The proposed new
substances and changes to existing substances are expected to be taken into
account in the 2015 updated RBMPs and programmes of measures. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Member States' first RBMPs, and
their progress on complying with the EQS for the existing PS, are currently
being assessed.  However, because the end of the first RBMP cycle (i.e. in
2015) has not yet been reached, and the EQSD did not come properly into play
until mid 2010, it would be premature to conclude on the success of the MS in
meeting the chemical status objective in 2015.  However, the preliminary assessment
shows that significant percentages of water bodies are currently failing to
achieve the objective of good chemical status (e.g. 28% of surface water bodies
in BE, 29% in CZ, 16% in FR, 24% in NL).   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Indeed, the analysis of the RBMPs
done so far shows that many MS will use the provisions to apply exemptions from
meeting the 2015 chemical status objective on socio-economic grounds, either to
allow extension of the deadlines (WFD Article 4(4)) or, less frequently, to
lower the environmental objectives (WFD Article 4(5)). In the first RBMPs, at
least 15 MS are applying exemptions, and between them they are using all the
main grounds, i.e. technical unfeasibility, disproportionate costs, or natural
conditions not allowing timely improvement  in that order, i.e. technical
unfeasibility is cited more than twice as often as disproportionate costs,
which is cited in turn more than twice as frequently as natural conditions. It
can be concluded that in many MS there will be a delay in reaching the EQS for some
substances, meaning that those substances could pose a risk to or via the
aquatic environment for a longer period, although the precise risk cannot be
quantified. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Despite the current failures -
largely for substances that persist in the environment and/or undergo
long-range transport - there is evidence that the concentrations of some PS,
e.g. Mercury, have decreased in some countries, e.g. DE, since they were first
listed in 2001</span><a href="#_ftn10" name="_ftnref10" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[10]</span></sup></sup></a><span lang=EN-US>, even though the EQS
were not set until 2008.  Listing in itself appears to have contributed to
increased awareness of the need to take control measures, and, importantly, is
providing the monitoring data required to assess the effectiveness of the
measures. Timely compliance with the EQS in the EQSD is expected to increase as
technical advances are made. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>2.2.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>What is the issue or problem requiring
action? </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.2.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>General points </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>It is clear from monitoring data
that chemical pollution of water bodies remains an important issue to be
tackled at all levels.   Tens of thousands of chemicals are used daily in the
EU for multiple purposes</span><a href="#_ftn11" name="_ftnref11" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[11]</span></sup></sup></a><span lang=EN-US>. Some are active at
very low concentrations and therefore difficult to detect in water. Substances
of concern may be of synthetic or natural origin, and be produced deliberately
or unintentionally. They may be released into the aquatic environment, directly
or indirectly, during one or more phases of their lifecycle, from production
through use to disposal. They may show high direct toxicity to the aquatic
environment (microbial, plant or animal life) and/or pose a risk principally
via secondary poisoning because of their persistence and bioaccumulation, e.g.
in humans via the consumption of fish and shellfish. Their effects may be acute
and/or chronic. For example, the presence of brominated diphenyl ethers (BDEs)
(existing PS) in cord blood has been linked in epidemiological studies with
neurodevelopmental effects in infants; and neurodevelopmental effects, altered
habituation patterns, hyperactivity, learning and memory deficits have been seen
in animal studies with BDEs (Herbstman <i>et al</i> 2010; Costa <i>et al</i>
2011). </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.2.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Summary of main issues/problems </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the context of the required
review, and noting already the need to consider particularly the substances in
Annex III of the EQS Directive, the main issues to take into account are  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.2pt;text-indent:-14.35pt'><span lang=EN-US
style='line-height:103%'>(i)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>the availability of new information about risks
caused by existing PS and new chemicals,  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.2pt;text-indent:-14.35pt'><span lang=EN-US
style='line-height:103%'>(ii)<span style='font:7.0pt "Times New Roman"'> </span></span><span
lang=EN-US>the fact that some of the most harmful chemicals already on the PS
list or proposed for addition are ubiquitous persistent, bioaccumulative and
toxic (PBT) substances and, despite being already heavily regulated, will
produce widespread failures of the objective of good chemical status for many
years due to their intrinsic characteristics, especially if the EQS is set in
biota instead of water to improve detection, and  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.2pt;text-indent:-14.35pt'><span lang=EN-US
style='line-height:103%'>(iii)<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>the fact that there is a paucity of
fit-for-purpose monitoring data on which to base assessment of exposure</span><a
href="#_ftn12" name="_ftnref12" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[12]</span></sup></sup></a><span
lang=EN-US> and thus the prioritisation of new PS in future reviews.   </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.2.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>New information on risks to environment and human
health </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.5pt;margin-left:42.35pt'><span lang=EN-US>A range of new information was
reviewed, including data on ecotoxicity, environmental concentrations,
production and use, and assessments of persistence, bioaccumulation,
carcinogenicity, mutagenicity, reprotoxicity and endocrine disrupting
potential.  This information pointed to concerns regarding a number of
substances not yet identified as PS, and to a need to review the status and/or
EQS of some existing PS. It also pointed to the need to consider deriving EQS
for the identified substances in a specific matrix</span><a href="#_ftn13"
name="_ftnref13" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[13]</span></sup></sup></a><span
lang=EN-US>. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The selection of possible new PS
was conducted using the approaches outlined in WFD Article 16(2).  These
included taking account of risk assessments under other legislation (in
particular the chemicals, plant protection product (PPP) and biocides
legislation), and the assessment of intrinsic hazard and exposure according to
a simplified risk-based assessment.  As part of the latter, parallel monitoring
and modelling-based risk ranking exercises were undertaken, starting with lists
of approximately 1000 and 2000 substances, respectively. The prioritisation led
to a list of 15 possible new PS.  Some information on them is provided in the
table below.  Further information (including the EQSs derived) is provided in
Annexes II and V. Although several other substances were acknowledged to be of
concern, the risk was judged lower or the evidence for listing them at this
point was not as strong or complete. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Many of the 15 substances (e.g.
Dioxins, HBCDD, PFOS) are persistent and/or bioaccumulative as well as toxic,
and are therefore likely to remain in the environment for decades and/or affect
birds and/or mammals including humans via secondary poisoning. A number of
others (e.g. Cypermethrin, Dichlorvos) are characterised by their acute
toxicity. For some toxic substances, chronic effects may be more important than
acute effects, depending upon how the concentrations of the substance in water
vary, and upon the organisms affected.  Some of the substances show evidence of
probable or possible carcinogenicity in humans (e.g. Dioxins, Dicofol), others
are known or suspected endocrine disruptors (e.g. Heptachlor, the Estradiols). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.8pt;margin-left:42.35pt'><span lang=EN-US>National standards exist for some
of the substances in a number of MS; further details are provided in Annex II. 
The monitoring database referred to was compiled for the review.  </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:10.0pt;
line-height:107%'>Table summarising information on the 15 possible new PS: </span></b></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:12.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>Substance </span></b></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>Type/Use  </span></b></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>Concern </span></b></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>State of play in MS </span></b></p>
  </td>
 </tr>
 <tr style='height:92.45pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.85pt 0cm 5.35pt;height:92.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span style='font-size:10.0pt;line-height:
  99%'>17 alphaethinylestradiol </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>(EE2) </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:92.45pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:7.05pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Pharmaceutical;
  synthetic steroid hormone used mainly in oral contraceptives.  No production
  data available. Approx 32 million women in EU use EE2-based contraception. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:92.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Endocrine disruptive; prolonged exposure to low
  concentrations of EE2 has been shown to cause sex changes, alterations in
  reproductive capacity, and ultimately population collapse in fish (Kidd et
  al, 2007)   </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:92.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring database contains data from 3 countries, 2
  showing exceedance of EQS, 1 likely exceedance; literature predicts
  exceedances more widely. </span></p>
  </td>
 </tr>
 <tr style='height:69.55pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.85pt 0cm 5.35pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.4pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>17 betaestradiol (E2)<sup> </sup></span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Steroid hormone: excreted  naturally (approx 90%) in human
  and livestock urine but also (&lt;10%) as a result of pharmaceutical use (of
  which 90% from HRT). </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:69.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.45pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Endocrine disruptive;
  chronic studies show effects on sexual development and fecundity in fish. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.85pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring database (2 countries) and literature show
  exceedance of EQS. </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Aclonifen </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Herbicide, used on a range </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic to a range of aquatic </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.85pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>National standard </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:81.0pt'>
  <td width=102 style='width:76.7pt;border:solid black 1.0pt;padding:2.4pt 3.15pt 0cm 5.35pt;
  height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border:solid black 1.0pt;
  border-left:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>of arable crops. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Use &gt; 1000 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border:solid black 1.0pt;
  border-left:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>organisms. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border:solid black 1.0pt;
  border-left:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:11.4pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>exists in SE. 3 countries in monitoring database, FR data
  predominant and showing exceedance. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Authorised in 18 MS. </span></p>
  </td>
 </tr>
 <tr style='height:69.5pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Bifenox </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:.05pt;text-align:left;text-indent:-.05pt;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Herbicide,
  used to kill broadleaf weeds in cereal crops and grassland. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Use &gt; 200 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic to a range of aquatic organisms. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>3
  countries in monitoring database; FR data predominant and showing exceedance.
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Authorised in 19 MS. </span></p>
  </td>
 </tr>
 <tr style='height:81.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Cybutryne </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>(Irgarol®) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Biocide
  used as antifouling agent in coatings for boat hulls etc. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Use approx 10 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic; degrades only slowly and main degradation product
  (M1) also toxic; persists in sediments. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.3pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>National standard exists in SE. 4 countries in monitoring
  database; exceedance or near exceedance of EQS in </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>3. </span></p>
  </td>
 </tr>
 <tr style='height:126.95pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:126.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Cypermethrin </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:126.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Insecticidal pyrethroid plant protection product (PPP)  and
  biocide, used in arable farming, salmon farming, sheep dipping and wood
  preservation.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Use up to 100 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:126.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic to a range of aquatic organisms. Benthic
  invertebrates vulnerable because cypermethrin binds to sediment</span><a
  href="#_ftn14" name="_ftnref14" title=""><sup><span style='font-size:10.0pt;
  line-height:107%'><sup><span style='font-size:10.0pt;line-height:103%;
  font-family:"Times New Roman",serif;color:black'>[14]</span></sup></span></sup></a><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>. Use in the marine
  environment is authorised in a few countries of the world but prohibited in
  Canada</span><a href="#_ftn15" name="_ftnref15" title=""><sup><span
  style='font-size:10.0pt;line-height:107%'><sup><span style='font-size:10.0pt;
  line-height:103%;font-family:"Times New Roman",serif;color:black'>[15]</span></sup></span></sup></a><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'> where suspicion exists
  regarding a possible link with the death of lobsters </span><a href="#_ftn16"
  name="_ftnref16" title=""><sup><span style='font-size:10.0pt;line-height:
  107%'><sup><span style='font-size:10.0pt;line-height:103%;font-family:"Times New Roman",serif;
  color:black'>[16]</span></sup></span></sup></a><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>, the sensitivity of which has been
  assessed (e.g. Burridge et al 2000). </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:126.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>National
  standards exist in 2 MS (DK, UK). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.3pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>3 of 5 countries in monitoring database show exceedance of
  EQS; analytical method may have missed others. </span></p>
  </td>
 </tr>
 <tr style='height:127.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dichlorvos </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Organophosphorus insecticide and biocide, used in grain/nut
  stores, insecticidal sprays/strips. Use  a few kg to a few tonnes/yr in different
  MS; probably closer to lower figure since 2008 when decision on
  nonauthorisation as PPP took effect.  </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic particularly to aquatic invertebrates and fish;
  possibly carcinogenic to humans. </span><span style='font-size:10.0pt;
  line-height:107%'>(No longer authorised as PPP.) </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>National standards exist in 4 MS (BE, DE, IT, NL); IE simply
  monitors. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring database shows exceedance of EQS in 7 of 9 MS;
  analytical method may have missed others. </span></p>
  </td>
 </tr>
 <tr style='height:57.95pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:57.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Diclofenac<sup> </sup></span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:57.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>Pharmaceutical,
  used as NSAID. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Average consumption 0.46 g/person/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:57.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic, directly (e.g. chronic studies show effects on gills
  and kidneys in fish), and via secondary poisoning, e.g. vultures in India
  affected by veterinary use in cattle. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:57.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring and predictions show exceedances of the EQS in
  water in 7 MS </span></p>
  </td>
 </tr>
 <tr style='height:58.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dicofol </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Organochlorine PPP, until recently authorised for use on
  fruit and vegetable crops. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Possibly residual use. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Toxic; similar to DDT, recommended for designation as POP
  (Stockholm Convention); possibly carcinogenic to humans, possibly endocrine
  disruptive. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring database shows failure of EQS in ES and FR,
  likely elsewhere. </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dioxins (and </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Dioxins: by-products of </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PBTs, POPs (Stockholm Convention </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>National standards </span></p>
  </td>
 </tr>
 <tr style='height:104.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>dioxin-like PCBs)</span> <span style='font-size:
  10.0pt;line-height:107%'> </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.3pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>thermal combustion PCBs: chlorinated organic compounds
  formerly used to manufacture electrical equipment etc.; some also produced by
  combustion. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>and CLRTAP). Some congeners
  probably carcinogenic to humans; other possible effects include endocrine
  disruption, impairment of immune system, nervous system, reproduction. 
  Limits already set for presence in feed and food.  Baltic salmon not for
  export because dioxin limits exceeded. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>exist
  in 3 MS (DK, IT, SE). IE simply monitors. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Several MS report likely exceedance
  of EQS. </span></p>
  </td>
 </tr>
 <tr style='height:81.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>HBCDD </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.9pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:.05pt;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Industrial chemical, used as flame retardant, especially in
  polystyrene, including insulation boards. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Use up to 10000 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>PBT, SVHC under REACH, recommended
  POP. Possibly toxic to reproduction in humans. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.95pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>National
  standards exist in 2 MS (DK, SE). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.05pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Monitoring data mainly from literature show exceedances of
  EQS. </span></p>
  </td>
 </tr>
 <tr style='height:150.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:150.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Heptachlor/ Heptachlor epoxide </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:150.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Organochlorine insecticide, no
  longer authorised but secondary emissions possible. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:150.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>POP; very toxic to aquatic
  organisms; possibly/probably carcinogenic to humans, possibly endocrine
  disruptive.. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:150.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.95pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>National standards exist in 6 MS (AT, BE, IT, RO, NL, DE);
  CY and IE simply monitor. Monitoring database shows exceedance of biota EQS
  in at least 3 out of 6 MS and of corresponding water </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>EQS in at least 6 out of 12 MS;
  analytical method may have missed others </span></p>
  </td>
 </tr>
 <tr style='height:104.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PFOS </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>Industrial
  chemical, used in hydraulic aviation fluids, </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>photography, electroplating.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Use  100s of tonnes in 2000, less
  since 2008 but present in many existing products, especially textiles. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>PBT, POP. Toxic to animals
  especially mammals. Possible carcinogen in humans; possible effects on
  thyroid function.. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.95pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>National
  standards exist in 3 MS (CZ, DK, SE). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.95pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>4 countries in monitoring database, all showing exceedance
  of EQS </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Quinoxyfen </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Fungicide, used mainly on cereals,
  grape vines. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Use approx 70 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>PBT and vPvB properties.
  Accumulates particularly in sediments. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Monitoring
  data from 2 MS; some exceedances of EQS in FR. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Authorised in 17 MS. </span></p>
  </td>
 </tr>
 <tr style='height:81.0pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Terbutryn </span></p>
  </td>
  <td width=162 valign=top style='width:121.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Biocide,
  used especially in coatings for buildings, as preservative. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Use approx 200 tonnes/yr. </span></p>
  </td>
  <td width=214 valign=top style='width:160.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Toxic especially to algae and
  aquatic plants.. </span></p>
  </td>
  <td width=141 valign=top style='width:105.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.4pt 3.15pt 0cm 5.35pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.95pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>National
  standards exist in 2 MS (BG, CZ). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>5
  countries out of 9 in monitoring database </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>show exceedance of </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>EQS </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'><span lang=EN-US>The reasons for
reviewing the EQS and/or status for some existing PS (Anthracene, PolyBDEs,
DEHP, Lead, Naphthalene, Nickel, PAHs, Fluoranthene and Trifluralin) are
explained in Annex II.  In most cases, a (revised) EU Risk Assessment Report
(RAR) had become available since the existing EQS was established. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.2.4.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
                  </span><span lang=EN-US>Specific difficulties with ubiquitous
persistent, bioaccumulative and toxic (PBT) </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>chemicals </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.4.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Introduction </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>By definition, PBTs persist in
the environment, bioaccumulate in the trophic chain and are toxic. They are
classified in the WFD as Priority Hazardous Substances (PHS). Some are
Persistent Organic Pollutants (POPs) capable of causing long-range
transboundary pollution. They are largely ubiquitous and are found even in
remote areas, far away from any human activity (e.g. BDEs in remote alpine
lakes in Austria; brominated flame retardants, organohalogens and perfluorinated
compounds in the Arctic  see AMAP 2009). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The measures already taken
regarding several existing PBTs have reduced emissions significantly.  In
addition, the REACH Regulation is now providing a mechanism to identify PBTs as
substances of very high concern (SVHC) and, where they are included in Annex
XIV, they become subject to authorisation, which ensures their progressive
substitution on the market with less hazardous substances, where this is
economically and technically feasible. However, their existing concentrations,
particularly in sediment and/or biota, could still pose a risk to the aquatic
environment and/or to human health via the aquatic environment, and natural
recovery will generally take decades. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Because of their properties,
regulation of these substances under the WFD poses particular problems. Three
issues or sub-problems need to be considered, as follows. Full explanation is
provided in Annex III. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.4.2.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Presentational
issues related to large proportion of EQS failures </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Surface waters are assessed in
the WFD for their overall chemical status against all the EQS for PS, including
the ubiquitous PBTs.  Maps have to be produced for the RBMPs showing the
chemical status of each RBD. A bad situation for some chemicals can therefore
hide positive situations for other substances. The maps may then be dominated
by failures about which little more, if anything, can be done from the water
management perspective.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>It is obviously important that
the extent of the PBT problem be clarified and acknowledged, not hidden.
However, the influence of these substances on the assessment made under the WFD
seems disproportionate in relation to the possibilities for the policy to
deliver reductions in their environmental concentrations within the WFD timeframe. 
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.4.3.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Choice of
monitoring matrix for compliance checking </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The EQSD includes the flexibility
for MS to choose the matrix to monitor the PS. For most PS, EQS for water are
given in Annex I of the EQSD, but MS can choose to develop and use sediment
and/or biota standards that offer at least the same level of protection as
those provided for water. For three substances (Mercury, Hexachlorobenzene and
Hexachlorobutadiene), EQS for biota are given in the EQSD</span><a
href="#_ftn17" name="_ftnref17" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[17]</span></sup></sup></a><span
lang=EN-US> that MS have to use unless they develop and apply a water standard
that offers the same level of protection as the biota standard. Most of the
ubiquitous PBTs (and some other substances) are very hydrophobic. It is
therefore difficult to monitor them in water. The analytical techniques
available are rarely sensitive enough to reliably detect concentrations of the
order of the EQS, as the EQS is itself very close to (or below) the limit of
determination. This means that where the results of an analysis are below the
limit of determination, the concentration in the sample may still be higher
than the EQS. Commission Directive 2009/90/EC requires MS to use analytical
techniques that meet certain minimum quality requirements in relation to the
EQS, but it also establishes that if the analytical techniques don't meet those
minimum criteria, the best available techniques not entailing excessive costs
should be used. Because of this clause, some MS are applying water standards
for certain substances even though they are not able to monitor at the level of
that EQS. This allows them to conclude that &quot;there is no problem&quot;,
even though the application of a sediment or biota standard (set at more
measurable concentrations) might reveal extensive failure. Although legally
possible within the current legislative set-up, it is clearly unacceptable that
water bodies are categorised as having &quot;good chemical status&quot; while
they contain elevated values in sediment and/or biota that pose a risk to or
via the aquatic environment, and unacceptable that the use of different methods
by different MS leads to different reporting of similar situations. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The tendency for MS to monitor in
water is clear from the data gathered for the prioritisation database; only 11
MS provided data for biota, only 12 for sediment, but all 27 for water. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Knowledge and methodologies to
develop EQS for sediment and biota have evolved significantly, and it is now
possible to derive standards for these matrices (SCHER, 2010). However, this
expertise is not available in all MS. Although this issue of the choice of
matrix applies most obviously to substances identified as ubiquitous PBTs, it
may apply to others as well. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.4.4.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Reduced
monitoring effort for ubiquitous PBTs </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>An additional issue that has been
raised by MS in relation to these substances is the monitoring requirements.
The WFD (Annex V) and EQSD set minimum monitoring requirements which are
adapted to the RBMP cycle. For ubiquitous PBTs, any change in environmental
concentrations that might occur as a result of measures is likely to occur over
the long term (unless remediation is carried out) and therefore a lower
monitoring frequency would seem justified and possibly also a reduction in the
number of monitoring sites.  If MS choose to use a sediment or biota standard,
the default monitoring frequency is already lower.  The issue is how, for
ubiquitous PBTs, the monitoring frequency can be optimised to minimise the
administrative burden while still yielding sufficient information. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.2.5.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>Knowledge base  </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.5.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Introduction </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:5.4pt;margin-left:42.3pt;text-align:left;line-height:100%'><span
lang=EN-US>The process of identifying PS and setting EQS for them relies on the
availability of a range of information.  Data are needed on </span><span
lang=EN-US style='font-family:"Courier New"'>o</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Intrinsic
properties of the substances and their (eco)toxicological effects </span><span
lang=EN-US style='font-family:"Courier New"'>o</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Exposure, i.e.
environmental concentrations, preferably measured but otherwise reliably
modelled on the basis of production volumes, use patterns and/or emissions. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although a vast amount of
monitoring data was gathered for the current review of the PS list,
constituting a very significant improvement in relation to the last
prioritisation exercise, and although other sources of information including
modelling were used in the prioritisation process (as recommended by the
Scientific Committee on Toxicity, Ecotoxicity and the Environment</span><a
href="#_ftn18" name="_ftnref18" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[18]</span></sup></sup></a><span
lang=EN-US> following the previous exercise) to avoid missing substances not
already monitored, the process was to some extent still hampered by the
relative paucity of monitoring data for some substances, including the
unevenness of data collection across the EU. This prevented the proper
assessment of the risk posed by some substances that otherwise might have been
considered for prioritisation. There is a vicious circle: unless a substance is
already regulated, it is unlikely to be widely monitored  but if it is not
monitored and the environmental concentrations cannot be reliably modelled
either, estimation of the risk posed to and via the aquatic environment at EU
level may not be robust enough to justify regulation.  Since the listing of a
substance implies an obligation to monitor (i.e. an administrative cost) and to
take measures, it is not efficient to list substances that dont pose a risk;
at the same time, uncertainty could lead to some substances not being
identified as PS that should be. The situation is particularly difficult for
emerging pollutants (see Annex III). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Another issue of concern for some
substances is the quality of the monitoring data that are available.  As
indicated in section 2.2.4.3 on the issue of the monitoring matrix, certain
substances occur at very low concentrations below the determination limit of
the available analytical methods, but potentially still above the no-effect
level.  Despite monitoring, uncertainty may therefore remain regarding whether
the concentrations in the environment are likely to be harmful.  The monitoring
data for a number of PPPs (which are active at very low concentrations because
of their high toxicity) are often inadequate in this respect, since the
determination limit is higher than the no-effect level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although research is an obvious
source of information on new risks, the information is usually scattered and
does not provide an EU picture; it is therefore not always sufficient for
prioritisation.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>2.2.5.2.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Specific
problems to address </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.4pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US>The main issues
that need to be addressed are therefore the </span><span lang=EN-US
style='font-family:"Courier New"'>o</span><span lang=EN-US style='font-family:
"Arial",sans-serif'> </span><span lang=EN-US>lack of a clear mechanism for
collecting information at EU level, i.e. although Article 3 of Decision
2455/2001/EC specifies that &quot;MS shall ensure that the substance and
exposure-related data needed for the implementation of the COMMPS procedure are
made available&quot;, some MS provide a lot of data and some very little; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>lack of EU representativeness of monitoring
data, e.g.. 80% of the database compiled for the present review comes from two
MS; data for many substances (more than 800 out of the 1150) come from 3
countries or fewer; only for 30 substances do data come from more than 18
countries; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>need for more consistent implementation by MS of
WFD pressures and impacts analysis  which should act as a common driver for
the monitoring of substances posing a risk; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>bias towards monitoring pollutants that are
already regulated, meaning that for certain substances, in particular the
emerging pollutants, monitoring data are sparse, even though evidence exists
that among them there are a number that may pose a risk; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>quality of the monitoring data, i.e. the need
for analytical techniques to be used that are sufficiently sensitive to
determine concentrations at the no-effect level, so that the monitoring data
are &quot;fit for (the) purpose&quot; of prioritisation. </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:5.05pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'><span lang=EN-US> </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>2.3.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>What are the underlying drivers of the
problem? </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>For the possible new PS
identified in the current review, the fact that there is a need to regulate
them under the WFD probably results in part from imperfection in the models and
assumptions used in the implementation of the upstream legislation controlling
their authorisation and use.  The WFD acts in that respect as a &quot;safety
net&quot;. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the specific case of
pharmaceuticals, one significant source of emissions is the disposal of unused
pharmaceuticals. Although EU legislation obliges MS to establish take-back
schemes, it does not impose reporting obligations or efficiency targets. There
are therefore no comprehensive data on the functioning of the schemes, despite
a recent survey by the European Federation of Pharmaceutical Industries and
Associations (EFPIA). What is clear, though, is that a significant quantity of
unused drugs are discarded into the sink or toilet and therefore end up in
surface waters;  10 to 43% of interviewees in different MS discard medicines in
this way (Knappe, 2008). The amount of pharmaceuticals collected in various
European countries varies significantly, generally in the range of 10 to 100
tonnes per million inhabitants per annum. The rate is very high in Switzerland
followed by Ireland, Luxembourg, Sweden and France (EEA 2010).   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Improper disposal could be a
significant source of pollution by Diclofenac given its high usage and
potentially high quantities of unused doses (due to end of treatment,
medication change, non-compliance with prescription, or expiry). One 10-tablet
blister of a typical 50 mg dose can pollute up to 5 million litres of water
with concentrations above the EQS, i.e. a volume equivalent to the waste water
generated daily by a town of 20 000 inhabitants.  Improper disposal of unused
EE2 could also be a significant source of pollution, considering that a single
blister of pills for one menstrual cycle with the most common dose of 30 </span><span
style='font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span lang=EN-US>g
has the potential to pollute to concentrations above the EQS 24 million litres
of water, equivalent to the waste water generated daily by a city of 100 000
inhabitants.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>For the existing PS, the need for
reassessment arises because knowledge at the time they were listed did not
support sufficiently stringent EQS, nor proper status (as PHS).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>More generally, chemical
pollution of the environment, including of the aquatic environment, is almost
certainly aggravated by the fact that users of the chemicals do not bear the
cost of pollution, i.e. there is a market failure.  Related to this is the fact
that conventional urban waste water treatment is not capable of adequately removing
all the pollutants, and installing tertiary treatment on a widespread basis
would be expensive. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In relation to the problems
described for ubiquitous PBTs, it is clear that historic pollution accounts for
much of the contamination that exists and therefore for the difficulties faced
by MS in achieving good chemical status. The relatively uniform (with respect
to type of PS) requirements of the WFD and EQSD appear to aggravate those
difficulties. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The difference in choice of EQS
(and monitoring) matrix made by MS that results in very different assessments
for the same substance (especially ubiquitous PBTs) arises in part because the
EQSD and the Commission Directive 2009/90/EC on technical specifications for
chemical analysis do not provide enough guidance to limit the choice.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Finally, the paucity of
high-quality and fit-for-purpose monitoring data to support the prioritisation
exercise appears to result principally from the absence of a clear, targeted
mechanism to gather such data. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>2.4.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Who is affected by the problems
identified, in what ways and to what extent? </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As acknowledged in the WFD, water
is not a commercial product like any other but, rather, a heritage which must
be protected. At the same time, it is indeed a key economic resource.</span><span
lang=EN-US style='color:blue'> </span><span lang=EN-US>The increasing economic
development of Europe has not only increased the dependence on water resources
but also in many areas created more intensive pressures on them, in particular
on their quality.</span><span lang=EN-US style='color:blue'> </span><span
lang=EN-US>Many surface waters are used as sources of drinking water (60% of
the water abstracted in the EU for the production of drinking water comes from
surface water) and of water for a range of domestic, industrial, agricultural
and aquacultural purposes.  They also serve as receptors for waste including
industrial and domestic sewage effluents, and many receive a range of pollution
from diffuse sources such as run-off from urban and agricultural areas,
leachate from landfills and mine workings, and atmospheric deposition.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.75pt;margin-left:42.35pt'><span lang=EN-US>Where the objective of good
chemical status is not met, the concentrations of at least some PS in the
relevant water bodies are likely to be above no-effect levels and therefore a
risk to the aquatic environment and/or to human health through the aquatic
environment, for example via the consumption of drinking water, fish or
shellfish. Achieving good status is likely to become increasingly challenging
in the context of climate change, which is likely to result in more frequent
incidences of low river flows and depleted lakes and reservoirs (EC, 2009) therefore
leading to a higher concentration of pollutants. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Surface waters <i>in situ</i>
that support a healthy aquatic ecology are key for biodiversity. Around 70% of
the protected habitats and species in EU legislation are water related.
Chemical pollution can reduce the richness of the aquatic ecosystem and,
consequently, its functionality, hence decreasing its resilience, its capacity
to handle pollution (Cardinale 2011).  At the same time, the amenity value of
water bodies as features of the landscape that support recreational activities
such as angling, swimming and boating is reduced. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The potential effects of the 15
possible new PS are outlined in section 2.2.3 (see also Annexes II and V for
details). Because those effects, and likewise the effects of the existing PS,
are relevant to society as a whole, they are obviously also directly or
indirectly relevant to industry.  The industry sectors that produce or use the
possible new PS are indicated in the &quot;Type/Use&quot; column of the table
in section 2.2.3. In addition to them, the water and sewerage treatment
industry is inevitably concerned by the presence of chemical substances (in
general) in water bodies. In the context of implementing the EQSD, it is the
Member State Competent Authorities on whom the obligation to meet the EQS for
PS falls. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>2.5.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>How would the problem evolve, all things
being equal? </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The three main problems
identified would be expected, if no proposal were made, to evolve as described
below.  </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.5.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>New information on risks to environment and human
health </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>For the substances identified in
this review (existing and new PS), the baseline situation, in terms of
production, use and emissions, is in most cases subject to significant
uncertainty for several reasons. The most important is that several pieces of
legislation are already in place that will or may have an impact on the use and
emissions of some of the substances in the coming years, and therefore on their
concentrations in the aquatic environment.  The most important of these are the
WFD Programmes of Measures, the PPP legislation including the Directive on the
sustainable use of pesticides, .the REACH Regulation, industrial emissions
policy, and the legislation on biocides, pharmaceuticals, waste and POPs. Some
information on which substances are subject to the legislation, and on the
implications, is provided here; further details are in the tables in section
5.2 and in Annexes V and VI.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Decisions under the other
legislation are likely to lead to decreased emissions to water or no change. In
some cases, decisions are awaited on status (e.g. as a POP) or on continued
authorisation (e.g. as a biocide), and they might go either way. For example, a
decision not to exclude a particular biocide from Annex I to the Biocidal
Products Directive in the current review would mean no change.  Further, even
where a decision is made to restrict use, the measure might have greater or
lesser effect depending upon its scope. In the example of the biocides, exclusion
might not apply to all of the currently authorised product types. Even though
recommendations exist regarding the non-authorisation or POP designation of
some substances, the final decisions cannot be considered foregone conclusions.
</span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:35.05pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:35.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Legislation in </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>baseline </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'> </span></b></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.3pt 0cm 5.4pt;height:35.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Developments/general implications </span></b></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.3pt 0cm 5.4pt;height:35.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Relevant substances/specific implications </span></b></p>
  </td>
 </tr>
 <tr style='height:115.5pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.3pt 0cm 5.4pt;height:115.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>WFD </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Programmes of </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Measures in MS </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:115.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>MS currently defining measures for
  existing PS and RBSP on basis of 2009 RBMPs and Programmes of Measures.  Due
  to be operational by end 2012; reporting of impacts in 2015. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:115.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>All existing and proposed PS 
  uncertainty regarding the implementation of MS measures for existing PS and
  relevant RBSPs, and the possibility that the measures might affect more than
  the targeted substances, including (other) possible new PS. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Of 15 proposed PS, 10 are RBSP,
  therefore already subject to measures (see Annex VI), but in 8 cases in only
  1 to 3 MS. </span></p>
  </td>
 </tr>
 <tr style='height:184.45pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.3pt 0cm 5.4pt;height:184.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Plant Protection Products (PPP)
  legislation, especially the Sustainable Use of Pesticides Directive but </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Regulation (EC) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>No 2009/1107 </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:184.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.45pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>National
  Action Plans due by end 2012; measures - to be introduced 2013-2015  not yet
  defined. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Authorisation of individual active
  substances subject to periodic review; new information could change
  authorisation, and the Regulation also contains new criteria regarding
  PBT/vPvB substances. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:184.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Aclonifen,
  Bifenox, Cypermethrin, Quinoxyfen, - uncertainty regarding measures from NAPs
  and/or outcome of authorisation review. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Increasing likelihood of MS
  specifying buffer strips as well as other measures under Sustainable Use
  Directive; could decrease concentrations in water bodies. Aclonifen - EUlevel
  requirement since 2008 for buffer strips. Quinoxyfen  authorisation under
  Directive 91/414/EEC due to be reviewed in 2014 under the Regulation;
  conditions or withdrawal possible. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>(PPP legislation also relevant to
  Dichlorvos, Dicofol, Terbutryn, Trifluralin  but these are no longer
  authorised as PPPs.) </span></p>
  </td>
 </tr>
 <tr style='height:69.55pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.3pt 0cm 5.4pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Biocidal Products </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>98/8/EC </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Review programme ongoing covering 23 different types of
  biocides  could lead to change or withdrawal of authorisations. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Tigher restrictions on industrial
  use of creosote due to take effect May 2013. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:69.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Cybutryne  (1 product type),
  Cypermethrin (3 product types, Dichlorvos (1 product type), Terbutryn (3
  product types)  uncertainty regarding outcome of review. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Creosote restrictions relevant to
  Anthracene, Fluoranthene, Naphthalene, PAHs. </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.3pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>REACH </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Regulation </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Registration process ongoing; may
  bring new information and potential action, </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.3pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Existing PS: Anthracene, DEHP,
  Fluoranthene, Lead, Naphthalene, Nickel, PAHs; </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US>&nbsp;</span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:287.95pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:287.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border:solid black 1.0pt;
  border-left:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:287.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>even
  in the near future, on existing/proposed PS. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>In addition, substances may be
  added to </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.25pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>SVHC candidate list and then Annex XIV (the authorisation
  list) with a sunset date but possible exemptions for specified uses. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>REACH cannot affect emissions from
  existing products. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border:solid black 1.0pt;
  border-left:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:287.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Proposed PS: HBCDD, PFOS </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>  uncertainty regarding
  extent/impact of possible regulation for reasons given below. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Registration dossiers for the
  existing PS still to be assessed. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:100%'><span lang=EN-US style='font-size:10.0pt;
  line-height:100%'>DEHP and HBCDD  in Annex XIV, sunset date 2015; not yet
  known which uses will be authorised.  (Leaching from existing products
  containing these substances not directly affected, e.g. of DEHP from existing
  textiles, furniture and PVC construction materials such as flooring, roofing,
  piping; of HBCDD from insulation materials <i>in situ</i> and on disposal;
  but extent could change depending upon how long new use continues.) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>PFOS  in Annex XVII; not certain
  how quickly technical advances will allow substitution of </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>PFOS for the derogated uses </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>Anthracene
  (and related oils, pastes) and coal tar pitch high temperature (relevant to
  Anthracene, </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Fluoranthene, Naphthalene, PAHs)
  are on the SVHC candidate list. Not certain what the outcome of their further
  review will be. </span></p>
  </td>
 </tr>
 <tr style='height:219.0pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:219.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>POPs legislation: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Stockholm </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>Convention</span><a
  href="#_ftn19" name="_ftnref19" title=""><sup><span style='font-size:10.0pt;
  line-height:107%'><sup><span style='font-size:10.0pt;line-height:103%;
  font-family:"Times New Roman",serif;color:black'>[19]</span></sup></span></sup></a><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>, </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>POPs Protocol to </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>UNECE </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>CLRTAP</span><a
  href="#_ftn20" name="_ftnref20" title=""><sup><span style='font-size:10.0pt;
  line-height:107%'><sup><span style='font-size:10.0pt;line-height:103%;
  font-family:"Times New Roman",serif;color:black'>[20]</span></sup></span></sup></a><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>, and </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Regulation (EC) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>No 850/2004<a href="#_ftn21" name="_ftnref21"
  title=""><sup><sup><span style='font-size:10.0pt;line-height:103%;font-family:
  "Times New Roman",serif;color:black'>[21]</span></sup></sup></a> </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:219.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Under Stockholm Convention, for
  existing and new POPs, measures must be taken to either eliminate production
  and use (some exemptions possible) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>(Annex A), restrict production and
  use (Annex B), or reduce unintentional releases with the goal of eliminating
  them altogether (Annex C). </span><span style='font-size:10.0pt;line-height:
  107%'>Measures and/or exemptions could change. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:219.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Existing POPs - uncertainty
  regarding implementation/effectiveness of measures especially where complete
  phase-out of use not yet possible: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.5pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Existing PS: some polyBDEs (tetraBDE, pentaBDE, hexaBDE,
  heptaBDE) (Annex A); </span></p>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:5.1pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Proposed PS: Heptachlor, PCBs (Annex A), </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.9pt;
  margin-bottom:0cm;margin-left:8.5pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>PFOS (Annex B), Dioxins (Annex C) Measures for the BDEs and
  PFOS were agreed in 2010 and should significantly reduce emissions to the
  aquatic environment, but timeline for substitution of PFOS uncertain </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Possible POPs  uncertainty
  regarding listing: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.5pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:10.0pt;
  line-height:99%'>Trifluralin (existing PS), Dicofol and HBCDD (proposed PS)  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>EC Regulation addresses some other
  substances, i.e. PAHs are subject to release reduction provisions (relevant
  also to anthracene, fluoranthene, naphthaleme.) </span></p>
  </td>
 </tr>
 <tr style='height:127.0pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Industrial
  emissions Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>2010/75/EC </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>(IED)  recast of </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Integrated </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Pollution </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Prevention and </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Control (IPPC) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Directive </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>IED regulates industrial emissions
  to water and other environmental media including by integrated permitting for
  a wide range of industrial sectors, with emission controls based on Best
  Available Techniques (BAT). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Implementation of IED as of 2011
  likely to strengthen BAT and could therefore affect baseline for industrial
  chemicals discharged by industries  </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:127.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>Potentially
  all substances but particularly industrial chemicals discharged by
  industries, i.e.: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Existing PS: Anthracene, DEHP,
  Fluoranthene, Naphthalene, Nickel, Lead, PAHs. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Proposed PS: Dioxins and DL-PCBs,
  HBCDD, </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>PFOS </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>- uncertainty regarding changes to
  BAT implementation given that transposition date of IED likely not to be
  uniform, renewal of permits likely to follow different timetables, and new </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=111 style='width:83.4pt;border:solid black 1.0pt;border-top:none;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=232 valign=bottom style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>approach to BAT not effective until
  2014.. </span></p>
  </td>
 </tr>
 <tr style='height:81.0pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Waste legislation  several acts
  and decisions </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Latest Commission implementation
  report on EU waste legislation recognises progress but also important gaps.
  Further progress likely  could affect emissions to water from waste handling
  and/or disposal. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:81.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><span lang=EN-US style='font-size:10.0pt;line-height:98%'>Several
  substances could be affected.  uncertainty regarding specific measures. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>As an example, most recently, the
  Commission has announced that it  intends to propose limits on the amount of
  the two POPs (polyBDEs and PFOS) in waste</span><a href="#_ftn22"
  name="_ftnref22" title=""><sup><span style='font-size:10.0pt;line-height:
  107%'><sup><span style='font-size:10.0pt;line-height:103%;font-family:"Times New Roman",serif;
  color:black'>[22]</span></sup></span></sup></a><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>. </span></p>
  </td>
 </tr>
 <tr style='height:69.5pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Pharmaceutical legislation </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Commission study to be launched
  2011 building on existing information on the impact of pharmaceuticals on the
  aquatic environment. The impact of this Commission initiative is uncertain
  but could be significant in the long term. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.45pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Diclofenac, E2, EE2.  uncertainty regarding MS action on
  take-back schemes and outcome of Commission study. </span></p>
  </td>
 </tr>
 <tr style='height:58.0pt'>
  <td width=111 valign=top style='width:83.4pt;border:solid black 1.0pt;
  border-top:none;padding:2.45pt 2.9pt 0cm 5.4pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Other legislation </span></p>
  </td>
  <td width=232 valign=top style='width:174.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Rotterdam Convention: a substance
  listed in Annex III becomes subject to the Prior Informed Consent (PIC)
  procedure</span><a href="#_ftn23" name="_ftnref23" title=""><sup><span
  style='font-size:10.0pt;line-height:107%'><sup><span style='font-size:10.0pt;
  line-height:103%;font-family:"Times New Roman",serif;color:black'>[23]</span></sup></span></sup></a><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>. </span></p>
  </td>
  <td width=276 valign=top style='width:206.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.45pt 2.9pt 0cm 5.4pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:10.0pt;line-height:99%'>A
  recommendation to include PFOS, pentaBDE and octaBDE in Annex III will be
  considered in 2013  uncertainty regarding outcome. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>(PCBs, heptachlor and some other
  existing PS are already listed.) </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>With regard to the Programmes of
Measures and the RBSPs covered under ecological status, it is clear that
although 10 of the 15 proposed PS are designated as RBSPs, this only applies in
a few MS. This suggests that only a few MS would act on those substances in the
absence of a proposal to list them as PS</span><a href="#_ftn24"
name="_ftnref24" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[24]</span></sup></sup></a><span
lang=EN-US>, although it is not possible to predict which substances the MS
will identify as RBSPs in their updated RBMPs in 2015.  Less action could mean
more frequent exceedance of no-effect levels. In the few MS where proposed PS
have already been designated as RBSPs, a reduction in the risk to and/or via
the aquatic environment would be expected, depending upon the extent to which
measures are taken to reduce concentrations below their current levels and on
the level of the quality standard set by the MS.  As has been found for other
RBSPs, considerable variation between MS is observed, both in terms of the
magnitude of the standard and the chosen matrix (see Table in Annex VI),
meaning that without the harmonised EQS derived for each substance as a PS,
different baselines would likely be seen in the different MS. Some of the
standards are significantly less stringent than being proposed here. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the absence of a proposal to
list the possible new PS in the EQSD, the baseline scenario would include
almost no monitoring of those substances in the aquatic environment.  Most
would only be monitored in the few MS where they are listed as RBSPs.  Under
the Stockholm Convention there are some non-binding recommendations for the
monitoring of POPs; and Regulation (EC) No 850/2004 Article 9 requires
&quot;appropriate programmes and mechanisms&quot; to be established for the
regular provision of comparable monitoring data on the presence of Dioxins and
PCBs in the environment, though no specifications are given. The limited extent
of baseline monitoring of the proposed PS would make it difficult to judge the
effectiveness of the measures being taken under the Programmes of Measures or
other (nonWFD) EU legislation, and thus to adjust them if necessary, and
difficult to determine where remediation might be necessary. In addition, if
the proposed PS were not listed as such, decisions taken under the other
relevant legislation might take less note of the risk to the aquatic
environment and thus not lead to such effective measures. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>If no proposal were made to
change the EQS of the existing PS where new information indicates that they
should be more stringent, these substances could pose an unrecognised ongoing
risk. In the case of Nickel, it was recognised at the time the original EQS was
set that it was probably not protective enough and would have to be revised. If
the status of DEHP were not changed, too little attention might be paid to
emissions of this reprotoxic substance into the aquatic environment from
existing uses; the change is appropriate for an existing PS (by definition
posing a risk to or via the aquatic environment) recently included in Annex XIV
of REACH. If the status of Trifluralin were not changed, there would be no
effect on primary emissions since Trifluralin has not been approved for use as
a plant protection product (PPP) in the EU since 2007, but the EU position in
the POPs negotiations could be compromised, and there would be no strong driver
to carry out sediment remediation. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.5.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
      </span><span lang=EN-US>Specific difficulties with ubiquitous persistent,
bioaccumulative and toxic chemicals </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This issue relates to the
functioning of the EQSD and is therefore not affected directly by other
legislation other than the Directive 2009/90/EC on technical specifications for
chemical analysis. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>If there were no change,
widespread pollution by some of the existing ubiquitous PBTs could hide
improvements achieved for other substances in the second RBMP. In addition, if
some of the policy options related to substances were realised in the
legislation (introducing stricter EQS for some existing ubiquitous PBTs and
adding some new ubiquitous PBTs to the list of PHS), the second RBMP maps would
likely show a worse picture than the first, giving. the impression that the chemical
status in most if not all MS was getting worse rather than improving.  MS
would, among other things, be faced with the significant administrative burden
of having to explain and justify this in the plans and during the WFD
publicparticipation process.  The extent of this problem would depend on the
option chosen for the substances. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As regards the choice of the
matrix, the current legislation does not provide any incentive to improve the
information base by choosing the most appropriate matrix for substances such as
ubiquitous PBTs.  In the absence of a proposal to change the situation, MS
could continue to monitor in water even when another matrix would be more
suitable.  There would continue to be many false &quot;good chemical
status&quot; reports, harmonisation would not be achieved, and there would be
less scope for identifying and possibly remediating highly contaminated sites. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As regards the monitoring effort,
departure from the minimum requirements in the WFD requires technical
justification that some MS may not be in a position to elaborate.  MS would
continue to monitor on the basis of the minimum requirements in WFD Annex V and
in EQSD Article 3. These requirements might not be the most efficient for
ubiquitous PBTs. This would result in a waste of resources. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>2.5.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>Knowledge base </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although the availability of
monitoring data for the current prioritisation was much better than for the
first exercise, i.e. a much more substantial database was compiled this time,
there were still limitations. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>For future exercises, the
implementation of REACH and the PPP Regulation of 2009 hold the promise of
providing some assistance, although neither is likely to lead to the provision
of targeted, EU-wide monitoring data relating for example to emerging
pollutants. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>REACH implementation is likely to
generate a wealth of information on intrinsic properties and effects; a
mechanism will need to be put in place to access and use it for the
prioritisation. On the exposure side, the REACH evaluation tool allows requests
to industry for monitoring data for certain substances, but this mechanism will
not provide systematic representative information across the EU. It might be a
useful source of information but only to complement EU-wide monitoring. In any
case, this only refers to substances covered under the scope of REACH and will
not cover all emissions (e.g. those emitted from existing consumer products). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The second RBMP is expected to
provide more information than the first on MS monitoring of RBSPs, but the
extent of this is not yet clear.   Indications from the first RBMP reporting
are that most of the MS have identified a very limited number of specific
pollutants. There is also no clear mechanism for the data itself to be reported
at EU level. Unless the situation changes, reporting will be voluntary, and
although it could go into an EU database, it might still not be fit for purpose
for the reasons explained in section 2.2.5. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>2.6.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Does the EU have the right to act? </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Water pollution has a very
important transboundary character. 60% of the EU territory lies in shared river
basins (EC, 2007). Because of this, and because many substances that cause
pollution are used across the EU anyway, it is appropriate to set harmonised
EQS for them at EU level where a significant risk to or via the aquatic
environment is identified. Apart from the wider protection, a more level
playing field is ensured than when only a few MS set an EQS or the national EQS
are very different. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
25.35pt;margin-left:42.35pt'><span lang=EN-US>The Unions policy for
controlling the pollution of surface waters is set out in Article 16 of the
WFD.  Articles 16(4) and (8) of the WFD provide for the list of PS to be
reviewed every four years and the EQS within two years after the inclusion of
new substances on the list.  Article 8 of the EQSD provides for the review of
the PS list combining in the same proposal the identification of the substances
and the EQS. As regards the problems of ubiquitous PBTs and the knowledge base,
the proposals concern action aimed at improving the functioning of the existing
legislation. </span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>3.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>O</span><span lang=EN-US>BJECTIVES</span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'> </span></h1>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.85pt;margin-left:42.35pt'><span lang=EN-US>The obligations under the WFD are
referred to in previous sections. In line with those, the general objectives of
the proposal are the following: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:60.9pt'><span lang=EN-US style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Reduce
the risks to or via the aquatic environment posed by certain substances </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:60.9pt'><span lang=EN-US style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Improve
the functioning of the EQSD </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.55pt;margin-left:78.2pt;text-indent:-17.8pt'><span lang=EN-US
style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Provide
adequate tools to improve the future identification of substances of concern to
or via the aquatic environment at EU level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.65pt;margin-left:42.35pt'><span lang=EN-US>The specific objectives are the
following: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:60.9pt'><span lang=EN-US style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Consider
the latest scientific knowledge in the review of existing PS  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:60.9pt'><span lang=EN-US style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Identify
new PS and set EQS for them </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=584
 style='width:438.35pt;margin-left:60.4pt;border-collapse:collapse'>
 <tr style='height:26.75pt'>
  <td width=24 valign=top style='width:17.8pt;padding:.3pt 0cm 0cm 0cm;
  height:26.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=561 valign=top style='width:420.5pt;padding:.3pt 0cm 0cm 0cm;
  height:26.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.3pt;line-height:107%'><span lang=EN-US>Ensure
  improved knowledge, through monitoring, of the risks posed by existing and
  proposed PS and the effectiveness of measures taken to reduce or eliminate
  emissions </span></p>
  </td>
 </tr>
 <tr style='height:14.7pt'>
  <td width=24 valign=top style='width:17.8pt;padding:.3pt 0cm 0cm 0cm;
  height:14.7pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=561 valign=top style='width:420.5pt;padding:.3pt 0cm 0cm 0cm;
  height:14.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.3pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Improve communication of
  the progress on water quality under the WFD  </span></p>
  </td>
 </tr>
 <tr style='height:28.45pt'>
  <td width=24 valign=top style='width:17.8pt;padding:.3pt 0cm 0cm 0cm;
  height:28.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=561 valign=top style='width:420.5pt;padding:.3pt 0cm 0cm 0cm;
  height:28.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.3pt;line-height:107%'><span lang=EN-US>Strengthen
  the current legislation on the choice of the most suitable matrix for
  monitoring  </span></p>
  </td>
 </tr>
 <tr style='height:28.45pt'>
  <td width=24 valign=top style='width:17.8pt;padding:.3pt 0cm 0cm 0cm;
  height:28.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=561 valign=top style='width:420.5pt;padding:.3pt 0cm 0cm 0cm;
  height:28.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.3pt;line-height:107%'><span lang=EN-US>Reduce
  the administrative costs for MS by providing additional flexibility in the monitoring
  of ubiquitous PBTs while maintaining the effectiveness of the monitoring </span></p>
  </td>
 </tr>
 <tr style='height:26.75pt'>
  <td width=24 valign=top style='width:17.8pt;padding:.3pt 0cm 0cm 0cm;
  height:26.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=561 valign=top style='width:420.5pt;padding:.3pt 0cm 0cm 0cm;
  height:26.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.3pt;line-height:107%'><span lang=EN-US>Provide a
  mechanism to improve the knowledge base and make future identification of PS
  more effective </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:19.8pt;margin-left:42.3pt;text-align:left;line-height:100%'><span
lang=EN-US>These objectives are compatible with the overarching EU objective,
reinforced in the Treaty of Lisbon, that the EU will work for the sustainable
development of Europe based, in particular, on a high level of protection and
improvement of the quality of the environment.  </span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>4.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>P</span><span lang=EN-US>OLICY
OPTIONS</span><span lang=EN-US style='font-size:12.0pt;line-height:107%'> </span></h1>

<h2 style='margin-top:0cm;margin-right:0cm;margin-bottom:5.5pt;margin-left:
0cm;text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif;font-style:normal'>                   </span><b><span
lang=EN-US style='font-style:normal'>4.1.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Overview </span></b></h2>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:0cm;margin-left:42.3pt;margin-bottom:.0001pt;text-align:left;
line-height:100%'><span lang=EN-US>The options presented in this section
address one or more of the problems and objectives presented in sections 2.2
and 3. The table below shows the correspondence between the options and the
problems, sub-problems and objectives: </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=614
 style='width:460.55pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:10.85pt'>
  <td width=123 valign=top style='width:92.1pt;border:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Problem </span></b></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.1pt 0cm 5.35pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Sub-problem </span></b></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.1pt 0cm 5.35pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>General objective </span></b></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.1pt 0cm 5.35pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Specific objectives </span></b></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.1pt 0cm 5.35pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Options </span></b></p>
  </td>
 </tr>
 <tr style='height:41.9pt'>
  <td width=123 rowspan=2 valign=top style='width:92.1pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>New information on risks to environment and human health </span></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Existing substances </span></p>
  </td>
  <td width=123 rowspan=2 valign=top style='width:92.1pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Reduce the risks to or via the aquatic environment posed by
  certain substances </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Consider the latest scientific knowledge </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Ensure improved knowledge </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>through monitoring </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>A2 </span></p>
  </td>
 </tr>
 <tr style='height:41.95pt'>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Proposed substances </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.6pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Identify new substances that pose risks and set EQS for
  them Ensure improved knowledge through monitoring  </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>A3a-A3c </span></p>
  </td>
 </tr>
 <tr style='height:31.5pt'>
  <td width=123 rowspan=3 valign=top style='width:92.1pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.1pt 0cm 5.35pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Specific difficulties with ubiquitous PBTs </span></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Presentational issues </span></p>
  </td>
  <td width=123 rowspan=3 valign=top style='width:92.1pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Improve the </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>functioning of the </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>EQSD </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Improve communication of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>progress on water quality under </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>the WFD </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:31.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>B2a-B2b </span></p>
  </td>
 </tr>
 <tr style='height:31.55pt'>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Choice of matrix </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:.05pt;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Strengthen the current legislation on the choice of the
  most suitable matrix for monitoring </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:31.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>B3a-B3b </span></p>
  </td>
 </tr>
 <tr style='height:41.9pt'>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Monitoring effort </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Reduce the administrative costs for MS by providing
  additional flexibility in the monitoring of ubiquitous PBTs </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:41.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>B4a-B4b </span></p>
  </td>
 </tr>
 <tr style='height:41.95pt'>
  <td width=123 valign=top style='width:92.1pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>Knowledge base </span></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>- </span></p>
  </td>
  <td width=123 valign=top style='width:92.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.55pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Provide adequate tools to improve the identification of
  substances of concern  </span></p>
  </td>
  <td width=177 valign=top style='width:133.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.1pt 0cm 5.35pt;height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Provide a mechanism to improve the knowledge base and make
  future identification of PS more effective </span></p>
  </td>
  <td width=68 valign=top style='width:51.2pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.1pt 0cm 5.35pt;
  height:41.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>C2-C3 </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:4.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The sets of options relating to
ubiquitous PBTs and the knowledge base are independent of the substance options
and of each other.  </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><b><span
lang=EN-US style='font-style:normal'>4.2.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Policy options in relation to the
substances </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.2.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>Introduction </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The policy options considered in
this section refer to the inclusion of substances as PS in Annex X of the WFD,
the (re)determination of the status (PS or PHS) of the PS, and the revision or
establishment of EU-wide EQS for them.  If a substance is identified as a PS
but not a PHS, it can still be used, but the EQS should be met. For PHS, the
WFD foresees the cessation and phase-out of discharges, emissions and losses to
water in the long-term. This will usually require substitution or at least
severe restrictions on use. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Article 16 (6, 7, 8) of the WFD
establishes the obligation for the Commission to propose control measures at EU
level to achieve the emission objectives for PS and PHS (For the latter,
cessation and phase-out should occur within 20 years of the adoption of such
measures). Measures may involve process controls (including emission controls
for point sources) and product controls. However, several existing EU policies,
for example for industrial chemicals, PPPs, biocides and veterinary medicines,
include mechanisms and criteria that can be used to a greater or lesser extent
to develop and decide on such controls to address the risks identified by the
WFD. It would not be appropriate for the Commission to propose alternative
controls for specific substances on the basis of the WFD. This would create
unnecessary double regulation. Therefore, the options do not specify measures. 
They assume that the other EU policies will establish the most appropriate
controls and that measures might also be taken at MS level, as required by WFD
Article 11(3)(k). When the first PS list was established, existing legislation
was also seen as providing sufficient tools to enable appropriate measures. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As explained in section 2.5.1, a
number of the measures that might reduce emissions to water of certain existing
or proposed PS, such as authorisation for limited uses under REACH or 
withdrawal of an authorisation under the biocides or PPP legislation, or the
establishment of additional mitigation measures during use, are likely to be
taken under the baseline.  However, some might be triggered or accelerated as a
result of PS designation or EQS revision under the WFD, or as a result of
feedback from the monitoring conducted under the WFD  this being an obligation
for the substances listed as PS.  The interaction of the WFD/EQSD with other
legislation is explained further at the end of Annex VI.  </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.2.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>The options A1, A2 and A3 (a)-(c) </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>Option A1 is the no-policy-change
option; the baseline is explained in section 2.5. The other options relating to
substances are presented in the table below. They are fully based on the
outcome of the technical work presented in sections 1 and 2.2.3. They are
cumulative on the basis of theoretically increasing impacts, starting with
existing PS, adding newly identified substances except pharmaceuticals, and
finally adding pharmaceuticals (last because they have not hitherto been
regulated under the WFD). Existing PS not included in option A2 would not be
affected. The first option including newly identified substances (option A3a)
includes substances listed in Annex III of the EQSD, which there is an explicit
legal obligation to review. The outcomes of the technical review of the Annex
III substances are explained in the Commission Staff Working Paper
SEC(2011)1544 (European Commission 2011). Effectively five (if Dioxins and
Dioxin-like PCBs are counted as 2) of the 13 Annex III substances were
identified by the technical process.  </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=610
 style='width:457.4pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:46.5pt'>
  <td width=151 valign=top style='width:4.0cm;border:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.05pt;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Change or establishment of EQS in
  water?  </span></b></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Biota </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:98%'><b><span style='font-size:
  10.0pt;line-height:98%'>EQS proposed? </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'> </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>Change from PS or identified as </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>PHS? </span></b></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=151 rowspan=3 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Option A2: Change EQS and/or status
  of existing PS </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Anthracene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (minor) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Poly-BDE </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant<a href="#_ftn25" name="_ftnref25" title=""><sup><sup><span
  style='font-size:10.0pt;line-height:103%;font-family:"Times New Roman",serif;
  color:black'>[25]</span></sup></sup></a>) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y  </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>DEHP </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=151 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.05pt;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Change or establishment of EQS in
  water?  </span></b></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Biota </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><b><span style='font-size:
  10.0pt;line-height:99%'>EQS proposed? </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'> </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><b><span lang=EN-US style='font-size:10.0pt;line-height:
  98%'>Change from PS or identified as </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>PHS? </span></b></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=151 rowspan=11 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Lead </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (minor) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Naphthalene   </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (minor) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Nickel </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PAHs </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'> </span></b></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'> </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>   Benzo(a)pyrene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
  <td width=75 rowspan=4 valign=top style='width:56.0pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y  </span></p>
  </td>
  <td width=112 rowspan=5 valign=top style='width:84.0pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>   Benzo(b)fluoranthene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>   Benzo(k)fluoranthene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>   Indeno(1,2,3-cd)pyrene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>   Benzo(g,h,i)perylene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Fluoranthene </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y (significant) </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y  </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Trifluralin </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=151 rowspan=4 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:98%'><b><span lang=EN-US style='font-size:10.0pt;line-height:
  98%'>Option A3a: ExistingPS changes plus Annex </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>III substances </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Dicofol </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PFOS </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Quinoxyfen </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Dioxins and DL-PCBs </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:11.95pt'>
  <td width=151 rowspan=8 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:11.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Option A3b: ExistingPS changes plus
  Annex III substances plus other new substances excluding pharmaceuticals </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:11.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Aclonifen </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:11.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:11.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:11.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Bifenox </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Cybutryne </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Cypermethrin </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Dichlorvos </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>HBCDD </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Heptachlor/ heptachlor epoxide </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Y </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Terbutryn </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=151 rowspan=3 valign=top style='width:4.0cm;border:solid black 1.0pt;
  border-top:none;padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Option A3c: ExistingPS changes plus
  Annex III substances plus other new substances including pharmaceuticals </span></b></p>
  </td>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>17 alpha-ethinylestradiol </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>17 beta-estradiol  </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
 <tr style='height:45.55pt'>
  <td width=160 valign=top style='width:120.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:45.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Diclofenac </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:45.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Y </span></p>
  </td>
  <td width=75 valign=top style='width:56.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 3.55pt 0cm 5.4pt;
  height:45.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
  <td width=112 valign=top style='width:84.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 3.55pt 0cm 5.4pt;height:45.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>N </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Details of the proposed EQS are
provided in Annex II. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>4.3.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Policy options in relation to the specific
difficulties with ubiquitous PBTs </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>There are three sub-problems under
this heading, with their own objectives. </span>Options have been structured as
follows: </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=621
 style='width:466.1pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:23.15pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:23.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 4.4pt 0cm 5.4pt;height:23.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Presentation </span></b></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 4.4pt 0cm 5.4pt;height:23.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Choice of matrix </span></b></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 4.4pt 0cm 5.4pt;height:23.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Monitoring effort </span></b></p>
  </td>
 </tr>
 <tr style='height:31.55pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B1 </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>No change (presentation of all PS
  results together) </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>No change (choice is fully free) </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>No change (minimum frequency but
  some flexibility if technically justified) </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B2a </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Allow separate presentation of
  ubiquitous PBTs </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B2b </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Take ubiquitous PBTs out of chemical
  status </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:41.9pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B3a </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Conditioned to meeting or coming
  closest to the minimum performance criteria of Commission Directive
  2009/90/EC </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B3b </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Fixed choice for each substance </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:31.5pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B4a </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:31.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Introduce reduced monitoring
  obligations for ubiquitous PBTs if certain specified conditions are met </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=54 valign=top style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B4b </span></p>
  </td>
  <td width=183 valign=top style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Introduce reduced monitoring
  obligations for ubiquitous PBTs </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=54 valign=bottom style='width:40.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=183 valign=bottom style='width:137.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=192 style='width:144.1pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 4.4pt 0cm 5.4pt;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=192 valign=top style='width:144.1pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 4.4pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>(unconditional) </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:4.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'>  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The issues and options are
largely independent and therefore any combination of options (one per
sub-problem or column) is possible. The following substances have been
identified as ubiquitous PBTs: BDEs, Mercury, Tributyltin (TBT), PAHs (existing
PS) and Dioxins/DLPCBs; Heptachlor and heptachlor epoxide, HBCDD, PFOS
(possible new PS). </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.3.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>Option B1: No change </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option would mean continuing
as now.  The baseline is explained in section 2.5. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.3.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Option B2a presentation: Allow separate
presentation of ubiquitous PBTs  </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option identifies a number
of substances that are ubiquitous PBTs at EU level and allows MS to present the
assessment for some or all of these substances separately (e.g. in separate
maps) from that for the rest of the PS in the RBMPs, although the chemical and
overall status assessment would still need to include them. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.3.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Option B2b presentation: Take ubiquitous PBTs out
of chemical status </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option would mean that the
assessment of chemical status would no longer need to include the levels of
these substances, good chemical status could be met on the basis of meeting the
obligations only for the other PS. This would mean taking the substances out of
WFD Annex X and EQSD Annex I. There would not be a legally binding EU-wide
EQS.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The obligation to monitor and
report according to EQSD Article 3.3 would be kept in order to ensure that
there were at least a trend assessment of the concentrations of these
chemicals. No other legislative tool provides for their monitoring in the
aquatic environment at EU level. </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>4.3.4.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Option
B3a choice of matrix: Leave flexibility but link the choice to requirements of </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>Directive
2009/90/EC </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.65pt;margin-left:42.35pt'><span lang=EN-US>A preferred matrix/matrices for
monitoring and compliance checking for each substance would be identified (as
it is one of the outcomes of the technical process)</span><a href="#_ftn26"
name="_ftnref26" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[26]</span></sup></sup></a><span
lang=EN-US>. The choice of matrix would still be left to the MS except in cases
where  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>the available analytical technique fulfils the performance criteria
of Directive 2009/90/EC in one matrix and not in the other(s), or  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>no analytical technique meets the performance criteria but the
technique for one matrix performs significantly better than that for the other
matrix/matrices,  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>and there is an EQS available at
EU level for at least the matrix where the analytical technique performs
according to the criteria in Directive 2009/90/EC or performs better than in
the other matrix/matrices. In this case MS would have to use the matrix for
which Directive 2009/90/EC is fulfilled or for which the analytical technique
performs significantly better in relation to the criteria in Directive
2009/90/EC. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>A common example would be the
case of a hydrophobic and bioaccumulative substance where the EQS in water is
very low and an EQS for biota has been derived. The best available analytical
technique for water does not fulfil the requirements of Directive 2009/90/EC,
but it does for biota. In that case, MS would have to use the biota standard. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The assessment of the relative
performance of the analytical methods would be left to the MS, possibly with
some technical guidance to be developed at EU level, if needed to complement
the criteria given in Commission Directive 2009/90/EC. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.3.5.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Option B3b choice of matrix: Fix the preferred
matrix for each substance </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The choice of matrix for
monitoring and compliance checking would be fixed at EU level for each
substance, reflecting the outcome of the expert work (see Annex II).  </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>4.3.6.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Option
B4a monitoring: Introduce reduced monitoring obligations for ubiquitous </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>PBTs if
certain specified conditions are met </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Criteria for reducing the
monitoring effort for the substances identified as ubiquitous PBTs would be
established in the legislation, i.e. criteria for applying the flexibilities in
the WFD and EQSD as regards monitoring frequencies (based on &quot;technical
knowledge and expert judgement&quot;) and for reducing the number of sites at
which the ubiquitous PBTs need to be monitored.  This reduced monitoring effort
could apply without further justification only if there were enough information
on the presence of the substance in water bodies (in particular in sediment
and/or biota), i.e. there were a robust baseline of monitoring information.
This reduced monitoring would be without prejudice to the need to undertake
more detailed monitoring if local measures had to be taken and their
effectiveness had then to be assessed.  </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>4.3.7.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Option
B4b monitoring: Introduce reduced monitoring obligations for ubiquitous </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>PBTs
(unconditional) </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Allow reduced monitoring
(frequency and number of sites) for ubiquitous PBTs compared with the general
requirements for other PS. In this option the reduced monitoring effort could
be applied without preconditions. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>4.4.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Policy options in relation to improving
the knowledge base </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.4.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
    </span><span lang=EN-US>Option C1: No change </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option would mean continuing
as now.  The baseline is explained in section 2.5. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.4.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Options C2 and C3: Establishment of a watch list </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>These options would involve
establishing a watch list.  The aim would be to ensure targeted monitoring
across the EU of substances of possible concern, for example, emerging
pollutants, to provide a database of high-quality information fit for the
purpose of subsequent prioritisation exercises under the WFD.  Two approaches
would be possible, a watch list without a legal obligation, or a watch list
with a legal obligation.  The list would be &quot;dynamic&quot; with substances
being regularly added and removed. Approximately 20 would be on the list at any
one time, monitored by MS at 250-300 representative sites across the EU
according to agreed technical guidelines for monitoring (site selection,
sampling and analysis), with results being reported to the Water Information
System for Europe (WISE). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The technical details including
the structures that would be involved in supporting the operation of the watch
list are described in Annex III.  </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.4.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Option C2: Establish a watch list without legal
obligation </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option would entail establishing
a watch list on the basis of a voluntary system of monitoring and reporting.
The well-established informal decision-making process of the CIS would be used.
This has been operating well since 2001 and involves decision making by the WFD
Water Directors, hence ensuring political support in the MS. The technical
proposals on the selection of substances to monitor and the guidelines for
monitoring would be forwarded to the Water Directors for endorsement at one of
their twice-yearly meetings. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>4.4.4.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Option C3: Establish a watch list with legal
obligation </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option would entail
establishing a watch list through a legally binding instrument. This would
involve a legal provision that establishes the watch list in generic terms in
the legislation, with the obligation for MS to monitor and report to the
Commission, and a mandate for the Commission to develop the list of substances.
The list would be adopted by Commission Decision. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The structures involved in the
technical work and data collection would be the same as in option C2, including
the use of the CIS WGE/CMEP groups and the WISE reporting system. The technical
guidelines for the monitoring process would still be developed informally.
There is considerable experience in the CIS of developing informal guidance for
endorsement by the Water Directors. This procedure reduces significantly the
administrative burden but has proven efficient with high rates of uptake of the
guidelines by the MS. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.0pt;margin-left:42.35pt'><span lang=EN-US>Alternative options to formally
adopt the technical guidelines for the monitoring would entail a heavier and
longer administrative procedure that would, because of the need for
substancespecific updates, reduce the usefulness of the watch list, limiting
the frequency of renewal and thus its effectiveness at meeting the objective of
improving the knowledge base. Formal adoption of technical guidelines would
also not be consistent with what the Commission and the MS have been doing over
the past 10 years for the implementation of the WFD and the related Directives
(Floods, Groundwater, EQSD), a system that is highly appreciated as effective
and not entailing excessive administrative costs (see for example conclusions
of Water Directors meeting of December 2008 and CIS Work Programme 2010-2012</span><a
href="#_ftn27" name="_ftnref27" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[27]</span></sup></sup></a><span
lang=EN-US>).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
25.9pt;margin-left:42.35pt'><span lang=EN-US>In the consultation phase it was a
consensus view of the MS that the development of the technical work should be
done using existing structures.  </span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>5.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>A</span><span lang=EN-US>NALYSIS
OF IMPACTS AND COMPARISON OF THE OPTIONS</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%'> </span></h1>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.1.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Introduction </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The different sets of options (A,
B and C) address different problems and are of a different nature. For this
reason, this section sets out the analysis of impacts for the options in set A,
then a comparison of those options; then does the same for the options in sets
B and C. The criteria for comparison of the options have been adapted to the
nature of the options. In all cases, an assessment has been made as regards
effectiveness at reaching the general and specific objectives set out in
section 3. The options are compared relative to the &quot;no-change&quot;
options A1, B1 and C1; the baseline is explained in section 2.5. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.2.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Analysis of impacts of the substance
options </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.2.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
      </span><span lang=EN-US>General considerations as regards costs and
benefits of the substance options </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Annex IV includes a summary of
the approach used to assess the impacts. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although specific measures are
not proposed in the options at either EU or MS level, as explained in section
4.2.1, considerable efforts were made to obtain quantitative information
regarding the impacts of potential measures.  However, little quantitative
information was received for many of the substances, even on the potential
economic costs (see section 5.2.2). In view of this and of the uncertainty
regarding the measures that might be applied, a largely qualitative approach was
taken in the analysis. This appears proportionate considering the limited
direct effects of the proposed options, the fact that the decision processes
regarding action under other sectoral EU legislation usually include a
socio-economic analysis, and the fact that MS can apply exemptions regarding
attainment of the environmental objectives under the WFD (see section 5.2.1.2).
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Nevertheless, to the extent
possible, information on the scale of the benefits and costs is presented under
the various options. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>It should be borne in mind that
the Treaty establishes as one of the pillars of EU environmental policy the
control of pollution at source. This principle gives priority to upstream
controls on the assumption that, in general, rectification at source is more
costeffective than end-of-pipe solutions. The importance of considering
upstream measures was highlighted by MS and stakeholders during the
consultation; they also stressed the need to consider the feasibility of
phasing out certain substances that are currently in use and others that are
produced unintentionally. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.1.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Benefits </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This section presents
quantitative and qualitative information on the main generic benefits expected
from the substance options A2 to A3c. The magnitude would depend on the
ambition of the options. Positive impacts specific to the proposals for
individual substances are presented in later parts of section 5.2 on the
specific impacts of the individual substance options. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Since the options do not specify
measures, the assessment of the potential benefits of measures themselves (as
compared with the benefits of monitoring) can only be based on the potential
measures that might be taken at EU or MS level as a result of the proposal.
Realisation of some of the benefits would be in the long-term. Benefits to
health are extremely difficult to quantify, being dependent on many factors in
addition to exposure and intrinsic hazard. </span></p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span style='font-style:
normal'>Environmental benefits</span></u><span style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Regular monitoring and consequently increased knowledge of the
extent of water pollution, particularly valuable to assess the effectiveness of
the measures taken under the WFD and other sectoral legislation to limit the
emissions; this benefit would not be achieved under the other sectoral
legislation alone. It should be noted that monitoring of the substances in
option A2 already occurs, and that EQS for them already exist, but that changes
in the EQS matrix for some of those substances would be expected to improve the
quality of the monitoring data. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>The triggering of measures, including by feedback from monitoring,
to limit chemical emissions, with consequent improvements in biodiversity that
will result in a more resilient aquatic ecosystem, enhancing its capacity to
deliver ecosystem services such as the processing of excess nutrients
(Cardinale 2011). Recent studies from the JRC have estimated the monetary value
of the removal of nitrogen performed naturally by healthy river ecosystems in
the EU as being of the order of 373 million  per year (JRC, 2011).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Wider benefits to biodiversity, i.e. beyond the immediate aquatic
ecosystem, in view of the extensive interactions between different ecosystems
and organisms, including through migration. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Cleaner sediments (including as a result of remediation informed by
monitoring) meaning less potential for re-dissolution in the water column and
reduced uptake of harmful substances by plants and animals. </span></p>

<p class=MsoHeading7 style='margin-top:0cm;margin-right:0cm;margin-bottom:12.6pt;
margin-left:42.3pt'><u><span style='font-style:normal'>Economic benefits</span></u><span
style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Moving towards a level playing-field for
industry across the EU as regards the driver for the authorisation of
discharges, compared to the current situation where MS establish their own EQS
for some of the candidate PS. </span>National EQS for some substances differ by
several orders of magnitude (e.g. 2 orders of magnitude in the case of
Dichlorvos, 3 orders of magnitude in the case of Heptachlor, one order of
magnitude in the case of Terbutryn). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Reduced treatment costs for drinking water and industrial process
water. E.g. in the context of the 2006 impact assessment, based on data from 3
MS, estimated unit costs for removal of pesticides were 0.028 /m3 (Ecolas,
2005). Based on data from BE, DE, NL and UK, that study estimated that 74% of
surface waters used for the production of drinking water exceeded regularly the
standard of 0.1 </span><span style='font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span
lang=EN-US>g/l. Latest data from EUREAU suggest that the value of 74% is
probably overestimating the percentage of water bodies that show regular
exceedances, but in any case the costs are considerable. According to Eurostat
(2011, env_watq2_1), around 20 900 million cubic metres of surface water are
abstracted in the EU for drinking water production. Using these figures, the
following table presents estimated annual costs of treatment for three
different scenarios: </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:35.5pt'>
  <td width=431 style='width:323.4pt;border:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:35.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Percentage of surface water bodies
  used for the abstraction of drinking water that exceed regularly the standard
  for pesticides </span></p>
  </td>
  <td width=64 style='width:48.0pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>30% </span></p>
  </td>
  <td width=64 style='width:48.0pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>50% </span></p>
  </td>
  <td width=60 style='width:44.95pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:35.5pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.3pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>70% </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=431 style='width:323.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Estimated treatment cost (million 
  per year) </span></p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.55pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>175 </span></p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.55pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>292 </span></p>
  </td>
  <td width=60 style='width:44.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.55pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>409 </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Cleaner sediment implying cheaper management of waste from dredging.
Around 200 million cubic metres of sediment are dredged every year in the EU
(SedNet, 2004). Management costs are heavily dependent on the sediment quality
and vary from 1 to 45 /m<sup>3</sup>. Assuming that 10% of the material is
contaminated (value from the Port of Rotterdam) and hence requires higher disposal
costs in the range of 10 to 30 /m<sup>3</sup>, the annual expenditure in
handling contaminated dredged material is in the order of 200 to 600 million 
per year. The potential cost savings in the long term are therefore
significant. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.45pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>The potential for healthier, more productive commercial fisheries
and aquaculture. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.1pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Fostering of innovation to find substitutes for PHS. </span></p>

<p class=MsoHeading7 style='margin-top:0cm;margin-right:0cm;margin-bottom:12.6pt;
margin-left:42.3pt'><u><span style='font-style:normal'>Social and public health
benefits</span></u><span style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
10.5pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>More information for the public on the quality of the aquatic
environment; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Reduced bioaccumulation of many hazardous chemicals in humans,
reduced exposure (occupational and other) if less hazardous substitutes are
used; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Potential improvements in quality of fish and shellfish from
commercial fisheries, aquaculture and recreational fishing. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Improved amenity value of water bodies (tourism, angling, etc), and
reduced exposure for humans using them for bathing, surfing and other water
sports; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Cleaner water for livestock where surface water is used directly,
resulting in reduced accumulation in meat and milk, hence reduced human
exposure to hazardous substances, likewise, less accumulation in meat from game
drinking surface waters directly; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:55.95pt;text-indent:-14.1pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Reduced potential for accumulation of hazardous substances in crops
when untreated surface water is used for irrigation. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.1.2.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Costs </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The most important costs fall
into the &quot;economic&quot; category. If significant social or environmental
costs (beyond water) are involved they are mentioned in later sections. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The obligation to monitor PS
means that additional monitoring costs would apply to all the substance options
except option A2 which relates only to existing PS. These were estimated on the
basis of figures provided by MS for the existing PS (see Annex IV), and are
given in the relevant sections.  The Standard Cost Model was not used for these
estimates because of the availability of data from the MS, which allowed the
analysis to be tailored more realistically. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Since the options do not specify
measures, the assessment of the other potential costs of the options can only
be based on potential measures that might be taken at EU or MS level as a
result of the proposal.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The substances proposed as PHS,
with the exception of Quinoxyfen, are already regulated under other sectoral EU
legislation, and in some cases subject to (or likely to become subject to)
international conventions, in ways that should eventually achieve the cessation
or phaseout of emissions, subject to the availability of substitutes where
needed.  Therefore their designation as PHS is not expected to lead to any
significant impacts on the market (both in terms of users and producers) beyond
the baseline.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>For the other substances proposed
for addition to the PS list or a more stringent EQS, measures beyond the
baseline might be taken under the other EU legislation, but these and their
costs cannot be predicted. However, the chemicals (REACH), biocides and PPP
legislation contains provisions for authorisation decisions to take account of
socio-economic (including environmental) factors. Where measures are taken at
MS level, it is important to note that, although PS are selected from among
those posing a risk at EU level, local pollution and circumstances can vary
substantially and with them the costs of the measures. For example, the
treatment required at an Urban Waste Water Treatment Plant (UWWTP) will be
determined by the characteristics of the receiving water body, its uses and
other discharges. It should be noted that the majority of UWWTPs provide only
&quot;simple treatment&quot;, but that MS are already obliged to upgrade
certain plants to secondary treatment according to Article 4 of the Urban Waste
Water Treatment Directive and that the cost of doing this cannot be attributed
to the options in this IA. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In this context it is also
important to note that, if the relevant conditions are fulfilled (on the basis
of local assessment), MS may rely on certain exemptions, i.e. if measures to
achieve the WFD objectives are technically unfeasible, disproportionately
expensive, or would take longer than the WFD deadlines due to natural
processes, or if the origin of the problem is transboundary, exemptions under
WFD Article 4(4) (extension of deadlines) and 4(5) (lowering of objectives) may
be used for specific water bodies if all conditions listed in those Articles
are fulfilled. This provides MS with a legal safety net to deal with specific
situations in which the costs of achieving the environmental objectives would
significantly exceed the benefits  it is for MS to carry out this assessment.
Guidance on applying exemptions is available</span><a href="#_ftn28"
name="_ftnref28" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[28]</span></sup></sup></a><span
lang=EN-US>. Although exemptions relate to WFD environmental objectives and
thus to the obligations on MS, they can potentially indirectly apply to
emissions by individual operators. Whether MS would be able to take the
operators' position into account would depend upon the justification provided,
since the overall exemption would have to be justified to the public. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As indicated in section 5.2.1,
little quantitative information was received for many of the substances. It
seemed inappropriate to attempt a quantitative analysis combining those data
with the uncertain policy outcomes, bearing in mind the other points above. A
largely qualitative approach was therefore taken to assessing the costs of the
options, except in relation to the monitoring obligation. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The additional monitoring costs
would be borne by MS. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>On the basis of the information
obtained, the impacts on EU companies (see the following sections and
especially section 5.7) would be expected to be relatively small and not to
affect the competitiveness of individual MS or overall EU competitiveness. As
indicated in section 2.6, the setting of EQS at EU level should create a more level
playing field for the MS than when only a few MS set an EQS or the national EQS
are very different. As stated above, exemptions applied by MS could indirectly
apply to companies and thus keep costs within proportionate limits. Other
reasons for not expecting impacts on competitiveness are that relatively few
substances are involved compared with the total number on the market;
substitution is not seen as a likely requirement (beyond the baseline) for most
of the substances in the options, either because they are already heavily
regulated and will have to be substituted anyway or because they are not
designated as PHS and their use will generally be able to continue; most of the
producers involved are large (even multinational) and have an extensive product
portfolio; substitutes generally exist where necessary (further information
appears under the individual options below), and the need for measures to
control emissions to the aquatic environment from many of the substances is
also acknowledged in other parts of the world, e.g. in at least Australia</span><a
href="#_ftn29" name="_ftnref29" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[29]</span></sup></sup></a><span
lang=EN-US>, Canada (see footnote 15) and the USA</span><a href="#_ftn30"
name="_ftnref30" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[30]</span></sup></sup></a><span
lang=EN-US> regarding Cypermethrin, in at least the USA regarding
pharmaceuticals</span><a href="#_ftn31" name="_ftnref31" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[31]</span></sup></sup></a><span lang=EN-US> (although no
standards have so far been set), worldwide regarding the designated POPs.
Although Quinoxyfen use is currently still authorised in Australia, the
instructions for use are strong on the need to avoid any emissions to water.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Additional costs to producers
could include: the cost of (further) reducing point-source emissions at a
production site, temporary loss of overall sales volume while shifting to a
substitute product, the cost of investing in the development and production of
a substitute.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Costs to users/consumers would
also be expected to be relatively small, consisting of the possible additional
cost of substitute products, or an increase in the cost of water if water
companies pass on the - proportionate - costs of additional treatment, or of
cleaner energy.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Small and medium-sized
enterprises (SMEs) that might be affected by the options include pesticide and
coating formulators, textiles and plastics companies, construction companies,
dockyards, ship owners, fishermen, arable and salmon farmers, pharmacies, waste
management companies, and water companies.  However, with the exception of the
water companies, as explained further in the context of options A2 and A3c,
they would not be expected to face significant costs beyond the baseline. As
noted above in the context of EU companies generally, substitution is not seen
as a likely requirement for most of the substances, and where it is, it would
in most cases be required in the baseline, and subject to the availability of
substitutes. Impacts on SMEs relevant to the individual substances are
mentioned under the options below. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.2.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Uncertainties in the analysis of the substance
options </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.65pt;margin-left:42.35pt'><span lang=EN-US>Uncertainties in the analysis of
the benefits and costs of the substance options derive from: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Uncertainties in the exceedance of the proposed EQS in each MS,
especially where the prioritisation was based primarily on modelling; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.45pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Uncertainties in the baseline measures; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Uncertainties in the measures that would be taken to meet the EQS
and, if applicable, phase-out requirements; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Incomplete production and use data, e.g. production volume and
location, associated employment; use in some MS; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Limited estimates, if any, of the costs of reducing emissions from
industrial point sources and of removing pollutants at UWWTPs; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Relative paucity of data regarding the cost and possible impacts of
substitutes, where relevant; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.55pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Difficulty in attributing benefits to action on particular
substances and in quantifying them.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Not all the uncertainties apply
to all the substances, or to the same extent.  Notable substancespecific
uncertainties are given in the tables in the sections that follow, and/or in
the factsheets in Annex V. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The uncertainties exist despite
the substantial effort that went into compiling the monitoring database used
for the prioritisation, and despite the comprehensive consultation carried out
(see section 1.4) to gather the necessary data and information to underpin the
analysis. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>During the consultation, MS and
stakeholders in WG E stressed that unrealistic extrapolations and attempts at
quantitative estimates should not be done.  This view was expressed in relation
to, among other aspects, estimating the baseline concentrations where
monitoring data were not available, and the supporting study did not pursue an
early proposal to calculate concentrations on the basis of surface water
volumes to quantify the possible exceedance of the proposed EQS in
&quot;missing&quot; MS. The approach of using case studies to support the
assessment of impacts (see Annex IV) was designed to some extent to overcome
this. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Still, a few stakeholders
considered that the extent of the monitoring data for some substances
(Cypermethrin, EE2, Quinoxyfen) did not justify prioritisation. For
Cypermethrin, 3 out of 5 MS in the database showed exceedances of the EQS, and
many additional samples below the determination limit in those and other MS may
also have been above the EQS. Although sheep dipping used to be one of the main
uses of Cypermethrin in the UK (the MS showing the greatest number of
exceedances), this should no longer be the case, but no data are available
showing that exceedances don't still occur from other uses. Cypermethrin was
ranked high in the modelling as well as the monitoring-based prioritisation. 
For EE2, the data for 3 countries in the monitoring database were complemented
by literature data.  Quinoxyfen was reviewed because of its EQSD Annex III
status, and although only 2 MS provided monitoring data (most from FR, showing
isolated exceedances),  this PPP is authorised in 17 MS and is a PBT. Further
explanation regarding the monitoring and modelling-based prioritisation
processes is provided in the Commission Staff Working Paper SEC(2011)1544
(European Commission 2011).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although the starting point for
consultation was the membership of WG E, therefore mainly stakeholder groups,
several individual companies were contacted also directly by the Commission
and/or Entec. Indeed, for a number of the substances included in the options,
individual companies participated in the WG E and Sub-Group meetings and
provided some input directly to the technical work on EQS derivation. However,
despite repeated requests for information for the substance impacts reports,
and consultation on them, the amount and quality of data and information
received from MS and stakeholders was limited.  </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.2.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Analysis of impacts of Option A2: Change EQS
and/or status of existing PS </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The impacts of this option over
and above the baseline include those associated with changes to (i) the EQS
(ii) the monitoring matrix and (iii) the status of the substances. Specific
analysis for each substance is presented later in this section. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.3.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Change in the
EQS  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Impacts could result from the
potential need to take measures to meet a more stringent EQS for some of the
PS.  The measures required and the sectors involved would depend on the
substance.  The costs would depend on the type of measure and on the scale of
action, which would depend upon the extent of EQS exceedance.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.3.2.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Change in the
EQS matrix  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Biota monitoring is more
expensive per sample/analysis, but fewer sampling locations are needed and a
lower frequency (annual according to EQSD Art 3(2)(c), cf. monthly according to
WFD Annex V) due to the integrative character of biota. The impact of this
option on monitoring costs is therefore estimated to be neutral, although there
would be some adaptation costs for MS which have not previously monitored
routinely in biota. Currently the choice of matrix is left to MS and therefore
it is not appropriate to attribute such adaptation costs to this option.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As regards benefits, establishing
a biota standard at EU level for the substances for which it is the most
appropriate matrix due to their persistence and bioaccumulation potential would
encourage MS to monitor in biota, improve knowledge of the extent of the
problem (including the possible need for sediment remediation), and allow
better evaluation of the effectiveness of measures, thereby providing a better
basis for improved protection. The encouragement for MS to monitor in the most
suitable matrix, would come from: their no longer needing to develop their own
standard, for which many lack the expertise. Differences between MS would also
be reduced (a preliminary assessment of national EQS in 14 MS shows that the
national EQS for 35 substances differ by at least 2 orders of magnitude between
the country with the lowest and the highest EQS). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.3.3.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Change in
status </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The impacts of this change would
be in relation to the stricter regulation that applies to PHS cf. PS, i.e.  the
need to cease discharges, emissions and losses of the substance to water within
20 years of the adoption of the relevant measures at Community level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.3.4.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Summary of
specific impacts per substance </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>The table below summarises the
specific impacts per substance. More details are provided in the factsheets in
Annex V. Monitoring of these substances is in the baseline, but the information
obtained on Fluoranthene, PAHs and PolyBDEs would be expected to improve with
the expected shift from water to biota monitoring. </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.25pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'># </span></b></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:44.55pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Substance (main uses) </span></b></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* and proposed change </span></b></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  107%'>Summary of significant specific impacts </span></b></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>SMEs, notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:145.4pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>2 </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Anthracene </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.95pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>(Main use as component of coal tar pitch; some use in pure
  form in pyrotechnics.  </span><span style='font-size:9.0pt;line-height:99%'>Produced
  during combustion, therefore many sources, including metal </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>industry.) </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PHS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>possible inclusion in </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH Annex XIV; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>IED, waste legislation; POPs
  Regulation  could all reduce emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: MAC-EQS </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'> Improved coherence with
  chemical policy, i.e. with the outcomes of the risk assessment under </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.95pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Regulation (EC) No 793/93. Greater attention to reducing
  point source emissions due to more stringent MAC-EQS.<b> Negative:</b> No
  significant negative impacts expected as change is not major.  </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Emissions (partly natural) cannot be
  completely eliminated. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Local negative impacts on </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.35pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>SMEs cannot be discounted but unlikely to be significant
  given small magnitude of change; no information provided by stakeholders. </span><span
  style='font-size:9.0pt;line-height:99%'>Uncertainty re authorisation; </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.75pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%'>extent of
  failure of current </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>MAC.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:41.9pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>5 </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Poly-BDE </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.9pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>(Main use as flame retardants in polymers and </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PHS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>POPs (4 congeners); REACH; IED; waste
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>legislation (new limits </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Encouragement to MS to
  monitor in biota instead of monitoring (ineffectively) in water, </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:41.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Most impacts in baseline. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Substitutes exist. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>As regards SMEs: Possible local
  impacts on water </span></p>
  </td>
 </tr>
 <tr style='height:124.7pt'>
  <td width=19 style='width:14.4pt;border:solid black 1.0pt;border-top:none;
  padding:.55pt 0cm 0cm 5.4pt;height:124.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:124.7pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>textiles; only deca BDE still
  authorised, and no longer in </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.0pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>electrical/electronic products.)<b> </b> </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:124.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.8pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>proposed); possible inclusion of penta and octa BDEs in
  Rotterdam Convention  could all reduce emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: EQS, matrix </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:124.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>therefore
  better information for improved protection (see section 5.2.3.2).. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.45pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Negative: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Widespread presence makes
  it very difficult to reduce further the emissions, discharges and losses.  </span><span
  style='font-size:9.0pt;line-height:107%'>Potential local impacts, including
  if sediment remediation is needed. </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:124.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>companies
  and landfill operators. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.8pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Uncertainties re extent of EQS failure in MS due to
  inadequate analytical sensitivity; inclusion in Rotterdam Convention; effect
  of more stringent EQS on decaBDE use (and import).<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:197.15pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>12</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>DEHP </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(Main use as plasticiser in
  polymers, especially PVC, including in construction products and medical
  equipment.) </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:11.3pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>PS; included in REACH Annex XIV, sunset 2015 </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.8pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:100%'><span lang=EN-US style='font-size:9.0pt;line-height:100%'>(substitution
  in baseline); IED; waste legislation  could all reduce emissions<sup>32</sup>.
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: Status </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:6.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> Coherence with REACH;
  particular consideration under REACH authorisation process of uses affecting
  aquatic environment. <b>Negative: </b>Classification as PHS not likely to
  have impacts beyond baseline as regards production and use. Widespread
  presence in existing construction materials makes it difficult to reduce
  further the discharges, emissions and losses.  However, there might be local
  impacts if measures were taken at MS level. </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.6pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Most impacts in baseline. Substitutes exist, but incomplete
  info on environmental and health impacts </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>As regards SMEs: Possible impact on
  water companies (if required to increase removal rate of DEHP). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Uncertainty re outcome of
  authorisation process under </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>REACH. </span></p>
  </td>
 </tr>
 <tr style='height:156.35pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:156.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>20</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:156.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Lead </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.8pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>(Main use in batteries, accumulators, shot, ship keels, construction
  materials etc.)<b> </b></span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:156.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH (Evaluation of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.85pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Registration dossier); IED; waste legislation  have
  potential to reduce emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: EQS </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:156.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> Alignment of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.65pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:102%'><span lang=EN-US style='font-size:9.0pt;line-height:102%'>EQS
  with latest science; use of a &quot;bioavailable&quot; EQS and monitoring of bioavailable
  Lead would provide better data, possibly useful to target remediation.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> Change to </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>EQS not major </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(equivalent to a change from 7.2 to
  6 </span><span style='font-size:9.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>g/l total Lead, ),
  therefore no significant impact expected.  </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:156.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Most impacts in baseline. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.65pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Uncertainty re extent of failure of EQS in MS in absence of
  data on DOC. </span><span style='font-size:9.0pt;line-height:107%'>Local
  impacts, especially in areas with low DOC, cannot be discounted but no
  information provided by MS or stakeholders and not possible to estimate,
  though would be minor given small magnitude of change. </span></p>
  </td>
 </tr>
 <tr style='height:135.05pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:135.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>22</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:135.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Naphthalene </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.85pt;
  margin-bottom:1.65pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>(Main
  use as chemical intermediate, produced from coal tar pitch.  </span><span
  style='font-size:9.0pt;line-height:99%'>Produced during combustion, therefore
  many sources, including metal </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>industry.)<b> </b></span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:135.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH (including </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.4pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>possible addition of coal tar pitch high temperature to
  Annex XIV); IED; waste legislation; POPs Regulation  could all reduce
  emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: MAC-EQS </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:135.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.0pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'> Improved coherence with
  chemical policy. Possibly greater attention to reducing point source
  emissions </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.75pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>due
  to introduction of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>MAC-EQS.<b>
  </b></span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.0pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Negative:</span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'> No important impact expected as change of Annual Average
  EQS (AA-EQS) is not major and MACEQS is two orders of </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:135.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Emissions
  (partly natural) cannot be completely eliminated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.65pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Local negative impacts on SMEs cannot be discounted but no
  information provided by stakeholders and not possible to estimate. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty re authorisation, </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>and
  re failure of proposed </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>MAC.<b> </b></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><s>                                               
</s> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span style='font-size:6.5pt;line-height:
107%'>32</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
.35pt;margin-left:78.5pt;text-indent:-29.5pt;line-height:95%'><span lang=EN-US
style='font-size:10.0pt;line-height:95%'>  Since this impact assessment was
drafted, a proposal has also been tabled by Denmark to place restrictions
(under Annex XVII of REACH) on the placing on the market and use of certain
articles containing DEHP and three other phthalates  </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.15pt;margin-left:78.3pt;text-align:left;line-height:107%'><a
href="http://echa.europa.eu/documents/10162/17096/information_note_dk4phthalates_en.pdf"><span
style='font-size:10.0pt;line-height:107%;color:black;text-decoration:none'> </span></a><a
href="http://echa.europa.eu/documents/10162/17096/information_note_dk4phthalates_en.pdf"><span
lang=EN-US style='font-size:10.0pt;line-height:107%;color:blue'>http://echa.europa.eu/documents/</span></a><u><span
lang=EN-US style='font-size:10.0pt;line-height:107%;color:blue'>10162/17096/information_note_dk4phthalates_en.pdf</span></u><span
lang=EN-US style='font-size:10.0pt;line-height:107%'> </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
line-height:107%'> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.2pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>magnitude higher than AA-EQS. </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 0cm 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
 </tr>
 <tr style='height:176.45pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:176.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>23</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:176.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Nickel </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(Main use in alloys, metal </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>plating, batteries, steel manufacture.) </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:176.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH (Evaluation of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.85pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Registration dossier); IED; waste legislation  have
  potential to reduce emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: EQS </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:176.45pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> Alignment of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.7pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>EQS
  with the latest science available. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.65pt;
  margin-bottom:.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Reduced
  risk to or via the aquatic environment. Monitoring of bioavailable Nickel
  would provide better data. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> Significant tightening
  of the standard would lead to increased failure of EQS across EU, but
  variable among MS, driving upgrades in water treatment. </span><span
  style='font-size:9.0pt;line-height:107%'>(See text for details ) </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:176.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.9pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Local impacts possible on industrial SMEs and water
  companies. Costs to water companies/authorities and industry likely to be
  passed to consumers, directly or indirectly, within proportionate limits. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.05pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Assessment uncertain due to lack of monitoring datasets
  that contain the necessary data for calculation of bioavailability and lack
  of information on natural background concentrations.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:83.3pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:83.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>28</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:83.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PAHs </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.8pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>(Main
  use as component of coal tar pitch.  Produced during combustion, therefore
  many sources, </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>including metal industry.) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'> </span></b></p>
  </td>
  <td width=142 rowspan=6 valign=top style='width:106.25pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:83.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PHS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH (including </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.4pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>possible
  addition of coal tar pitch high temperature to Annex XIV); IED; waste
  legislation; POPs Regulation  - could all reduce emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Change: EQS and matrix for 4;
  MAC-EQS for Benzo(g,h,i)perylene </span></p>
  </td>
  <td width=140 rowspan=6 valign=top style='width:104.65pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:83.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:7.45pt;margin-bottom:
  .95pt;margin-left:0cm;text-indent:0cm;line-height:99%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Positive: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved coherence with
  chemical policy. Possibly greater attention to reducing point source
  emissions of some PAHs due to introduction of  MACEQS. Biota standard would
  allow better assessment of the extent of the problem and of the effectiveness
  of measures. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Negative:</span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'> Dependent upon whether additional measures needed. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=164 rowspan=6 valign=top style='width:123.05pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:83.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Emissions (partly natural) cannot be
  completely eliminated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.65pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Local
  negative impacts on SMEs cannot be discounted but no information provided by
  stakeholders and not possible to estimate. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Uncertainty re authorisation of coal
  tar pitch and extent of failure of proposed EQS and </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>MAC. </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:6.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Benzo(a)pyrene </span></b></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:6.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Benzo(b)fluoranthene </span></b></p>
  </td>
 </tr>
 <tr style='height:10.8pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:6.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Benzo(k)fluoranthene </span></b></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:6.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Indeno(1,2,3-cd)pyrene </span></b></p>
  </td>
 </tr>
 <tr style='height:49.75pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:49.75pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:6.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:49.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Benzo(g,h,i)perylene </span></b></p>
  </td>
 </tr>
 <tr style='height:145.4pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>15</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Fluoranthene </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.5pt;
  margin-bottom:1.65pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>(Main
  use as component of coal tar pitch.  Not produced or used in pure form. </span><span
  style='font-size:9.0pt;line-height:99%'>Produced during combustion, therefore
  many sources, including metal </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>industry.)<b> </b></span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH (including </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.4pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>possible addition of coal tar pitch high temperature to
  Annex XIV); IED; waste legislation; POPs Regulation  could all reduce
  emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: EQS </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.25pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:
  </span></b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved
  coherence with chemical policy. Biota standard would allow better assessment
  of the extent of the problem and of the effectiveness of measures </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>.
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.15pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Negative: </span></b><span lang=EN-US style='font-size:
  9.0pt;line-height:107%'>Shift to biota standard likely to result in a
  significant increase in failures. </span><span style='font-size:9.0pt;
  line-height:107%'>Potential local impacts if sediment remediation is needed. </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:145.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Emissions
  (partly natural) cannot be completely eliminated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.65pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Local negative impacts on SMEs cannot be discounted but no
  information provided by stakeholders and not possible to estimate. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty re authorisation of coal
  tar pitch; extent of failure of current EQS.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:93.65pt'>
  <td width=19 valign=top style='width:14.4pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 0cm 0cm 5.4pt;height:93.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>33</span></p>
  </td>
  <td width=155 valign=top style='width:116.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:93.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Trifluralin </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(Use as herbicide no longer
  authorised.) </span></p>
  </td>
  <td width=142 valign=top style='width:106.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:93.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS; </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Recommended POP; </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>PPP
  legislation (recently excluded from Annex I of Dir 91/414/EEC)  emissions
  should be declining. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Change: Status </span></p>
  </td>
  <td width=140 valign=top style='width:104.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:93.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.9pt;
  margin-bottom:1.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:
  </span></b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Change of
  status would ensure coherence with latest scientific information and PPP
  policy. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.45pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Negative:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> No significant negative 
  impact expected as non-authorisation is already in the baseline.  </span></p>
  </td>
  <td width=164 valign=top style='width:123.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 0cm 0cm 5.4pt;height:93.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.25pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Uncertainty re possible need for local remediation and re
  outcome of POPs negotiations. No negative impacts on SMEs expected, except
  possibly  in the short term for producer in Hungary if production has to
  stop;  POP designation likely in baseline anyway. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:12.4pt;margin-left:42.3pt;text-align:left;line-height:96%'><span
lang=EN-US>* </span><span lang=EN-US style='font-size:9.0pt;line-height:96%'>WFD
Programmes of Measures relevant in all cases; uncertain impacts. See Annex V
for information on other relevant legislation in baseline.</span><span
lang=EN-US> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The main positive and negative
impacts of this option are summarised in the table in section 5.3.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The setting of a more stringent
EQS for Nickel (2 </span><span style='font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span
lang=EN-US>g/l bioavailable, corresponding to around 5.6 </span><span
style='font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span lang=EN-US>g/l
total dissolved, cf 20 </span><span style='font-family:"Segoe UI Symbol",sans-serif'>&#956;</span><span
lang=EN-US>g/l total dissolved) would be likely to drive local upgrades of
industrial and/or urban WWTPs, and better control of industrial discharges into
urban sewer systems. The need would have to be assessed at local level, as the
impact would depend on local conditions (nickel bioavailability and hence
toxicity depends on environmental conditions such as pH, dissolved organic
carbon and hardness, dilution of the discharges in the receiving water body,
interactions with other discharges in the basin, etc). Application of a biotic
ligand model (a tool to determine bioavailability on the basis of the
environmental conditions) to available monitoring data shows potential
significant failures in some countries: BE (4 to 56% of samples), DE (6 to
52%), IT (18 to 72%), RO (6 to 27%), SI (0.3 to 8%), the range depending upon
the effect on bioavailable Nickel concentrations of the combination of
environmental conditions . Datasets containing the necessary information to
calculate bioavailability show negligible impact in SE, significant in the UK
(9 to 26%). Estimates for the UK indicate that approximately 2% of the UWWTPs
might need upgrading, requiring whole-life investment of the order of 2 billion
 and attendant additional running costs. This is considered to be a worst case
as the ambient concentrations of Nickel in the UK are among the highest in the
EU. The estimate is based</span><span lang=EN-US style='font-size:9.0pt;
line-height:103%'> </span><span lang=EN-US>on a EQS<sub>bioavailable</sub> of 2
</span>&#956;<span lang=EN-US>g l<sup>-1</sup>, and would be lower if an EQS of
4 </span>&#956;<span lang=EN-US>g l<sup>-1</sup> were adopted as proposed by
the industry stakeholder. This higher EQS could only be arrived at if it were
accepted that the field data provided by the industry removed any uncertainty
about the lowest no effect concentration derived in lower-tier studies, a
position not agreed upon by the Sub-Group on PS as a whole. The importance of
considering bioavailability and natural background concentrations was stressed
by MS and stakeholders during consultation. Industry provided estimates
suggesting that the number of industry installations that would fail to comply
with an EQS of 2 </span>&#956;<span lang=EN-US>g l<sup>-1</sup> would be
significantly greater, depending upon the sector, than the number failing to
comply with an EQS of 4 </span>&#956;<span lang=EN-US>g l<sup>-1</sup>. For
example, in 12 out of 16 sectors, no sites would be compliant at 2 </span>&#956;<span
lang=EN-US>g l<sup>-1</sup>, whereas at 4 </span>&#956;<span lang=EN-US>g l<sup>-1</sup>
only 3 sectors would be non-compliant at all sites. However, the estimates were
not based on a full consideration of bioavailability and appear to represent a
worst-case scenario. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.45pt;margin-left:42.35pt'><span lang=EN-US>Otherwise in this substance option,
no significant costs would be expected for EU industry or for MS, as changes
compared to the baseline are relatively minor. As in the case of some other
substances, the outcome of the REACH authorisation process for DEHP, which is
used as a plasticiser, largely in the manufacture of flexible PVC, cannot be
predicted. The main industry stakeholder argued that DEHP should not be
designated a PHS. However, the listing of DEHP in Annex XIV already implies
eventual substitution and phase-out provided suitable alternative substances or
technologies are economically and technically viable. This would be consistent
with PHS designation and contribute to the WFD objective of phasing out
emissions to the aquatic environment. However, as noted in the above table, DEHP
is widespread in existing construction materials in situ.  A high proportion of
its use is indoor, for example in flooring and flexible water pipes, and this
is considered to account for a high proportion of the emissions to water. Some
outdoor use, for example in roofing materials, also contributes, but the PVC
common in window frames, guttering and downpipes is, according to the
information available, largely unplasticised (i.e. rigid) and therefore should
not contribute. Although the REACH process is likely to achieve complete
substitution in the end, meeting the WFD objective within its 20-year timeline
could still imply a need to replace existing (in situ) construction materials.
However, any such action would be subject to consideration of the costs.
Exemptions regarding the 20 year deadline could be applied, as explained above,
on the grounds of disproportionate costs or technical non-feasibility. The
assessment of early (before end-of-life) replacement costs would need to take
into account the disposal/recycling costs, including those to the environment.
The emissions of DEHP to the environment from incineration and landfill have
been calculated in the EU Risk Assessment Report to be very low compared with
those from use, but the cost of manufacturing replacement materials would also
have to be considered. As noted above, guidance on applying exemptions is
available</span><a href="#_ftn32" name="_ftnref32" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[32]</span></sup></sup></a><span lang=EN-US>.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Regarding other existing PS: On
Trifluralin, comments were received from the main industry stakeholder
questioning whether it should be designated a PHS in the absence of
confirmation of POP classification, but it is clearly a PBT. On PAHs, over half
of MS drew attention during the review to analytical difficulties with some
PAHs because of their low EQS in water; the introduction of a biota EQS should
help. </span></p>

<p class=MsoHeading8 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US
style='font-size:11.0pt;line-height:103%;font-family:"Calibri",sans-serif;
font-style:normal'>                   </span><span lang=EN-US>5.2.4.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'>      </span><span
lang=EN-US>Analysis of impacts of Option A3a: Existing-PS changes plus Annex
III substances </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As options for substances are
cumulative, this option includes all impacts of option A2 plus those described
in this section. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The additional monitoring costs
(based on unit costs of 1-2.4 million  per substance, see Annex IV) are
estimated at 4-9.6 million  per year (i.e. between 5 and 14% of the estimated
current costs of monitoring of existing PS in EU 27, see Annex IV). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.4.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Summary of
specific impacts per substance </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>The table below summarises the
specific impacts per substance and section 2.2.3 outlines the main uses and
reasons for concern. Other details are provided in Annex V.  All the additional
substances in this option are proposed as PHS. In all cases, the major positive
impact (which would not be in the baseline) would be that WFD monitoring would
provide information on the extent of the problem and the effectiveness of the
measures taken. This would in turn provide feedback to other policies to inform
further decision making, e.g. to improve the efficacy of measures (where
necessary), and allow better targeting of sediment remediation. </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.25pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline*  </span></b></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, SMEs,
  notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:93.6pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.2pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Dicofol </span></b></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>POPs legislation could become
  relevant. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Recently
  excluded from Annex I of Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>91/414/EEC; emissions to water
  likely to fall. </span></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'> See text above table.
  Coherence with and feedback to PPP policy. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.95pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Negative</span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>: Potential local impacts if sediment remediation needed
  (more likely in ES, IT and/or FR than other MS).  </span></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Most impacts in baseline as
  authorisation recently withdrawn. Uncertainty re outcome of POPs
  negotiations, and re extent of failure of EQS in several MS due to inadequate
  sensitivity of analytical method. </span><span style='font-size:9.0pt;
  line-height:107%'>No negative impacts on SMEs expected. </span></p>
  </td>
 </tr>
 <tr style='height:114.35pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.2pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>PFOS </span></b></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>POPs legislation (Annex B) applies 
  restrictions on production and use. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>REACH  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>restrictions; IED; waste legislation
  (new limits proposed); will help to reduce emissions to water. </span></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> See text above table. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.4pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Feedback
  to chemicals and waste policy. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Potential local impacts if
  sediment remediation needed.  </span></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Most impacts in baseline. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>As regards SMEs: Possible local
  impacts on landfill operators though also likely to be in baseline. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Uncertainty
  re timeline for availability of substitutes in aviation, photography,
  photolithography (temporary exemptions in baseline), and re extent of failure
  of EQS in some MS. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></b></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Quinoxyfen </span></b></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Regulation (EC) No </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>1107/2009 criteria re </span></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>See text above table. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Feedback to PPP policy. Benefits </span></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Substitutes exist (including
  improved management practices), though question </span></p>
  </td>
 </tr>
 <tr style='height:155.7pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.2pt 0cm 5.4pt;height:155.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:155.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>PBTs
  could lead to wihdrawal of PPP authorisation in 2014. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.1pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Sustainable Use of Pesticides Directive could lead to
  decrease in emissions to water. </span></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:155.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.85pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>for aquatic biodiversity.<b> Negative</b>: If authorisation
  withdrawn there would be substitution costs but not significant according to
  the available information. Largest impacts expected in MS with highest
  consumption (DE, ES, FR, IT), and in hops (due to there being fewer
  alternative products).  </span></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:155.7pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>raised
  regarding possible increased risk of resistance development. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>As regards SMEs: possible impact on
  PPP formulators and retailers while market adjusts.  Possible impact on
  arable farmers </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>(including possible need to change
  management practices). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Phase-out would rely on
  non-reauthorisation following  scheduled review under PPP legislation, such
  that most impacts would in fact be in baseline. Uncertainy re outcome of that
  review, and re: extent of failure of EQS in absence of widespread monitoring
  to match widespread authorisation; possible decline in use as a result of
  resistance. </span></p>
  </td>
 </tr>
 <tr style='height:104.05pt'>
  <td width=84 valign=top style='width:62.95pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.2pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Dioxins and DL-PCBs </span></b></p>
  </td>
  <td width=117 valign=top style='width:87.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>POPs legislation applies; IED and
  waste legislation  could all reduce emissions. </span></p>
  </td>
  <td width=185 valign=top style='width:138.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> See text above table. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.3pt;
  margin-bottom:1.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Feedback
  to industrial emissions and waste policies Reduced risk of exceedance of food
  standard in fish. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Potential for costs of cleaner
  energy to be passed on to consumers, within proportionate limits. </span><span
  style='font-size:9.0pt;line-height:107%'>Potential local impacts if sediment
  remediation needed. </span></p>
  </td>
  <td width=233 valign=top style='width:174.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.2pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Most impacts in baseline. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainties re extent of failure
  in many MS due to insufficient senstivity of analytical method. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:12.4pt;margin-left:42.3pt;text-align:left;line-height:96%'><span
lang=EN-US>* </span><span lang=EN-US style='font-size:9.0pt;line-height:96%'>WFD
Programmes of Measures relevant in all cases; uncertain impacts. See Annex V
for information on other relevant legislation in baseline.</span><span
lang=EN-US>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The main positive and negative
impacts of this option are summarised in the table in section 5.3. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the case of Quinoxyfen, its
authorisation for use under Directive 91/414/EEC (i.e. its inclusion in Annex
I) expires in 2014 and it will need to be reviewed. The results of the
prioritisation process under the WFD will be provided for the review process
under the PPP policy, in order to inform future decisions. If the authorisation
for using Quinoxyfen as a PPP were not renewed, there would be negative impacts
on the producer and on formulators/retailers (although they could be totally or
partially compensated by substitutes). There would also be impacts on farmers
due to the need to find substitutes, but several are authorised and available,
though apparently fewer for hops than for other crops. There is some concern
that resistance to another group of fungicides used to prevent powdery mildew
could increase (HGCA 2009). However, it should be noted in this context that the
WFD allows 20 years for phase-out of emissions to be achieved, compatible with
the timescales over which industry could be expected to develop additional
products and/or strategies to overcome resistance problems. It should also be
noted that alternative management practices in hops can be used effectively to
minimise the need for PPP treatment. In view of the new criteria in Regulation
(EC) No 1107/2009 regarding PBTs, withdrawal of authorisation, and therefore
the impacts indicated here, would be expected to fall within the baseline.
Indeed, achievement of the WFD phase-out objective would rely on a decision
under the PPP Regulation to refuse reauthorisation, and designation as a PHS
under the WFD does not prejudge the outcome of the PPP review. The main industry
stakeholder questioned the listing of Quinoxyfen in view of the available
monitoring data (see section 5.2.2). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Apart from monitoring costs, no
other significant impact of this substance option is expected compared with the
baseline. </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.2.5.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option A3b: Existing-PS changes plus Annex III substances </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>plus other
new substances excluding pharmaceuticals </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As options for substances are
cumulative this option includes all impacts of options A2 and A3a plus those
described in this section. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The additional (cumulative)
monitoring costs (based on unit costs of 1-2.4 million  per substance, see
Annex IV) are estimated at 12-28.8 million  per year (between 17 and 41% of
the estimated current costs of monitoring of PS in EU 27, see Annex IV). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.5.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Summary of
specific impacts per substance  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>The table below summarises the
specific impacts per substance and section 2.2.3 outlines the main uses and
reasons for concern. Other details are provided in Annex V. Of the additional
substances in this option, two (HBCDD and heptachlor) are proposed as PHS. As
in option A3a, WFD monitoring would provide information on the extent of the
problem and the effectiveness of the measures taken. This would in turn provide
feedback to other policies to inform further decision making, e.g. to improve
the efficacy of measures (where necessary), and, in the case of the two
proposed PHS, allow better targeting of sediment remediation. The option
includes several PPPs and biocides.  Collectively, therefore, the option would
contribute to reducing the potential for the drinking water standard for total
pesticides to be exceeded. </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.25pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.3pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* </span></b></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.3pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.3pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>SMEs, notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:104.0pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Aclonifen </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.8pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>PPP legislation. Recent introduction of compulsory buffer
  strips under Directive 91/414/EEC, NAPs due under Sustainable Use Directive 
  could reduce emissions. </span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>See text above table.
  Feedback to </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:116%'><span lang=EN-US
  style='font-size:9.0pt;line-height:116%'>PPP policy. Benefits for aquatic
  biodiversity from enforciing the EQS.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Stricter requirements might be
  needed locally to meet the EQS.  </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.8pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>As
  regards SMEs: A need to take additional measures would affect arable farmers
   but mostly in baseline. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty regarding extent of EQS
  exceedance in many MS due to lack of widespread monitoring and changes under
  PPP legislation.; uncertainty re peak concentrations. </span></p>
  </td>
 </tr>
 <tr style='height:104.0pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Bifenox </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PPP legislation: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>NAPs due under </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:15.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Sustainable Use
  Directive  - buffer strips and other measures could reduce emissions.<b> </b></span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive: </span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>See text above table.
  Feedback to </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:116%'><span lang=EN-US
  style='font-size:9.0pt;line-height:116%'>PPP policy. Benefits for aquatic
  biodiversity from enforciing the EQS.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Stricter requirements might be
  needed locally to meet the EQS.  </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.3pt 0cm 5.4pt;height:104.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.8pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>As
  regards SMEs: A need to take additional measures would affect arable farmers
   but mostly in baseline. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty regarding extent of EQS
  exceedance in many MS due to lack of widespread monitoring and changes under
  PPP legislation; uncertainty re peak concentrations.<b> </b></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US>&nbsp;</span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.2pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* </span></b></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>SMEs, notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:197.15pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Cybutryne </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Biocidal Products Directive  under
  review; outcome could affect authorisation. </span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:102%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  102%'>Positive:</span></b><span lang=EN-US style='font-size:9.0pt;line-height:
  102%'> See text above table. Feed-back to biocides policy. Stimulation of
  innovation to find additional alternatives.  Employment opportunities if more
  frequent mechanical cleaning/maintenance. Benefits for aquatic biodiversity
  from enforciing the EQS.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Substitution costs if substitution
  is needed to meet the EQS.  Labour costs if use more frequent mechanical
  cleaning/maintenance. Increased shipping fuel costs/CO<sub>2</sub> etc
  emissions if alternatives less effective. Additional costs might be passed on
  to consumers/passengers. Potential local impacts if sediment remediation is
  needed.  </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.85pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>As
  regards SMEs: Possible impacts on coating formulators, dockyards, ship
  owners, fishermen, but low since not PHS. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:99%'><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'>Limited number of
  available chemical substitutes.  Toxicity possibly not much lower, or little
  studied.  Natural biocides being investigated.  Nonbiocidal fouling release
  coatings (e.g. silicone-based) have been developed. Mechanical cleaning also
  possible. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainties re outcome of biocidal
  products review, possible impact of national bans on use on small boats. </span></p>
  </td>
 </tr>
 <tr style='height:238.5pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:238.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Cypermethrin </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:238.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PPP legislation: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>NAPs due under </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:14.85pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>Sustainable Use
  Directive  - buffer strips and other measures could reduce emissions. </span><span
  style='font-size:9.0pt;line-height:107%'>Biocidal Products Directive  under
  review; outcome could affect authorisation.<b> </b></span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:238.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.8pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:104%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  104%'>Positive:</span></b><span lang=EN-US style='font-size:9.0pt;line-height:
  104%'> See text above table. Feed-back to PPP and biocides policy. Benefits
  to biodiversity. Significant potential benefits to fisheries and angling. <b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: For its use on crops, stricter
  requirements might be needed locally as a result of WFD monitoring and the
  need to meet the EQS. Costs to textile factories of increased effluent
  treatment and costs of substitution if needed to meet the EQS, but none
  expected to be significant. Possible impact on use in sea-lice treatment by
  salmon farmers. </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:238.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.55pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>As regards SMEs: A need to take additional measures would
  affect arable farmers  but mostly in baseline. Salmon farmers could be
  affected though EQS exist in DKand UK. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.5pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Alternatives available if needed, e.g. hydrogen peroxide in
  salmon farming, alternative PPPs in agriculture. Uncertainties re extent of
  failure of proposed EQS in several MS in absence of sufficiently sensitive
  analytical method; extent of failure in UK following ban on use in sheep
  dipping in UK; extent to which used for sheep dipping in other MS; likely
  trend in use in agriculture and forestry; outcome of biocidal products
  review.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:104.05pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Dichlorvos </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.65pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Biocidal
  Products Directive  under review; outcome could affect authorisation. </span><span
  style='font-size:9.0pt;line-height:99%'>Recently excluded from Annex I of
  Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>91/414/EEC <b> </b></span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Positive:</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'> See text above table.
  Feedback to biocides policy Benefits for aquatic biodiversity from enforciing
  the EQS.   <b>Negative</b>: Possible reduction in range of uses, e.g. to
  indoor use, but no significant impacts likely unless authorisation withdrawn,
  in which case in baseline.  </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:104.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>As regards SMEs: Possible impacts on
  product formulators, but likely only as part of baseline. Uncertainties re
  extent of failure of proposed EQS in several MS in absence of sufficiently
  sensitive analytical method; and re outcome of biocidal products review.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* </span></b></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>SMEs, notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:197.15pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>HBCDD </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:9.0pt;line-height:107%'>POPs legislation could
  become relevant.  Inclusion in Annex XIV of REACH could affect authorised
  uses. </span><span style='font-size:9.0pt;line-height:107%'>IED and waste
  legislation could reduce emissions to water. </span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Positive:</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'> See text above table. Feed-back to
  chemicals and waste policy. Potential </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>improvements for </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.35pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>aquaculture/fisheries/angling;
  potential for improving human health; stimulation of innovation; benefits to
  producers of alternatives including potential employment; employment in
  remediation work. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Possible loss of employment at
  single production site in the EU, but likely to be in baseline. Potential
  local impacts if measures taken at local level to meet EQS or to remediate 
  sediments. </span><span style='font-size:9.0pt;line-height:107%'>Po </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:197.15pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.8pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:99%'><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'>Most impacts in baseline,
  including, e.g. impacts on product manufacturers, construction companies  and
  landfill operators, among them some SMEs,  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Substitutes being developed, but
  uncertainties re timeline for availability (none yet for certain types of polystyrene,
  though in pipeline) and environmental and health impacts. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Uncertainties
  also re designation as POP; possible authorised uses under Annex XIV of
  REACH; impacts of waste disposal route </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>(incineration cf landfill). </span></p>
  </td>
 </tr>
 <tr style='height:93.6pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Heptachlor/ heptachlor epoxide </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>POPs legislation </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(including ban under </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Regulation (EC) No 850/2004)) and
  exclusion from </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Annex I of Directive 91/414/EEC </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>responsible for reducing emissions. 
  </span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.85pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Positive:</span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'> See text above table. Benefits for aquatic biodiversity
  from enforciing the EQS by, e.g. additional water treatment or sediment
  remediation, thence better protection of human health from secondary
  poisoning.<b> Negative</b>: Potential local impacts if additional water
  treatment or sediment remediation undertaken.  </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:93.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.25pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Uncertainty re extent of failure of proposed EQS in several
  MS in absence of sufficiently sensitive analytical method. </span><span
  style='font-size:9.0pt;line-height:107%'>No negative impacts on SMEs
  expected.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:166.15pt'>
  <td width=97 valign=top style='width:72.85pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.15pt 0cm 5.4pt;height:166.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Terbutryn </span></b></p>
  </td>
  <td width=119 valign=top style='width:89.05pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:166.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Biocidal
  Products Directive  under review; outcome could affect authorisation.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Excluded from </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Annex I of Directive 91/414/EEC
  within past 10 years.<b> </b></span></p>
  </td>
  <td width=238 valign=top style='width:178.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:166.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:102%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  102%'>Positive:</span></b><span lang=EN-US style='font-size:9.0pt;line-height:
  102%'> See text above table. Feed back to the biocides policy. Benefits to
  biodiversity, and to angling. Sustainable Urban Drainage (SUDs) could have
  shared benefits, e.g. flood control, energy saving.  Stimulation of
  innovation in construction to minimise need for biocidal coatings.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Negative</span></b><span
  lang=EN-US style='font-size:9.0pt;line-height:99%'>: Installation and
  maintenance of SUDs (variable costs depending upon type). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Costs of  substitutes if needed. </span></p>
  </td>
  <td width=166 valign=top style='width:124.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.15pt 0cm 5.4pt;height:166.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.25pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>As
  regards SMEs: Possible impacts on coating formulators, construction industry,
  but low since not PHS. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Limited information on substances that can be substituted
  on a like-for-like basis. Altenerative building and surface design possible,
  also mechanical cleaning. Uncertainties re outcome of biocidal products
  review; extent of failure of EQS now that no longer used as herbicide. <b> </b></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:12.4pt;margin-left:42.3pt;text-align:left;line-height:96%'><span
lang=EN-US>* </span><span lang=EN-US style='font-size:9.0pt;line-height:96%'>WFD
Programmes of Measures relevant in all cases; uncertain impacts. See Annex V
for information on other relevant legislation in baseline.</span><span
lang=EN-US>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The main positive and negative
impacts of this option are summaried in the table in section 5.3. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The outcome of reviews under
other policies could result in the restriction of certain uses for PPPs or
biocides, hence triggering substitution costs. However, the data gathered do
not allow quantitative assessment of costs. According to the information
available, there are substitutes for all the substances, although for some this
might be more difficult (in particular for Cybutryne and Terbutryn).
Nevertheless, as they are not identified as PHS, listing would not necessarily
imply substitution.  For Cybutryne, the international nature of shipping and
the relevance of the International Maritime Organisation's International
Convention on the Control of Harmful Anti-fouling Systems on Ships</span><a
href="#_ftn33" name="_ftnref33" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[33]</span></sup></sup></a><span
lang=EN-US> might need to be considered if national measures were not
sufficient to allow achievement of the EQS. For Cypermethrin, additional
management measures might be needed locally in salmon farming to ensure that it
could remain in the portfolio of sea-lice treatments, as it still is in
Scotland despite a national EQS. It should be possible to manage without
substitutes, but they exist for aquaculture (e.g. application of hydrogen
peroxide) and agriculture (alternative pyrethroids) if needed, though some
costs could arise in relation to vine weevil control in the (unlikely) event
that Cypermethrin use could not continue (ADAS, 2010, HGCA 2009)</span><span
lang=EN-US style='font-size:9.0pt;line-height:103%'>. </span><span lang=EN-US>The
inclusion of Cypermethrin was questioned by the main industry stakeholder as
explained in section 5.2.2. </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.2.6.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option A3c: Existing-PS changes plus Annex III substances </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>plus other
new substances including pharmaceuticals </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As options for substances are
cumulative this option includes all impacts of options A2, A3a and A3b plus
those described in this section.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The additional (cumulative)
monitoring costs (based on unit costs of 1-2.4 million  per substance, see
Annex IV) are estimated at 15-36 million  per year (between 22 and 52% of the
estimated current costs of monitoring of PS in EU 27, see Annex IV). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>5.2.6.1.</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Summary of
specific impacts per substance </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>The three additional substances in
this option are all pharmaceuticals, although one is also excreted naturally. 
The table below summarises the specific impacts for these substances and
section 2.2.3 outlines the main uses as well as the reasons for concern. Other
details are provided in the text below the table and in Annex V. For these
substances, as in the other options, a significant benefit of PS status is that
WFD monitoring would provide information on the extent of the problem and the
effectiveness of any measures taken. This would in turn provide feedback to pharmaceuticals
policy. Since pharmaceuticals have not hitherto been regulated under the WFD,
their regulation would bring new elements into play, notably public health
considerations. The three substances under consideration are different in
character (uses, sources, alternatives) and therefore also from a regulatory
point of view (see Annex VI). </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:21.25pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.75pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* </span></b></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.75pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.75pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, SMEs,
  notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:176.4pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>17 alphaethinylestradiol </span></b></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Urban
  Waste Water Treatment Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(UWWTD). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Pharmaceuticals
  (including pharmacovigilance) legislation. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Take-back schemes. </span></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:101%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  101%'>Positive: </span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:101%'>See text above table. Benefits for aquatic biodiversity,
  especially fish, from meeting the EQS, due to lower endocrine disruptive
  exposure. Benefits to commercial and recreational fishing. Lower risk of
  drinking water containing the substance hence potential savings in drinking
  water treatment.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Potential local costs if
  additional waste water treatment undertaken. (See text below re possible
  costs.) Possible one-off costs in the longer term for pharmaceutical
  companies to switch to alternative products, </span></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.15pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Substitute
  (progestogen) exists for  contraceptive pill use that exhibits lower impacts
  on aquatic wildlife and higher removal rates in conventional waste water
  treatment plants, though not necessarily suited to all patients. Other
  contraceptive methods also available (though may be less effective).
  Doctor/patient choice maintained, but could be influenced by information
  about environmental impact. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>As regards SMEs: A possible shift in
  the long term towards substitute(s) (through changed prescription practices)
  would involve medical practices and pharmacies but would be unlikely to have
  any significant negative impacts. </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.75pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Baseline* </span></b></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Summary of significant specific
  impacts </span></b></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Remarks re substitution, SMEs,
  notable uncertainties </span></b></p>
  </td>
 </tr>
 <tr style='height:114.35pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.75pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US>&nbsp;</span></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>but overall market maintained. </span></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:114.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.5pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:.1pt;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Expansion of take-back schemes could involve some costs but
  also some benefits for public authorities and wastehandlers. Water companies
  could face higher costs if additional waste water treatment required, but
  substitution and take-back expansion should benefit them and drinking water
  treatment costs can be reduced. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty regarding variation in
  EQS exceedance across MS. </span></p>
  </td>
 </tr>
 <tr style='height:176.4pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>17 betaestradiol (E2) </span></b></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Urban
  Waste Water Treatment Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>(UWWTD). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Pharmaceuticals (including
  pharmacovigilance) legislation: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Take-back schemes. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Nitrates and pesticides legislation
  related to slurry spreading and buffer strips.<b> </b></span></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
  margin-bottom:1.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:101%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  101%'>Positive: </span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:101%'>See text above table. Benefits for aquatic biodiversity,
  especially fish,   from meeting the EQS, due to lower endocrinedisruptive
  exposure. Benefits to commercial and recreational fishing. Lower risk of
  drinking water containing the substance hence potential savings in drinking
  water treatment.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Negative</span></b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>: Potential local costs if
  additional waste water treatment undertaken and/or livestock farmers need to
  fence water courses beyond the requirements under other legislation. </span><span
  style='font-size:9.0pt;line-height:107%'>(See text below re possible costs.) </span></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:176.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span lang=EN-US style='font-size:9.0pt;
  line-height:99%'>Substitution of limited relevance. As regards SMEs:
  Livestcok farmers could face additional costs for fencing water courses.
  Expansion of take-back schemes (limited relevance for E2) could involve some
  costs but also some benefits for public authorities and wastehandlers. Water
  companies could face higher costs if additional waste water treatment
  required, but source-control measures should reduce the need for this and
  drinking water treatment costs can be reduced. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty regarding variation in
  EQS exceedance across MS.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:217.85pt'>
  <td width=102 valign=top style='width:76.7pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.75pt 0cm 5.4pt;height:217.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Diclofenac </span></b></p>
  </td>
  <td width=128 valign=top style='width:95.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:217.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Pharmaceuticals (including
  pharmacovigilance) legislation: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Take-back schemes. </span></p>
  </td>
  <td width=176 valign=top style='width:132.3pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:217.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Positive:
  </span></b><span lang=EN-US style='font-size:9.0pt;line-height:99%'>See text
  above table. Benefits for aquatic and other biodiversity from meeting the </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:115%'><span lang=EN-US
  style='font-size:9.0pt;line-height:115%'>EQS. Benefits to commercial and
  recreational fishing.<b> </b></span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.8pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Negative</span></b><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>: Potential local costs if additional water treatment
  undertaken. (See text below re possible costs.) Possible one-off costs in the
  longer term for pharmaceutical companies to switch to alternative products,
  but overall market maintained.<b> </b></span></p>
  </td>
  <td width=213 valign=top style='width:159.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.75pt 0cm 5.4pt;height:217.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Substitute NSAIDs exist with similar
  therapeutic efficacy that are easier to remove in UWWTPs. Doctor/patient
  choice maintained, but could be influenced by information about environmental
  impact. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>As
  regards SMEs: A possible shift in the long term towards substitute(s)
  (through changed prescription practices) would involve medical practices and
  pharmacies but would be unlikely to have any significant negative impacts.
  Expansion of take-back schemes could involve some costs but also some
  benefits for public authorities and wastehandlers. Water companies could face
  higher costs if additional treatment required, but substitution and take-back
  expansion should benefit them. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Uncertainty regarding variation in
  EQS exceedance across MS.  </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:12.4pt;margin-left:42.3pt;text-align:left;line-height:96%'><span
lang=EN-US>* </span><span lang=EN-US style='font-size:9.0pt;line-height:96%'>WFD
Programmes of Measures relevant in all cases; uncertain impacts. See Annex V
for additional information on the baseline.</span><span lang=EN-US>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>All three have been used for
several years as pharmaceutical ingredients, and 17 beta-estradiol (E2) is also
naturally excreted by humans and other mammals. The benefits deriving from
their pharmaceutical application are reflected in their widespread use.
However, they can pose a significant risk to the aquatic environment if their
concentration is higher than the proposed environmental quality standard, as is
found and has been indicated in section 2.2.3. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although their addition to the PS
list would be aimed principally at gathering monitoring data in the immediate
future, this section presents measures that might be used by MS to address the
potential environmental risk posed by them. It is not possible to assess the
costs and benefits of such measures in detail, as explained in section 5.2.1.1.
However, some cost estimates are presented below. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Although one possible measure
would be end-of-pipe treatment (improvement of UWWTPs). source-control measures
might be more cost-effective. They could contribute to reducing the need for
and cost of end-of-pipe treatment.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As mentioned in section 2.3, a
significant source of emissions of pharmaceuticals, despite the existence of
take-back schemes, is the disposal of unused products. In the absence of good
knowledge regarding the functioning of these schemes, including of their set-up
(e.g. whether financing is public, private or mixed), it is difficult to assess
the impacts of change. However, the figures cited in section 2.3 suggest that
there is room for improvement  (as confirmed by the Pharmaceutical Group of the
European Union). This could significantly reduce the emissions of Diclofenac
and EE2. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Another approach to consider
would be the promotion of more environmentally-friendly alternatives. For
example, several Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) exist that
could be used instead of Diclofenac, with similar therapeutic efficacy</span><a
href="#_ftn34" name="_ftnref34" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[34]</span></sup></sup></a><span
lang=EN-US> but allowing easier removal in conventional UWWTPs (Roig 2010).
Information to patients, doctors and pharmacists about the environmental impact
of medicines could influence prescription if there were valid alternatives, as
is the case for Diclofenac.  In Stockholm (SE), an Environmental Classification
System was established in 2005 that includes information to doctors,
pharmacists and patients, leading to a significant impact on the prescription
behaviour of health professionals, although comprehensive information on the
success of the scheme is not available (Knappe 2008). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The oral pharmaceutical
alternative to EE2-based oral contraceptives is the progestogen-based
&quot;mini-pill&quot; which currently has an estimated market share of 8.5%.
The efficiency of the contraception is identical (0.3 unintended pregnancies
per 100 women). However, the EE2based pill is not replaceable in all cases by
the progestogen-based mini-pill.. Progestogens are also endocrine disrupting
substances but the rate of removal in waste water treatment plants is
significantly higher than for EE2 (Roig 2010; Chang. <i>et al,</i> 2011). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As regards E2, improved take-back
schemes would be relevant to its pharmaceutical use, but the main measures
would have to focus on reducing emissions due to natural human and livestock
excretion which account for 90% of total emissions, e.g. improvements to UWWTPs
and protection of water courses from livestock excreta; the former would reduce
emissions also from the pharmaceutical uses.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.4pt;margin-left:42.35pt'><span lang=EN-US>As stated above, source control
measures might be more efficient than end-of-pipe treatment. In selecting the
most cost-effective measures MS would need to take into account the timing, in
particular the fact that the EQS are not to be achieved in the short term, but
only 10 years from now, and that there are possibilities for exemptions to
extend the deadline on grounds of disproportionate cost or technical
non-feasibility.  As noted above, guidance on applying exemptions is available</span><a
href="#_ftn35" name="_ftnref35" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[35]</span></sup></sup></a><span
lang=EN-US>.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.2pt;margin-left:42.35pt'><span lang=EN-US>It is however not possible to
estimate how much end-of-pipe treatment would be needed across the EU. This is
very much dependent on local conditions. Nevertheless, some cost estimates for
upgrading UWWTPs to remove E2 are available; they assume that no sourcecontrol
measures are taken and in that respect represent worst-case scenarios. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:71.85pt;text-indent:-30.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>For England and Wales (UK), an estimate of 18 
per inhabitant per year was derived</span><a href="#_ftn36" name="_ftnref36"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[36]</span></sup></sup></a><span
lang=EN-US>. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.9pt;margin-left:73.1pt;line-height:125%'><span lang=EN-US>based on a
modelling exercise using an EQS stricter than the one proposed (2.7 10<sup>-4</sup>
</span>&#956;<span lang=EN-US>g/l instead of 4.0 10<sup>-4</sup> </span>&#956;<span
lang=EN-US>g/l). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:71.85pt;text-indent:-30.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>For Switzerland, an increase of 5 to 25% in
relation to conventional treatment costs depending upon the size of the plant
has been estimated, resulting overall in 11-18  per inhabitant per year
depending on the number of plants to be upgraded (Abegglen <i>et al</i>, 2009).
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>These costs would fall on water
companies (sometimes SMEs) but would likely be passed to consumers in full or
in part in higher water bills, within proportionate limits. The increased
treatment would result in a significant increase in energy use due to the
increased treatment (equivalent to 1 million tons of CO<sub>2</sub> in England
and Wales, an increase of 20% in relation to the current energy consumption in
UWWTPs). On the other hand, the technologies used for the enhanced treatment
would also eliminate many other pollutants and thus improve the quality of the
discharge significantly, making it easier to treat water downstream for the
production of drinking water and therefore implying potential savings.
Additional benefits are discussed in section 5.2.1.1. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The cost of fencing to avoid
livestock access to water courses is estimated at between 2 and 12 /ha/year
(quoted in Entec 2011); it is not possible to estimate how much fencing would
be required in total.  The costs could fall largely on livestock farmers
(generally SMEs) but be attributed in part to requirements under other
legislation such as the Nitrates Directive. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As mentioned above, not only the
costs but also the benefits of applying measures (as noted in the table) are
difficult to quantify. However, on the basis of the evidence for concern noted
in section 2.2.3 and the generic benefits presented in section 5.2.1.1
including the value of a resilient aquatic ecosystem, significant benefits from
meeting the EQS would be expected. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Uncertainties in the assessment
of benefits and costs arise not only from uncertainties in the extent of
exceedance of the EQS in different MS given the limited monitoring coverage and
often inadequate analytical sensitivity, but also from the absence of
information on production of the substances in the EU, and from the limited
experience of reducing the environmental impact of pharmaceuticals in use.
These uncertainties suggest that until further monitoring data have been
gathered to inform the policy making, it would not be appropriate to propose
measures at EU level; measures to influence prescription could in fact only be
taken at MS level since there are currently no mechanisms in the EU legislation
to do this. However, the evidence of pollution is considered sufficient to
include E2, EE2 and Diclofenac in the list of PS and to establish an EQS at EU
level. In addition to reviewing the monitoring data, the Commission will
explore in its study on the environmental impact of pharmaceuticals the need to
provide mechanisms to address the issue at EU level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>During the consultation process
the pharmaceutical industry expressed clearly its opposition to the inclusion
of any pharmaceutical on the list of WFD priority substances, favouring a more
holistic approach towards regulating the environmental impact of pharmaceutical
products. On the other hand, the environmental NGOs favoured inclusion. No
other stakeholder indicated a clear preference for one or another substance
option, although comments were made regarding some individual substances, as
reported above. The fact that all the substances reached this stage of the review
reflected the existence of concern about them. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.3.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>        </span></b><b><span
lang=EN-US style='font-style:normal'>Comparison of the substance options </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the following table the
options A1 to A3 are compared.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>Effectiveness is compared on the
basis of the objectives set out in section 3.The diversity of impacts covered
by the different options does not allow an overall assessment of efficiency. As
an alternative, the main positive and negative impacts of the options are
presented in the table. The cost of monitoring the existing PS is estimated at
69m  per year (see Annex IV). </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=617
 style='width:462.5pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Effectiveness </span></b></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Main positive impacts  </span></b></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Main negative impacts  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>A1: No change </span></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>0 </span></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'> </span></p>
  </td>
 </tr>
 <tr style='height:196.15pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:196.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>A2: Existing PS  </span></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:196.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.15pt;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved
  knowledge of the extent of the risks from existing PS (through the setting of
  biota standards for poly-BDE, PAH and Fluoranthene). </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>No
  improved knowledge of the risks posed by newly identified substances.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Latest
  scientific information on the risks posed by additional substances not
  considered. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:3.6pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Failure to optimise protection against identified risks
  from new substances not included in the PS list. </span></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:196.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.2pt;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Better
  and more robust knowledge of the extent of the risks, coherence of the
  existing EQSs with the latest scientific and technical progress developed in
  the context of the chemicals policy, which would allow MS and other policies
  to take the necessary measures to reduce the risks caused by these substances
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.3pt;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>to
  or via the aquatic environment. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Improved protection of human health
  and aquatic biodiversity. </span></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:196.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.25pt;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Potential
  significant costs to upgrade some industrial and UWWTPs (for Nickel),
  depending on local conditions. Costs would fall initially on water
  authorities/companies and industries but likely be passed to consumers,
  within proportionate limits. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Effectiveness </span></b></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Main positive impacts  </span></b></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Main negative impacts  </span></b></p>
  </td>
 </tr>
 <tr style='height:206.4pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:206.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>A3a: Existing </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS plus Annex </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>III substances </span></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:206.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved
  knowledge of the extent of the risks from existing PS (through the setting of
  biota standards for poly-BDE, PAH and Fluoranthene) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Very
  limited improvement in knowledge of the risks posed by newly identified
  substances.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Latest
  scientific information on the risks posed by several additional substances
  not considered. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Failure to optimise protection
  against identified risks from several substances not included in the PS list.
  </span></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:206.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above plus: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.15pt;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Information
  about the presence of and  extent of the risk caused by the additional
  substances and about the effectiveness of largely baseline measures at
  reducing or phasing out emissions. Valuable data and information for decision
  making on targeted remediation and in the context of the PPP, chemicals, industrial
  emissions and waste policy. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Additional protection of human
  health and aquatic biodiversity. </span></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:206.4pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above plus: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Estimated
  additional monitoring costs of 4  9.6m  per year, which would fall on MS.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Possible substitution costs for
  Quinoxyfen if not in baseline; could fall on the producers, formulators,
  farmers and/or consumers depending upon the substitute. </span></p>
  </td>
 </tr>
 <tr style='height:185.75pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:185.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>A3b: Existing </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS plus Annex </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>III plus other new excluding
  pharmaceuticals </span></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:185.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+++
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved
  knowledge of the extent of the risks from existing PS (through the setting of
  biota standards for poly-BDE, PAH and Fluoranthene) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Significant
  improvement in knowledge of the risks posed by newly identified substances.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Latest
  scientific information on the risks posed by pharmaceuticals not considered. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>No protection provided for
  identified risks from pharmaceuticals. </span></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:185.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above plus: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Valuable
  data and information for decision making in the context of the biocides
  policy </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Additional protection of human
  health and aquatic biodiversity. </span></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:185.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above but: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:6.65pt;
  margin-bottom:4.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:118%'><span lang=EN-US style='font-size:9.0pt;line-height:118%'>Estimated
  additional monitoring costs of 12  28.8m  per year, which would fall on MS;
  plus </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Possible
  costs to producers/formulators/consumers of substitutiing  Cybutryne and Terbutryn
  (though not PHS); possible reduction in portfolio of treatment options for
  sea-lice in salmon farming if Cypermethrin could no longer be used for that
  purpose. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:179.75pt'>
  <td width=92 valign=top style='width:69.3pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 1.35pt 0cm 5.4pt;height:179.75pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>A3c: Existing </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>PS plus Annex </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>III plus other new including
  pharmaceuticals </span></p>
  </td>
  <td width=174 valign=top style='width:130.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:179.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++++
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Improved
  knowledge of the extent of the risks from existing PS (through the setting of
  biota standards for poly-BDE, PAH and Fluoranthene) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Very
  significant improvement in knowledge of the risks posed by newly identified
  substances.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Latest
  scientific information on the risks fully considered. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Protection optimised against
  identified risks from all the prioritised substances. </span></p>
  </td>
  <td width=174 valign=top style='width:130.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:179.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above plus: </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.65pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Improved information on the extent of
  pollution by pharmaceuticlas, and  EU-wide EQS as benchmarks for deciding
  measures at MS level.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Additional protection of human
  health and aquatic biodiversity. </span></p>
  </td>
  <td width=176 valign=top style='width:131.75pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 1.35pt 0cm 5.4pt;height:179.75pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>As
  above but: </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:6.65pt;
  margin-bottom:3.95pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:118%'><span lang=EN-US style='font-size:9.0pt;line-height:118%'>Estimated
  additional monitoring costs of 15  36m  per year, which would fall on MS;
  plus: </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Possible costs of additional </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>UWWTP upgrades to remove E2 </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>if locally required and not
  sufficient in option A2. Costs would fall initially on water
  authorities/companies but likely be passed to consumers, within proportionate
  limits.  </span><span style='font-size:9.0pt;line-height:107%'>Costs for
  livestock fencing could fall on farmers. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
12.45pt;margin-left:42.3pt;line-height:95%'><span lang=EN-US style='font-size:
10.0pt;line-height:95%'>Magnitude of impact as compared with the baseline
scenario (the baseline is indicated as 0) + means positive (number of +
indicates magnitude)</span><span lang=EN-US> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>No disproportionate costs have
been identified at EU level, and option A3c achieves the objectives to the
greatest extent as it contains the complete outcomes of the prioritisation
process. Option A3c is therefore the preferred option. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>If MS found that disproportioante
costs would be incurred locally, the exemptions under the WFD could be used for
particular water bodies if the conditions set out in the WFD were fulfilled, as
explained in section 5.2.1.2. According to the available information, though,
it is unlikely that such disproportionate costs would arise at many locations,
except in the case of ubiquitous PBTs. </span>MS would inevitably consider the
implications for newly identified PS of their existing Programmes of Measures
before considering the need for further measures. <span lang=EN-US>Some of them
might already have been included as RBSPs or be affected by measures for other
substances. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Option A3c ensures gathering of
data to inform measures locally and possibly at EU level for all the
prioritised substances. If the available information were not sufficient to
decide on the need for measures at the time of adopting the Programmes of Measures
, MS would be expected to identify, in their Programmes, the monitoring
required to inform this decision, as well as the monitoring required to judge
the effectiveness of any measures.The estimated monitoring costs are calculated
linearly on the basis of a unit cost per substance (see Annex IV). This
approach, which has the merit of simplicity, overestimates the costs for the
options with the largest number of substances. These will have a better cost
ratio per substance since sampling costs  increase less steeply as the number
of substances increases. Further, should upgrades to UWWTPs be required, or
sediment remediation be undertaken, the costs per substance would decrease,
i.e. they should not be multiplied by the number of substances. The benefits
would extend beyond the targeted substances.  </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.4.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Analysis of impacts of options in relation
to the ubiquitous PBTs </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the consultation phase, the
identification of options to address the problems relating to ubiquitous PBTs
was welcomed particularly by MS, but also by stakeholders.  </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.4.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
                        </span><span lang=EN-US>Analysis of impacts of Option
B2a on presentation: Give more flexibility on </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>presentation 
</span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This is a relatively simple
option that allows MS to adapt the presentation of the chemical status in the
RBMP, separating ubiquitous PBTs and the rest of the substances. No significant
costs are identified for this option. Some small costs might be involved in the
production of different maps for the plans, but these are not considered
significant. As regards potential negative impacts, as this option would not
oblige MS to present PBTs separately, some discrepancy in presentation of the
results between MS might occur.   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In terms of benefits, the
flexibility in the presentation would still maintain legal certainty as the
definition of chemical status would not change. There would also be some
administrative savings as MS would not need to justify in the RBMP the
situation as regards ubiquitous PBTs, but would use the rationale provided in
the EU legislation to present separately the information on these substances.
It should be recalled that the RBMP are subject to compulsory public
consultation.  </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.4.2.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option B2b on presentation: Take ubiquitous PBTs out of </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>chemical
status </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This would represent a major
change in the WFD and EQSD. It would reduce the level of environmental
protection because there would be no EU EQS and no driver for taking measures. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The first implementation cycle of
the WFD has not yet ended . Changing the goal posts before the 2015 deadline
for achieving the objectives would create legal uncertainty. This option is
also not fully consistent with the general objectives of the WFD to establish a
high level of protection for the aquatic environment, as it would exempt some
of the most dangerous substances from key obligations of the Directive. 
However, it would be a very straightforward way of addressing the problem of
presentation. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The environmental NGOs expressed
concern about both options B2a and B2b effectively because they considered that
less attention would be given to the problem of ubiquitous PBTs. Most MS
favoured option B2a. </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.4.3.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option B3a on choice of matrix: Leave flexibility but link the </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>choice to
requirements of Directive 2009/90/EC </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The main driver for the choice of
the matrix should be the intrinsic properties of the substance and its
environmental fate, together with the possibilities to effectively monitor the
environmental concentrations to manage risks. However, flexibility in the
choice of matrix is highly appreciated by MS. and factors such as tradition and
experience in the MS, the expertise in the national laboratories and the
maintenance of long time series of monitoring data could play a role. For
example IT has a long tradition of monitoring sediments in coastal and
transitional waters. Independently of the discussion about the appropriateness
of setting standards at EU level for sediment and biota, some MS consider that
water standards are useful in any case for the purpose of setting emission
limits in the permits for waste water discharges, even when far below the
sensitivity of state-of-the-art analytical techniques. Where it is possible to
monitor reliably in any of the matrices, leaving MS the choice of the matrix
allows them to take advantage of their experience and expertise. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option, while also providing
flexibility to adapt monitoring strategies quickly to progress in analytical
techniques would at the same time lead to improved harmonisation of the
assessment of chemical status. Adaptation costs might be faced by MS without
experience in monitoring and analysing specific substances in certain
matrices.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This option might introduce lack
of legal clarity if there are no standard international analytical methods for
certain substances, with internationally accepted analytical sensitivities. If
this is the case, it will not be straightforward to assess which available
method performs better and it could depend on the laboratory.   </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.4.4.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option B3b on choice of matrix: Fix the preferred matrix for </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>each
substance </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>A preferred matrix could be
selected for each substance on the basis of the intrinsic properties and
environmental fate and taking into account the performance of the best
available monitoring technique. This would ensure a high level of harmonisation
of the assessment of chemical status. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>On the other hand, for some
substances the preferred matrix is not clear cut and may depend on the local
environment and nature of the emissions. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Adaptation costs might be faced
by some MS without experience in monitoring and analysing specific substances
in certain matrices. There would be no possibility to adapt quickly to progress
in analytical techniques that could improve the sensitivity in certain
matrices. This could hinder progress in the development of analytical
techniques for these other matrices. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>One of the advantages of this
option is the legal clarity it would provide, as the matrix would be fixed at
EU level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>As implied above, more MS
favoured maintaining some flexibility in the choice of matrix, although some
favoured fixing the matrix in order to ensure comparability of results. </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.4.5.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option B4a on monitoring: Introduce reduced monitoring </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>obligations
for ubiquitous PBTs if certain specified conditions are met  </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Costs could be saved because of
reduced monitoring effort and reduced administrative burden for MS; the
justification for the reduced effort would be in the EU legislation. The option
could cover up to 8 ubiquitous PBTs (the 4 existing PS and 4 proposed), but the
estimates in this section only cover the 4 existing (see section 5.7.1 for
interactions between options). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>It is estimated that the
reduction in monitoring effort could save between 20 and 30% of the monitoring
costs. This is a conservative estimate, since the default frequency in water is
monthly (WFD Annex V) and in sediment and biota it is annually (EQSD Article
3.2c). The potential reduction in frequency of analysis for the water matrix is
estimated to be from 12 samples per annum to 1 or 2 and for biota from 1 per
annum to 1 every two or three years. This would give potential reductions of
between 50% and 90%. In addition there could be additional savings by reducing
the number of monitoring points to take into account the ubiquitous nature of
the substances. However, taking into account the uncertainty as regards the
availability of a robust monitoring baseline in all MS, the potential savings
are reduced to an estimate of 20-30%. These savings are considered achievable
in the short term. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>If monitoring costs were reduced
for all existing 4 ubiquitous PBTs in the 20-30% range, 0.8 to 2.9 million 
per annum could be saved across the EU (between 1 and 4% of the overall estimated
current costs of monitoring of PS).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The reduced administrative burden
arising from not having to justify reduced monitoring effort for each of the
substances is estimated at several man-days of work per RBMP. There are 176
RBDs. However, some countries have a strong national approach to implementating
the WFD and would probably reuse the administrative effort for all or several
of their RBDs (e.g. UK, IE, AT, PL, PT, NL). If this were taken into account,
justification would be derived first hand for only about 120 RBDs. If applied
to all 4 existing ubiquitous PBTs, the savings would amount to 1000 to 2500 
man-days across the EU per RBMP cycle.  </span></p>

<h3 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>5.4.6.</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Analysis
of impacts of Option B4b on monitoring: Introduce reduced monitoring </span></h3>

<h4 style='margin-left:84.3pt;text-indent:-42.5pt'><span lang=EN-US>obligations
for ubiquitous PBTs (unconditional) </span></h4>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In the long term, the reductions
in monitoring costs and administrative burden would likely be the same as those
under option B4a.  However, the absence of a requirement for a robust baseline
could reduce the monitoring costs still further in the short term.  At the same
time, it would mean that certain undesirable trends or hotspots could be
overlooked. Although the ubiquitous nature of the pollution from these
substances means that differences between MS are likely not to be significant
overall, local differences for some substances could be large (e.g. in water
bodies that were/are subject to direct emissions compared with water bodies
that are impacted by atmospheric deposition). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>MS were generally in favour of
reducing the monitoring obligation for ubiquitous PBTs. The few MS who
expressed a preference for one or other option were approximately equal in
number.  </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.5.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Comparison of options in relation to the
ubiquitous PBTs </span></b></h2>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>In the following table, options B1,
B2a and B2b,  options B1, B3a and B3b, and options B1, B4a and B4b are compared
in their respective sets with regard to their effectiveness, efficiency and
consistency, taking account of the objectives in section 3 and the existing
legislation. </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:27.2pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Effectiveness </span></b></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Efficiency  </span></b></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Consistency </span></b></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.1pt;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Overall mark </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>B1: No change </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
 </tr>
 <tr style='height:18.0pt'>
  <td width=280 colspan=2 valign=top style='width:210.0pt;border-top:none;
  border-left:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:
  none;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><i><span style='font-size:
  10.0pt;line-height:107%'>Options on presentation</span></i><sub><span
  style='font-size:14.0pt;line-height:107%'> </span></sub></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border:none;border-bottom:
  solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border:none;border-bottom:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
 </tr>
 <tr style='height:95.3pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B2a: More </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>flexibility on presentation</span><span
  lang=EN-US> </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Avoids presentational issue although formally chemical
  status would still be affected by the ubiquitous PBTs. </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Efficient as no major costs involved
  and reduced administrative burden for MS. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Retains coherence with the
  objectives of the WFD, providing more flexibility in terms of presentation of
  information on status. </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:95.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>+++++ </span></p>
  </td>
 </tr>
 <tr style='height:64.25pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:64.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B2b: Take ubiquitous PBTs out of
  chemical status</span><span lang=EN-US> </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:64.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Avoids presentational issue
  completely but undermines the objective of reducing the risks posed by
  certain substances. </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:64.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Efficient as no major costs involved
  and reduced administrative burden for MS. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:64.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>--
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Incoherent with the overall
  objectives of the WFD and of chemicals policy. </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:64.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>+ </span></p>
  </td>
 </tr>
 <tr style='height:18.0pt'>
  <td width=280 colspan=2 valign=top style='width:210.0pt;border-top:none;
  border-left:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:
  none;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><i><span style='font-size:
  10.0pt;line-height:107%'>Options on monitoring matrix</span></i><sub><span
  style='font-size:14.0pt;line-height:107%'> </span></sub></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border:none;border-bottom:
  solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border:none;border-bottom:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
 </tr>
 <tr style='height:126.3pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:126.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B3a: Leave </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>flexibility
  but link the choice of matrix with requirements of </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>2009/90/EC </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:126.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Strong
  driver for using the most appropriate matrix. Contributes to improved
  knowledge of the risks of substances and effectiveness of measures. Possible
  to take into account local situation. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Possible lack of legal certainty if
  no international analytical standards. </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:126.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Retention of some flexibility would
  allow MS to adapt to local circumstances and tradition/experience.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Moderate adaptation costs for some
  MS. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:126.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.0pt;
  margin-bottom:6.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:99%'><span lang=EN-US style='font-size:9.0pt;line-height:99%'>Reinforces
  the role of Directive 2009/90/EC. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Contributes to improved assessment
  of effectiveness of measures taken by other policies. </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:126.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>++++ </span></p>
  </td>
 </tr>
 <tr style='height:116.05pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:116.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B3b: Fix the preferred matrix for
  each substance </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:116.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Strong driver for using the most
  appropriate matrix. Contributes to improved knowledge of the risks of
  substances and effectiveness of measures. Difficult choice in some cases. Not
  possible to take into account local situations. </span><span
  style='font-size:9.0pt;line-height:107%'>Legal certainty. </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:116.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>-
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Higher adaptation costs for MS that have no
  tradition/experience to monitor in biota. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:116.05pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>&#8776;
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Less flexible to adapt to scientific
  and technical progress in analytical techniques. </span><span
  style='font-size:9.0pt;line-height:107%'>Could hinder progress in analytical
  techniques for other matrices. </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:116.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>+ </span></p>
  </td>
 </tr>
 <tr style='height:18.0pt'>
  <td width=280 colspan=2 valign=top style='width:210.0pt;border-top:none;
  border-left:solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:
  none;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><i><span style='font-size:
  10.0pt;line-height:107%'>Options on reduced monitoring</span></i><sub><span
  style='font-size:14.0pt;line-height:107%'> </span></sub></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border:none;border-bottom:
  solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border:none;border-bottom:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:18.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Effectiveness </span></b></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Efficiency  </span></b></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Consistency </span></b></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.1pt;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Overall mark </span></b></p>
  </td>
 </tr>
 <tr style='height:95.3pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B4a: Reduced monitoring obligations
  if certain specified conditions are met </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Reduces administrative burden and
  monitoring costs for MS.  </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.0pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%'>Ensures that a robust monitoring baseline is available,
  hence contributing to good knowledge of the risks to or via the aquatic
  environment of ubiquitous PBTs. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>&#8776; </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:95.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>++ </span></p>
  </td>
 </tr>
 <tr style='height:84.95pt'>
  <td width=115 valign=top style='width:86.2pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 3.35pt 0cm 5.4pt;height:84.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>B4b: Reduced monitoring obligations
  (unconditional) </span></p>
  </td>
  <td width=165 valign=top style='width:123.8pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:84.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Reduces administrative burden and
  monitoring costs for MS.  </span></p>
  </td>
  <td width=162 valign=top style='width:121.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:84.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>&#8776;
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Does not guarantee a robust
  monitoring baseline in all MS, therefore not ensuring a good knowledge of the
  risks to or via the aquatic environment of ubiquitous PBTs. </span></p>
  </td>
  <td width=122 valign=top style='width:91.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 3.35pt 0cm 5.4pt;height:84.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>&#8776; </span></p>
  </td>
  <td width=55 valign=top style='width:41.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 3.35pt 0cm 5.4pt;
  height:84.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>+ </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
12.45pt;margin-left:42.3pt;line-height:95%'><span lang=EN-US style='font-size:
10.0pt;line-height:95%'>Magnitude of impact as compared with the baseline
scenario (the baseline is indicated as 0): ++ strongly positive; + positive; 
 strongly negative;  negative; &#8776; marginal/neutral</span><span
lang=EN-US> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Therefore the preferred options
are B2a, B3a and B4a. </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.6.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Analysis of impacts of options to improve
the knowledge base </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.6.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
      </span><span lang=EN-US>Analysis of impacts of Option C2: Establish a
watch list without legal obligation. </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Monitoring costs would be the
most important costs associated with this option: estimated at 2 to 4 million 
per year for the EU (between 3 and 6% of the overall estimated current costs of
monitoring of PS, see Annex IV). These cost estimates were considered
reasonable by MS and the JRC. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>There would be some
administrative costs to develop the technical specifications for monitoring.
These would arise from the need to hold meetings of MS and stakeholder experts
(estimated 3 per year with 40 participants) and  additional work of an average
of 10 working days per substance. This would result in additional administrative
costs of 0.2 million  per year. These figures are based on the experience of
the Chemical Monitoring and Emerging Pollutants (CMEP) sub-group. In fact, the
costs attributable to the option would be lower as the CMEP group would meet
anyway to deliver on the CIS work programme. </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:11.8pt;margin-left:42.3pt;text-align:left;line-height:100%'><span
lang=EN-US>The lack of a legal obligation would produce uncertainties in the
outcome due to pressures on MS to prioritise legal obligations in their
budgets. This is evidenced by the fact that the rate of reporting to the EEA of
new voluntary data streams is low, e.g. emissions to water, only 6 MS reporting
fully according to specifications, 10 MS have not reported at all. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Further, participating MS would
unfairly carry the costs, and due to non-participants it might not be possible
to draw an EU picture and therefore the usefulness of the expenditure would
decline significantly. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.6.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Analysis of impacts of Option C3: Establish a
watch list with legal obligation </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The costs of this option would be
similar to those for option C2. However, there would be some additional costs
for comitology and administration within the Commission. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The legal obligation would make
the outcome more certain to meet the objectives, i.e. to provide EU-wide
datasets, and ensure fairer sharing of the costs among MS.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Both MS and stakeholders
supported the idea of the watch list, a few indicating their preference as
regards the formal status (2 for legal obligation, 3 for voluntary approach, 5
no position). </span></p>

<h2 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                      </span><b><span
lang=EN-US style='font-style:normal'>5.7.</span></b><b><span lang=EN-US
style='font-family:"Arial",sans-serif;font-style:normal'>         </span></b><b><span
lang=EN-US style='font-style:normal'>Comparison of the options to improve the
knowledge base </span></b></h2>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><b><span lang=EN-US> </span></b></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:27.2pt'>
  <td width=97 valign=top style='width:73.0pt;border:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Option </span></b></p>
  </td>
  <td width=219 valign=top style='width:164.15pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 5.5pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Effectiveness </span></b></p>
  </td>
  <td width=244 valign=top style='width:183.25pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 5.5pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%'>Efficiency  </span></b></p>
  </td>
  <td width=59 valign=top style='width:43.9pt;border:solid black 1.0pt;
  border-left:none;padding:.55pt 5.5pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:.1pt;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'>Overall mark </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=97 valign=top style='width:73.0pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 5.5pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>C1: No change </span></p>
  </td>
  <td width=219 valign=top style='width:164.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
  <td width=244 valign=top style='width:183.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>0 </span></p>
  </td>
  <td width=59 valign=top style='width:43.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 5.5pt 0cm 5.4pt;
  height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%'>0 </span></p>
  </td>
 </tr>
 <tr style='height:74.6pt'>
  <td width=97 valign=top style='width:73.0pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 5.5pt 0cm 5.4pt;height:74.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>C2: Establish a watch list without
  legal obligation </span></p>
  </td>
  <td width=219 valign=top style='width:164.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:74.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Increased knowledge but likely to
  suffer important data gaps (incomplete coverage of MS) and lack of adherence
  to technical specifications due to the voluntary character. </span></p>
  </td>
  <td width=244 valign=top style='width:183.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:74.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>+
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Value for money (i.e. return on MS
  administrative - including monitoring - costs)  limited by the likelihood of
  data gaps. </span></p>
  </td>
  <td width=59 valign=top style='width:43.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 5.5pt 0cm 5.4pt;
  height:74.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.05pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%'>++ </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:74.65pt'>
  <td width=97 valign=top style='width:73.0pt;border:solid black 1.0pt;
  border-top:none;padding:.55pt 5.5pt 0cm 5.4pt;height:74.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>C3: Establish a watch list with
  legal obligation </span></p>
  </td>
  <td width=219 valign=top style='width:164.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:74.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:9.0pt;line-height:99%'>Increased knowledge and likely to
  cover all or most of the EU countries in a harmonised way (i.e. following the
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'>technical specifications) </span></p>
  </td>
  <td width=244 valign=top style='width:183.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.55pt 5.5pt 0cm 5.4pt;height:74.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span lang=EN-US style='font-size:9.0pt;line-height:107%'>++
  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%'>Very high efficiency (i.e. return on
  MS adminstrative  including monitoring - costs)  as the watch list would
  provide targeted highquality EU datasets that would be fit for purpose for PS
  prioritisation. </span></p>
  </td>
  <td width=59 valign=top style='width:43.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.55pt 5.5pt 0cm 5.4pt;
  height:74.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.1pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%'>++++ </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
12.45pt;margin-left:42.3pt;line-height:95%'><span lang=EN-US style='font-size:
10.0pt;line-height:95%'>Magnitude of impact as compared with the baseline
scenario (the baseline is indicated as 0): ++ strongly positive; + positive;
overall mark is sum of individual magnitudes.</span><span lang=EN-US> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Therefore the preferred option is
C3. </span></p>

<h2 style='margin-left:91.05pt;text-indent:-42.5pt'><b><span lang=EN-US
style='font-style:normal'>5.8.</span></b><b><span lang=EN-US style='font-family:
"Arial",sans-serif;font-style:normal'> </span></b><b><span lang=EN-US
style='font-style:normal'>Cumulative impacts, interactions across the various
options and significant distributional effects </span></b></h2>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.8.1.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Interactions and cumulative impacts </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.65pt;margin-left:42.35pt'><span lang=EN-US>There are a number of links
between the various options. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.75pt;margin-left:59.85pt;text-indent:-18.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>As regards the substances: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Options including new substances imply a net
increase in monitoring costs (for public authorities) of 4-9.6 million  per
year for option A3a, 12-28.8 million  for option A3b and 15-36 million  for
option A3c. Although the same unit costs have been used for all options, it is
likely that the options with a larger number of substances would benefit from smaller
unit costs per substance, as costs such as sampling increase less steeply as
the number of substances increases.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.0pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>There are two substances for which end-of-pipe
measures (in particular advanced treatment of urban waste water) have been
identified as potentially effective and possibly requiring local implementation
(Nickel and E2). Since there would likely be an overlap between the locations
(with high population density) requiring upgrade of UWWTPs under option A2 (for
Nickel) and under option A3c (for  E2), the costs would not be additive. If
these measures were implemented for Nickel and E2 they would also have a
positive impact on reducing the emissions of other pollutants covered in this
impact assessment (e.g. Lead, DEHP, BDEs, HBCDD), other existing PS (Mercury,
Cadmium, Nonylphenol, etc) and many other pollutants, representing good value
for the investment by public authorities or private companies (and indirectly
the consumers). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.75pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>As regards options for substances and ubiquitous PBTs: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The establishment of biota standards for the
ubiquitous PBTs among the existing PS (those identified in option A2 but
included in all the substance options), and the change from water to biota
monitoring that options B3a or b would imply for those substances would result
in higher rates of failure of EQSs. This would however provide a more accurate
picture of  the risks posed by those substances and of the effectiveness of
measures taken, and would allow MS to take better-informed decisions on the
need to undertake remediation at contaminated sites.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The extent to which the options addressing
presentational aspects of ubiquitous PBTs would have an impact would depend
upon the choice of substance option; the impact would be greater, the more
cumulative the substance option, since it would relate not only to stricter EQS
for existing substances but also additional ubiquitous PBTs.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>If the ubiquitous PBTs were taken out of the
chemical status assessment (option B2b), the general objective of  reducing the
risks posed by substances would be affected, as the WFD would not constitute a
driver for improvement anymore. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>If any of the substance options A3 were
selected, the option B4 on reduced monitoring efforts would provide cost
savings for the 2 to 4 additional new ubiquitous PBTs (2 substances in option
A3a and 4 in options A3b or A3c). The savings would be realised immediately in
the case of option B4b or in the longer term in case of B4a, as for the latter
a monitoring baseline would need to be established. The potential cost savings
are estimated to be in the range of those calculated for the existing 4
ubiquitous PBTs (0.8 to 2.9 million  per annum across the EU). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.75pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>As regards options for ubiquitous PBTs and for improving the
knowledge base: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>New monitoring costs due to the watch list (2-4
million  per year) would likely be (at least partly, possibly totally in the
long term) compensated by the estimated reductions in the monitoring costs for
ubiquitous PBTs (0.8 to 2.9 million  per year in the short term, additional
similar amount in the long term). The value for money, though, would be
significantly greater for the watch list. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.15pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>As regards the sub-options for ubiquitous PBTs: Although the
sub-options on presentation, monitoring matrix and frequency are independent,  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>providing flexibility in presentation or taking
ubiquitous PBTs out of the chemical status assessment could make it easier for
MS to accept a shift towards more biota monitoring (whichever monitoring option
applied); conversely, greater harmonisation of the monitoring matrix would be
likely to lead to more comparable approaches to presentation under the flexible
presentation option. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='line-height:103%;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
lang=EN-US>taking the ubiquitous PBTs out of the chemical status assessment
would already reduce the monitoring obligation to that required for trend
monitoring.  Therefore the additional impact of adopting one of the options on
reduced monitoring frequency would be lower than if the ubiquitous PBTs had not
been taken out of chemical status. </span><span lang=EN-US style='font-family:
"Courier New"'>o</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
</span><span lang=EN-US>fixing monitoring in the biota matrix would already
reduce the monitoring frequency if MS were previously monitoring in water. 
Therefore the additional impact of adopting one of the options on reduced
monitoring frequency would be lower than if the matrix had not been fixed in
biota. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.8.2.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Cumulative impacts of the package of preferred
options </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.15pt;margin-left:42.35pt'><span lang=EN-US>Taking account of the interactions
outlined above and the information summarised in sections 5.3, 5.5 and 5.7, the
preferred options (all substances - A3c; flexible presentation for ubiquitous
PBTs  B2a; choice of matrix linked to analytical sensitivity  B3a;
conditional reduced monitoring for ubiquitous PBTs  B4a; and a watch list with
legal obligation  C3) would be likely to have the following main benefits: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>all the latest scientific information reviewed
would be taken into account; </span><span lang=EN-US style='font-family:"Courier New"'>o</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>MS
would be encouraged to monitor in biota when most appropriate; </span><span
lang=EN-US style='font-family:"Courier New"'>o</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>a more accurate
picture would be obtained of pollution by ubiquitous PBTs; </span><span
lang=EN-US style='font-family:"Courier New"'>o</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>there would be
a significant improvement in knowledge of the risks posed by all 15 of the
prioritised substances and the ubiquitous PBTs among the existing PS, and of
the effectiveness of measures for these substances, allowing
introduction/improvement of measures at EU and MS level, better targeting of
sediment remediation, and optimisation of protection from identified risks -
thus leading to benefits to biodiversity and human health; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.95pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>measures applied to reduce the risks from some
substances (e.g. Nickel) would be seen to reduce the risks from others (e.g.
E2) as well; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>the harmonisation of EQS for more substances
would provide a more level playing field for businesses in different MS; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>the administrative burden associated with
explaining the failure of the chemical status objective as a result of
ubiquitous PBTs would be reduced, and the public would receive clearer
information; and </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-indent:-18.0pt'><span
lang=EN-US style='line-height:103%;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span><span
lang=EN-US>savings of approx 0.8-2.9 m  per annum on monitoring ubiquitous
PBTs would be expected, which could be invested in improving the information
base for future prioritisation exercises, i.e. the watch list; </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:42.35pt'><span lang=EN-US>and the following main costs: </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>estimated additional monitoring costs, to public
authorities, of 15  36m  per year for the whole of the EU; </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.05pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>costs to public authorities and private
companies, likely passed to consumers, of additional UWWT to remove Nickel and
E2, costs to industry to reduce point source industrial emissions of Nickel,
and costs to livestock farmers to install fencing to keep animals away from
water courses to reduce E2 emissions to water, although some of those costs
could fall under other legislation and would be within proportionate limits;
estimates for the UK (which has among the highest Nickel concentrations in the
EU) are: whole-life costs of the order of 2 billion  to meet a 2 </span>&#956;<span
lang=EN-US>g l<sup>-1</sup> EQS<sub>bioavailable</sub> for Nickel by upgrading
2% of UWWTPs (fewer if EQS at 4 </span>&#956;<span lang=EN-US>g l<sup>-1</sup>),
and less than 19 billion  (upgrade of fewer than 9% of UWWTPs, 20-year
lifetime cost which is in net present value) to meet a 4 10<sup>-4</sup> </span>&#956;<span
lang=EN-US>g l<sup>-1</sup> EQS for E2, plus attendant running costs (noting
that the costs for Nickel and E2 would not be fully additive);; the cost of
fencing to avoid livestock access to water courses is estimated at between 2
and 12 /ha/year (it is not possible to estimate how much fencing would be
required in total, and at least some of the costs would fall under other
legislation);   </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:78.55pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>the possible costs, unkown but not likely to be
significant, of substituting Quinoxyfen, if authorisation not anyway withdrawn
under the PPP legislation; these could fall on the producers, formulators,
farmers and/or consumers depending upon the substitute; </span><span
lang=EN-US style='font-family:"Courier New"'>o</span><span lang=EN-US
style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>approx 2-4 m 
per annum to operate the watch-list. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Overall, the preferred options
would achieve the most objectives with the greatest efficiency while ensuring
coherence with the existing legislation. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.8.3.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Distributional effects of the package of preferred
options </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:42.35pt'><span lang=EN-US>The most significant
distributional effects of the preferred options can be summarised as follows. 
However, it should be remembered that there is uncertainty about how many
effects would be in the baseline. Generic environmental and health benefits are
not referred to here. Most of the distributional effects relate to the
preferred substance option (A3c) rather than the options addressing the other general
objectives, although some relating to the latter are noted in the final bullet.
</span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>Sector-specific </span><span lang=EN-US style='font-family:"Courier New"'>o</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>Since
several agricultural PPPs are included in the preferred option, effects on PPP
producers and formulators, and on farmers, could be higher than in many other
sectors, although many of the effects would be in the baseline anyway because
of introduction of new requirements under the Sustainable Use of Pesticides
Directive.  Effects relating to the producer of Trifluralin (in HU, for export)
and to the producer, formulators and users of Quinoxyfen could be the most
significant. Farmers could also bear costs associated with fencing watercourses
to reduce E2 emissions (see above). On the other hand, farmers could benefit
from improved ecosystem services. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The preferred substance option would involve
including pharmaceuticals in the PS list for the first time, but none of the
three pharmaceuticals is proposed as a PHS and no measures are proposed at EU
level. Nevertheless, there could be an impact on the pharmaceutical sector in
the long term if measures at MS level were taken to influence prescription and
promote pharmaceutical alternatives with lesser environmental impact. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The commercial fisheries and aquaculture sectors
could be affected positively by improved water quality and fish health.  The
introduction of an EQS for Cypermethrin could require some salmon farmers to
use alternative management methods to apply the substance or substitutes.  The
introduction of an EQS for Cybutryne could lead to changes in maintenance
practices for ship owners. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
2.0pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The commercial leisure sector (angling, boating)
could be similarly affected. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span style='line-height:103%;
font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The water sector (public and/or private) would
be affected by any of the substance options because of the possible need to
upgrade some UWWTPs to meet the EQS for substances discharged via this route,
in particular E2 and Nickel. </span>Other substances would be impacted, e.g.
DEHP, HBCDD. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The waste sector would likely have to address
end-of-life aspects of some products containing the proposed PS, e.g. HBCDD,
and there might be implications (in relation to other substances too, e.g.
PFOS, BDEs) for the handling of landfill leachate.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>There could be indirect impacts on the
construction sector from the requirement to meet an EQS for Terbutryn (although
relevant measures are unlikely) and to phase out emissions of HBCDD to the
aquatic environment.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts in a number of other industry sectors
would be expected to be already in the baseline: e.g. energy generation and
metal production (in relation to stricter EQS for PAHs in particular),
transport (in relation to the need to find a substitute for PFOS in aviation),
textiles/polymers (in relation to BDEs, DEHP and HBCDD).  However, measures to
meet the stricter EQS for Nickel could involve the relevant industry sectors
(e.g. alloys, metal plating, batteries, pigments, other chemicals, stainless
steel production, mining). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts in the public sector would most
obviously relate to monitoring costs, but some public sector investment might
be involved also in infrastructure, in particular the upgrading of UWWTPs where
these are in public ownership (see above), possibly also in the context of
landfill-site management. Sustainable Urban Drainage systems (SUDS) targeting
urban run-off might also receive public investment but would also have other
benefits (flood risk management). Although there might need to be some public
investment in awareness-raising relevant to pharmaceuticals prescription and
disposal, spending on health care might be reduced in the longer term. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts on the public at large would likely
include the passing on of any additional water treatment costs (urban and
industrial waste water) or costs of cleaner energy, and the additional direct
or indirect costs of substitutes, if needed.  They could also include
encouragement to change behaviour, e.g. in relation to the disposal of unused
pharmaceuticals. Significant impacts on employment in industry would not be
expected (see producer section below). Some employment opportunities might
arise in sediment remediation and mechanical cleaning as a substitute for
biocidal coatings. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
4.75pt;margin-left:59.85pt;text-indent:-18.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Producer and user-specific: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The overall impacts on producers are difficult
to assess, because, despite extensive consultation, it has not been possible in
many cases to determine who they are (therefore the size and
resilience/capacity for diversification of the enterprise, although most of
those identified are large) or where production is located, even whether it
occurs within the EU.  The production of some substances (Dichlorvos,
Heptachlor, PFOS) no longer occurs in the EU. Dichlorvos and PFOS are
manufactured in India and China, respectively and imported.  There could be
impacts on a producer (Israelbased) of HBCDD in NL which employs approximately
90 workers in the production of brominated compounds, and a producer of
Trifluralin (for export) in HU.  It is not clear whether Dicofol is still
produced in IT, nor whether the production of Quinoxyfen by a large US-based
company occurs in the EU.  Cybutryne may be produced in CH by a large DE-based
company; Terbutryn production occurs in part outside the EU. It should be
remembered that most substitution costs, including those relating to
employment, would be in the baseline. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>There could be impacts on formulators of some
PPPs and biocides, including the formulators of biocidal coatings, since there
are EU formulators for most of these substances and they are not necessarily
restricted to the MS where the substances are used.  However, other (existing and/or
new) products would be likely to take the place of substances whose use had to
decrease or cease, and these could in theory be handled by the same
formulators. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.7pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts on the users of the
products/formulations could occur as described for the sectors in the first
main bullet. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.45pt;margin-left:59.85pt;text-indent:-18.0pt'><span lang=EN-US
style='line-height:103%;font-family:"Arial",sans-serif'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><span
lang=EN-US>MS- and region-specific </span><span lang=EN-US style='font-family:
"Courier New"'>o</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
</span><span lang=EN-US>The possible geographical impacts on producers and
formulators are covered under the previous point. An additional observation is
that trade (import, export) with third countries is unlikely to be affected
significantly beyond the baseline for most substances.  This is because, of the
substances known to be relevant, i.e. proposed PHS that are currently imported
into the EU or manufactured in the EU for export, most (DEHP, Dicofol, HBCDD,
Heptachlor, PFOS, Trifluralin) are already and/or are expected to be further
restricted under the baseline. An exception could be Quinoxyfen, depending upon
where it is manufactured (information not available). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Regulation of the PPPs would most likely affect
all MS, but to different extents influenced by factors including crop type and
value, production area, and production intensity. The MS with the largest use
of agricultural PPPs are FR, IT, ES, DE, UK, PT; those with the most intense
use are BE and NL (EC, 2006), and this list could be indicative of the MS that
would likely be among the most affected by the preferred substance option,
which includes several PPPs. Indeed, FR is noted to have the largest
consumption of two of the PPPs, i.e. Aclonifen and Bifenox, and is also among
the highest users of Quinoxyfen and Cypermethrin. As indicated above,
formulators of PPPs are not necessarily restricted to the MS where they are
used or authorised. The data obtained did not allow the degree of correlation
to be determined. However, for the above four PPPs, the information obtained
showed that the number of products containing these substances was higher in FR
than in other MS, and since all four substances are in the preferred package,
FR could be more affected than some other MS. The picture is less clear for
many of the MS partly because, despite the widespread authorisation of these
substances, few MS provided monitoring data, and the prioritisation of two of
the substances was based primarily on modelling (taking account of use). Even
in MS like FR, the effects would be limited, however, since only one substance
is proposed as a PHS, most of the costs (e.g. of implementing buffer strips)
are likely to be in the baseline, and larger farming and PPP (formulation and
use) sectors are likely to be able to handle any need to decrease or cease
emissions.  </span><span lang=EN-US style='font-family:"Courier New"'>o</span><span
lang=EN-US style='font-family:"Arial",sans-serif'> </span><span lang=EN-US>In
relation to the inclusion of pharmaceuticals, the effects on authorities
(monitoring obligation initially); and in due course also on patients and
medical professionals (in relation to take-back schemes and prescription
practice) could be greater in some MS than others, depending upon their per
capita consumption of the pharmaceuticals.  For example, DE would likely be
more affected than ES, because per capita consumption of Diclofenac is
several-fold higher.  Likewise, effects in MS with lower per capita consumption
of the contraceptive pill (e.g. EL, PL) would be less. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts in relation to certain substances could
be more noticeable in MS with extensive coastlines, and significant dockyards,
that have not already restricted the use of Cybutryne, and possibly in MS with
more aquaculture (specifically salmon farming, i.e. in IE, UK, (NO) if using
Cypermethrin). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Impacts related to substances present
significantly in urban waste water discharges (e.g. BDE, DEHP, HBCDD, Ni, PFOS,
pharmaceuticals), would be likely to be felt mainly in MS with higher
population density and lower water resources (smaller water courses)
(especially UK, NL and parts of DE); these substances are distributed
throughout the substance options. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.1pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Sub-regional impacts might be seen in relation
to Nickel (as a result of effects of local conditions on bioavailability), E2
(because of differences in the extent and intensity of livestock farming as
well as conurbations) and PAHs (according to the influence of natural sources
and conditions). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.5pt;margin-left:78.45pt;text-indent:-17.9pt'><span lang=EN-US
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>The positive impact of the option to flexibly
present the results of monitoring ubiquitous PBTs should by definition benefit
all MS.  The other preferred nonsubstance options should also benefit all MS
though those with a tradition of monitoring only in water could face more
adaptation costs.  All MS would benefit from the possibility provided by the
watch list to improve the prioritisation process and thus ensure that long-term
EU-wide obligations are introduced only for substances most relevant at that
level. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'><span lang=EN-US>In conclusion,
the preferred options do not appear to have significant unfair distributional
impacts when the baseline is taken into account. </span></p>

<h3 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:103%;font-family:"Calibri",sans-serif;font-style:normal'>                   </span><span
lang=EN-US>5.8.4.</span><span lang=EN-US style='font-family:"Arial",sans-serif'>
     </span><span lang=EN-US>Approach to translating the options into a
legislative proposal </span></h3>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
25.7pt;margin-left:42.35pt'><span lang=EN-US>The options above would be
implemented by amending the EQSD 2008/105/EC and WFD Annex X. </span></p>

<h1 style='margin-left:0cm;text-indent:0cm'><span lang=EN-US style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif;font-weight:normal'>                   </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>6.</span><span lang=EN-US
style='font-size:12.0pt;line-height:107%;font-family:"Arial",sans-serif'>           </span><span
lang=EN-US style='font-size:12.0pt;line-height:107%'>M</span><span lang=EN-US>ONITORING
AND EVALUATION</span><span lang=EN-US style='font-size:12.0pt;line-height:107%'>
</span></h1>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The WFD contains built-in
monitoring and evaluation processes.  Regular monitoring of the environmental
concentrations of the PS and PHS is foreseen in the Directive. MS report every
six years (as part of the River Basin Management Plan) on chemical status and
their programmes of measures. In addition, MS report monitoring data annually
to the EEA as part of the State of the Environment reporting. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In addition, the implementation
of the WFD in accordance with the Common Implementation Strategy, involving as
it does working groups such as the WG E on Chemical Aspects, allows the
Commission to obtain informal oral and written feedback from MS on the
implementation and effectiveness of the Directive and of any relevant
measures.  Feedback can also be obtained from other stakeholder groups on the
wider impacts of the legislation, and this would be done during the course of
the next review due in four years. <br clear=all style='page-break-before:always'>
</span></p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:.5pt;margin-left:37.35pt;text-align:center'><b><u><span
lang=EN-US style='font-style:normal'>ANNEX I: Glossary / List of acronyms</span></u></b><b><span
lang=EN-US style='font-style:normal'> </span></b></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=609
 style='width:456.65pt;margin-left:42.55pt;border-collapse:collapse'>
 <tr style='height:18.35pt'>
  <td width=95 valign=top style='width:70.9pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>AA-EQS  </p>
  </td>
  <td width=514 valign=top style='width:385.7pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Annual Average EQS </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>BDE     </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Brominated Diphenylether </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>CIS       </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Common Implementation
  Strategy for the Water Framework Directive </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>CMEP  </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Chemical Monitoring and
  Emerging Pollutants Sub-group of WGE </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>COMMPS </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Combined Monitoring and
  Modelling-based Prioritisation </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>CSTEE </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Scientific Committee on
  Toxicity, Ecotoxicity and the Environment </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>DEHP  </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Bis(2-ethylhexyl)phthalate </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>DL-PCB </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Dioxin-like Polychlorinated biphenyl </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>DOC  </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Dissolved Organic Carbon </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>E2         </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>17 beta-estradiol </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>EE2 </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>17 alpha-ethinylestradiol </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>EEA </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>European Environment Agency
  </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>EFPIA </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US>European
  Federation of Pharmaceutical Industries and Associations </span></p>
  </td>
 </tr>
 <tr style='height:67.15pt'>
  <td width=95 valign=top style='width:70.9pt;padding:0cm 0cm 0cm 0cm;
  height:67.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>EQS </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:67.15pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US>Environmental Quality Standard, i.e. the concentration of a
  particular pollutant or group of pollutants in water, sediment or biota which
  should not be exceeded in order to protect human health and the environment
  (WFD Article 2.35) </span></p>
  </td>
 </tr>
 <tr style='height:53.4pt'>
  <td width=95 valign=top style='width:70.9pt;padding:0cm 0cm 0cm 0cm;
  height:53.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>EQSD </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:53.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:.05pt;line-height:107%'><span
  lang=EN-US>Environmental Quality Standards Directive (Directive 2008/105/EC
  of the European Parliament and the Council on environmental quality standards
  in the field of water policy) </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>GAC </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US>Granular
  Activated Carbon (tertiary water treatment) </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>HBCDD </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Hexabromocyclododecane </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>HELCOM </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Helsinki Convention for
  the protection of the Baltic Sea </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>HRT     </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Hormone Replacement Therapy </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=95 style='width:70.9pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>ICPDR</p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>International Convention
  for the Protection of the Danube River </span></p>
  </td>
 </tr>
 <tr style='height:53.4pt'>
  <td width=95 valign=top style='width:70.9pt;padding:0cm 0cm 0cm 0cm;
  height:53.4pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>IPPC </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:53.4pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US>Integrated Pollution Prevention and Control Directive (Directive
  2008/1/EC of the European Parliament and of the Council of 15 January 2008
  concerning integrated pollution prevention and control) </span></p>
  </td>
 </tr>
 <tr style='height:18.35pt'>
  <td width=95 valign=bottom style='width:70.9pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>JRC      </p>
  </td>
  <td width=514 valign=bottom style='width:385.7pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Joint Research Centre of
  the European Commission </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:2.7pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US>&nbsp;</span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=609
 style='width:456.6pt;margin-left:42.55pt;border-collapse:collapse'>
 <tr style='height:18.35pt'>
  <td width=94 valign=top style='width:70.85pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>MAC-EQS </p>
  </td>
  <td width=514 valign=top style='width:385.7pt;padding:0cm 0cm 0cm 0cm;
  height:18.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Maximum Allowable Concentration EQS </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>MS       </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Member State(s) </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>NAP     </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>National Action Plan </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>NSAID </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Non-steroidal
  Anti-inflammatory Drug </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>OSPAR </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Oslo-Paris Convention for
  the protection of the North Sea </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>PBT      </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Persistent Bioaccumulative and Toxic </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>PCB     </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Polychlorinated biphenyl </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>PHS      </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Priority Hazardous
  Substance under the Water Framework Directive </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>Poly-BDE </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Poly-Brominated Diphenyl Ethers </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>POP      </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Persistent Organic
  Pollutants under the Stockholm Convention </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>PPP      </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Plant Protection Product </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>PS         </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.2pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Priority Substance under
  the Water Framework Directive </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>RAR  </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Risk Assessment Report </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>RBD  </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:1.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>River Basin District </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>RBMP </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>River Basin Management
  Plan under the Water Framework Directive </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>RBSP </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>River Basin Specific Pollutant </p>
  </td>
 </tr>
 <tr style='height:53.35pt'>
  <td width=94 valign=top style='width:70.85pt;padding:0cm 0cm 0cm 0cm;
  height:53.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>REACH </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:53.35pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.0pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US>Regulation (EC) No 1907/2006 of the European Parliament and of the
  Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation
  and Restriction of Chemicals (REACH)  </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>SCTEE </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>= CSTEE </p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>SME </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US>Small and medium-sized
  enterprises </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>SVHC </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US> Substance of Very High
  Concern </span></p>
  </td>
 </tr>
 <tr style='height:39.6pt'>
  <td width=94 valign=top style='width:70.85pt;padding:0cm 0cm 0cm 0cm;
  height:39.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>TGD-EQS </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:39.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:.05pt;line-height:107%'><span lang=EN-US>Technical Guidance
  Document for deriving EQS (European Commission, 2011b) </span></p>
  </td>
 </tr>
 <tr style='height:39.6pt'>
  <td width=94 valign=top style='width:70.85pt;padding:0cm 0cm 0cm 0cm;
  height:39.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>UWWTD </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:39.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:.05pt;margin-bottom:.0001pt;text-indent:.05pt;line-height:107%'><span
  lang=EN-US>Urban Waste Water Treatment Directive (Council Directive
  91/271/EEC of 21 May 1991 concerning urban waste-water treatment) </span></p>
  </td>
 </tr>
 <tr style='height:25.8pt'>
  <td width=94 style='width:70.85pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>UWWTP </p>
  </td>
  <td width=514 style='width:385.7pt;padding:0cm 0cm 0cm 0cm;height:25.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US>Urban
  Waste Water Treatment Plant </span></p>
  </td>
 </tr>
 <tr style='height:45.95pt'>
  <td width=94 valign=top style='width:70.85pt;padding:0cm 0cm 0cm 0cm;
  height:45.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>WFD </p>
  </td>
  <td width=514 valign=bottom style='width:385.7pt;padding:0cm 0cm 0cm 0cm;
  height:45.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.0pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:.05pt;line-height:
  107%'><span lang=EN-US>Water Framework Directive (Directive 2000/60/EC of the
  European Parliament and of the Council of 23 October 2000 establishing a
  framework for Community action in the field of water policy) </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.6pt;margin-left:0cm;text-align:left;text-indent:0cm'><span
lang=EN-US style='font-size:11.0pt;line-height:103%;font-family:"Calibri",sans-serif'>                   </span><span
lang=EN-US>WG E                        Working Group E on Chemical Aspects
(under the Strategic Coordination </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:113.95pt'><span lang=EN-US>Group for the Common
Implementation Strategy of the WFD) </span></p>

<p class=MsoNormal align=left style='margin-left:0cm;text-align:left;
text-indent:0cm'><span lang=EN-US style='font-size:11.0pt;line-height:103%;
font-family:"Calibri",sans-serif'>                   </span><span lang=EN-US>WISE 
            Water Information System for Europe (</span><a
href="http://water.europa.eu/"><span lang=EN-US style='color:blue'>http://water.europa.eu</span></a><a
href="http://water.europa.eu/"><span lang=EN-US style='color:black;text-decoration:
none'>)</span></a><span lang=EN-US>  </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> <br clear=all
style='page-break-before:always'>
</span></p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.25pt;margin-left:37.35pt;text-align:center'><b><u><span
lang=EN-US style='font-style:normal'>ANNEX II: Summary of the prioritisation
process and the establishment of EQS</span></u></b><b><span lang=EN-US
style='font-style:normal'> </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>This annex summarises the main
criteria for the identification of priority substances (PS) and the results of
the technical work done to review existing PS (EQS and PHS status), to identify
new P(H)S and to set EQS for them. </span></p>

<p class=MsoHeading8 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>Criteria for the identification of PS</span></u><span
lang=EN-US style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>According to WFD Article 16(2) PS
should be identified among those causing a risk to or via the aquatic
environment, by means of </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:53.5pt;text-indent:-11.65pt'><span lang=EN-US
style='line-height:103%'>a.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Risk assessment carried out under the chemicals,
PPP and biocides legislation (Regulation </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>(EEC) No.793/93, Directive
91/414/EEC and Directive 98/8/EC respectively) </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:53.5pt;text-indent:-11.65pt'><span lang=EN-US
style='line-height:103%'>b.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span
lang=EN-US>Targeted risk assessments focusing on aquatic ecotoxicity and on
human toxicity via the aquatic environment </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.95pt;margin-left:53.5pt;text-indent:-11.65pt'><span lang=EN-US
style='line-height:103%'>c.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span><span lang=EN-US>Simplified risk-based assessment procedure based
on scientific principles taking particular account of  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.85pt;margin-left:96.55pt;text-indent:-24.0pt'><span lang=EN-US
style='line-height:103%'>i.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Evidence regarding the intrinsic hazard of the
substances,  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:96.55pt;text-indent:-24.0pt'><span lang=EN-US
style='line-height:103%'>ii.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Evidence from monitoring of widespread
contamination </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.45pt;margin-left:96.55pt;text-indent:-24.0pt'><span lang=EN-US
style='line-height:103%'>iii.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Other factors that may indicate widespread
contamination such as production volumes and use patterns </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Some of the above points make
particularly clear the importance of considering the route of exposure, i.e.
substances identified as PS/PHS must be relevant to or via the aquatic
environment, not other environmental compartments alone. </span></p>

<p class=MsoHeading8 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>Summary of the prioritisation exercise and its
results</span></u><span lang=EN-US style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The first list of 33 PS was
established by Decision 2455/2001</span><a href="#_ftn37" name="_ftnref37"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[37]</span></sup></sup></a><span
lang=EN-US> in 2001 (effectively Annex X of the WFD).  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>At the time the first list was
identified, very few risk assessment were available under the chemicals, PPP
and biocides legislation. The COMMPS procedure</span><a href="#_ftn38"
name="_ftnref38" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[38]</span></sup></sup></a><span
lang=EN-US> was developed as a simplified risk-based assessment that combined
the available information on the intrinsic hazard of substances (point c.(i)
above) with estimates of exposure based on monitoring information (point c.(ii)
above) and modelling information derived from production volumes and use
patterns (point c.(iii) above). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In view of the large number of
potentially harmful substances, it was necessary in the current review, as for
the first list, to conduct a prioritisation process to identify those most
likely to cause harm to or via the aquatic environment. The prioritisation
process was based on the criteria set out in the WFD Article 16(2) (see above),
taking account of the experience gained with the COMMPS procedure used to
establish the first list. An opinion</span><a href="#_ftn39" name="_ftnref39"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[39]</span></sup></sup></a><span
lang=EN-US> on that procedure from the Scientific Committee on Toxicity,
Ecotoxicity and the Environment (CSTEE), and discussions among Commission
services, MS and stakeholder experts, were considered in the development by WG
E of an improved methodology. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>A combination of different
approaches was considered best to identify candidates for the list.  Each of
the approaches in WFD Article 16(2) was pursued in parallel.  The simplified
riskbased assessment used outputs from extensive monitoring and modelling
exercises. In the context of considering assessments under other legislation,
attention was also given to Substances of Very High Concern (SVHCs) under
REACH, and substances of concern under the Convention on Persistent Organic
Pollutants (POPs).  Substances of concern at MS level were also examined, as
well as the substances identified in Annex III of the EQS Directive.  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The parallel prioritisation
processes, which were subject to expert review in the Sub-Group on Review, led
to separate but complementary lists of substances.  The lists or at least the
highest-priority substances on each list were amalgamated and subjected to a
short-listing procedure.  The range of processes took advantage of the most
relevant available information.  Inevitably there was some overlap between the
lists, despite the independence of the processes, and this made the case for
prioritising some substances particularly strong. The individual prioritisation
processes and the short-listing procedure were followed by further shortlisting
on the basis of detailed dossiers prepared by the Commission and MS experts. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Because the implementation of the
legislation on chemicals, PPP and biocides has progressed substantially since
the previous prioritisation, it was possible to refer to many more risk
assessments under those other pieces of legislation, including some in draft
stage and others prepared on a voluntary basis. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Particular attention was paid to
the risk ratio for each substance, i.e. the measured environmental
concentration divided by the predicted no-effect concentration, and to evidence
of persistence or bioaccumulation. The status of the substances was considered
on the basis of information relating to the criteria for substances of very high
concern in Article 57 of the REACH Regulation, for example the PBT and very
Persistent very Bioaccumulative (vPvB) criteria, in association with
information on exposure of and via the aquatic environment. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Existing substances (EQS and PHS
status) were reviewed on the basis of revised or finalised risk assessment
reports and decisions made under other legislation. Consideration was given to
observations from MS regarding analytical difficulties. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>In setting the EQS, use was made
of the revised Technical Guidance Document on the Derivation of Environmental
Quality Standards, which provided improved scope for considering the setting of
standards in biota and/or sediment where relevant, as compared with the 2005
version that was used for the setting of the EQS for the first list of PS. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>Further details of the technical
process are provided in Commission Staff Working Paper SEC(2011)1544 (European
Commission 2011). </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
22.2pt;margin-left:42.35pt'><span lang=EN-US>The conclusions of the
prioritisation process were that the substances listed in the table below pose
a risk to or via the aquatic environment for the reasons indicated, and that
there are </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:2.9pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'><s><span lang=EN-US>                                                                 
                                                                                     </span></s><span
lang=EN-US> </span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:5.75pt;
margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:right;
text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
line-height:107%'>report Opinion adopted at the 11th CSTEE plenary meeting on
the 28th of September 1999. </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.15pt;margin-left:78.3pt;text-align:left;line-height:107%'><u><span
lang=EN-US style='font-size:10.0pt;line-height:107%;color:blue'>http://ec.europa.eu/health/ph_risk/committees/sct/docshtml/sct_out49_en.htm</span></u><span
lang=EN-US style='font-size:10.0pt;line-height:107%'>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>therefore technical grounds for
regulating them under the WFD. (See also Annex V for more information on the
substances.)  </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:141.7pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>CAS# </span></b></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:10.0pt;line-height:107%'>Main reasons for prioritisation as
  PS (or PHS) </span></b></p>
  </td>
 </tr>
 <tr style='height:23.45pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>57-63-6 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>17 alphaethinylestradiol </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Endocrine disruptive; risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>50-28-2 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>17 beta-estradiol<sup> </sup></span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Endocrine disruptive; risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>74070-46-5 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Aclonifen </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked high in modelling based prioritisation;
  bioaccumulative and toxic (and some evidence of persistence); risk ratio
  &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>42576-02-3 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Bifenox </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked high in modelling based prioritisation, very toxic,
  risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>28159-98-0 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Cybutryne (Irgarol®) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Substance of concern in MS, toxic, risk ratio &gt;1;
  degrades only slowly; main degradation product (M1) also toxic; persists in
  sediments. </span></p>
  </td>
 </tr>
 <tr style='height:23.45pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>52315-07-8 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Cypermethrin </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked very high in monitoring-based prioritisation and
  high in modelling-based prioritisation; very toxic; risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>62-73-7 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Dichlorvos </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked very high in monitoring-based prioritisation, medium
  in modelling-based prioritisation, risk ratio &gt;1; possibly carcinogenic to
  humans (IARC 2B, Carc. Cat. 3 probable under Dangerous Substances Directive);
  potential for local mutagenicity. </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>15307-79-6 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Diclofenac<sup> </sup></span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Toxic; risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>115-32-2 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dicofol </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Annex III substance; ranked high in monitoring and in
  modelling based prioritisation, risk ratio &gt;1; recommended for designation
  as POP (Stockholm Convention); possibly carcinogenic to humans, possibly
  endocrine disruptive; organochlorine PPP, similar to DDT.  </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>1746-01-6 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dioxins (and dioxinlike PCBs) </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Annex III substances. POPs (Stockholm Convention and
  CLRTAP). PBT properties. Ranked very high in monitoring-based prioritisation;
  some congeners probably carcinogenic to humans, possibly endocrine
  disruptive. </span></p>
  </td>
 </tr>
 <tr style='height:35.0pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>3194-55-6 / </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>25637-99-4 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>HBCDD </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked high in modelling-based prioritisation; PBT, SVHC
  under REACH, recommended POP, EU RAR conclusion of risk to aquatic
  environment. </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>76-44-8/ </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>1024-57-3 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Heptachlor/Heptachlor epoxide </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked very high in monitoring -based prioritisation; POP
  (Stockholm </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Convention); very toxic to aquatic organisms; risk ratio
  &gt;1; possibly/probably carcinogenic to humans, possibly endocrine
  disruptive. </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>1763-23-1 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PFOS </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Annex III substance, PBT, POP, risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:12.0pt'>
  <td width=87 valign=top style='width:65.0pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>124495-18-7 </span></p>
  </td>
  <td width=137 valign=top style='width:102.4pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Quinoxyfen </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:12.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>PBT and vPvB properties </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=87 style='width:65.0pt;border:solid black 1.0pt;border-top:none;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>886-50-0 </span></p>
  </td>
  <td width=137 style='width:102.4pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.6pt 2.9pt 0cm 5.35pt;
  height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Terbutryn </span></p>
  </td>
  <td width=396 valign=top style='width:296.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 2.9pt 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Ranked high in modelling based prioritisation, medium in
  monitoringbased prioritisation, toxic, risk ratio &gt;1 </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The conclusions of the assessment
of new technical information regarding existing PS are presented in the table
below.  (See also Annex V for more information on the substances.) For other
existing substances, there was either no new risk assessment report or no
grounds within such a report to make a (significant) change to the EQS or a
change to the status of the substance. </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><span lang=EN-US> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:23.95pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>PS n<sup>o</sup># </span></b></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Substance </span></b></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border:solid black 1.0pt;
  border-left:none;padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Rationale for review/nature of change </span></b></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>2 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Anthracene </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:.05pt;
  line-height:107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>Review
  of the EQSs prompted by revised RAR for pitch.  Conclusion that high acute
  toxicity justifies setting MAC equal to AA-EQS. </span></p>
  </td>
 </tr>
 <tr style='height:23.95pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>PS n<sup>o</sup># </span></b></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%'>Substance </span></b></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Rationale for review/nature of change </span></b></p>
  </td>
 </tr>
 <tr style='height:69.5pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>5 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Poly (including octa) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>BDE </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:69.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.3pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Modelling-based
  prioritisation identified octa BDE (BDE-197) as a priority.  EQS for the
  group of BDEs (hitherto for penta BDE (CAS 32534-81-9)) therefore reviewed to
  cover octabromo BDE (CAS 32536-52-0) and take account of new information. 
  However, proposed EQS (more stringent than before) based on BDE 99 (penta
  derivative). Extension of PHS status to octa BDE on grounds of PBT properties
  </span></p>
  </td>
 </tr>
 <tr style='height:58.0pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>12 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>DEHP </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.35pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:-.05pt;line-height:
  107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>Reprotoxic
  Cat 1B (Reg (EC) No 1272/2008), in Annex XIV of REACH (since 2011), EU RAR
  (2008) suggests need to limit risk of secondary poisoning in relation to food
  chains based on aquatic organisms, especially mussels, and a need to limit
  the risks to children in relation to exposure via the environment (taking
  account of existing risk reduction measures). </span><span style='font-size:
  10.0pt;line-height:107%'>Change status to PHS. </span></p>
  </td>
 </tr>
 <tr style='height:35.0pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>15 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:35.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Fluoranthene </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:35.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.35pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Review of the EQSs
  prompted by revised RAR for pitch. Conclusion that biota EQS is critical
  EQS.  Corresponding water EQS much more stringent than existing EQS.  MAC
  also more stringent. </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>20 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Lead </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.35pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:-.05pt;line-height:
  107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>EU VRAR
  2008, SCHER review of VRAR 2009, first draft of Chemical Safety Report for
  REACH registration, and need to consider bioavailability.  Review of EQS
  promised at time of 2006 Commission proposal.  EQS <sub>bioavailable</sub>
  now proposed. </span></p>
  </td>
 </tr>
 <tr style='height:23.5pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>22 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Naphthalene   </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:23.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:.05pt;margin-bottom:.0001pt;text-indent:.05pt;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Review of the EQSs
  prompted by revised RAR for pitch. Conclusion that need slightly more
  stringent EQS for freshwater and introduction of MAC. </span></p>
  </td>
 </tr>
 <tr style='height:46.5pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>23 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Nickel </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'> </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:46.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.3pt;margin-bottom:
  1.6pt;margin-left:.05pt;text-indent:0cm;line-height:99%'><span lang=EN-US
  style='font-size:10.0pt;line-height:99%'>New information (EU RAR 2008, SCHER
  review of RAR 2009, additional industry studies related to REACH
  registration), and need to consider bioavailability. Review of EQS promised
  at time of 2006 Commission proposal.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>EQS <sub>bioavailable</sub> now proposed. </span></p>
  </td>
 </tr>
 <tr style='height:80.95pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:80.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>28 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:80.95pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PAHs </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Benzo(a)pyrene </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Benzo(b)fluoranthene </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Benzo(k)fluoranthene </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.35pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:99%'><span style='font-size:10.0pt;line-height:
  99%'>Indeno(1,2,3cd)pyrene </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Benzo(g,h,i)perylene </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:80.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:10.0pt;
  line-height:107%'>Review of the EQSs prompted by revised RAR for pitch. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.3pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  lang=EN-US style='font-size:10.0pt;line-height:107%'>Conclusions: Biota EQS
  is critical EQS for all but Benzo(g,h,i)perylene.  Corresponding water EQS
  more stringent than existing EQS.  Introduction of MAC for three PAHs;
  slightly changed MAC for Benzo(a)pyrene. Revised EQS for Benzo(g,h,i)perylene
  slightly less stringent in freshwater, more stringent in saltwater. </span></p>
  </td>
 </tr>
 <tr style='height:58.0pt'>
  <td width=29 valign=top style='width:21.55pt;border:solid black 1.0pt;
  border-top:none;padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>33 </span></p>
  </td>
  <td width=140 valign=top style='width:105.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Trifluralin </span></p>
  </td>
  <td width=450 valign=top style='width:337.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.6pt 0cm 0cm 5.35pt;height:58.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.3pt;margin-bottom:
  0cm;margin-left:.05pt;margin-bottom:.0001pt;text-indent:-.05pt;line-height:
  107%'><span lang=EN-US style='font-size:10.0pt;line-height:107%'>PBT
  (Identified as PBT by the TC NES Subgroup on identification of PBT and vPvB
  Substances, EC, 2006). Probable POP (Identified as fulfilling POP screening
  criteria by the TC NES Subgroup, EC, 2006; considered by EU delegation to
  UNECE CLRTAP Executive Board December 2010 to warrant POP designation.) </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><u><span lang=EN-US
style='font-style:normal'>The revision and derivation of EQS</span></u><span
lang=EN-US style='font-style:normal'>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
15.0pt;margin-left:42.35pt'><span lang=EN-US>EQS for the first list of PS were
set in the Environmental Quality Standards Directive (2008/105/EC)<sup> </sup></span><a
href="#_ftn40" name="_ftnref40" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[40]</span></sup></sup></a><span
lang=EN-US> in 2008.  The rationale for the EQS Directive is well explained in
the Commission Communication (COM (2006) 397 final) that accompanied the
Commission proposal</span><a href="#_ftn41" name="_ftnref41" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[41]</span></sup></sup></a><span lang=EN-US>. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.8pt;margin-left:42.35pt'><span lang=EN-US>A guidance document was used to
set standards for the first list of PS</span><a href="#_ftn42" name="_ftnref42"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[42]</span></sup></sup></a><span
lang=EN-US>. Standards were set only in water, except for three substances
(mercury and its compounds, hexachlorobenzene and hexachlorobutadiene) for
which they were set in biota, with the proviso that if MS chose to use a water
standard it should be equally protective.  According to Article 3(2) of the EQS
Directive, MS may opt to apply EQS for sediment and/or biota instead of the
water standards in the Directive but they too should offer at least the same
level of protection as the prescribed water standards. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'><span lang=EN-US>The 2005 guidance has been
revised</span><a href="#_ftn43" name="_ftnref43" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[43]</span></sup></sup></a><span lang=EN-US> and substantially
expanded to update to the latest scientific and technical knowledge. The new
guidance, which received a generally favourable opinion from the SCHER in 2010
has been used to update EQS for existing substances, derive EQS for other
matrices than water, and derive EQS for the newly identified substances. The
following tables present the updated and derived standards for existing and new
substances. </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'><span lang=EN-US>Proposed changes to EQS and status
for existing PS: </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.4pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:37.2pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'># </span></b></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Substance </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:2.9pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed AA-QS </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.35pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span lang=EN-US style='font-size:6.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>water</span></b><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>µg/l
  (Existing)<b> </b></span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.5pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span lang=EN-US style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed      MAC-</span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>QS <sub>water</sub>
  </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>µg/l
  (Existing) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed
            Biota </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>EQS </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>µg/kg
  ww </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 5.4pt;height:37.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Change to PHS? </span></b></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>2 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Anthracene </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>0.1 (0.4) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>5 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Poly (including octa) </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BDE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>F  4.9 10<sup>-8</sup>
  (0.0005) S  2.4 10<sup>-9</sup> (0.0002) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:23.55pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.14 (na) S  0.014 (na) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>0.0085 </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:10.8pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>12 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>DEHP </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>15 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Fluoranthene </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>6.3 10<sup>-3</sup>
  (0.1) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>0.12 (1.0) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>30  </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:31.55pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>20 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Lead </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=center style='margin:0cm;margin-bottom:.0001pt;
  text-align:center;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>F  1.2 <sub>bioavailable</sub>
  (7.2) S  1.3 <sub>bioavailable</sub> (7.2) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>F  14.25 (na) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>S  14.25 (na) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>22 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Naphthalene   </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:29.15pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  2.0 (2.4) S  2.0 (1.2) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>130 (na) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>130 (na) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>23 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Nickel </span></b></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>F  4 <sub>bioavailable</sub> (20) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>S  8.6 <sub>bioavailable</sub>
  (20) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:49.55pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  34 S  34 </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:10.8pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>28 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>PAHs </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%'> </span></b></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:10.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benzo(a)pyrene </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup>
  (0.05) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:21.0pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.27 (0.1) S  0.027 (0.1) </span></p>
  </td>
  <td width=129 rowspan=4 valign=top style='width:96.55pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:100%'><span lang=EN-US
  style='font-size:9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Benzo(a)pyrene
  as marker </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>2 for
  fish </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.2pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span lang=EN-US style='font-size:9.0pt;
  line-height:107%;font-family:"Arial",sans-serif'>5 for crustaceans and
  cephalopods 10 for molluscs </span></p>
  </td>
  <td width=67 rowspan=5 valign=top style='width:50.6pt;border-top:none;
  border-left:none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benzo(b)fluoranthene </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup>
  (0.03*) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>F  0.017 (na) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>S  0.017 (na) </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benzo(k)fluoranthene </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup>
  (0.03*) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:21.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>F  0.017 (na) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>S  0.017 (na) </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Indeno(1,2,3-cd)pyrene
  </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup>
  (0.002**) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:31.55pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span lang=EN-US
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benzo(g,h,i)perylene
  </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.85pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>F  8.2 10<sup>-3</sup> </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>S  8.2 10<sup>-4</sup> </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>(0.002**) </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:10.7pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  8.2 10<sup>-3</sup> (na) S  8.2 10<sup>-4</sup>
  (na) </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:31.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
 </tr>
 <tr style='height:10.85pt'>
  <td width=31 valign=top style='width:23.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>33 </span></p>
  </td>
  <td width=156 valign=top style='width:117.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Trifluralin </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=116 valign=top style='width:86.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 5.4pt;height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 5.4pt;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.3pt;margin-bottom:.0001pt;text-align:left;
line-height:107%'><span style='font-size:10.0pt;line-height:107%;font-family:
"Arial",sans-serif'>Notes to the table: </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=599
 style='width:448.95pt;margin-left:42.55pt;border-collapse:collapse'>
 <tr style='height:10.85pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:10.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>PHS
  means priority hazardous substance </span></p>
  </td>
 </tr>
 <tr style='height:12.2pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>F means freshwater </span></p>
  </td>
 </tr>
 <tr style='height:12.15pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>S
  means other surface waters </span></p>
  </td>
 </tr>
 <tr style='height:12.15pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>Eco
  means the standard is set for protection of ecology </span></p>
  </td>
 </tr>
 <tr style='height:12.2pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>If
  not specified the standards apply to both freshwater and other surface
  waters. </span></p>
  </td>
 </tr>
 <tr style='height:12.2pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>(na) means not
  available </span></p>
  </td>
 </tr>
 <tr style='height:12.2pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:12.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span lang=EN-US
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>If
  left blank means no standard or no change to standard or status proposed </span></p>
  </td>
 </tr>
 <tr style='height:22.85pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:22.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:22.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>The existing
  standards for the two PAH marked with (*) and the two marked as (**) are
  given in Directive 2008/105/EC as the sum of the two compounds. </span></p>
  </td>
 </tr>
 <tr style='height:23.05pt'>
  <td width=24 valign=top style='width:18.0pt;padding:0cm 0cm 0cm 0cm;
  height:23.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=575 valign=top style='width:430.95pt;padding:0cm 0cm 0cm 0cm;
  height:23.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>For the PAHs, the
  AA-QS water of </span><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup> µg/l </span><span
  style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>corresponds
  to the biota EQS and benzo(a)pyrene can similarly apply as a marker for all
  five PAHs. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Proposed EQS and PHS status for newly identified
substances: </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=615
 style='width:461.4pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:37.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Substance </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:2.9pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed AA-QS </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:48.8pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:6.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>water</span></b><b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>µg/l<b>
  </b></span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border-top:solid black 1.0pt;
  border-left:none;border-bottom:solid black 1.0pt;border-right:none;
  padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:1.25pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:1.3pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>QS <sub>water</sub> </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>µg/l 
  </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>MAC-</span></b></p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed             Biota
  </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>EQS </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>µg/kg ww </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border:solid black 1.0pt;
  border-left:none;padding:.35pt 2.9pt 0cm 0cm;height:37.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>PHS? </span></b></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Dicofol </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:32.35pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  1.3 10<sup>-3</sup> S  3.2 10<sup>-5</sup>
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>33 </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>PFOS </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:27.7pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.00065  S  0.00013 </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:20.65pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  36 S  7.2 </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>9.1 </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Quinoxyfen (tbc) </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:42.65pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.15  S  0.015 </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:15.6pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  2.7  S  0.54 </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:29.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Dioxin </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Sum of </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>PCDD+PCDF+PCB-DL </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>8.0 10<sup>-3</sup> µg.kg<sup>-1 </sup>TEQ
  </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:29.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Aclonifen </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:42.65pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.12  S  0.012  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:10.65pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.12  S  0.012  </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Bifenox </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:25.65pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  1.25 10<sup>-2</sup> <sup> </sup>S 
  1.25 10<sup>-3</sup>  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:13.15pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.04 S  0.004  </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:10.8pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Cybutryne </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>0.0025  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>0.016<b> </b> </span></p>
  </td>
  <td width=39 style='width:28.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:10.8pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Cypermethrin </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:32.35pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  8.2 10<sup>-5</sup> S  8.2 10<sup>-6</sup>
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  5.8 10<sup>-4</sup> S  5.8 10<sup>-5</sup>
  </span></p>
  </td>
  <td width=39 valign=top style='width:28.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Dichlorvos </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:37.3pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  6 10<sup>-4</sup>  S  6 10<sup>-5</sup> 
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.3pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  7 10<sup>-4</sup>  S  7 10<sup>-5</sup> 
  </span></p>
  </td>
  <td width=39 style='width:28.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>HBCDD </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:32.35pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  1.6 10<sup>-3</sup> S  0.8 10<sup>-3</sup>
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:13.15pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.52 S  0.052 </span></p>
  </td>
  <td width=39 valign=bottom style='width:28.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>167 </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Heptachlor/ heptachlor epoxide </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:32.35pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  2.1 10<sup>-7</sup> S  1.0 10<sup>-8</sup>
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.85pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  3 10<sup>-4</sup> S  3 10<sup>-5</sup>
  </span></p>
  </td>
  <td width=39 style='width:28.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>6.7 10<sup>-3</sup>  </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Yes </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Terbutryn </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:40.2pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.065 S  0.0065 </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:13.15pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.34 S  0.034 </span></p>
  </td>
  <td width=39 style='width:28.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>17alpha-ethinylestradiol</span></b><i><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></i></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:27.3pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  3.5 10<sup>-5</sup>   S  7 10<sup>-6</sup>
  </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=39 style='width:28.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.25pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>17beta-estradiol</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <i> </i></span></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:.3pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>F  4 10<sup>-4</sup> </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>S  8 10<sup>-5 </sup></span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=39 valign=bottom style='width:28.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
 <tr style='height:21.2pt'>
  <td width=183 valign=top style='width:137.4pt;border:solid black 1.0pt;
  border-top:none;padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Diclofenac </span></b></p>
  </td>
  <td width=120 valign=top style='width:90.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:45.15pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>F  0.10 S  0.01 </span></p>
  </td>
  <td width=77 valign=top style='width:58.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=39 valign=bottom style='width:28.9pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=129 valign=top style='width:96.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:.35pt 2.9pt 0cm 0cm;height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
  <td width=67 valign=top style='width:50.6pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:.35pt 2.9pt 0cm 0cm;
  height:21.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>No </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>                   </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>   If
left blank means no standard proposed </span></p>

<p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>                   </span><span
style='font-size:10.0pt;line-height:107%;font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
style='font-size:10.0pt;line-height:107%;font-family:"Arial",sans-serif'>    TEQ
means toxic equivalents </span></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:50.95pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><b><u>ANNEX III: Background and details
regarding ubiquitous PBTs and knowledge base</u> </b></p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:.05pt;
margin-bottom:11.25pt;margin-left:37.35pt;text-align:center'><b><u><span
style='font-style:normal'>(watch list) options</span></u></b><b><span
style='font-style:normal'> </span></b></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'><b>Ubiquitous
PBTs </b></p>

<p class=MsoHeading8 style='margin-left:42.3pt'>Presentational issues </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Many measures have already been taken to reduce or
eliminate emissions of these substances, and there is little more, if anything,
that can be done from the water management perspective to improve the
situation, other than plug outstanding implementation gaps or attempt
remediation (if technically and economically feasible) of highly contaminated
&quot;hotspots&quot;. For some substances, additional measures might still be
possible in other policy areas, e.g. those dealing with diffuse or air
emissions, but the persistence of the substances means that it may take many
years  thus well beyond a RBMP cycle - for any of the measures (other than
remediation) to have an impact on the levels in the aquatic environment, which
in many cases are a legacy of past use or the unintended consequences of human
activities. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The WFD (Article 4) and the EQSD (Article 6)
contain exemption mechanisms that could be used by MS to justify not meeting
the EQS, i.e. on the grounds that doing so would not be technically feasible or
would entail disproportionate costs, that the achievement of the objectives
will take longer than the WFD timelines due to natural conditions, or that the
pollution has a transboundary origin.  However, these exemptions would need to
be used widely, and the improvements made in relation to other substances would
be hidden.  Indeed, waters are assessed in the WFD for their overall chemical
status against all the EQS and therefore a bad situation for some chemicals (in
this case PBTs) could blur even a rather positive situation for other
substances. The &quot;maps&quot; used for reporting of chemical status would
then be dominated by failures. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Since the outcome of the current review could add
several ubiquitous PBTs to the PS list, and since some of those already
identified in 2001 could be subject to more stringent EQS, it is likely that
the failure rate would increase. Theoretically, given that the possible new PS
referred to here are ubiquitous and often present in concentrations higher than
the no-effect levels, MS should have identified them as RBSPs under the WFD and
an EQS should have been set at national level. However, this has happened only
rarely (see table in Annex V) and, as a consequence, listing these substances
as PS could indeed have a significant impact on the chemical status.  </p>

<p class=MsoHeading8 style='margin-left:42.3pt'>Choice of monitoring matrix </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The EQSD, in its final form as agreed by the
legislator, includes the flexibility for MS to choose the matrix to monitor the
PS. EQS for water are given in Annex I of the EQSD, but MS can choose to
develop and use sediment and/or biota standards that offer at least the same
level of protection as those provided for water. The exception to this is the
case of three substances (Mercury, Hexachlorobenzene and Hexachlorobutadiene),
for which EQS for biota are given in the EQSD<a href="#_ftn44" name="_ftnref44"
title=""><sup><sup><span style='font-size:12.0pt;line-height:103%;font-family:
"Times New Roman",serif;color:black'>[44]</span></sup></sup></a> that MS have
to use unless they develop and apply a water standard that offers the same
level of protection as the biota standard (hence the water standards in Annex I
are never used for these three substances). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Knowledge and methodologies to develop EQS for
sediment and biota have evolved significantly, and it is now possible to derive
standards for these matrices (SCHER, 2010). However, this expertise is not
available in all MS. For example, the  Sub-Group on Review (which worked on the
prioritisation and EQS derivation) received significant input from around one
third of the EU MS, all from the EU15. The information in the first RBMP shows
that, except in a few Member States, the number of national or river basin
standards set by Member States is very limited, demonstrating the limited
experience of many MS at deriving EQS. In addition, from a MS survey done in
2011, only 5 MS have indicated they might use the flexibility in the EQSD to
derive their own standards for sediment and/or biota for substances other than
the three for which such standards are provided at EU level. The biota
standards for these three, though, are used by almost all MS (19 out of the 20
who responded). This demonstrates a preference for using the EU standard,
probably because it is seen as robust but also because its provision eliminates
the need for MS to derive a national (equally protective) water standard.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Most of the ubiquitous PBTs are very hydrophobic.
It is therefore difficult to monitor them in water. The analytical techniques
available are rarely sensitive enough to reliably detect concentrations of the
order of the EQS, as the EQS is itself very close to (or below) the limit of
determination. This means that where the results of an analysis are below the limit
of determination, the concentration in the sample may still be higher than the
EQS. Commission Directive 2009/90/EC requires MS to use analytical techniques
that meet certain minimum quality requirements in relation to the EQS, but it
also establishes that if the analytical techniques don't meet those minimum
criteria, the best available techniques not entailing excessive costs should be
used. Because of this clause, some MS are applying water standards for certain
substances even though they are not able to monitor at the level of that EQS.
The fact that PBTs tend to accumulate in sediment and biota means that their
concentrations are likely to be higher in those matrices than in water. The
analytical methods are therefore more likely to be adequate, and more likely to
demonstrate exceedance of the EQS established for those matrices. MS which
apply a water EQS set at a level below the limit of determination of the
analytical technique might therefore conclude that &quot;there is no
problem&quot;, even though the application of a sediment or biota standard
might reveal extensive failure. Although legally possible within the current
legislative set-up, it is clearly unacceptable that water bodies are
categorised as having &quot;good chemical status&quot; while they contain elevated
values in sediment and/or biota that pose a risk to or via the aquatic
environment. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The assessments of chemical status reported by MS
in their first RBMPs illustrate the problem. For example, in one MS using the
biota standard for Mercury, 100% of surface water bodies fail to achieve good
chemical status. A neighbouring country, which suffers the same problem of
widespread Mercury pollution by atmospheric deposition, monitors in water and
reports a failure rate of only 0.4%. Although it is not clear whether the
latter country's EQS is equally protective, the fact is that a very similar
environmental situation is assessed and reported in a very different way due to
the choice of matrix.  Another MS that had orally indicated widespread failure
of the Mercury standard in biota has reported in the RBMPs a failure rate based
on a water standard of only 8.4%.  </p>

<p class=MsoHeading8 style='margin-left:42.3pt'>Monitoring effort </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.15pt;margin-left:42.35pt'>An additional issue that has been raised by MS in
relation to these substances is the monitoring requirements. The WFD (Annex V)
sets minimum monitoring requirements which are adapted to the RBMP cycle. They
aim at: </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:1.0pt;margin-left:78.2pt;text-align:left;text-indent:-17.8pt'><span
style='line-height:103%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;
</span></span>providing a general assessment of the status of waters in the
basin (surveillance monitoring - monthly frequency during one year within the
6-year cycle),  </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.05pt;
margin-bottom:5.7pt;margin-left:78.2pt;text-align:left;text-indent:-17.8pt;
line-height:100%'><span style='line-height:100%;font-family:"Courier New"'>o<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp; </span></span>establishing
the status of the water bodies with a sufficient level of confidence and
measuring the improvements resulting from the programmes of measures
(operational monitoring (guideline) - monthly frequency throughout the cycle as
a guideline).  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The EQSD prescribes a minimum frequency for
compliance monitoring of sediment and/or biota of once every year and for trend
assessment once every three years. The WFD and the EQSD allow for reduced
frequency if justified on the basis of technical knowledge and expert
judgement. For ubiquitous PBTs, any change in environmental concentrations that
might occur as a result of measures is likely to occur over the long term
(unless remediation is carried out) and therefore a lower monitoring frequency
would seem justified. A reduction in the number of monitoring sites might also
be reasonable.  If MS choose to use a sediment or biota standard, the default
monitoring frequency is already lower (annually rather than monthly).  The
issue is how, for ubiquitous PBTs, the monitoring frequency can be optimised to
minimise the administrative burden while still yielding sufficient information.
</p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'><b>Knowledge
base </b></p>

<p class=MsoHeading8 style='margin-left:42.3pt'>Emerging pollutants </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The NORMAN network<a href="#_ftn45"
name="_ftnref45" title=""><sup><sup><span style='font-size:12.0pt;line-height:
103%;font-family:"Times New Roman",serif;color:black'>[45]</span></sup></sup></a>
defines emerging pollutants as: &quot;pollutants that are currently not
included in routine monitoring programmes at the European level and which may
be candidates for future regulation, depending on research on their (eco)toxicity,
potential health effects and public perception and on monitoring data regarding
their occurrence in the various environmental compartments&quot;.  In addition,
there are many unregulated &quot;emerging substances&quot; which have been
detected in the environment but whose fate, behaviour and effects are not yet
well enough understood for them to be necessarily regarded as pollutants.  The
NORMAN database of these emerging pollutants and emerging substances numbers
some 750 substances. </p>

<p class=MsoHeading8 style='margin-left:42.3pt'>Watch list technical details
and structural support </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.65pt;margin-left:42.35pt'>The technical elements of the proposed watch list
would be as follows: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.85pt;margin-left:78.55pt;text-indent:-18.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Selection of the substances to monitor (around 20±5) in
accordance with the following criteria: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:96.55pt;text-indent:-18.0pt'><span style='font-family:"Segoe UI Symbol",sans-serif'>&#8722;</span><span
style='font-family:"Arial",sans-serif'> </span>(Emerging) pollutants for which
there is evidence from the information available (e.g. from research and MS
monitoring or studies, and taking into account use patterns and available
monitoring and ecotoxicological data) that they may pose a risk to or via the
aquatic environment at EU level, but for which there are insufficient data or
insufficiently high-quality data to assess the risk </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:78.55pt;text-indent:-18.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Development of guidelines (substance-specific, if appropriate)
on:  </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=541
 style='width:405.85pt;margin-left:78.55pt;border-collapse:collapse'>
 <tr style='height:13.0pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:13.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:13.0pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'>selecting representative stations (250-300 across the EU)
  (to be selected by MS) </p>
  </td>
 </tr>
 <tr style='height:14.65pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>sampling methods and/or
  periods  </p>
  </td>
 </tr>
 <tr style='height:14.65pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>the monitoring
  matrix/matrices (water, sediment and/or biota) </p>
  </td>
 </tr>
 <tr style='height:14.65pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>the minimum number of
  samples (1-5, average of 2, per year per station) </p>
  </td>
 </tr>
 <tr style='height:14.65pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:14.65pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>the analytical methods
  and/or minimum performance criteria  </p>
  </td>
 </tr>
 <tr style='height:13.05pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:13.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=517 valign=top style='width:387.85pt;padding:.3pt 0cm 0cm 0cm;
  height:13.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>any other technical needs
  to deliver a high quality dataset.  </p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'>Existing structures would be
used for the technical work and for data collection. In particular, the
technical work would be done using the existing informal structures of the WFD
Common Implementation Strategy (CIS), in particular the WG E and its sub-group
on Chemical Monitoring and Emerging Pollutants (CMEP), co-chaired by the JRC.
Experts from MS, stakeholders and the Commission are represented and they have
the experience and the expertise for this task. Other options such as
establishing a new group have been considered but seemed superfluous and
inefficient in comparison. Data collection would be done using the Water
Information System for Europe (WISE) managed by the EEA - an already a
wellestablished EU system for collecting water data. Alternative options
considered (e.g. establishing an ad-hoc system for reporting) would likely be
more expensive and less effective. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'>The additional monitoring involved, which would be
done by MS, would be limited. Current water-related monitoring requirements are
already quite substantial across the EU, not only for the WFD PS (estimated
cost ca. 69 million Euros annually, see Annex IV) but also for other WFD
obligations (ecological status), other Water Directives (Bathing Water,
Nitrates, Urban Waste Water) and other water-related international commitments
(OSPAR, HELCOM, Barcelona Convention, Rhine Commission, ICPDR, etc). The
proposal for the watch list to have 20±5 substances monitored at 250-300
stations is considered reasonable noting that: </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=593
 style='width:444.65pt;margin-left:54.55pt;border-collapse:collapse'>
 <tr style='height:68.15pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:68.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=569 valign=top style='width:426.65pt;padding:.3pt 0cm 0cm 0cm;
  height:68.15pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.1pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'>For
  each substance on the watch list a minimum of information would need to be
  gathered (available monitoring data, ecotoxicological information, use
  patterns, etc). This would imply additional work for the WG E and the CMEP
  sub-group. The proposal is consistent with the amount of work that the
  existing groups can handle without increasing significantly the
  administrative costs. </p>
  </td>
 </tr>
 <tr style='height:125.05pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:125.05pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=569 valign=top style='width:426.65pt;padding:.3pt 0cm 0cm 0cm;
  height:125.05pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'>There
  is a pragmatic limit on how many substances can be considered in detail for
  prioritisation in each of the regular reviews of the PS list. In the current
  review, the prioritisation process arrived at a short-list of 41 substances
  for detailed consideration, and in 15 substances being proposed for addition
  to the list (the subject of options A3aA3c above). This has been used as a
  guideline: a watch list of 20 substances renewed on average every two years
  would provide monitoring data on about 40 substances every 4 years. This
  would provide substantial and probably sufficient input for the objective of
  the regular review of the PS., especially in view of the other possible
  sources of information including the data on RBSPs. </p>
  </td>
 </tr>
 <tr style='height:40.6pt'>
  <td width=24 valign=top style='width:18.0pt;padding:.3pt 0cm 0cm 0cm;
  height:40.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-family:
  "Segoe UI Symbol",sans-serif'>&#8722;</span><span style='font-family:"Arial",sans-serif'>
  </span></p>
  </td>
  <td width=569 valign=top style='width:426.65pt;padding:.3pt 0cm 0cm 0cm;
  height:40.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:3.1pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'>There
  are 110 RBDs in the EU, 176 if each national part is considered separately.
  The figure of 250-300 stations would provide for at least one station per RBD
  and more in the case of large RBDs. This would provide an EU-wide picture. </p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.55pt;margin-left:42.35pt'>To ensure that the watch list served its purpose
and was as cost-effective as possible, it would be updated regularly and the
results subjected to expert scrutiny. If one year of monitoring showed that
there was no significant risk at EU level, the relevant substance could be
removed.  There would be annual electronic reporting to WISE, and the data
would be analysed by the experts of the WG E/CMEP sub-group. If the information
were not conclusive after a year, the substance would be kept on the watch
list. If the information were considered sufficient for risk assessment
purposes, the substance would be replaced by another. It is estimated that on
average the substances would remain on the list for 2 years. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> <br clear=all style='page-break-before:always'>
</p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:.15pt;
margin-bottom:11.25pt;margin-left:37.35pt;text-align:center'><b><u><span
style='font-style:normal'>ANNEX IV: Approach to the assessment of impacts</span></u></b><b><span
style='font-style:normal'> </span></b></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.9pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Assessment of impacts arising from regulation of the substances </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.0pt;margin-left:42.35pt'>According to the provisions of the WFD and EQSD, the
review addressed the following issues: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.95pt;margin-left:77.85pt;text-indent:-36.0pt'><span style='line-height:103%'>(i)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Determine whether additional substances should be identified as
PS or PHS and if so, to establish the appropriate EQS for each substance in
water, sediment and/or biota. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.95pt;margin-left:77.85pt;text-indent:-36.0pt'><span style='line-height:103%'>(ii)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>In relation to existing PS and PHS and considering any new
technical/scientific information: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:99.25pt;text-indent:-21.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>review the existing EQS </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:99.25pt;text-indent:-21.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>establish, if appropriate, EQS for sediment and/or biota </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.15pt;margin-left:99.25pt;text-indent:-21.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>review the PHS classification  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.5pt;margin-left:77.85pt;text-indent:-36.0pt'><span style='line-height:103%'>(iii)<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Consider the need for control measures for both existing and
newly identified PS and PHS (according to Article 16(6) of the WFD and Article
7 of EQSD). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>In relation to (i) and (ii) above, the choice of
matrix (i.e. water, sediment and/or biota), and the determination of the EQS,
are largely scientific/technical decisions that take account of the behaviour
of a particular substance in the environment and the availability of relevant
scientific information.   There are also established criteria for identifying
PS as PHS (set out in the WFD, and closely linked with REACH, as indicated in
Recital 28 of the EQSD).  These are described in the Commission Staff Working
Paper SEC(2011)1544 (European Commission 2011).  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>To support the imact assessment, a study was
conducted by the consultancy Entec.  A bottom-up approach was developed that
allowed the assessment of impacts substance by substance, allowing aggregation
of impacts in the different options.  The methodology is described in detail in
the report by Entec (Entec, 2011b). The individual substance reports from Entec
are also available (Entec, 2011) . The fact sheets in Annex V of this report
summarise the main results of the assessment of impacts for each of the
substances.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The main elements of the methodology were the
following: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.0pt;text-indent:-14.15pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>The
approach to undertaking the impact assessment was based around a case study
approach for individual substances in order to assess the impacts of the
possible outcomes of the review, using the best available information.  In this
approach, a number of case studies (generally two or three per substance) were
carried out at a MS level.  The intention was to allow the impacts within the
MS to be assessed in more detail than would be possible at the EU-level, due to
the lesser amount of data collection and consultation required.  This approach
is also more feasible where data availability is limited.  Multiple case
studies were deemed necessary for each substance to ensure that the range of
potential impacts (e.g. in different MS and impacts on different sectors) was
covered.  Assumptions were applied because of data gaps. An assessment
(predominantly qualitative) was then made of the applicability of the case
study findings at the EU level. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.0pt;text-indent:-14.15pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>The
primary selection criterion for the initial case study (or studies) was
monitoring data.  In particular, MS where the monitoring data showed failure of
the current or likely EQS were selected, to ensure that at least one case study
was undertaken on a MS where impacts were likely to be identified.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.0pt;text-indent:-14.15pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>The
impact of applying control measures for one substance on other substances was
considered (since the application of measures for control of one substance may
also imply control of other substances to a greater or lesser extent). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:56.0pt;text-indent:-14.15pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>A
largely qualitative approach was taken to the assessment of impacts.  The scope
for quantifying the benefits, especially the environmental and social benefits
(cf economic) was particularly limited.  Although it was possible to put a
figure on some costs (e.g. for advanced UWWT) and benefits (e.g. for
recreational angling) it was not always possible to extrapolate. Section
5.2.1.1 presents the main benefits that were considered in dealing with
substances. More information can be found in section 2.6.7 of the methodology
report (Entec, 2011b). </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Assessment of additional monitoring costs for the substances  </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Calculations were done using bottom-up (starting
from unit costs for analysis) and top-down (starting from overall figures on
expenditure by MS) approaches to estimate the costs of adding substances to the
PS list.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>A questionnaire was circulated to MS in 2010 to
gather information on the costs of monitoring the existing PS. 22 MS replied
and 16 gave information on monitoring costs, i.e. unit costs for sampling and
analysis in the different matrices and overall current costs of monitoring of
WFD PS. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>Two complementary methodological approaches were
applied to these data to calculate monitoring costs. They are explained below. </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><u><span style='font-style:
normal'>Bottom-up approach</span></u><span style='font-style:normal'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:49.05pt'>Some data treatment was carried out on the unit costs,
i.e. removal of outliers and calculation of average unit values for sampling
and analysis in water (total and dissolved), sediment and biota. The results
were as follows (EU average): </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=513
 style='width:384.8pt;margin-left:41.75pt;border-collapse:collapse'>
 <tr style='height:13.25pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:10.0pt;
  line-height:107%;font-family:"Arial",sans-serif'>Unit costs </span></b></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border:solid black 1.0pt;
  border-left:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Euros </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border:solid black 1.0pt;
  border-left:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:13.25pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Sample water </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.25pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.45pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>128 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Average of total and dissolved (112 and
  145) </span></p>
  </td>
 </tr>
 <tr style='height:13.25pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Sample sediment </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.25pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>228 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:13.25pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Sample biota </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.25pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.3pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>422 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:13.25pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Analysis water </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.25pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.25pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>133 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>Average of total and
  dissolved (105 and 162) </span></p>
  </td>
 </tr>
 <tr style='height:13.2pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Analysis sediment </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.2pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.35pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>128 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:13.3pt'>
  <td width=145 valign=top style='width:108.8pt;border:solid black 1.0pt;
  border-top:none;padding:1.75pt 5.75pt 0cm 5.35pt;height:13.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Analysis biota </span></p>
  </td>
  <td width=72 valign=top style='width:54.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:1.75pt 5.75pt 0cm 5.35pt;
  height:13.3pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.3pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>151 </span></p>
  </td>
  <td width=296 valign=top style='width:222.0pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:1.75pt 5.75pt 0cm 5.35pt;height:13.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>The proportions of sampling in water, sediment and
biota were extracted as a starting point from the monitoring database compiled
for the review. They were: 93% in water, 6% in sediment, 1% in biota. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:49.05pt'>A weighted average of the sampling and analytical
costs using these percentages resulted in the following unit costs: </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=265
 style='width:198.8pt;margin-left:41.75pt;border-collapse:collapse'>
 <tr style='height:13.25pt'>
  <td width=185 valign=top style='width:138.8pt;border:solid black 1.0pt;
  padding:3.45pt 5.45pt 0cm 5.45pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>Sample weighted
  average </span></p>
  </td>
  <td width=80 valign=top style='width:60.0pt;border:solid black 1.0pt;
  border-left:none;padding:3.45pt 5.45pt 0cm 5.45pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:3.45pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>137 Euros</span></p>
  </td>
 </tr>
 <tr style='height:13.25pt'>
  <td width=185 valign=top style='width:138.8pt;border:solid black 1.0pt;
  border-top:none;padding:3.45pt 5.45pt 0cm 5.45pt;height:13.25pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%;font-family:"Arial",sans-serif'>Analysis weighted
  average </span></p>
  </td>
  <td width=80 valign=top style='width:60.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:3.45pt 5.45pt 0cm 5.45pt;
  height:13.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:3.45pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>133 Euros</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>The Commission implementation report on the WFD
Monitoring programmes of 2009<a href="#_ftn46" name="_ftnref46" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[46]</span></sup></sup></a> identified 18535 sampling stations in
23 MS where PS are being monitored, including operational and surveillance
monitoring.  Extrapolation on the basis of population gives around 21500
stations in the EU27 in which PS are monitored. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>The minimum frequency of monitoring depends on the
type of monitoring: monthly during one year out of six in the case of
surveillance monitoring and monthly for operational monitoring. But there are
flexibilities to reduce the frequency on the basis of technical knowledge and expert
judgement. For monitoring in biota or sediment, the minimum frequency is once
per year (Article 3(2)c of EQSD); a reduced frequency is also possible on the
basis of technical knowledge and expert judgement. Trend analysis in sediment
and biota for a number of PS as per Article 3(3) of the EQSD is once every 3
years. Overall, a value of 2 samples per year will be used. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>It was necessary to take into account that only
substances discharged into water bodies are monitored in them.  Moreover, each
sampling point is adequate to monitor the presence of a certain group of
substances: pesticides, industrial chemicals, metals, substances linked to
consumer products/conurbations/UWWTPs, etc.. It was assumed for the cost
calculation that an average of between 20% and 40% of the substances (8 to 16)
are monitored per sample per station.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>On the basis of the above assumptions, the total
estimated cost of current monitoring of existing PS in the EU27 was calculated
to lie within the range 51 to 97 million . </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>The unit costs are assumed to be robust since they
are based on data from a good balance of MS (geographically and
socio-economically). Still, the basis of some assumptions could change. For
example, the proportion of sediment and biota sampling is likely to increase as
the EQSD is more fully implemented (Article 3(2)) and additional MS develop
expertise in this. Water samples would still form the highest proportion as the
frequency of monitoring is much higher. Changing from the current figures of
93, 6 and 1% respectively to 80, 15 and 5% would result in an increase of 1
million  per year<sup>48</sup>, so a small percentage of the overall cost
range calculated above.  </p>

<p class=MsoHeading8 style='margin-left:49.05pt'><u><span style='font-style:
normal'>Top-down approach</span></u><span style='font-style:normal'>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>In response to the questionnaire referred to
above, 11 MS provided the overall costs of monitoring existing PS.
Extrapolation to the whole of the EU27 on the basis of population leads to an
estimate of the total costs of monitoring for existing PS of 57 million .  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>A sensitivity analysis was done to consider the
influence of particular MS data on the estimate, since of the 11 MS, 4 were
from the EU15 and 7 from the EU12, and costs and expenditure tend to be higher
in the former. Extrapolating separately resulted in 41 million (if only EU12
data were used) and 94 million (if only EU15 data were used). This confirms
that the estimate of 57 million is towards the lower end of the range.  </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:48.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoHeading8 style='margin-left:49.05pt'><u><span style='font-style:
normal'>Conclusions</span></u><span style='font-style:normal'>  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>Feedback from MS confirms the robustness of the
assumptions and results.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:49.05pt'>There are a number of sources of uncertainty: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Flexibility
provided by the WFD for MS to tailor monitoring programmes to the local
situation and to select the matrix for monitoring. A good overview was obtained
from the reporting in 2007 (Article 8 of WFD) and the Monitoring report of 2009<sup>47</sup>,
although programmes may have been adapted later on at the RBMP stage.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Data
on unit costs were obtained from only 16 MS.  However, they covered a good
geographical and socioeconomic range, and the plausibility of the results was
confirmed by several MS and the JRC. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.0pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Data
on the overall costs of monitoring of existing PS were obtained from only 11
MS, of which only 4 were from the EU15.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Monitoring
of new substances may need some development costs that are not reflected in the
unit costs, which relate to routine monitoring of existing PS.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>New
substances (either newly proposed PS or substances added to the watch list) are
not the same as the existing PS. However, the types of substances are similar,
the analytical techniques are frequently the same, and there is no reason to
believe that costs will differ substantially.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:57.25pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>For
a few substances the analytical costs may be higher if very low determination
limits are required. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:49.05pt'>Resulting estimates for costs of monitoring for the
EU (for the overall costs the lowest and the highest of the two calculations
based on the two independent approaches is given): </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=567
 style='width:425.4pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:26.35pt'>
  <td width=369 style='width:277.1pt;border:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Million  </p>
  </td>
  <td width=69 style='width:51.4pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.35pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'>Average</p>
  </td>
  <td width=65 style='width:48.9pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>Low </p>
  </td>
  <td width=64 style='width:48.0pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>High </p>
  </td>
 </tr>
 <tr style='height:26.3pt'>
  <td width=369 style='width:277.1pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Unit costs sampling (weighted average for
  all matrices)</p>
  </td>
  <td width=69 style='width:51.4pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>128 </p>
  </td>
  <td width=65 style='width:48.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>- </p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>- </p>
  </td>
 </tr>
 <tr style='height:26.3pt'>
  <td width=369 style='width:277.1pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Unit costs analysis (weighted average for
  all matrices) </p>
  </td>
  <td width=69 style='width:51.4pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>133 </p>
  </td>
  <td width=65 style='width:48.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>- </p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>- </p>
  </td>
 </tr>
 <tr style='height:26.35pt'>
  <td width=369 style='width:277.1pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Overall costs of monitoring of existing PS </p>
  </td>
  <td width=69 style='width:51.4pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>69 </p>
  </td>
  <td width=65 style='width:48.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>41 </p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>97 </p>
  </td>
 </tr>
 <tr style='height:26.3pt'>
  <td width=369 style='width:277.1pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.3pt 0cm 5.35pt;height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>Unit costs per PS based on overall
  monitoring </p>
  </td>
  <td width=69 style='width:51.4pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>1.7 </p>
  </td>
  <td width=65 style='width:48.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>1 </p>
  </td>
  <td width=64 style='width:48.0pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.3pt 0cm 5.35pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'>2.4 </p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.9pt;margin-left:48.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoHeading9 style='margin-left:42.3pt'>Cost estimate for the watch
list (relevant to options C2 and C3) </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'>Estimated annual monitoring costs for the watch list
are in the following table using the unit costs derived above for sampling and
analysis and the range in number of stations, substances and the average
frequency of 2 samples per year, as presented in section 4.4.2: </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=351
 style='width:263.4pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:26.35pt'>
  <td width=111 style='width:83.4pt;border:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>Million  </p>
  </td>
  <td width=120 style='width:90.0pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>15 substances </p>
  </td>
  <td width=120 style='width:90.0pt;border:solid black 1.0pt;border-left:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>25 substances </p>
  </td>
 </tr>
 <tr style='height:26.3pt'>
  <td width=111 style='width:83.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:26.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>250 stations </p>
  </td>
  <td width=120 style='width:90.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>2.0 </p>
  </td>
  <td width=120 style='width:90.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:26.3pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>3.3 </p>
  </td>
 </tr>
 <tr style='height:26.35pt'>
  <td width=111 style='width:83.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>300 stations </p>
  </td>
  <td width=120 style='width:90.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>2.4 </p>
  </td>
  <td width=120 style='width:90.0pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:26.35pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'>4.0 </p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>These costs are calculated considering one sample
per analysis. This substantially overestimates the costs, as some of the
substances will be of the same type and therefore will be analysed in the same
sample. If indeed only one sample were needed for all the substances, the costs
would be halved.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>However, there is also an important source of
underestimation. The analytical costs that were reported by MS refer to routine
analysis of existing PS. There is a need to consider development and adaptation
costs for the substances in the watch list, as they may not be analysed on a
routine basis in the MS. This could result in higher costs per analysis.
Increasing the unit costs of analysis by 50% would result in an increased
annual cost for the watch list of 25%, resulting in a total of 2.5 to 5 million
 for the whole EU. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>It is estimated that the above sources of
overestimation and underestimation would partially cancel each other out. The
range of the cost estimate (2 to 4 million ) is considered robust, as
confirmed by consultation with MS, and represents between 3 and 6% of the
current average overall costs of monitoring of PS (69 million, average of the
range 41-97 million ). </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.7pt;margin-left:48.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:85.1pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:85.1pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> <br clear=all style='page-break-before:always'>
</p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:.15pt;
margin-bottom:11.25pt;margin-left:37.35pt;text-align:center'><b><u><span
style='font-style:normal'>ANNEX V: Substance factsheets</span></u></b><b><span
style='font-style:normal'> </span></b></p>

<p class=MsoHeading8 style='margin-top:0cm;margin-right:0cm;margin-bottom:8.2pt;
margin-left:42.3pt'><b><span style='font-style:normal'>Contents </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>17-alpha-ethinylestradiol.........................................................................................................84
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>17-beta-estradiol......................................................................................................................85
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Aclonifen.................................................................................................................................86
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Anthracene
..............................................................................................................................87
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Bifenox....................................................................................................................................88
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Cybutryne................................................................................................................................89
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Cypermethrin...........................................................................................................................90
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>DEHP
......................................................................................................................................91
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Dichlorvos...............................................................................................................................93
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Diclofenac
...............................................................................................................................94
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Dicofol.....................................................................................................................................95
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Dioxins and
DL-PCBs.............................................................................................................96
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Fluoranthene............................................................................................................................97
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>HBCDD...................................................................................................................................98
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.3pt;margin-left:42.35pt'>Heptachlor...............................................................................................................................99
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Lead.......................................................................................................................................100
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Naphthalene...........................................................................................................................102
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Nickel....................................................................................................................................103
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>PAH.......................................................................................................................................104
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>PBDEs...................................................................................................................................105
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>PFOS .....................................................................................................................................106
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Quinoxyfen............................................................................................................................107
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.35pt;margin-left:42.35pt'>Terbutryn...............................................................................................................................108
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Trifluralin..............................................................................................................................109
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>These substance factsheets are essentially based
on the information in Entec (2011) and technical documents (EQS dossiers,
source-screening and measures sheets) produced during the review process. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'> </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>17-alpha-ethinylestradiol
  (EE2) factsheet</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=310 valign=top style='width:232.2pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=310 valign=top style='width:232.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.2pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  </td>
  <td width=310 valign=top style='width:232.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Fresh 3.5 10<sup>-5</sup> 
  Salt 7 10<sup>-6</sup> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Endocrine disruptive;
  risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Synthetic
  steroid most commonly used as the oestrogen component of combined oral
  contraceptives; also in the treatment of menopausal and post-menopausal
  symptoms and for other medicinal purposes. No data on production in the EU,
  though indications of production in DE. Approx 32 million women use EE2-based
  oral contraceptives in the EU. Consumption varies widely, from 52% of women
  between 15 and 49 years old in DE to 3.4% in PL. EE2 is excreted by people
  that consume it (57-85% is excreted unchanged) and enters the environment primarily
  through the sewerage wastewater system.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  and predictions show exceedances of the EQS in water (see
  &quot;Uncertainties&quot;). Emissions may be reduced due to improvement in
  waste water treatment driven by the general good status objective of the WFD.
  Public awareness of take-back schemes for unused or expired pharmaceuticals
  very variable (73% Swedish know, 77% British do not). Data on success of
  take-back schemes generally lacking but also very variable. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:126.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:126.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Some potential
  measures identified but effectiveness very difficult to estimate as no
  experience of reducing environmental impact of pharmaceuticals in use.
  Current EU legislation does not provide the mechanisms to take most of these
  measures at EU level. Most feasible measures (e.g. improvement of take-back
  schemes, information to patients, doctors and pharmacists to influence
  prescription and achieve partial replacement by alternative contraceptives,
  etc) would be expected to reduce consumption of EE2 over the long term and
  increase that of alternatives, e.g. the progestogen-only pill, whose active
  hormone undergoes higher removal rates in UWWTPs. Long-term economic impacts
  on pharmaceutical companies producing EE2-based contraceptive pills due to
  reduced sales (current sales in EU are estimated at several hundred million
  ) unless they can move into the market for alternatives. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: Monitoring costs for MS. Depending on the
  design of the take-back schemes and awareness raising programmes, there might
  be additional costs incurred by public bodies. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:78.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:78.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.4pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality and therefore better possibilities for targeting
  measures.  Environmental benefits of decreasing environmental concentrations
  below no-effect levels, in particular for fish, possible increase in
  sustainability of fish stocks through reduced negative impacts on fish
  reproduction. Benefits for wider biodiversity related to increased fish
  stocks. Potential economic and social benefits related to commercial fisheries
  and recreational uses (angling). Economic benefits for pharmaceutical
  companies selling alternatives to EE2. Lower risk of endocrinedisrupting
  substances in drinking water, hence potential savings in drinking water
  treatment. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Fisheries, medical,
  pharmaceuticals. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical impacts:
  Widely used across the EU, but higher usage in DE, PT, BE, FR, NL and HU.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent
  of monitoring of this &quot;emerging pollutant&quot; limited (3 countries in database,
  plus literature). Usefulness of monitoring information also limited because
  limits of detection usually 2 orders of magnitude higher than the EQS. No
  information on production in the EU. Uncertainties regarding effectiveness of
  measures due to the lack of experience in reducing the environmental impact
  of pharmaceuticals in use.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>17-beta-estradiol (E2)
  factsheet</span></b><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.2pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=310 valign=top style='width:232.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.2pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  </td>
  <td width=310 valign=top style='width:232.15pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Fresh 4 10<sup>-4</sup> 
  Salt 8 10<sup>-5</sup> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Endocrine disruptive;
  risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:89.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:89.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Naturally-occurring
  steroidal oestrogen produced by humans, livestock and wild animals.  Also
  used to manufacture synthetic oestrogenic and hormonal products. Natural
  excretion of E2 by humans and animals accounts for around 90% of emissions to
  surface waters. Excretion from livestock is 10 times higher than from humans
  (estimated in the EU at 1000 kg/day for livestock vs 100 kg/day for humans)
  but human discharge is fully to water, cf. only a fraction of the livestock
  excretion. Therefore human and livestock emissions to water estimated to be
  of the same order of magnitude. Pharmaceutical uses of E2 account for less
  than 10% of total emissions, of which 90% due to hormone replacement
  therapies (HRT) (800 to 2200 kg/year) the rest to use in oral contraceptives.
  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:58.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:58.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  and predictions show exceedances of EQS in water (see
  &quot;Uncertainties&quot;). Emissions to surface water from human excretions
  may be reduced due to improvement in waste water treatment driven by general
  good status objective of the WFD. Emissions from livestock likely to be
  reduced due to increased protection of water courses at farm level driven by
  WFD, Nitrates Directive and the Directive on the Sustainable Use of
  Pesticides, through the implementation of buffer strips.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:159.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:159.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Some potential
  measures have been identified but effectiveness very difficult to estimate.
  Measures should focus on reducing emission due to human and livestock
  excretion (e.g. improvements to UWWTPs and protection of water courses from
  livestock). Emissions from pharmaceutical uses would be reduced at the same
  time by improved UWWTPs.  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Difficult to estimate the
  need for additional measures to reduce emissions to water from livestock
  beyond the baseline. Cost of fencing to avoid livestock access to water
  courses is estimated at 2 to 12 /ha/year.  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:100%'><span
  style='font-size:9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Estimated
  costs to upgrade UWWTPs to remove E2: For England and Wales: 18  per
  inhabitant per year based on a stricter EQS than that proposed; For CH: 11-18
   per inhabitant per year depending upon the number of plants to be upgraded.
  These costs assume no source control and, if entailed, would likely be passed
  through in full or in part to consumers, within proportionate limits
  (exemptions could be applied on grounds of disproportionality or
  non-feasibility). Significant increase in energy use due to increased
  treatment (equivalent to 1 million tons of CO<sub>2</sub> in England and
  Wales). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:78.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:78.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality and therefore better possibilities for targeting
  measures.  Environmental benefits of decreasing environmental concentrations
  below no-effect levels, in particular for fish, possible increase in
  sustainability of fish stocks through reduced negative impacts on fish
  reproduction. Benefits for wider biodiversity related to increased fish
  stocks. Potential economic and social benefits related to commercial
  fisheries and recreational uses (angling). Increased waste water treatment
  will reduce discharge of many other pollutants. Lower risk of
  endocrine-disrupting substances in drinking water, hence potential savings in
  drinking water treatment. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Fisheries, livestock farming,
  pharmaceuticals, sewerage/water. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical impacts:
  Highest emissions estimated for FR, DE, UK, IT, ES, PL, IE and NL.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties
  regarding the proportion of E2 from livestock that reaches surface waters.
  Uncertainties about the effectiveness of the WFD measures included in the
  baseline to limit human and livestock E2 emissions to water. Limited
  monitoring information available for this &quot;emerging pollutant&quot; (2
  countries in database, plus literature) and its usefulness is reduced because
  llimits of determination often higher than the EQS).  </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Aclonifen factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.12 µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Ranked high in modelling based prioritisation;
  bioaccumulative and toxic (and some evidence of persistence); risk ratio
  &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Herbicide
  manufacture and use (over 1000 tonnes/yr).  Use as pre-emergence herbicide on
  a range of arable crops, especially potatoes, peas, maize, sunflowers.  Also
  in forestry (tree nurseries). Losses to water by way of spray-drift, run-off,
  spills.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  data from 3 MS; exceedances of EQS in FR (which has the highest use and the
  most substantial monitoring dataset). Losses to water likely to decrease as a
  result of recently introduced requirement under Directive 91/414/EEC for
  buffer strips next to water courses. Likely to be aided by implementation of
  the Directive on Sustainable Use of Pesticides. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:43.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Buffer strips already
  obligatory, but wider strips and/or additional measures might be locally
  required in response to monitoring results. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality; feedback to the PPP authorisation process. 
  Possible additional benefits to biodiversity if measures improved. Reduced
  risk of failure of individual and total pesticides standards in drinking
  water. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Note: Many benefits
  expected to be achieved under the baseline, but could be accelerated if
  improved knowledge of concentrations leads to better management, e.g. wider
  buffer strips, better timing of application, more widespread restrictions on
  spray-equipment cleaning methods. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Agriculture (arable). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical impacts:
  Widely used in EU (18 MS in 2008) but 70% in FR.  7 formulators in FR, 1 in
  SE (the casestudy MS); no data for other MS.  Active substance produced in FR
  by DE-based company. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent
  of failure of EQS following recent introduction of buffer zones under
  Directive 91/414/EEC and adoption of the Directive on the Sustainable Use of
  Pesticides.  Uncertainty regarding peak concentrations following application.
  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Anthracene factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> More
  stringent MAC for existing substance. </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Unchanged
  (PHS due to PBT properties) </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:18.3pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:159%'><b><span style='font-size:9.0pt;line-height:
  159%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:159%;font-family:"Arial",sans-serif'> <b>QS
  <sub>freshwater, eco</sub>  Proposed corresponding EQS in freshwater:</b>  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed MAC:  </span></b></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Unchanged </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Not relevant </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>0.1 &#956;g/l (cf 0.4
  &#956;g/l) </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Review of the QSs prompted by revised RAR for pitch. 
  Conclusion that high acute toxicity justifies setting MAC equal to AA-EQS.<b>
  </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Aromatic hydrocarbon. 
  Occurs naturally in fossil fuels/derivatives and is produced during
  combustion; is therefore emitted from many industrial processes using fossil
  fuels or involving combustion. Pure anthracene (approx 1000 tonnes per annum
  in EU) manufactured from coal tar pitch for limited range of uses (e.g.
  pyrotechnics 0.2 tonnes).  Produced in larger quantities (estimated 27000
  tonnes per annum) in coal-tar distillation products. Coal tar pitch can be
  considered main use; in binding agents for e.g. electrodes, road
  construction, roofing. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Total
  emissions highest from coke production, aluminium production, creosote and
  wood preservation (restricted conditions since 2003), domestic fuel
  combustion, vehicle engines, tyres (production and use), agricultural burning
  and forest fires, though half-life in air short, therefore atmospheric
  deposition relatively low cf some other PAHs, though still significant.
  Emissions to water (approx 9 tonnes in E-PRTR 2008) highest from metals
  production.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>4 MS
  report current failure of existing AA-EQS. Monitoring database reports some
  concentrations higher than proposed MAC. Regulation (EC) No 850/2004 on POPs
  imposes release reduction provisions; REACH Annex XVII restrictions. possible
  inclusion in Annex XIV; IPPC Directive/IED; Directive 2004/107 on
  concentrations in air; Directive  98/70/EC on PAH content of diesel; Various
  BATs and BREFs, e.g. for aluminium production; Regulation (EC) No 1881/2006
  on food standards for PAHs; inclusion in Annex I of Directive 98/8/EC
  effective from May 2013.. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:0cm;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Mostly in baseline,
  since existing AA-EQS already 0.1 &#956;g/l and existing MAC only four-fold
  less stringent, and emissions to water should be phased out anyway. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Possibly additional measures
  directed at (industrial) point source emissions (more relevant to MAC than
  diffuse sources).  </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: None beyond baseline, except possibly
  additional permitting administration and additional targeted monitoring in
  the short term. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Mostly in baseline,
  but possible acceleration of local improvements in water quality and
  ecosystem health. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Note: Although accumulation in biota is relevant
  (secondary poisoning), critical EQS remains direct toxicity. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Coal tar distillation; energy,
  metals production. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical impacts: 
  Relevant industries (point sources) more prevalent in some MS than others. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  current MAC in all MS; inclusion or not in REACH Annex XIV. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Bifenox factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>1.25 10<sup>-2</sup> µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Ranked high in
  modelling based prioritisation, very toxic, risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Herbicide manufacture and use (over 200 tonnes/yr).  Use
  as post-emergence herbicide predominantly on winter cereal crops, also on
  some grasslands. Losses to water by way of spray-drift, run-off, spills.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Monitoring data from 3 MS; exceedances of EQS in FR
  (which has the highest use and the most substantial monitoring dataset).
  Losses to water likely to decrease as a result of Directive on Sustainable
  Use of Pesticides. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>If buffer strips already
  obligatory (as in some MS), no additional cost to farmers; additional
  measures might be locally required in response to monitoring results. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; feedback to the PPP
  authorisation process.  Possible additional benefits to biodiversity. Reduced
  risk of failure of individual and total pesticides standards in drinking
  water. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:90.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:90.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Note: Many benefits
  expected to be achieved under the baseline, but could be accelerated if
  improved knowledge of concentrations leads to better management, e.g. (wider)
  buffer strips, better timing of application, more widespread restrictions on
  spray-equipment cleaning methods. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Agriculture (arable). </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts: Widely authorised in EU (19 MS) but most use in FR. Marketed by 3
  companies in FR and 3-4 in UK (the case-study MS); no data for other MS, but
  production of active substance likely to be in Israel (head office of producer
  based there). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Extent of failure of EQS following recent adoption of the
  Directive on the Sustainable Use of Pesticides.  Uncertainty regarding peak
  concentrations following application. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Cybutryne factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .3pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.0025 µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Substance of concern in MS, toxic, risk ratio &gt;1;
  degrades only slowly; main degradation product (M1) also toxic; persists in
  sediments. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Biocidal
  (algicidal) use - approx 10 tonnes/yr in EU (incomplete data) - especially as
  antifouling agent in coatings for boat hulls (commercial, recreational) and
  on marine equipment/constructions, but also in coatings on buildings.  Losses
  to water mainly by leaching from coated surfaces; some losses during
  application.  Leaching losses in NL continental shelf sea estimated at 850 kg
  in 2007.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:47.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.2pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  database contains data from 3 MS and CH showing exceedance or near-exceedance
  of proposed EQS in 2 MS and CH); data in literature confirm potential for
  exceedance. Some national bans on use for small vessels have recently come
  into force. Uses as antifouling agent and film/masonry preservative currently
  being reviewed under the Biocidal Products Directive 98/8/EC; outcome could
  affect baseline. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:53.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:53.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.15pt;margin-bottom:
  5.85pt;margin-left:0cm;text-indent:0cm;line-height:102%'><span
  style='font-size:9.0pt;line-height:102%;font-family:"Arial",sans-serif'>Any
  additional material costs for substitutes.  Labour costs if use more frequent
  mechanical cleaning/maintenance. Increased shipping fuel costs/CO<sub>2</sub>
  etc emissions if alternatives less effective.  Costs might be passed on to
  consumers/passengers.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. Possibly sediment remediation costs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.15pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality; feedback to the biocidal products authorisation
  process; information to support remediation.  Possible benefits to
  biodiversity, and to fisheries and angling. Stimulation of innovation to find
  additional alternatives.  Employment opportunities if more frequent
  mechanical cleaning/maintenance. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: Some benefits likely to
  be achieved under the baseline, but not all MS have national bans in place
  and only small vessels are covered. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Coatings, Construction,
  Fisheries, Leisure (angling, boating), Transport (shipping)  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.2pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts:  Produced by BASF (DE-based), possibly in CH.  MS with coastlines
  likely to benefit most, especially if (partial) ban not already in place (as
  in DK, SE, UK). Benefits to third countries if EU boats use less harmful
  antifouling agent. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  EQS following introduction in some MS of national bans.  Extent of use on
  buildings. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .3pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Cypermethrin factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>8.2 10<sup>-5</sup> µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Ranked very high in
  monitoring-based prioritisation and high in modelling-based prioritisation;
  very toxic; risk ratio </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>&gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Insecticidal
  PPP and biocide: approx up to 100 tonnes/yr used in EU.  Used as PPP on
  arable crops, in orchards and forestry, and as biocide in wood preservatives
  and for veterinary use (sheep dipping, salmon farming).  Secondary release
  from textile factories using wool. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  database contains data from 5 MS showing exceedance of proposed EQS in 3 MS,
  in particular UK. National ban on use in sheep dipping now in force in UK.
  Biocidal uses currently being reviewed under the Biocidal Products Directive
  98/8/EC; outcome could affect baseline.  Use in salmon farming apparently
  declining but could be temporary due to practice of rotating chemical
  treatments to cope with resistance development. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:136.7pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:136.7pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Costs to arable
  farmers of implementing buffer zones. Costs to sheep farmers of measures to
  reduce entry of cypermethrin into water (possibly of the order of 10 million
  Euros per MS based on estimates by the UK). Costs to textile factories of
  effluent treatment. Costs to salmon farmers of using management measures to
  ensure compliance with EQS. In Scotland, a quality standard was introduced
  several years ago but salmon farmers have been able to continue using
  Cypermethrin with appropriate management   If cypermethrin use could not
  continue (despite no proposal to designate it as a PHS), possible cost of
  finding substitutes to maintain portfolio of treatments for rotation,
  although alternative treatment using hydrogen peroxide (less harmful to
  environment) already being developed. Additional material costs for
  substitutes, if relevant. In horticulture and cereal cropping, alternatives
  generally available, plus possibility of controlling certain pests by
  irrigation management. Loss of cypermethrin (though not foreseen in the options)
  would have only a minor impact, except in the context of vine weevil control,
  where in the UK at least there could be some costs (ADAS 2010, HGCA 2009). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS.   </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; feedback to the PPP
  and biocidal products authorisation processes.  Possible benefits to
  biodiversity and to fisheries and angling.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: Some benefits likely to
  be achieved under the baseline where ban on use in sheep dipping already
  introduced. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Aquaculture, Agriculture,
  Pesticides (Biocides, Plant Protection Products). </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts:  Formulations manufactured by 5 companies in EU, location not known;
  active substance produced at least partly outside EU.  Authorised in most
  MS.  Impacts less severe where ban on use in sheep dipping already in place. 
  Salmon farming only an issue for DK, IE, UK. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent
  of failure of proposed EQS in several MS in absence of sufficiently sensitive
  analytical method. Extent of failure in UK following ban on use in sheep
  dipping in UK. Extent to which used for sheep dipping in other MS (ES, FR,
  IT, RO have high numbers of sheep). Likely trend in use in agriculture and
  forestry. Outcome of Biocidal Products Directive review.   </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>DEHP factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  status for existing substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Unchanged<b>  </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>As in existing EQS Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.1pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Reprotoxic
  Cat 1B (Reg (EC) No 1272/2008), SVHC under REACH and listed in Annex XIV of
  REACH, EU RAR (2008) suggests need to limit risk of secondary poisoning in
  relation to food chains based on aquatic organisms, especially mussels, and a
  need to limit the risks to children in relation to exposure via the
  environment (taking account of existing risk reduction measures). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:84.95pt'>
  <td width=619 colspan=2 style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:84.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Industrial
  chemical, used as plasticiser in polymers, mainly in flexible PVC (for
  roofing, piping, tubing, flooring, furniture, clothing etc) and, to a limited
  extent in some non-polymer products.  Emissions to environment during
  production, formulation, use and disposal  highest from disposal (consisting
  mainly of emissions from nonmanaged disposal, i.e. waste remaining in the
  environment from use), but also significant through run-off, washing/abrasion
  etc during use, especially from outdoor polymer use to soil and from indoor
  use to water. EPRTR reports 21 tonnes emitted through UWWTPs in 2008 (approx
  97% of total to water), 10 tonnes from chemical industry to air, but these
  emissions may not cover many of the emissions from use.</span> </p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Failures of EQS
  currently in at least four MS (data not complete).  REACH Annex XIV
  authorisation required from Feb 2015; temporary authorisation for some uses
  likely  possible derogations for some uses.  Eventual substitution, therefore
  decrease in emissions from new use, expected in due course.  (Substitutes
  exist for DEHP and final product type. DEHP was 18% of plasticiser use in
  2009.) But emissions from existing use likely to continue for some time.
  Legislation on industrial emissions contains measures relevant to DEHP and
  PVC.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Directives on
  incineration and landfill of waste contain generic requirements.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:132.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:132.3pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Mostly in baseline. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  6.0pt;margin-left:0cm;text-indent:0cm;line-height:100%'><span
  style='font-size:9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Impacts
  on DEHP producers and companies processing flexible PVC (approx 800 in EU),
  including impacts on employment (though could shift to alternative
  substances/products), and additional cost of substitutes, estimated at 9 to
  21% in 2008 (could be passed to consumers, but could decrease with increased
  use). Additional water treatment (waste water, storm water run-off, landfill
  leachate) including cost of SUDs and energy costs, CO<sub>2</sub> emissions.
  To cease all emissions, replacement of many PVC fixtures/fittings/products;
  costs of correct disposal. However, such water treatment or product
  replacement before natural &quot;end-of-life&quot; would be subject to
  assessment of costs, including environmental costs, and exemptions on the
  basis of disproportionate costs and non-feasibility could be applied. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: Possibly remediation costs (MS and/or
  industry). Possibly costs of scheme(s) to remove products from use (though
  such schemes unlikely). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Mostly in baseline. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better water quality and reduced build-up of DEHP in
  sediments; potential for better human health. Knock-on benefits of measures
  such as SUDs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:70.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:70.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: PHS designation
  consistent with approach under REACH. Many benefits expected to be achieved
  under the baseline, but could be accelerated/enhanced. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Construction, electrical,
  footwear, medical, plastics/polymers, textiles, water/sewerage. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts: Production in fewer than 10 MS
  (possibly only 7 sites remaining); considerable variation in reported
  releases (E-PRTR) to water and air. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:24.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:24.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Extent of failure of EQS in some MS. Exact number of DEHP
  producers. Data on human health and environmental impacts of some
  alternatives. Outcome of REACH authorisation process. In addition to REACH, </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:24.2pt'>
  <td width=619 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:2.05pt 2.95pt 0cm 5.4pt;height:24.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>separate consideration being given to banning use in electrical
  equipment and PVC  outcome not certain. Impacts on import. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.95pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<span style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Dichlorvos factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-QS
  <sub>freshwater, eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>6 10<sup>-4</sup> µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Ranked
  very high in monitoring-based prioritisation, medium in modelling-based
  prioritisation, risk ratio &gt;1; possibly carcinogenic to humans (IARC 2B,
  Carc. Cat. 3 probable under Dangerous Substances Directive); potential for
  local mutagenicity. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:37.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:37.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Use
  as organophosphorus insecticide.  Residual non-authorised use as PPP.  Possible
  losses from biocidal use, e.g. from indoor use on grain/nut stores, use of
  insecticidal sprays etc (largely indoor but also outdoor, including domestic
  use).  Leaching from disposal of unused products. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:27.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Monitoring shows evidence of failure of EQS in 7 MS,
  possibly others. Losses to water should decrease since no longer in Annex I
  of Directive 91/414/EEC (effective as of 2008). </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:0cm;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Possibly additional
  water treatment costs. Possible costs to current producers if consumption
  decreases, e.g. if certain product types no longer authorised (though impacts
  most likely in baseline). </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; potential for better
  water quality and ecosystem health; therefore potential for better
  aquaculture/fisheries/angling.   </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note:  Most use apparently
  indoors, but some outdoor use (e.g. on mosquitoes) still authorised, and
  disposal could pose a risk. Exposure in humans largely by inhalation. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Biocidal product manufacturers,
  Consumers. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts: Possible impacts on India (producer) depending upon outcome of
  Biocidal Products review, and on one or more EU product formulators. 
  Authorisation already withdrawn in DK, SE, UK. Reported use seems highest in
  IT. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS in several MS in absence of sufficiently sensitive analytical
  method. Outcome of Biocidal Products Directive review. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Diclofenac factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=309 valign=top style='width:232.1pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=310 valign=top style='width:232.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=309 valign=top style='width:232.1pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.75pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed: MAC-EQS <sub>freshwater,eco</sub></span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=310 valign=top style='width:232.25pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.1 µg/l (freshwater), 0.01 µg/l (saltwater) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>75 µg/l (freshwater),
  7.5 µg/l (saltwater) </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Toxic; risk ratio
  &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.65pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Non-steroidal
  anti-inflammatory drug (NSAID), suitable for human and veterinary use, first
  introduced in the UK in 1979. Diclofenac has anti-inflammatory, antipyretic
  and analgesic action. Four producers in the EU according to ESIS. Average
  consumption of 0.46 g per person per year but varies widely (0.05 to 0.89
  based on data from 9 MS). Emissions via excretion and discard of unused
  medicines in sink/toilet or domestic waste. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:58.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:58.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  and predictions show exceedances of the EQS in water (DE, FR, IT, UK, SE, AT,
  PL). Consumption of NSAIDs has shown an upward trend over recent years in
  Central and Eastern European countries (Inotai A et al ,2010). Public
  awareness of take-back schemes for unused or expired pharmaceuticals very
  variable (73% Swedish know, 77% British do not). Data on success of take-back
  schemes generally lacking but also very variable. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:105.65pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:105.65pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.65pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>A wide range of
  measures could be implemented but effectiveness very difficult to estimate as
  no experience of reducing environmental impact of pharmaceuticals in use.
  Current EU legislation does not provide the mechanisms to take most of these
  measures at EU level. Most feasible measures (e.g. improvement of take-back
  schemes, influence of prescription, information to patients, doctors and
  pharmacists, etc) are expected to have a long-term effect to reduce
  consumption of diclofenac and increase other alternative anti-inflammatory
  drugs. Long-term economic impacts on pharmaceutical companies producing
  diclofenac due to reduced sales, unless they can move into the market for
  alternatives. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: Monitoring costs for MS. Depending on the
  design of the take-back schemes and awareness-raising programmes, there might
  be additional costs incurred by public bodies. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:37.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality and therefore better possibilities for targeting
  measures.  Environmental benefits to decrease environmental concentrations
  below no-effect levels, in particular for fish. Economic benefits for
  pharmaceutical companies selling alternatives to diclofenac. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Medical, pharmaceutical. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts: Widely used across the EU, but
  higher usage per inhabitant in DE, EE, PL, SE and UK. Production in the EU
  located in DE and IT.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Limited information about levels in the aquatic
  environment in large parts of the EU.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Important
  uncertainties as regards the effectiveness of the measures due to the lack of
  experience in reducing the environmental impact of pharmaceuticals in use.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Dicofol factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, sec pois</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.85pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>33 µg/kg biota ww </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.3 10<sup>-3</sup>
  µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Annex
  III substance; ranked high in monitoring and in modelling based
  prioritisation, risk ratio &gt;1; recommended for designation as POP
  (Stockholm Convention); possibly carcinogenic to humans, possibly endocrine
  disruptive; organochlorine PPP, similar to DDT.   </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:37.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:37.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.45pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Possibly
  residual (non-authorised) use as PPP, predominantly against mites and ticks
  on fruits, vegetables and ornamentals, thence losses to water by way of
  spray-drift, run-off, spills.  Otherwise secondary release, e.g. by leaching,
  from contaminated soils and sediments.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:27.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Monitoring shows evidence of failure of EQS in ES and FR,
  with uncertainty regarding other MS. Losses to water should decrease since no
  longer in Annex I of Directive 91/414/EEC (effective as of March 2010). </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS.  Possibly sediment remediation costs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; remediation if
  necessary, with potential for better water quality and better biota and human
  health; potential for better aquaculture/fisheries/angling. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: Most benefits expected
  to be achieved under the baseline, but could be accelerated if monitoring
  results lead to remediation. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): None particularly beyond
  baseline (assuming no longer manufactured in EU). </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts: Impacts on ES, IT and non-EU producers already in baseline (assuming
  not manufactured in EU only for export). Dicofol was authorised in 11 MS,
  many of which withdrew authorisation in the 1990s. ES, FR and IT known to
  have been users until 2010 - might have more need for remediation. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.85pt 0cm 5.4pt;height:27.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Extent of failure of proposed EQS in several MS in
  absence of sufficiently sensitive analytical method. Extent of failure of EQS
  following exclusion from Annex I of Directive 91/414/EEC. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Dioxins and
  Dioxin-like-PCBs factsheet</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, sec pois  </sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>8 10<sup>-3</sup> µg
  TEQ/kg biota wwNone calculated. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Annex III substances. POPs (Stockholm Convention and
  CLRTAP). PBT properties. Ranked very high in monitoring-based prioritisation;
  some congeners probably carcinogenic to humans, possibly endocrine
  disruptive. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:122.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:122.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Dioxins are
  unintentional by-products of thermal processes involving organic matter, e.g.
  during power station combustion, non-ferrous metals production and other
  industrial manufacturing, waste incineration, forest fires. Atmospheric
  deposition widespread. Direct emissions to water from organic chemicals
  production, pig-iron and steel production, chlorine-based industries, e.g.
  paper production, textile washing/bleaching. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>PCBs are chlorinated
  organic compounds formerly produced and used in EU in manufacturing
  electrical and hydraulic equipment and lubricants etc; 12 congeners are
  dioxin-like. Combustion of waste may produce some DL-PCBs. Atmospheric
  deposition occurs. Most direct emissions to water are from urban wastewater
  treatment plants, probably from ongoing use of PCB-based flooring, sealants
  and paints. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Secondary emissions of dioxins and DL-PCBs possible, e.g.
  leaching from landfills and contaminated soils, release from sediments.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:78.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:78.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  shows evidence of failure of tentative water and/or sediment EQS in several
  MS, and some exceedances of draft biota EQS. Emissions have decreased because
  of action under international and EU POPs, waste and industrial emissions
  legislation, including ELVs on emissions of dioxin from waste incineration,
  BREFs on emissions from industrial processes, requirements for the disposal
  of PBC-containing waste and restrictions on transboundary movements of
  hazardous waste. PCBs banned for use in open applications since 1976
  (Directive 76/403/EEC) and closed applications since 1985 (Directive
  85/467/EEC), though remain in flooring, sealants, paints etc.  Food standards
  exist. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:95.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:95.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.9pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Most costs in
  baseline. Possibly additional water-treatment costs, including energy/CO<sub>2</sub>
  emissions. Possibly accelerated measures to reduce the likelihood of dioxins
  formation in industrial/domestic combustion processes (e.g. optimal
  combustion conditions, fuel switching), to capture dioxins from emitted
  gases, and to reduce the likelihood of accidental fires.  Possibly 5-10%
  reduced efficiency of blast furnace operation with optimised emissions.
  Possible earlier investment in measures (e.g. insulation) to reduce fuel
  consumption. Possible costs to replace PCB-containing materials and items in
  buildings (and dispose of PCB-containing items correctly).  Possible passing
  on of costs from industry to consumers, especially energy costs. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS.  Possibly sediment remediation costs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Most
  benefits in baseline. Better knowledge of water quality; avoidance of
  environmental accumulation (by accelerated measures); remediation if
  necessary; potential for better water quality and better biota and human
  health; potential for better aquaculture/fisheries/angling; improved consumer
  confidence (though could be lower in the short term); reduced likelihood of
  exceeding food standard and WHO Tolerable Daily Intake. Possible stimulation
  of innovation; benefits to producers of abatement/cleaner technologies.
  Possible employment in remediation work.   </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:59.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:59.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Note: Most costs and benefits expected to be realised
  under the baseline, but could be accelerated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): None particularly beyond
  baseline. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts: Most impacts already in baseline;
  could be higher remediation costs in some MS due to concentration of certain
  industries. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS in several MS in absence of sufficiently sensitive analytical
  method. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Fluoranthene factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:100%'><b><span style='font-size:9.0pt;line-height:100%;
  font-family:"Arial",sans-serif'>Proposal:</span></b><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'> Biota EQS as critical
  EQS.  Corresponding water EQS much more stringent than existing EQS.  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>MAC also more
  stringent. </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Unchanged
  (PS) </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, hh</sub>  </b></span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed corresponding EQS in freshwater:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed MAC:  </span></b></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.75pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>30 &#956;g/kg biota ww (freshwater and marine) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>6.3 10<sup>-3</sup> &#956;g/l (cf 0.1 &#956;g/l)
  (freshwater and marine) </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>0.12 &#956;g/l (cf
  1.0) (freshwater and marine) </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Review of the QSs
  prompted by revised RAR for pitch.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Aromatic hydrocarbon. 
  Occurs naturally in fossil fuels/derivatives and is produced during
  combustion; is therefore emitted from industrial processes using fossil fuels
  or involving combustion. Not produced or used in pure form. Used through use
  of coal tar pitch, high temperature (CTPHT); production approx 800000 tonnes
  in 2004 in EU, small amount imported, more than one third exported. Main use
  in binding agents for e.g. electrodes, furnace lining materials (refractories),
  road construction, roofing.  Also present in creosote, tar paints, tyres
  etc..  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Reported
  emissions to water approx 8.5 tonnes in E-PRTR 2008, highest from the energy
  sector (mainly from refining and combustion) and metals production (particularly
  aluminium, though 2009 emissions from one major contributor are much lower).
  Other emissions to water from production of basic organic chemicals, and from
  wood treatment with creosote etc.  Emissions from incomplete combustion
  (including from vehicles, domestic fuel and agricultural burning, and
  wildfires) may lead to atmospheric deposition.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>8
  Member States report current failure of existing AA-EQS in at least one water
  body. INERIS monitoring database reports some concentrations higher than
  proposed EQS and MAC. Regulation (EC) No 850/2004 on POPs imposes release
  reduction provisions; REACH Annex XVII restrictions. possible inclusion in
  Annex XIV; IPPC Directive; Directive 2004/107 on concentrations in air;
  Directive 98/70/EC on PAH content of diesel. Various BATs and BREFs, e.g. for
  aluminium production; Regulation (EC) No 1881/2006 on food standards for
  PAHs, inclusion in Annex I of Directive 98/8/EC effective from May 2013.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:53.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:53.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:0cm;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Possibly additional
  measures directed at (industrial) point source emissions. Possible additional
  waste water treatment. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: Possible change in monitoring costs due to
  shift to biota standard. Possibly remediation costs (MS and/or industry). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality (due to switch to biota monitoring). Improvement
  in water quality; decreased scope for accumulation in the environment
  (fluoranthene binds to particles), potential for better biota health and
  better aquaculture/fisheries/angling (including reduced wastage); potential
  for better human health (though carcinogenicity not confirmed). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Chemicals, energy, metals
  production. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts:  Relevant industries (point
  sources) more prevalent in some MS than others. Possible greater impact on ES
  aluminium producers if still using the Söderberg technique.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS and MAC in some MS.inclusion or not in REACH Annex XIV </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>HBCDD factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, sec pois</sub>  </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.7pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>167 µg/kg biota ww </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.6 10<sup>-3</sup>
  µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Ranked high in modelling-based prioritisation; PBT, SVHC
  under REACH and included in Annex XIV of REACH, recommended POP, EU RAR
  conclusion of risk to aquatic environment.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Industrial
  chemical, used as flame retardant in polymers: insulation boards (Expanded
  PolyStyrene, eXtruded PolyStyrene), electronic equipment (High Impact
  PolyStyrene), textile coatings (for furniture etc.). Produced in NL, approx
  6000 tonnes in 2005. Emissions to environment from all phases of life cycle.
  Approx half of total emissions are to wastewater from formulation. Estimated
  to be in 200 million homes.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:58.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:58.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.8pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  shows some exceedances of water and biota EQS. REACH Annex XIV authorisation
  required from August 2015; temporary authorisation for some uses likely.
  Eventual substitution, therefore decrease in emissions from new use,
  expected.  Possible POP designation (Stockholm Convention, CLRTAP) would also
  reduce emissions from new use. But emissions from old uses likely to
  continue, including from disposal of building materials in landfills, and
  HBCDD will persist in the environment. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:74.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:74.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.8pt;margin-bottom:
  5.85pt;margin-left:0cm;text-indent:0cm;line-height:100%'><span
  style='font-size:9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Mostly
  in baseline. Enhanced effluent treatment at production sites. Enhanced waste
  water treatment costs and CO<sub>2</sub> emissions.  In the absence of
  alternative substance for use in EPS/XPS, possible additional cost of
  alternative insulation materials. Possible safety issues if not equally fire
  retardant. HIPS alternative could mean + 4-5 per TV. Costs to current producer
  and at least 50 formulators, including effects on employment (up to 30 000
  EPS/XPS jobs). Possible costs to users (at least 600) and consumers. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS, possibly remediation costs (MS and/or industry). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:58.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:58.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Mostly
  in baseline. Better knowledge of water quality; remediation if necessary,
  resulting in better water quality and ecosystem health; decreased scope for
  bioaccumulation, therefore potential for better biota health; potential for
  better aquaculture/fisheries/angling; improved consumer confidence (though
  could be lower confidence in the short term); potential for better human
  health; stimulation of innovation; benefits to producers of alternatives
  including potential employment; employment in remediation work. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:70.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:70.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:0cm;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Note: PHS designation
  consistent with approach under REACH. Most costs and benefits expected to be
  realised under the baseline  dependent upon REACH Annex XIV authorisations;
  could be accelerated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Chemicals production,
  construction, electronic equipment, textiles. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts: One production site in EU (NL), but
  products produced at 50 sites throughout EU. Use lower in Scandinavia due to
  different national fire regulations.  Benefits likely beyond the EU. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.7pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.7pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Possible
  authorised uses under Annex XIV of REACH; timeline for availability of
  alternatives (none yet for EPS/XPS, though in pipeline); environmental and
  health impacts of chosen alternatives; impacts of waste disposal route
  (incineration cf landfill). </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Heptachlor factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, hh</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.8pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.5pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>6.7 10<sup>-3</sup> µg/kg biota ww </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>2.1 10<sup>-7</sup>
  µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Ranked very high in monitoring -based prioritisation; POP
  (Stockholm Convention); very toxic to aquatic organisms; risk ratio &gt;1;
  possibly/probably carcinogenic to humans, possibly endocrine disruptive. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Organochlorine insecticide.  Possibly (unlikely) residual
  (non-authorised) use.  Otherwise secondary release, e.g. by leaching from
  contaminated soils and sediments.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  shows evidence of failure of biota EQS in 3 MS and corresponding water EQS in
  at least 6 MS. Losses to water should decrease since no longer in Annex I of
  Directive 91/414/EEC and use prohibited by Regulation (EC) No 850/2004. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Possibly additional water-treatment costs (to remove
  leached heptachlor), including energy/CO<sub>2</sub> emissions. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS.  Possibly sediment remediation costs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; remediation if
  necessary, with potential for better water quality and better biota and human
  health; potential for better aquaculture/fisheries/angling. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:70.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:70.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: Most benefits expected
  to be achieved under the baseline, but could be accelerated if monitoring
  results lead to remediation. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): None particularly beyond
  baseline. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts: Most impacts already in baseline;
  could be higher remediation costs in MS with heavier previous use. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS in several MS in absence of sufficiently sensitive analytical
  method. </span></p>
  </td>
 </tr>
 <tr style='height:16.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.8pt 0cm 5.4pt;height:16.9pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Lead factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=293 valign=top style='width:219.5pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:none;
  padding:3.35pt .35pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>   </span><b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>      Revised
       EQS      taking     account </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>bioavailability, for existing substance,
  </span></p>
  </td>
  <td width=17 valign=top style='width:12.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:3.35pt .35pt 0cm 0cm;
  height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>of </span></p>
  </td>
  <td width=309 valign=top style='width:231.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .35pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Unchanged (PS) </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=293 valign=top style='width:219.5pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:none;
  padding:3.35pt .35pt 0cm 0cm;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.6pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:159%'><b><span style='font-size:9.0pt;line-height:
  159%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:159%;font-family:"Arial",sans-serif'> <b>QS
  <sub>freshwater, eco</sub>  Proposed corresponding EQS in freshwater:</b>  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed MAC: </span></b></p>
  </td>
  <td width=17 style='width:12.9pt;border-top:none;border-left:none;border-bottom:
  solid black 1.0pt;border-right:solid black 1.0pt;padding:3.35pt .35pt 0cm 0cm;
  height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=309 valign=top style='width:231.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .35pt 0cm 0cm;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>1.2(fresh), 1.3(salt) (bioavailable) µg/l (cf 7.2 µg/l) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Not applicable </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>14.25 µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>New information (EU VRAR 2008, SCHER
  review of VRAR 2009, first draft of Chemical Safety Report for REACH
  registration), and need to consider bioavailability. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Main sources (production, use etc):</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:126.35pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:126.35pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  6.05pt;margin-left:5.4pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Production approx 1.5
  million tonnes per annum in EU, consumption slightly higher, value approx 3
  billion Euros.  At least 8 primary (from ore) production sites in at least 5
  MS, approx 30 secondary (recycling) production sites in at least 12 MS.
  Production associated with mining/extraction of other metals, especially
  zinc. Main uses: in batteries/accumulators, also in shot, boat keels,
  weights, building materials (roofing), cable sheathing, glass, solder
  material, chemical compounds, some paints.  Value of use in EU: another 3
  billion Euros/annum. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Emissions
  to water highest from battery production, primary and secondary lead and
  sheet lead production (including mining), pulp/paper production, ferrous and
  non-ferrous metal processing, power generation, lead crystal glass
  production, plastic treatment, lead piping, waste disposal including landfill
  and incineration. Also from diffuse sources: hunting/fishing, road run-off
  (tyres, vehicle exhausts), roof run-off, soil erosion; and indirectly via
  atmospheric deposition (vehicular and industrial emissions to air, wildfires)
  (all of which may also enter surface water via UWWTPs). E-PRTR 2008 reports
  total EU emissions of lead to water of 135 tonnes from 586 facilities. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:58.2pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:58.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Eight
  MS report failure of current EQS in up to 2.8% of freshwater bodies. Proposed
  EQS (bioavailable) effectively slightly more stringent than existing;
  compliance likely to be similar (i.e. at approx 6 cf 7.2 µg/l total lead),
  though could be poorer where dissolved organic carbon (DOC) low.   Subject to
  control under several Directives and Regulations, including REACH, IPPC/IED,
  Drinking Water Directive, Groundwater Directive, WEEE Directive, Batteries
  Directive.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Costs:</span></b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:53.9pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:53.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:5.4pt;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Mostly in baseline.
  Possible increase in need for control measures (e.g. SUDs for run-off) and/or
  remediation at/near historic mining sites and/or other contaminated areas
  where DOC levels are low. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin
  costs: Possible slight increase in monitoring costs for some MS, i.e. those
  not already monitoring the parameters required to run biotic ligand models.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Many
  in baseline. Better water quality and ecosystem health (lead is
  bioaccumulative and toxic); potential for improved aquaculture/fishing;
  potential for better human health/IQ; employment in control/remediation work.
  Focus on bioavailability likely to lead to better monitoring information,
  therefore also better targeting of control measures/remediation. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:101.3pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:101.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.2pt;margin-bottom:
  6.05pt;margin-left:5.4pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Note: Lead is
  classified as Reprotoxic 1A, i.e. could be considered a PHS on the grounds of
  an equivalent level of concern.  However, exposure of humans via surface
  waters is relatively low compared with exposure via other routes. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Construction, mining, energy,
  sewerage/water. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts:  Possibly greater costs in MS reporting failure of existing EQS.
  Possibly greater costs in MS with high number of facilities reporting high
  total emissions to water, esp. FR, PL, UK, and/or in MS with higher
  percentage of lead communication pipes, e.g. FR, IE, UK (estimated cost of
  replacement in UK approx £810 billion in 2005.) </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:24.25pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .35pt 0cm 0cm;height:24.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Extent of failure of current EQS, and
  extent of variation in DOC (thus bioavailability of lead) across the EU. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Effectiveness of lower lead standard in
  drinking water (10 µg/l) at reducing lead in domestic effluent.  </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:13.85pt'>
  <td width=619 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:2.05pt 5.75pt 0cm 5.4pt;height:13.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Effectiveness of
  existing and possible additional measures at contributing to meeting the EQS.
  </span></p>
  </td>
 </tr>
</table>

<span style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'><br clear=all style='page-break-before:always'>
</span>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Naphthalene factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=310 valign=top style='width:232.6pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposal:</span></b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> Slightly more
  stringent EQS for freshwater, introduction of MAC for existing substance. </span></p>
  </td>
  <td width=309 valign=top style='width:231.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Unchanged
  (PS) </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=310 valign=top style='width:232.6pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:20.75pt;
  margin-bottom:0cm;margin-left:0cm;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:159%'><b><span style='font-size:9.0pt;line-height:
  159%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:159%;font-family:"Arial",sans-serif'> <b>QS
  <sub>freshwater, eco</sub>  Proposed corresponding EQS in freshwater:</b>  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed MAC:  </span></b></p>
  </td>
  <td width=309 valign=top style='width:231.7pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>2.0 &#956;g/l (cf 2.4 &#956;g/l) (same for marine cf 1.2)
  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Not relevant </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>130 &#956;g/l (cf
  none) </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Review of the QSs
  prompted by revised RAR for pitch.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Aromatic hydrocarbon. 
  Occurs naturally in fossil fuels/derivatives and is produced during
  combustion; is therefore emitted from industrial processes using fossil fuels
  or involving combustion. Production (approx 200000 tonnes per annum in EU)
  from coal tar and petroleum for use as a chemical intermediate (in the
  production of plasticiser intermediates, pesticides and dyestuffs) mothballs,
  grinding wheels and pyrotechnics. Approx 25% exported.  Also present in
  creosote, tar paints etc..  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Reported
  emissions to air and water (approx 192 and 190 tonnes respectively in E-PRTR
  2008) highest from the energy sector (especially to water, mainly from oil
  drilling/refining) and metals (including aluminium) production. Other
  emissions to water from wood treatment with creosote etc.  Emissions from
  incomplete combustion (including from vehicles, domestic fuel and
  agricultural burning, and wildfires) could lead to atmospheric deposition,
  but half-life in air short.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:89.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:89.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>2 MS
  (RO, UK) report current failure of existing AA-EQS in at least one water
  body. INERIS monitoring database reports no concentrations higher than
  proposed EQS or MAC. EU RAR calculates PECs that could locally exceed AA-EQS
  or MACs close to industrial point sources. Regulation (EC) No 850/2004 on
  POPs imposes release reduction provisions; REACH Annex XVII restrictions.
  possible inclusion in Annex XIV; IPPC Directive; Directive 2004/107 on
  concentrations in air; Directive 98/70/EC on PAH content of diesel; Directive
  98/8/EC  restrictions on biocidal use; Directive 91/414/EEC excludes
  naphthalene-based PPPs. Various BATs and BREFs, e.g. for aluminium
  production; Regulation (EC) No 1881/2006 on food standards for PAHs;
  inclusion in Annex I of Directive 98/8/EC effective from May 2013.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:59.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:59.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Mostly in baseline, since little change in AA-EQS and no
  reported exceedance of proposed MAC. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Possibly additional measures directed at (industrial)
  point source emissions if MAC exceeded.  </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: None beyond baseline, except possibly
  additional permitting administration and additional targeted monitoring in
  the short term in relation to the MAC. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Mostly in baseline,
  but possible acceleration of local improvements in water quality and
  ecosystem health. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Chemicals, energy, metals
  production. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts:  Producers located in AT, BE, DE,
  DK, ES, FR, IT, NL, UK. Could be more affected than other MS by any need for
  additional point-source controls in view of introduction of MAC. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS and MAC in some MS. Inclusion or not in REACH Annex XIV </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Nickel factsheet </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=293 valign=top style='width:219.5pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:none;
  padding:3.35pt .4pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>   </span><b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>      Revised
       EQS      taking     account </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>bioavailability, for existing substance,
  </span></p>
  </td>
  <td width=17 valign=top style='width:12.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:3.35pt .4pt 0cm 0cm;
  height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>of </span></p>
  </td>
  <td width=309 valign=top style='width:231.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Unchanged (PS) </span></p>
  </td>
 </tr>
 <tr style='height:49.55pt'>
  <td width=293 valign=top style='width:219.5pt;border-top:none;border-left:
  solid black 1.0pt;border-bottom:solid black 1.0pt;border-right:none;
  padding:3.35pt .4pt 0cm 0cm;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:7.55pt;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:159%'><b><span style='font-size:9.0pt;line-height:
  159%;font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:159%;font-family:"Arial",sans-serif'> <b>QS
  <sub>freshwater, eco</sub>  Proposed corresponding EQS in freshwater:</b>  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Proposed MAC: </span></b></p>
  </td>
  <td width=17 valign=top style='width:12.9pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:3.35pt .4pt 0cm 0cm;
  height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:8.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'>&nbsp;</p>
  </td>
  <td width=309 valign=top style='width:231.95pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 0cm;height:49.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>2 or 4 (fresh), 8.6 (salt) (bioavailable) µg/l  (cf 20
  µg/l) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Not applicable </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>34 µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>New
  information (EU RAR 2008, SCHER review of RAR 2009, additional industry
  studies related to REACH registration), and need to consider bioavailability.
  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Main sources (production, use etc):</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  5.95pt;margin-left:5.4pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Production (from ore)
  approx 80000 tonnes per annum in EU (500 million Euros). Mined in 21 European
  countries. Used mainly (85% of &quot;new&quot; nickel) in alloys, also in
  metal plating, batteries, pigments, other chemicals, steel production
  (especially stainless).  Products (wide range, e.g. vehicles, domestic appliances
  and fittings, chemical plants, medical equipment) valued at 40 billion
  Euros/annum in EU. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Emissions
  to water (467 tonnes reported in E-PRTR for 2008) highest from industrial
  processes (including pulp and paper processing, electrolytic and chemical processes),
  steel products in contact with water (including heating elements), waste
  disposal, mining.  Significant flow through UWWTPs. Emissions to air (350
  tonnes in EPRTR for 2008) from combustion, some of which reaches water by
  atmospheric deposition (directly and via soil). Inputs also from manure use
  in agriculture. Some diffuse sources, e.g. urban road run-off, pass through
  UWWTPs. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.1pt;margin-bottom:
  0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>9 MS
  report failure of current EQS in up to 3.7% of rivers. EQS (bioavailable) of
  2 µg/l or 4 µg/l effectively more stringent than existing (i.e. at approx 5.6
  or 11.2 cf 20 µg/l total dissolved Nickel, assuming standard dissolved
  organic carbon (DOC), pH and hardness), therefore failures more likely,
  particularly in areas with low DOC. Estimated failure  up to approx 50% of
  monitoring sites in some MS at 2 µg/l . Nickel subject to control under
  several Directives and Regulations, including REACH, IPPC/IED, Drinking Water
  Directive, Groundwater Directive, WEEE Directive, Batteries Directive, but
  probably not sufficient to achieve revised EQS..  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Costs:</span></b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  6.05pt;margin-left:5.4pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Possible increase in
  need for control measures to reduce industrial Nickel emissions to UWWTPs
  especially where DOC levels are low (e.g. improved BAT; precipitation/reverse
  osmosis to treat effluent at source  65% removal possible, capital cost per
  reverse osmosis unit 30,000 , plus running costs).  Reduced Nickel usage in
  vehicle parts (tyres etc) and road surfaces. Possible replacement of domestic
  appliances. Possible additional treatment of landfill leachate (25-40%
  removal; cost per plant 90,000-180,000 , plus annual running costs around
  35-100 ; additional water treatment at UWWTPs (£335 million per annum in UK
  for sand filtration and GAC), measures to reduce atmospheric emissions
  (low-sulphur fuels, desulphurisation - £100-1000 million/tonne decrease),
  lime dosing of abandoned mines (£3.5 million capital cost, £1 million/annum
  to run). </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin
  costs: Possible slight increase in monitoring costs for some MS, i.e. those
  not already monitoring the parameters required to run biotic ligand models.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  .05pt;margin-left:5.4pt;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Some in baseline, but
  stricter EQS likely to lead to better water quality and ecosystem health
  (nickel is toxic and can accumulate in soils/sediments), therefore potential
  for improved aquaculture/fishing. Focus on bioavailability likely to lead to
  better monitoring information, therefore also better targeting of control
  measures/remediation.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Benefits to human health mainly if
  measures lead to decreased atmospheric emissions. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:43.55pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:5.4pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Chemicals, domestic appliances,
  metal alloys, mining, energy, sewerage/water. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts:  Possibly greater costs in MS reporting failure of existing EQS.
  Possibly greater costs in MS with high number of facilities reporting high
  total emissions to water, esp. FR, DE, IE, IT, UK. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:16.85pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=3 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 0cm;height:27.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
  margin-left:5.4pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent
  of failure of current EQS, and extent of variation in DOC, pH (thus
  bioavailability of nickel) across the EU.  Effectiveness of existing and
  possible additional measures at contributing to meeting the EQS. </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>PAHs factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.6pt'>
  <td width=310 valign=top style='width:232.75pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Biota EQS as critical EQS for all but Benzo(g,h,i)perylene.  Corresponding
  water EQS more stringent than existing EQS.  MAC introduced for three PAHs;
  slightly changed for Benzo(a)pyrene. Revised EQS for Benzo(g,h,i)perylene
  slightly less stringent in freshwater, more stringent in saltwater. </span></p>
  </td>
  <td width=309 valign=top style='width:231.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.05pt 2.85pt 0cm 5.4pt;height:68.6pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Unchanged
  (PHS) </span></p>
  </td>
 </tr>
 <tr style='height:65.95pt'>
  <td width=310 valign=top style='width:232.75pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:65.95pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, hh</sub>  </b></span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'> </span></b></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed corresponding EQS in freshwater:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed MAC:  </span></b></p>
  </td>
  <td width=309 valign=top style='width:231.6pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:2.05pt 2.85pt 0cm 5.4pt;height:65.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  3.6pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>2 or 5 or 10
  &#956;g/kg biota ww (fish, crustaceans &amp; cephalopods, molluscs,
  respectively, in fresh and marine water); Benzo(a)pyrene as marker. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>1.7 10<sup>-4</sup>
  ug/l </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Review of the QSs
  prompted by revised RAR for pitch.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:116.0pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:116.0pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  6.05pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Aromatic hydrocarbon. 
  Occurs naturally in fossil fuels/derivatives and is produced during
  combustion; is therefore emitted from industrial processes using fossil fuels
  or involving combustion. Not produced or used in pure form. Used through use
  of coal tar pitch, high temperature (CTPHT); production approx 800000 tonnes
  in 2004 in EU, small amount imported, more than one third exported. Main use
  in binding agents for e.g. electrodes, furnace lining materials
  (refractories), road construction, roofing.  Also present in creosote, tar
  paints, tyres etc..  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Reported
  emissions to water approx 10 tonnes in E-PRTR 2008, highest from metals
  production (particularly aluminium) and the energy sector (mainly from
  refining and combustion). Other emissions to water from production of basic
  organic chemicals, animal and vegetable products from food/beverage industry,
  wood treatment with creosote etc.  Emissions from incomplete combustion
  (including from vehicles, domestic fuel and agricultural burning, and
  wildfires) may lead to atmospheric deposition.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:78.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:78.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>6 to
  10 MS report current failure of existing AA-EQS for some PAHs (most commonly
  Indeno(1.2.3-cd)pyrene and Benzo(g,h,i)perylene, in one or more water bodies.
  Calculated PECs in EU-RAR indicate that concentrations could be higher than
  proposed EQS and MAC. Regulation (EC) No 850/2004 on POPs imposes release
  reduction provisions; REACH Annex XVII restrictions. possible inclusion in
  Annex XIV; IPPC Directive; Directive 2004/107 on concentrations in air;
  Directive 98/70/EC on PAH content of diesel. Various BATs and BREFs, e.g. for
  aluminium production; Regulation (EC) No 1881/2006 on food standards for
  PAHs; inclusion in Annex I of Directive 98/8/EC effective from May 2013.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:53.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:53.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:5.95pt;
  margin-left:0cm;text-indent:0cm;line-height:100%'><span style='font-size:
  9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Possibly additional
  measures directed at (industrial) point source emissions. Possible additional
  waste water treatment.  Possible costs related to changes in domestic fuel
  use. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Admin costs: Possible change in monitoring costs due to
  shift to biota standards. Possibly remediation costs (MS and/or industry). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality (due to switch to biota monitoring). Improvement
  in water quality; decreased scope for accumulation in the environment (binds
  to particles), potential for better biota health and better
  aquaculture/fisheries/angling (including reduced wastage); potential for
  better human health (most PAHs are carcinogenic), though existing food
  standards should already be met and protective. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:43.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:43.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Chemicals, energy, metals
  production. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts:  Relevant industries (point
  sources) more prevalent in some MS than others. Possible greater impact on ES
  aluminium producers if still using the Söderberg technique.  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:2.05pt 2.85pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  proposed EQS and MAC in some MS. Inclusion or not in REACH Annex XIV </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>PBDE factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.65pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Biota EQS (and correspondingly more stringent water EQS) for existing
  substance, intended to cover additionally commercial octa BDE (BDE-197).  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.75pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS
  for tetra, penta, hexa and hepta BDEs   </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, hh</sub>  </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.75pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.5pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>8.5 10<sup>-3</sup> µg/kg biota ww   </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>4.9 10<sup>-8</sup>
  µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.7pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Modelling-based
  prioritisation identified octa BDE (BDE-197) as a priority.  EQS for the
  group of BDEs (hitherto for penta BDE (CAS 32534-81-9)) therefore reviewed to
  cover octaBDE (CAS 32536-52-0) and take account of new information.  However,
  proposed EQS based on BDE 99 (penta derivative). Biota recognised as most
  appropriate matrix.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:89.3pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:89.3pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Industrial
  chemicals, used as flame retardants. Only deca BDE still used in EU  mainly
  as flame retardant for textiles (drapery, upholstery) and in
  non-electrical-equipment-related polymers.  Not chemically bound. Emissions
  to environment (air, water, soil) from all phases of life cycle, therefore
  from formulation and new use of deca BDE products, and from use and disposal
  of existing products, including furniture, upholstery, carpets, drapery,
  computers, televisions, automotive parts (penta BDE particularly from
  flexible polyurethane foam, octa BDE and deca BDE from housings for
  electrical and electronic products).  Commercial deca BDE contains deca and
  nona BDE and a trace of the octa BDE derivative, and can debrominate. E-PRTR
  emissions to water mainly from textile factories and UWWTPs.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:78.95pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:78.95pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Five
  MS report current failure of existing standards. Penta and octa BDE subject
  to restricted use under Regulation (EC) No 552/2009  use effectively banned
  in EU since 2004. POP designation (Regulation (EC) No 850/2004) for tetra,
  penta, hexa, and hepta derivatives since 2010. Deca BDE banned in electrical
  and electronic equipment since 2008 (Directive 2002/96/EC); other uses
  continue; not produced in EU, but imported (60k tonnes produced worldwide in
  2007). Alternatives exist. Disposal controlled by WEEE directive. Limits in
  waste being proposed.  Voluntary control (VECAP) for industrial emissions.
  Possible inclusion of penta and octa BDEs in Rotterdam Convention. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:80.6pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:80.6pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.5pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Mostly in baseline.  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:6.0pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:normal'><span style='font-size:9.0pt;font-family:"Arial",sans-serif'>Possibly
  enhanced waste water treatment costs and CO<sub>2</sub> emissions to meet
  lower EQS. More stringent treatment of landfill leachate.  </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.7pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin
  costs: Possible slight change to monitoring costs (shift from water to biota
  monitoring) for MS; possibly increased identification of sites for
  remediation. Possibly costs of scheme(s) to remove products from use (though
  such schemes unlikely). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.7pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Most
  in baseline. Better water quality and ecosystem health; decreased scope for
  bioaccumulation, therefore potential for better biota health; potential for
  better aquaculture/fisheries/angling; improved consumer confidence; potential
  for better human health; employment in remediation work. Biota monitoring
  could improve quality of monitoring information, therefore also the targeting
  of remediation. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:70.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:70.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: PHS designation of
  penta BDE (technical/commercial mixture) consistent with approach under
  Stockholm convention. Most costs and benefits expected to be realised under
  the baseline. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Textiles, sewerage/water. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts:  Possible impacts on producers
  outside EU if need to meet lower EQS for lower brominated congeners leads to
  restrictions on use of deca BDE. Benefits likely beyond the EU. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  EQS in MS due to inadequate analytical sensitivity. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.75pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>PFOS factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>biota, sec pois</sub>  </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt 2.9pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.7pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>9.1 µg/kg biota ww </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>6.5 10<sup>-3</sup>
  µg/l </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Annex III substance,
  PBT, POP, risk ratio &gt;1<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Industrial
  chemical, not produced in EU.  Used in fire-fighting foams (residual use due
  to end 2011), coatings in photography and photolithography (semi-conductors),
  wetting agents in electroplating (until 2015), mist suppressants in chromium
  plating, and hydraulic aviation fluids.  Possible emissions from use/disposal
  of old products (carpets, textiles), and from soils/sewage sludge/sediments.<b>
  </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  database contains data from 3 MS and NO, all showing exceedances of proposed
  EQS. REACH (Annex XVII) derogations for some uses.  However, gradual
  substitution, therefore decrease in emissions from new use, expected.  POP
  designation (Stockholm Convention) should also reduce emissions from new use.
  But emissions from old uses likely to continue, and PFOS will persist in the
  environment. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:53.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:53.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.5pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:100%'><span
  style='font-size:9.0pt;line-height:100%;font-family:"Arial",sans-serif'>Remediation
  of soil/sediment and/or enhanced waste water treatment costs and CO<sub>2</sub>
  emissions.  Possible earlier development costs for alternatives in
  photography, photolithography, aviation. In the absence of alternatives, cost
  of phasing out emissions to water could be disproportionate. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS, possibly remediation costs (MS and/or industry). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality; remediation if necessary, resulting in better
  water quality and ecosystem health; decreased scope for bioaccumulation,
  therefore potential for better biota health; potential for better
  aquaculture/fisheries/angling; improved consumer confidence; potential for
  better human health (workers, consumers); stimulation of innovation;
  potential employment in remediation work. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:59.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:59.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: PHS designation consistent
  with approach under REACH. Many benefits expected to be achieved under the
  baseline, but could be accelerated. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Aviation industry.
  Semi-conductor industry. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical impacts:
  Probably no differences in EU. Possible impact on China (only producer).  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Spatial distribution
  of PFOS in environment; extent of failure of EQS; timeline for availability
  of alternatives. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt 2.9pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Quinoxyfen factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.25pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>QS
  <sub>freshwater, eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .45pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.15 µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>- </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Annex III substance;
  PBT properties. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:37.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:37.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Use
  as PPP (fungicide), predominantly on cereals and grape vines, thence losses
  to water by way of spray-drift, run-off, spills. Otherwise secondary release,
  e.g. by leaching, from contaminated soils and sediments. EU sales 68 000
  kg/yr.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:68.65pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:68.65pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Limited
  monitoring data (2 MS) shows isolated exceedance of EQS in FR, but authorised
  in 17 MS, therefore uncertainty regarding other MS. Losses to water could
  decrease with introduction of National Action Plans for PPPs under the
  Sustainable Use of Pesticides Directive; current authorisation under
  Directive 91/414/EEC acknowledges need to limit risk to aquatic environment;
  exclusion from Annex I of that Directive would be expected to follow after
  review of authorisation in 2014 given position in Regulation (EC) No.
  1107/2009 on not authorising PBTs, if PBT properties confirmed. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:64.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:64.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.9pt;margin-bottom:
  5.95pt;margin-left:0cm;text-indent:0cm;line-height:normal'><span
  style='font-size:9.0pt;font-family:"Arial",sans-serif'>Costs to one (major
  agrochemical) producer and formulators/retailers unless can provide
  substitute products.  Costs to users if substitutes more expensive.  Possible
  concern regarding resistance of powdery mildew to alternatives, although
  several alternatives are authorised (Entec 2011, ADAS 2010, HGCA 2009). Fewer
  of them may be suitable for hops than for other crops. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Better knowledge of water quality; potential for better
  water quality and biodiversity, better biota and human health,
  aquaculture/fisheries/angling. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:53.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:53.9pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Agrochemicals, Arable farming. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:4.85pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts: Impacts particularly on farmers in DE, ES, FR, IT (highest sales in
  these MS); possibly on employment if production localised; US-based company
  but location of production of active substance not known.; at least 6
  formulators/marketers in FR, 3 in UK. (case-study MS); no data for other MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Extent of failure of proposed EQS in several MS in
  absence of widespread monitoring.  Possibility of decrease in use under
  baseline because of resistance. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .45pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:.35pt;
margin-bottom:0cm;margin-left:-28.4pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'>&nbsp;</p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Terbutryn factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  priority substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.3pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> <b>AA-EQS
  <sub>freshwater,eco</sub> </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.065 µg/l </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Not relevant </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale:  </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Ranked high in
  modelling based prioritisation, medium in monitoring-based prioritisation,
  toxic, risk ratio &gt;1 </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:27.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.2pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Biocidal (algicidal) use - approx 200 tonnes/yr in EU -
  especially in coatings on buildings, from which run-off occurs.<b> </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:47.9pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:47.9pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.6pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Monitoring
  data from 9 countries shows exceedances of EQS in 4 MS and CH. Losses to
  water could be lower in coming years because no longer in Annex I of
  Directive 91/414/EEC (2003 and 2007 staged withdrawal of herbicidal use
  authorisation in different MS).  Uses as preservative for film, wood, masonry
  currently being reviewed under the Biocidal Products Directive 98/8/EC;
  outcome could affect baseline. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:43.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Installation and maintenance
  of sustainable urban drainage systems (SUDs) (variable depending upon type).
  Possible enhanced waste water treatment. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs:
  Monitoring costs for MS. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:2.55pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Better
  knowledge of water quality; feedback to the biocidal products authorisation
  process.  Possible benefits to biodiversity, and to angling. Reduced risk of
  failure of drinking water standards. SUDs could have shared benefits, e.g.
  flood control, energy saving.  Stimulation of innovation in construction to
  minimise need for biocidal coatings. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:70.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:70.25pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Note: Some benefits expected
  to be achieved under the baseline, but not all MS have SUDs in place to
  capture run-off in urban areas, and this could lead to improvements, as could
  changes in pattern of use. </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Sectors (most relevant): Construction, Coatings </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Geographical impacts:  Marketed by two companies in EU.
  Products formulated in various MS, including LV; active substance produced at
  least partly outside EU. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of failure of
  EQS now that no longer used as herbicide.  Availability of substitutes. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Trifluralin factsheet</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposal:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> New
  status for existing substance </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed status:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> PHS </span></p>
  </td>
 </tr>
 <tr style='height:33.2pt'>
  <td width=310 valign=top style='width:232.7pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>Proposed critical EQS:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>
  Unchanged<b>  </b></span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Proposed corresponding
  EQS in freshwater:</span></b><span style='font-size:9.0pt;line-height:107%;
  font-family:"Arial",sans-serif'>  </span></p>
  </td>
  <td width=309 valign=top style='width:231.65pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:3.35pt .4pt 0cm 5.4pt;height:33.2pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.15pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>As in existing EQS Directive </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Rationale: </span></b></p>
  </td>
 </tr>
 <tr style='height:70.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:70.25pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:5.2pt;margin-left:0cm;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>PBT - identified as PBT by the TC NES Subgroup on
  identification of PBT and vPvB Substances, EC, 2006. </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Probable POP - identified as
  fulfilling POP screening criteria by the TC NES Subgroup, EC, 2006;
  considered by EU delegation to UNECE CLRTAP Executive Board December 2010 to
  warrant POP designation. </span></p>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>PBT criteria met even if POP designation not confirmed.
  (P criterion for PBT is less stringent than for POP, i.e. 120d cf 180d in
  soil). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Main sources
  (production, use etc):</span></b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:58.2pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:58.2pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Possibly
  residual (non-authorised) use as PPP (herbicide), thence losses to water by
  way of spray-drift, run-off, spills. Possible isolated emissions via UWWTPs
  due to recovery/disposal of hazardous waste (data for ES and IT in E-PRTR
  2007, 2008). However, no longer authorised for use in EU.  Possible emissions
  from production (for export) in HU, though none reported in E-PRTR. Possible
  secondary release, e.g. by leaching from contaminated soils and sediments.<b>
  </b></span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>BASELINE</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:37.55pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:37.55pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.1pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Current
  failure of EQS in CY, ES, HU, IT, NL, RO, SK. No further primary emissions
  from use expected at present (authorisation under Directive 91/414/EEC
  withdrawn in 2009). Any emissions from production in HU would have to cease
  if POP designation agreed.  Possibly secondary emissions from disturbed sediments.
  </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>IMPACTS </span></b></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Costs:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:43.5pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:43.5pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:6.05pt;
  margin-left:0cm;text-indent:0cm;line-height:99%'><span style='font-size:9.0pt;
  line-height:99%;font-family:"Arial",sans-serif'>Possible cost to producer in
  HU if production for export had to cease, with possible loss of jobs unless
  redeployment possible  though these costs would be in baseline if designated
  as POP. </span></p>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Admin costs: Possibly
  remediation costs (MS and/or landowners). </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Benefits: </span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:27.25pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:27.25pt'>
  <p class=MsoNormal style='margin:0cm;margin-bottom:.0001pt;text-indent:0cm;
  line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>Remediation if necessary, with potential for better water
  quality and better biota and human health; potential for better
  fisheries/aquaculture/angling. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Special points:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>  </span></p>
  </td>
 </tr>
 <tr style='height:80.65pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:80.65pt'>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
  3.05pt;margin-left:0cm;text-indent:0cm;line-height:129%'><span
  style='font-size:9.0pt;line-height:129%;font-family:"Arial",sans-serif'>Note:
  PHS designation consistent with latest scientific information and approach
  under PPP legislation.  Some impacts would be in baseline if POP designation
  agreed. Sectors (most relevant): Agrochemicals, Arable farming </span></p>
  <p class=MsoNormal style='margin-top:0cm;margin-right:5.0pt;margin-bottom:
  0cm;margin-left:0cm;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Geographical
  impacts: Possible impact in HU if production causes emissions, as production
  would have to cease.  Impacts otherwise greatest in MS where use was greatest
  and/or exceedance of EQS is observed, if remediation proves necessary. </span></p>
  </td>
 </tr>
 <tr style='height:16.8pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.8pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Uncertainties:</span></b><span
  style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Extent of
  contamination of soils/sediments and secondary emissions.  POP designation. </span></p>
  </td>
 </tr>
 <tr style='height:16.85pt'>
  <td width=619 colspan=2 valign=top style='width:464.35pt;border:solid black 1.0pt;
  border-top:none;padding:3.35pt .4pt 0cm 5.4pt;height:16.85pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:11.2pt;
margin-left:42.55pt;text-indent:0cm;line-height:107%'><span style='font-size:
9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:0cm;margin-bottom:0cm;
margin-left:42.55pt;margin-bottom:.0001pt;text-indent:0cm;line-height:107%'><span
style='font-size:9.0pt;line-height:107%;font-family:"Arial",sans-serif'> </span></p>

<p class=MsoHeading7 align=center style='margin-top:0cm;margin-right:.5pt;
margin-bottom:11.25pt;margin-left:37.35pt;text-align:center'><b><u><span
style='font-style:normal'>ANNEX VI: Description of the main policies affecting
the baseline and interactions with</span></u></b><b><span style='font-style:
normal'> <u>the WFD</u> </span></b></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.9pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Implementation of the WFD: measures in river basin management plans
(RBMPs) </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The 13 existing substances that have been assessed
are already included as PS or PHS in Annex X of the WFD, with EQSs listed in
Annex I of the EQS Directive.  For these substances, measures should already
have been identified and their implementation be underway or planned where
failures of the EQS occur.  The approach to achieving phase-out of emissions of
PHS should also be under consideration. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>For all existing substances there are existing EU
measures. Measures sheets have been compiled for all of them. See factsheets in
Annex V for summary information.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>One of the difficulties involved in assessing the
impacts of a change to an existing substance is to understand the extent to
which MS intend to undertake measures, the detail of those measures, and their
likely effectiveness. The WFD requires MS to adopt and publish RBMPs and
programmes of measures in December 2009. 20 MS have adopted plans and
programmes at the time of writing this impact assessment report. Another 3 are
expected to adopt them in 2011. The remaining 4 are expected to have longer
delays.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Once the plans and programmes are adopted, the WFD
gives MS until December 2012 at the latest to make operational the measures.
This means the details about implementation of the measures are being developed
at the moment. This leads to considerable uncertainty in assessing the ultimate
effectiveness of measures.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>In addition to substance-specific measures,
another source of uncertainty stems from a number of generic measures that are
included in the programmes of measures that aim to improve water quality and/or
reduce concentrations of certain types of pollutants in the environment.  These
are relevant to both existing and proposed substances.  For example, the study
by EcoLogic and ACTeon (2010) which reviewed agricultural measures in WFD draft
programmes across Europe identifies some of these measures.  This provided
information relevant to proposed substances including general information on
PPP policies and trends, and information on diffuse nutrient pollution that
could contribute towards addressing substances such as 17 beta-estradiol (e.g.
measures to reduce nutrient input to rivers, such as preventing cattle reaching
river banks).   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.95pt;margin-left:42.35pt'>There are also a range of measures to address water
quality that are not specific to a substance and will provide overall
improvements, while at the same time contributing towards compliance of
specific substances (i.e. including the existing and proposed substances
assessed here).  Such measures include: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.2pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Improved
wastewater treatment; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Addressing
urban runoff (both water quality and flood risk) through use of Sustainable
Urban Drainage Systems (SUDS); </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.95pt;margin-left:99.3pt;text-indent:-14.2pt;line-height:110%'><span
style='line-height:110%'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Measures to address morphology pressure, including improving
riparian habitats; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.85pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Measures
to address rural diffuse pollution (particularly reductions in nitrogen and
phosphorus inputs), for example by controls on manure spreading, preventing
cattle reaching river banks, general PPP measures. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.8pt;margin-left:42.35pt'>While not necessarily targeted at particular
existing or proposed substances, over time these measures have the potential to
contribute towards achieving the EQSs of a range of substances. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'>Some of the proposed substances are explicitly
considered by some MS, where they are defined as Specific Pollutants.  This
means that the relevant MS are already committed to monitoring the substance
and addressing any failures of the (existing) EQS.  However as the EQS is
self-defined by the MS, it may still be necessary for the MS to undertake
further work if the substance were to be defined as a PS/PHS, potentially with
a more stringent EQS.  Information collected from WG E representatives to the
Commission (note that not all MS provided information) indicates that 10 of the
15 proposed substances are already included as specific pollutants in at least
one MS.  Heptachlor, PCBs, and Dioxins are the most commonly monitored,
probably as a result of obligations under the Stockholm Convention. </p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=593
 style='width:444.5pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:34.0pt'>
  <td width=147 style='width:110.0pt;border-top:solid black 1.0pt;border-left:
  none;border-bottom:solid black 1.0pt;border-right:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Substance </span></b></p>
  </td>
  <td width=340 style='width:255.25pt;border-top:solid black 1.0pt;border-left:
  none;border-bottom:solid black 1.0pt;border-right:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><b><span style='font-size:9.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>MS including the substance as specific
  pollutant </span></b></p>
  </td>
  <td width=106 style='width:79.25pt;border-top:solid black 1.0pt;border-left:
  none;border-bottom:solid black 1.0pt;border-right:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  9.0pt;line-height:107%;font-family:"Arial",sans-serif'>Number of MS </span></b></p>
  </td>
 </tr>
 <tr style='height:18.15pt'>
  <td width=147 valign=top style='width:110.0pt;border:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:18.15pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Aclonifen </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;border:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:18.15pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  8.0pt;line-height:107%;font-family:"Arial",sans-serif'>SE (0.2 µg/l; 0.1
  mg/kg sediment) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;border:none;padding:4.75pt 5.75pt 0cm 0cm;
  height:18.15pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.65pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>1 </span></p>
  </td>
 </tr>
 <tr style='height:17.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:17.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Cybutryne </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:17.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>SE (0.003 µg/l in marine water;
  0.0002-0.0008 mg/kg dw) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:17.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.65pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>1 </span></p>
  </td>
 </tr>
 <tr style='height:34.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Cypermethrin </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.5pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>DK (1 µg/kg in river or lake sediment)   </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>UK (0.1 ng/l annual mean; 0.4 ng/l 95<sup>th</sup>
  percentile) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:34.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>2 </span></p>
  </td>
 </tr>
 <tr style='height:26.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:26.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Dichlorvos </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:26.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-.05pt;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>BE (0.0007 µg/l average, 0.007 µg/l
  MAC), IT (0.01 µg/l), NL (0.0006 µg/l), IE (monitored but no EQS), DE (0.0006
  µg/l) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:26.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>5 </span></p>
  </td>
 </tr>
 <tr style='height:86.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:86.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Dioxins (and DL-PCBs) </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:86.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:4.7pt;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:98%'><span style='font-size:8.0pt;line-height:
  98%;font-family:"Arial",sans-serif'>DK (between 0.00005-0.0001 µg/kg WW in
  marine bivalves; between 0.1-0.2 µg/kg WW in marine sediment; between 0.0002-</span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>0.0004 µg/kg WW in marine fish),  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.15pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>IT (sum T.E. PCDD, PCDF and PCB dioxin-like): 0.002 µg/kg
  dw </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>SE (0.9 ng TEQ fish/kg; 8 pg TEQ mammals/g) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>IE (monitored but no EQS) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:86.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>4 </span></p>
  </td>
 </tr>
 <tr style='height:43.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:43.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>HBCDD </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:43.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.15pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>DK (0.2 µg/kg WW marine fish) </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>SE (0.3 µg/l in freshwater, 0.03 µg/l in
  marine water; 0.9 mg/kg sediment; 1.5 mg/kg biota) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:43.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>2 </span></p>
  </td>
 </tr>
 <tr style='height:35.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Heptachlor </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:35.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>AT (0.004 µg/l),  BE (0.009 µg/l
  average; 0.09 µg/l MAC),  IT (0.005 µg/l),  RO (0.0002 µg/l), CY (monitored
  but no EQS), IE (monitored but no EQS), NL (0.0005 µg/l), DE (0.1 µg/l) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:35.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>8 </span></p>
  </td>
 </tr>
 <tr style='height:51.0pt'>
  <td width=147 valign=top style='width:110.0pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:51.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>PFOS </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:51.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.15pt;margin-left:.1pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>DK (0.2 µg/kg WW marine fish)  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:7.05pt;margin-left:.05pt;text-align:left;text-indent:0cm;
  line-height:107%'><span style='font-size:8.0pt;line-height:107%;font-family:
  "Arial",sans-serif'>CZ 25 µg/l  </span></p>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>SE (30 µg/l in freshwater; 3 µg/l in
  marine water; 0.006 mg/kg biota) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;padding:4.75pt 5.75pt 0cm 0cm;
  height:51.0pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.75pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>3 </span></p>
  </td>
 </tr>
 <tr style='height:16.65pt'>
  <td width=147 valign=top style='width:110.0pt;border:none;border-bottom:solid black 1.0pt;
  padding:4.75pt 5.75pt 0cm 0cm;height:16.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:5.4pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>Terbutryn </span></p>
  </td>
  <td width=340 valign=top style='width:255.25pt;border:none;border-bottom:
  solid black 1.0pt;padding:4.75pt 5.75pt 0cm 0cm;height:16.65pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>CZ (0.1 µg/l), BG (0.01 µg/l) </span></p>
  </td>
  <td width=106 valign=top style='width:79.25pt;border:none;border-bottom:solid black 1.0pt;
  padding:4.75pt 5.75pt 0cm 0cm;height:16.65pt'>
  <p class=MsoNormal align=center style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.7pt;margin-bottom:.0001pt;text-align:center;
  text-indent:0cm;line-height:107%'><span style='font-size:8.0pt;line-height:
  107%;font-family:"Arial",sans-serif'>2 </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:18.85pt;
margin-bottom:14.0pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:97%'><span style='font-size:8.0pt;line-height:97%;font-family:"Arial",sans-serif'>Based
on WISE electronic submission from 19 MS (AT, BE, BG, CZ, DE, EE, FI, FR, HU,
IE, IT, LT, LV, NL, PL, RO, SE, SK and UK) plus data from ENTEC (2011) for DK
and CY  </span></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>In summary, there is considerable uncertainty
regarding the impact that the WFD programmes of measures will have in reducing
the emissions of existing and proposed PS, and ultimately in reducing their
presence in the environment.  </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Plant Protection Products </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Active substances may only be included in PPPs in
the EU if they are authorised by inclusion on Annex I of Directive 91/414/EEC
(regarding placement of PPPs on the market).  Individual active substances can
be added to Annex I by individual directives which, in some cases, include
requirements or restrictions on use of the substance (for example requirements
to leave a buffer zone around surface water bodies). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Directive 91/414/EEC will be replaced by
Regulation (EC) No 1107/2009 in June 2011 which maintains the authorisation of
active substances at EU level.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:42.35pt'>Directive 2009/128/EC, establishing a framework for
community action to achieve the sustainable use of pesticides, will be
implemented from 2011.  The directive includes measures to:<b> </b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.15pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Include
instructions on safety, storage and disposal of pesticides with sales; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.2pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Improve
public awareness of possible risks from the use of pesticides; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Promote
research programmes aimed at determining the impacts of pesticide use on human
health and the environment; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Provide
systems for regular inspection of pesticide application equipment. These must
commence by 2016 and be carried out at least once every five years, and a
certification programme put in place; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Generally
prohibit the use of aerial spraying (from a plane or helicopter) of pesticides
(although derogations are possible); </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Take
measures to avoid pollution of the aquatic environment, such as using the most
efficient application techniques, establishing buffer strips, planting hedges
along waterbodies, and reducing or eliminating use in areas with a high
likelihood of runoff of surface water or sewers (e.g. roads and railways); </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Promote
low-pesticide pest management methods (including integrated pest management and
organic farming); </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.8pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Minimising
or prohibiting use of pesticides in sensitive areas including Natura 2000 sites
and public spaces (such as parts or sports grounds). </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>All of these measures must be implemented in
National Action Plans, which are to be communicated to the Commission by 14
December 2012.  As the plans have not been produced yet, there is some
uncertainty about the exact measures that will be put into place, but the
directive clearly has the potential to reduce concentrations of PPPs in water. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The Directive complements well the action under
the WFD but does not replace it.  The EQS under the WFD provide a benchmark for
assessing whether measures are effective, and the WFD focuses on PPPs that have
been identified as posing a risk to the aquatic environment. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The substances that are included in the policy
options and that are concerned by the PPP legislation are Trifluralin, Dicofol,
Quinoxyfen, Aclonifen, Bifenox, Cypermethrin, Dichlorvos, Heptachlor and
Terbutryn. </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Biocides </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:42.35pt'>Directive 98/8/EC on the placing on the market of
biocidal products aims to: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.15pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Harmonise
the European market for biocidal products and their active substances; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Provide
a high level of protection for people, animals and the environment through risk
assessment; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.75pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Ensure
products are sufficiently effective against the target species. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Active substances that are authorised for use are
placed on to Annex I of the directive.  However the review programme, i.e. the
approval for placing on Annex I, is still ongoing.  The review covers 23
different product types including, for example, disinfectants, preservation
products, non-agricultural pesticides, and anti-fouling products.  It does not
include PPPs, which are covered under Directive 91/414/EEC. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>A Commission proposal (COM(2009) 267) to replace
Directive 98/8/EC is currently under negotiation.  The regulation aims to
improve the functioning of the internal market in biocidal products while
maintaining the high level of the environmental and human health protection. 
As under Directive 98/8/EC there would be a two-tiered authorisation process:
inclusion of the active substance in Annex I, followed by authorisation of the
biocidal product. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The substances that are included in the policy
options and that are concerned by the biocides legislation are Cybutryne,
Cypermethrin, Dichlorvos and Terbutryn. </p>

<p class=MsoHeading8 style='margin-left:42.3pt'><b><span style='font-style:
normal'>Persistent organic pollutants </span></b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.95pt;margin-left:42.35pt'>The Stockholm Convention on Persistent Organic
Pollutants is a global treaty to protect human health and the environment from
chemicals that remain intact in the environment for long periods, become widely
distributed geographically, accumulate in the fatty tissue of humans and
wildlife, and have adverse effects to human health or to the environment.  The
Stockholm Convention was adopted in 2001 and entered into force in 2004.  It
required parties to take measures to eliminate or reduce the release of POPs
into the environment.  There were twelve original POPs, including pesticides,
industrial chemicals and by-products.  In 2009, nine additional chemicals were
added to the annexes of the Stockholm Convention.  There are three
classifications: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Annex
A (elimination): parties must take measures to eliminate the production and use
of the chemicals listed under Annex A.  In some cases, specific exemptions for
ongoing use or production may be made; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Annex
B (restriction): parties must take measures to restrict the production and use
of the chemicals listed under Annex B in light of any applicable acceptable
purposes and/or specific exemptions listed in the Annex; </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.8pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Annex
C (unintentional production): parties must take measures to reduce the
unintentional releases of chemicals listed under Annex C with the goal of
continuing minimisation and, where feasible, ultimate elimination. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The convention is implemented in the EU through
Regulation (EC) No 850/2004.  The regulation complements earlier Community
legislation on POPs and aligns it with the provisions of the international
agreement.  The regulation contains provisions regarding production, placing on
the market and use of chemicals, management of stockpiles and wastes, and
measures to reduce unintentional releases of POPs. Furthermore, MS must set up
emission inventories for unintentionally produced POPs, national implementation
plans (NIPs) and monitoring and information exchange mechanisms. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
14.0pt;margin-left:42.35pt'>The WFD mechanism can ensure monitoring of these
substances in the aquatic environment and facilitate progress towards the
cessation/phase-out objective.  It has been recognised that under the Stockholm
and UNECE LRTAP Conventions there is a general lack of coordinated monitoring
or regional surveys that focus on POPs in the freshwater environment<a
href="#_ftn47" name="_ftnref47" title=""><sup><sup><span style='font-size:12.0pt;
line-height:103%;font-family:"Times New Roman",serif;color:black'>[47]</span></sup></sup></a>.
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The following substances relevant to this
assessment are included under the Stockholm Convention: Heptachlor, Dioxins,
PCBs, some polyBDEs (tetraBDE, pentaBDE, hexaBDE, heptaBDE) and PFOS.  </p>

<h5 style='margin-left:42.3pt'>REACH </h5>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Regulation (EC) No 1907/2006 deals with the
Registration, Evaluation, Authorisation and Restriction of Chemical Substances
(REACH). It entered into force in June 2007.  The aim of REACH is to improve
the protection of human health and the environment through the better and
earlier identification of the intrinsic properties of chemical substances.  The
regulation required manufacturers and importers to gather information on the
properties of their chemical substances, and to register the information in a
central database. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
6.8pt;margin-left:42.35pt'>The elements in REACH include: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>All
substances are covered by the REACH regulation unless they are explicitly
exempted;  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
9.25pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Registration
requires manufacturers and importers of chemicals (1 tonne or above per year)
to obtain relevant information on their substances and to use those data to identify
and apply the appropriate risk management measures. Substances not included
include those that are regulated elsewhere (e.g. PPPs, biocides and medicinal
products), those present at very low risk, or those occurring in nature that
have not been chemically modified (e.g. minerals, ores); </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Substances
of very high concern may be included in the Candidate List and may be made
subject to authorisation (inclusion in Annex XIV).  For these substances to
continue to be used, applicants will have to demonstrate that risks associated
with uses of each substance are adequately controlled or that the
socio-economic benefits of their use outweigh the risks.  Applicants must also
analyse whether there are safer suitable alternative substances or technologies.
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.8pt;margin-left:99.3pt;text-indent:-14.2pt'><span style='line-height:103%'><span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Restrictions
can be placed on the manufacture, marketing or use of particular substances. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.6pt;margin-left:42.35pt'>DEHP and HBCDD have been added to REACH Annex XIV for
authorisation (February </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>2011).  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Other substances included in this assessment are
being considered for authorisation.  This includes Anthracene (and related
oils, pastes) and coal tar pitch high temperature (relevant to PAHs,
Anthracene, Fluoranthene, Naphthalene).  If these substances are indeed added
to Annex XIV, then, depending on the outcome of the authorisation process, the
baseline for these substances could change substantially. In any case the WFD
will monitor the concentrations of these substances in the aquatic environment
and, in the case of PAHs and Anthracene, progress towards the cessation/phase-out
objective. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The substances that are included in the policy
options and that are concerned by REACH are Anthracene, BDE, DEHP, Lead,
Naphthalene, Nickel, PAH, Fluoranthene, PFOS and HBCDD.  </p>

<h6 style='margin-top:0cm;margin-right:0cm;margin-bottom:11.4pt;margin-left:
42.3pt;line-height:103%'><span style='font-size:12.0pt;line-height:103%'>Industrial
emissions </span></h6>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The Directive on Industrial Emissions (Directive
2010/75/EC) recasts seven existing Directives relating to industrial emissions
into a single coherent legislative instrument.  The recast covers the
Integrated Pollution Prevention Control (IPPC) Directive, the Large Combustion
Plants Directive, the Waste Incineration Directive, the Solvents Emissions
Directive, and three Directives on Titanium Dioxide.  The directive has been
developed to: improve implementation of BAT; reduce limitations of compliance
enforcement and environmental improvements; reduce unnecessary administrative
burden; improve scope and provision to achieve Thematic Strategy objectives of
air, waste and soil. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The Directive uses the concept of Best Available
Techniques (BAT).  Emission limits and operating conditions contained in the
IPPC authorisation permits are based on BAT, taking into account the technical
characteristics of an installation, its geographic location and the local
environmental conditions.  BAT reference documents (BREFs) are produced by the
European IPPC-Bureau for each sector.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Potentially all substances are concerned by the
industrial emissions directive, although those that are not produced or are
only formulated in the EU may not be concerned. </p>

<h6 style='margin-top:0cm;margin-right:0cm;margin-bottom:11.4pt;margin-left:
42.3pt;line-height:103%'><span style='font-size:12.0pt;line-height:103%'>Pharmaceutical
legislation </span></h6>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The approval process for medicinal products for
human use is described in Directive 2001/83/EC (Directive of the European
Parliament and of the Council on the Community code relating to medicinal
products for human use) and further amendments. In this directive, the basic
parameter for approval is a positive risk/benefit evaluation of the product,
which includes a safety and efficacy assessment. As a further parameter, the
potential environmental risk posed by the medicinal product should be
assessed and, on a case-bycase basis, specific arrangements to limit it shall
be envisaged.(EU Directive 2004/27, Article 8 (3b)). In any event,
environmental impact cannot constitute a criterion for refusing marketing
authorisation for a human medicinal product. However, it is a criterion for
veterinary medicinal products.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>For existing pharmaceutical products for human use
there is no obvious mechanism to revise marketing authorisations on the basis
of the environmental impacts. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>There is a commitment by the Commission to look at
the environmental impact of pharmaceuticals. A study will be launched in 2011
which will build on a large range of studies and information available<a
href="#_ftn48" name="_ftnref48" title=""><sup><span style='font-size:10.0pt;
line-height:103%'><sup><span style='font-size:10.0pt;line-height:103%;
font-family:"Times New Roman",serif;color:black'>[48]</span></sup></span></sup></a>.
Impact of this Commission initiative in the longer term is uncertain at the
moment. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The substances that are included in the policy
options and that are concerned by the pharmaceuticals legislation are EE2, E2
and Diclofenac. </p>

<h6 style='margin-top:0cm;margin-right:0cm;margin-bottom:11.4pt;margin-left:
42.3pt;line-height:103%'><span style='font-size:12.0pt;line-height:103%'>Waste
legislation </span></h6>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Waste legislation covers a large share of the
entire EU environmental acquis and includes thirteen main legislative acts
adopted by the European Parliament and the Council and a large number of
related decisions adopted through comitology procedures. The overall scope of
this legislation is the prevention or reduction of waste production, the
re-use, the recycling, other types of recovery than recycling and the disposal
of different categories of waste; permitting and control of disposal
operations, mainly landfills; and shipments of waste within the EU as well as
to and from third countries.   </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The basic requirements are laid down by the Waste
Framework Directive 2008/98/EC which is complemented by specific legislation
addressing particular environmental threats associated with waste. This
specific legislation includes harmonised rules on waste management practices,
including strict emission limits and operating requirements for the
incineration and landfill of waste; harmonised rules on shipments  of waste;
and product specific  legislation setting targets for collection, re-use,
recovery and recycling and introducing producer responsibility principles for
specific waste  streams derived from consumer goods, in particular packaging
waste, end of life vehicles, waste electrical and electronic equipment, mining
waste and batteries. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The latest Commission implementation report
COM(2009)633 recognises progress on the implementation of the waste legislation
but also important implementation gaps. Further progress in the coming years
may have an important influence on the baseline for some of the substances
identified under the review, as important emissions to water may be generated
by waste handling and/or disposal. </p>

<h6 style='margin-top:0cm;margin-right:0cm;margin-bottom:11.4pt;margin-left:
42.3pt;line-height:103%'><span style='font-size:12.0pt;line-height:103%'>Interactions
of main upstream policies with the WFD </span></h6>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.7pt;margin-left:42.35pt'>Existing policies at EU level, at least for
industrial chemicals, PPPs and biocides, include appropriate mechanisms that
can be used to develop process and product controls to address the risks
identified by the WFD.<b> </b></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:71.85pt;text-indent:-30.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Emission controls are best suited to reducing, where necessary,
the emissions of PS.  However, they may also be appropriate to control the
emissions to water of PHS of natural origin or those produced unintentionally,
which it may not be possible to eliminate completely. In the context of the
2006 proposal the Commission stated that there were already a number of pieces
of EU legislation that set emission controls for </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
12.85pt;margin-left:73.05pt'>point sources (notably the Urban Waste Water
Treatment Directive and the IPPC) and concluded that additional emission
controls were best developed and implemented at MS level. This conclusion is
still valid. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
7.15pt;margin-left:71.85pt;text-indent:-30.0pt'><span style='line-height:103%;
font-family:"Arial",sans-serif'><span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Product controls, such as limits on production or use, appear to
be best suited to the cessation and phase-out objective for PHS although they
may also be useful to reduce emissions from a particular use, e.g. by
restriction. A range of tools is already available in the EU legislation: </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.35pt;margin-left:108.55pt;text-indent:-24.0pt;line-height:100%'><span
style='line-height:100%;font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Under REACH, the evaluation, restriction and authorisation
processes <span style='font-family:"Courier New"'>o</span><span
style='font-family:"Arial",sans-serif'>            </span>Under the PPP
legislation, the evaluation, restriction and authorisation processes and
periodic review </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:108.55pt;text-indent:-24.0pt'><span style='line-height:103%;
font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Under the biocides legislation, the evaluation, restriction and
authorisation processes and periodic review </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
5.4pt;margin-left:108.55pt;text-indent:-24.0pt'><span style='line-height:103%;
font-family:"Courier New"'>o<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span>Under the pharmaceuticals legislation, the authorisation and
review processes for veterinary medicines. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>One of the main objectives of these EU legislative
instruments is to prevent the placing in the market of substances that may
cause unacceptable risks. PPPs and biocides require risk assessment prior to
authorisation. Industrial chemicals need to be registered under REACH,
including a chemical safety assessment. If the latter shows the need to limit
the risks, the registrant is required to take and recommend adequate risk
management measures. Where registration alone is not sufficient to manage the
risks, restriction or authorisation may be used. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The WFD identifies PS by assessing the risks to
the aquatic environment, largely relying on monitoring information. The WFD
prioritisation process acts as a safety net to ensure that the assumptions and
results of the risk assessments carried out for placing in the market of
certain substances under other legislation, including any mitigation measures
that are applied, are actually delivering adequate protection of water
resources and of human health via the aquatic environment. The WFD can also
identify substances posing a risk that have been in use for many years, in some
cases without having been subjected to a proper risk assessment. The WFD can
then feed back to these upstream policies the information gathered that
demonstrates unacceptable risks, for these policies to act according to their
established procedures.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>As regards the pharmaceutical legislation, since
2004 it requires applications for the authorisation of new products to be
accompanied by an Environmental Risk Assessment. However, the results of this
assessment are not considered in the risk-benefit balance that is the basis of
the authorisation for human medicines, though it is for veterinary medicines.
As regards human pharmaceuticals authorised before 2004, there is no mechanism
in the legislation to address environmental impacts. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The diagram on the following page illustrates the
interaction of some of the main upstream policies regulating the use and
placing on the market of substances (i.e. REACH, PPPs, biocides,
pharmaceuticals) with the WFD priority substances process. The white boxes
indicate WFD processes. The potential role of the watch list as per options C
in the text is also included.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>The central vertical process describes the main
steps of the WFD prioritisation exercise, including a risk assessment step that
uses data on substances exposure and effects. Upstream policies constitute an
important source of data for the WFD prioritisation exercise and on the other
hand they also benefit from the monitoring data gathered under the WFD.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Interactions with other policies (waste,
industrial emissions) are not included in the diagram. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> <br clear=all style='page-break-before:always'>
</p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:54.25pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'><img border=0 width=559 height=826
id="Picture 150649" src="IA_files/image002.gif"></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.65pt;margin-left:193.7pt;text-align:left;text-indent:0cm;
line-height:107%'><span style='font-size:9.0pt;line-height:107%;font-family:
"Arial",sans-serif'>Exchange of information and/or triggers for action between
policies</span></p>

<p class=MsoNormal align=right style='margin-top:0cm;margin-right:6.95pt;
margin-bottom:8.1pt;margin-left:0cm;text-align:right;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<h6 align=center style='margin-top:0cm;margin-right:.25pt;margin-bottom:11.25pt;
margin-left:37.35pt;text-align:center;line-height:103%'><u><span
style='font-size:12.0pt;line-height:103%'>ANNEX VII: List of stakeholders
involved in the consultation</span></u><span style='font-size:12.0pt;
line-height:103%'>  </span></h6>

<p class=MsoHeading7 style='margin-top:0cm;margin-right:0cm;margin-bottom:.5pt;
margin-left:42.3pt'><u><span style='font-style:normal'>List of stakeholders
members of the Working Group E on Chemical Aspects</span></u><span
style='font-style:normal'> </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Organisation </span></p>
  </td>
  <td width=161 style='width:120.55pt;border:solid black 1.0pt;border-left:
  none;padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Sector </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>ECPA (European Crop Protection Association) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Pesticides </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Business Europe </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Business organisation </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>AESGP (Association of the European Self-Medication Industry) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Pharmaceuticals </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>AISE (International Association for Soaps, Detergents and Maintenance
  Products) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Detergents </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>CEPI (Confederation of European Paper Industry) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Pulp and paper </span></p>
  </td>
 </tr>
 <tr style='height:35.45pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>CONCAWE (European Oil Companies' Association for Environment, Health
  and Safety in Refining and Distribution) </span></p>
  </td>
  <td width=161 valign=top style='width:120.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Oil  </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EFPIA (European Federation of pharmaceuticals Industries and
  Associations) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Pharmaceuticals </span></p>
  </td>
 </tr>
 <tr style='height:35.5pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUCETSA (European Committee of Environmental Technology Suppliers
  Association) </span></p>
  </td>
  <td width=161 valign=top style='width:120.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Equipment suppliers </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUDA (European Dredging Association) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Dredgers </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Greenpeace </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Environmental NGO </span></p>
  </td>
 </tr>
 <tr style='height:35.5pt'>
  <td width=458 valign=top style='width:343.8pt;border:solid black 1.0pt;
  border-top:none;padding:8.45pt 5.75pt 0cm 5.35pt;height:35.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Commission OSPAR </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:35.5pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:-.05pt;line-height:107%'><span style='font-size:10.0pt;
  line-height:107%'>International Convention Secretariat </span></p>
  </td>
 </tr>
 <tr style='height:35.45pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>COPA-COGECA (Committee of Agricultural Organisations in the European
  Union - General Committee for Agricultural Co-operation) </span></p>
  </td>
  <td width=161 valign=top style='width:120.55pt;border-top:none;border-left:
  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:35.45pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Agriculture </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EEB (European Environmental Bureau) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Environmental NGO </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUREAU (European Union of National Associations of Water Suppliers) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Water utilities </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EURELECTRIC (The Union of the Electricity Industry) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Energy  </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>WWF (World Wild Fund) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Environmental NGO </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>CEFIC (European Chemical Industry Council) </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Chemical </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUROMETAUX </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Metals </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUROFER </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Metals </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=458 style='width:343.8pt;border:solid black 1.0pt;border-top:none;
  padding:8.45pt 5.75pt 0cm 5.35pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>EUROMINES </span></p>
  </td>
  <td width=161 style='width:120.55pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:8.45pt 5.75pt 0cm 5.35pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Mining </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.35pt;margin-left:42.35pt'>The list is also available on the Register of
Commission Expert Groups<a href="#_ftn49" name="_ftnref49" title=""><sup><sup><span
style='font-size:12.0pt;line-height:103%;font-family:"Times New Roman",serif;
color:black'>[49]</span></sup></sup></a>. </p>

<p class=MsoHeading7 style='margin-left:42.3pt'><u><span style='font-style:
normal'>List of stakeholders addressed in the targeted consultation</span></u><span
style='font-style:normal'>  </span></p>

<table class=TableGrid border=0 cellspacing=0 cellpadding=0 width=619
 style='width:464.35pt;margin-left:37.15pt;border-collapse:collapse'>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Organisation </span></b></p>
  </td>
  <td width=164 style='width:122.95pt;border:solid black 1.0pt;border-left:
  none;padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><b><span style='font-size:
  10.0pt;line-height:107%'>Sector </span></b></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>FEAP (Federation of European Aquaculture Producers)*
  </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Aquaculture </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>EMPA/AEPM (European Mollusc Producers Association)* 
  </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Aquaculture </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Europêche* </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Fisheries </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>European Anglers' Alliance </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Angling </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>ETF (European Transport Workers' Federation) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Transport </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>EAPO (European Association of Fish Producer
  Organisations) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Fisheries </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>CESA (Community of European Shipyards Associations) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Shipping </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>COCERAL </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Grain producers </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>EGA (European Generic Medicines Association) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Pharmaceuticals </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>CPME  (Standing Committee of European Doctors) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>PGEU (Pharmaceutical Group of the European Union) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>European Patients' Forum </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>EPHA  (European Public Health Alliance) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.15pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>HAI Europe (Stichting Health Action International
  Europe) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.1pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>HEAL (Health &amp; Environment Alliance) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Public Health </span></p>
  </td>
 </tr>
 <tr style='height:24.0pt'>
  <td width=455 style='width:341.4pt;border:solid black 1.0pt;border-top:none;
  padding:0cm 5.75pt 0cm 5.4pt;height:24.0pt'>
  <p class=MsoNormal align=left style='margin:0cm;margin-bottom:.0001pt;
  text-align:left;text-indent:0cm;line-height:107%'><span style='font-size:
  10.0pt;line-height:107%'>BEUC (The European Consumers' Organisation) </span></p>
  </td>
  <td width=164 style='width:122.95pt;border-top:none;border-left:none;
  border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;padding:0cm 5.75pt 0cm 5.4pt;
  height:24.0pt'>
  <p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:.05pt;margin-bottom:.0001pt;text-align:left;
  text-indent:0cm;line-height:107%'><span style='font-size:10.0pt;line-height:
  107%'>Consumers </span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-top:0cm;margin-right:4.95pt;margin-bottom:
12.45pt;margin-left:42.3pt;line-height:95%'>* <span style='font-size:10.0pt;
line-height:95%'>These three organisations are represented on the Strategic
Coordination Group under which WG E operates, but do not have members in WG E
itself; they were targeted because of the particular relevance to them of the
substances under review.</span> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

<h6 align=center style='margin-top:0cm;margin-right:0cm;margin-bottom:11.25pt;
margin-left:37.35pt;text-align:center;line-height:103%'><u><span
style='font-size:12.0pt;line-height:103%'>ANNEX VIII: References</span></u><span
style='font-size:12.0pt;line-height:103%'> </span></h6>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Abegglen C, Rosenstiel R, Ort C, Schärer M.
Weitergehende Verfaren zur Elimination von organischen Spurenstoffen bei
kommunalen Abwasserreinigungsanlagen. Varianten und Kosten. <i>Korrespondenz
Abwasser, Abfall</i> 2009, 56:6, 584-592. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.0pt;margin-left:42.35pt'>ADAS UK Ltd 2010. Impact of changing pesticide
availability on horticulture. Report for Defra.
http://randd.defra.gov.uk/Document.aspx?Document=IF01100_10191_FRP.pdf </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>AMAP 2009: Persistent Organic Pollutants in the
Arctic. <i>Science of the Total Environment Special Issue</i>. 408:2851-3051.
Elsevier, 2010 </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Apoteket, 2006. Environment and pharmaceuticals.
Published by Apoteket AB (The National Corporation of Swedish Pharmacies),
Stockholm County Council and Stockholm University.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
13.75pt;margin-left:42.35pt'>Burridge LE, Haya K, Waddy SL, Wade J, 2000. The
lethality of anti-sea lice formulations Salmosan® (Azamethiphos) and Excis®
(Cypermethrin) to stage IV and adult lobsters (Homarus americanus) during
repeated short-term exposures. Aquaculture 182, 27-35. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Cardinale BJ. Biodiversity improves water quality
through niche partitioning. <i>Nature</i> 2011, 472, 86-89.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>CGEDD, 2010. Conseil Général de lEnvironnement et
du Développement durable. Médicament et environnement. La régulation du
médicament vis-à-vis du risque environnemental. Paris, November 2010. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Chang H, Wan Y, Wu S, Fan Z, Hu J. Occurrence of
androgens and progestogens in wastewater treatment plants and receiving river
waters: Comparison to estrogens. <i>Water Research</i> 2011, 45, 732-740. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Costa LG, Giordano G. Is decabromodiphenyl ether
(BDE-209) a developmental neurotoxicant? <i>Neurotoxicology</i> 2011, 32, 9-24.
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:42.35pt'>Ecolas, 2005. Assessing economic impacts of the
specific control measures for priority substances and priority hazardous
substances regulated under article 16 of the Water </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.6pt;margin-left:0cm;text-align:left;text-indent:0cm'><span
style='font-size:11.0pt;line-height:103%;font-family:"Calibri",sans-serif'>                   </span>Framework
      Directive.        European        Commission       DG       ENV.       July
        2005. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_background/ecolas_reportpdf/_EN_1.0_&amp;a=d"><span
style='color:blue'>http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents
</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_background/ecolas_reportpdf/_EN_1.0_&amp;a=d"><span
style='color:blue'>/priority_substances/supporting_background/ecolas_reportpdf/_EN_1.0_&amp;a=d</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_background/ecolas_reportpdf/_EN_1.0_&amp;a=d"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:11.8pt;margin-left:42.3pt;text-align:left;line-height:100%'>Entec,
2011. Substance impact reports. Prepared to support this impact assessment.
http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents
/priority_substances/supporting_substances </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:5.0pt;
margin-bottom:11.8pt;margin-left:42.3pt;text-align:left;line-height:100%'>Entec,
2011b. Methodology report. Prepared to support this impact assessment.
http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents
/priority_substances/supporting_substances </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>European Commission, 2006. Impact assesssment of
the Thematic Strategy on Sustainable Use of Pesticides. SEC(2006)894. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>European Commission, 2009. White paper - Adapting
to climate change: towards a European framework for action. COM(2009)147
final.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>European Commission, 2009b. Common Implementation
Strategy for the Water Framework Directive. Guidance Document on Exemptions to
the Environmental Objectives. <a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/documentn20_mars09pdf/_EN_1.0_&amp;a=d"><span
style='color:blue'>http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_document
</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/documentn20_mars09pdf/_EN_1.0_&amp;a=d"><span
style='color:blue'>s/documentn20_mars09pdf/_EN_1.0_&amp;a=d</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/documentn20_mars09pdf/_EN_1.0_&amp;a=d"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'>European
Commission, 2011. Commission Staff Working Paper SEC(2011)1544. <a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_substances"><span
style='color:blue'>http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents
</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_substances"><span
style='color:blue'>/priority_substances/supporting_substances</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/thematic_documents/priority_substances/supporting_substances"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>European Commission, 2011b. Common Implementation
Strategy for the Water Framework Directive. Technical Guidance Document for
deriving Environmental Quality Standards. <a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/tgd-eqs_cis-wfd/_EN_1.0_&amp;a=d"><span
style='color:blue'>http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_document
</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/tgd-eqs_cis-wfd/_EN_1.0_&amp;a=d"><span
style='color:blue'>s/tgd-eqs_cis-wfd/_EN_1.0_&amp;a=d</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/guidance_documents/tgd-eqs_cis-wfd/_EN_1.0_&amp;a=d"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>European Environment Agency (EEA), 2010.
Pharmaceuticals in the environment. EEA Technical Report No. 1/2010.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Eurostat, 2011. Database env_watq2_1 Annual water
abstraction by source and by sector. <a
href="http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=env_watq2_1&amp;lang=en"><span
style='color:blue'>http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=env_watq2_1&amp;lang=en</span></a><a
href="http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=env_watq2_1&amp;lang=en"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Herbstman JB, Sjödin A, Kurzon M, Lederman SA,
Jones RS, Rauh V, Needham LL, Tang D, Niedzwiecki M, Wang RY, Perera F.
Prenatal Exposure to PBDEs and Neurodevelopment. <i>Environmental Health
Perspectives</i> 2010, 118:5, 712-9. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>HGCA 2009. Pesticide availability for cereals and
oilseeds following revision of Directive 91/414/EEC; effects of losses and new
research priorities. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Inotai A,  <a
href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hank%C3%B3%20B%22%5BAuthor%5D"><span
style='color:blue'>Hankó B</span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22Hank%C3%B3%20B%22%5BAuthor%5D"><span
style='color:black;text-decoration:none'>,</span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22M%C3%A9sz%C3%A1ros%20A%22%5BAuthor%5D"><span
style='color:black;text-decoration:none'> </span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22M%C3%A9sz%C3%A1ros%20A%22%5BAuthor%5D"><span
style='color:blue'>Mészáros A</span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22M%C3%A9sz%C3%A1ros%20A%22%5BAuthor%5D"><span
style='color:black;text-decoration:none'>, </span></a>2010  Trends in the
non-steroidal anti-inflammatory drug market in six Central-Eastern European
countries based on retail information. Pharmacoepidemiol Drug Saf. 19(2)
183-90.<a href="http://www.ncbi.nlm.nih.gov/pubmed/20014174"><span
style='color:black;text-decoration:none'>  </span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed/20014174"><span style='color:blue'>http://www.ncbi.nlm.nih.gov/pubmed/20014174</span></a><a
href="http://www.ncbi.nlm.nih.gov/pubmed/20014174"><span style='color:black;
text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
8.25pt;margin-left:42.35pt;line-height:126%'>JRC, 2011. Estimation of the value
of natural nitrogen removal in rivers and lakes. In preparation. Kidd KA,
Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW. Collapse
of a fish population after exposure to a synthetic estrogen. <i>Proceedings of
the National Academy of Sciences</i> 2007, 104:21, 8897-8901. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Knappe, 2008. Kampa E, Vidaurre R. Deliverable
3.3. Identification of options for the design of future instruments to limit
pollution from pharmaceutical products into water.  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Lepper P, 2005. Manual on the Methodological
Framework to Derive Environmental Quality Standards for Priority Substances in
accordance with Article 16 of the Water Framework Directive (2000/60/EC).  </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Roig B, 2010. Pharmaceuticals in the Environment:
Current knowledge and need assessment to reduce presence and impact. Edited by
Benoit Roig. ISBN: 9781843393146. Published by IWA Publishing, London, UK. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
1.0pt;margin-left:42.35pt'>SCHER (Scientific Committee on Health and
Environmental Risks), Opinion on Chemicals and the Water Framework Directive:
Technical Guidance for Deriving Environmental Quality </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.6pt;margin-left:0cm;text-align:left;text-indent:0cm'><span
style='font-size:11.0pt;line-height:103%;font-family:"Calibri",sans-serif'>                   </span>Standards,
                                                       October                                                          2010.
</p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'><a
href="http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_127.pdf"><span
style='color:blue'>http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_127.pdf</span></a><a
href="http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_127.pdf"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
0cm;margin-left:42.35pt;margin-bottom:.0001pt'>SCTEE (Scientific Committee on
Toxicity, Ecotoxicity and the Environment), Opinion on the Setting of
Environmental Quality Standards for the Priority Substances included in Annex X
of Directive 2000/60/EC in Accordance with Article 16 thereof. Adopted during
the 43rd plenary meeting of 28 May 2004. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:11.4pt;margin-left:42.3pt;text-align:left;line-height:103%'><a
href="http://ec.europa.eu/health/archive/ph_risk/committees/sct/documents/out230_en.pdf"><span
style='color:blue'>http://ec.europa.eu/health/archive/ph_risk/committees/sct/documents/out230_en.pdf</span></a><a
href="http://ec.europa.eu/health/archive/ph_risk/committees/sct/documents/out230_en.pdf"><span
style='color:black;text-decoration:none'> </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>SedNet, 2004. European Sediment Research Network.
Contaminated Sediments in European River Basins<a href="http://www.sednet.org/"><span
style='color:black;text-decoration:none'>. </span></a><a
href="http://www.sednet.org/"><span style='color:blue'>http://www.sednet.org</span></a><a
href="http://www.sednet.org/"><span style='color:black;text-decoration:none'>  </span></a></p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
.85pt;margin-left:42.35pt'>SRU, 2007. German Advisory Council on the
Environment. Statement Nb. 12, April 2007. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:.6pt;margin-left:0cm;text-align:left;text-indent:0cm'><span
style='font-size:11.0pt;line-height:103%;font-family:"Calibri",sans-serif'>                   </span>Pharmaceuticals
                               in                                the                                  Environment.
</p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>http://www.umweltrat.de/SharedDocs/Downloads/EN/04_Statements/2007_Statement_12_Ph
armaceuticals_Environment.pdf?__blob=publicationFile </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Sundseth K, Pacyna JM, Pacyna EG, Munthe J, Belhaj
M, Astrom S. Economic benefits from decreased mercury emissions: Projections
for 2020. <i>Journal of Cleaner Production</i> 2010, 18, 386-394. </p>

<p class=MsoNormal style='margin-top:0cm;margin-right:5.05pt;margin-bottom:
11.55pt;margin-left:42.35pt'>Swedish Medical Products Agency, 2009. Sustainable
Development and Pharmaceuticals. Post Conference Booklet. 10-11 November. </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:10.8pt;margin-left:42.55pt;text-align:left;text-indent:0cm;
line-height:107%'> </p>

<p class=MsoNormal align=left style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:42.55pt;margin-bottom:.0001pt;text-align:left;
text-indent:0cm;line-height:107%'> </p>

</div>

<div><br clear=all>

<hr align=left size=1 width="33%">

<div id=ftn1>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.4pt;margin-left:0cm'><a href="#_ftnref1" name="_ftn1" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[1]</span></span></span></a> Directive 2000/60/EC of the
European Parliament and of the Council of 23 October 2000 establishing a </p>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.6pt;margin-left:78.55pt;line-height:98%'>framework for Community action in the
field of water policy [OJ L327 of 22.12.2000].  <a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:02000L0060-20090113:EN:NOT"><span
style='color:blue'>http://eur</span></a><a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:02000L0060-20090113:EN:NOT"><span
style='color:blue'>lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:02000L0060-20090113:EN:NOT</span></a><a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:02000L0060-20090113:EN:NOT"><span
style='color:black;text-decoration:none'> </span></a></p>

</div>

<div id=ftn2>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.6pt;
margin-bottom:.15pt;margin-left:78.55pt;text-align:justify;text-justify:inter-ideograph;
text-indent:-36.0pt;line-height:105%'><a href="#_ftnref2" name="_ftn2" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[2]</span></span></span></a> An EQS is defined as the
concentration of a particular pollutant or group of pollutants in water,
sediment or biota which should not be exceeded in order to protect human health
and the environment (WFD Article 2.35) </p>

</div>

<div id=ftn3>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.9pt;margin-left:0cm'><a href="#_ftnref3" name="_ftn3" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[3]</span></span></span></a> Study Contract No
070307/2009/547548/SER/D1 </p>

</div>

<div id=ftn4>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref4" name="_ftn4" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[4]</span></span></span></a>
For the existing substances under review, some of the supporting information
for the study was prepared by a second consultancy, WRc (with input from
Milieu). </p>

</div>

<div id=ftn5>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.35pt;margin-left:0cm'><a href="#_ftnref5" name="_ftn5" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[5]</span></span></span></a> Directive 2008/105/EC of the
European Parliament and of the Council of 16 December 2008 on </p>

<p class=footnotedescription style='margin-left:78.55pt;line-height:99%'>environmental
quality standards in the field of water Policy [OJ L 348, 24.12.2008, p. 84]<a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008L0105:EN:NOT"><span
style='color:black;text-decoration:none'> http://eur</span></a><a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008L0105:EN:NOT"><span
style='color:black;text-decoration:none'>lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008L0105:EN:NOT
</span></a></p>

</div>

<div id=ftn6>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.45pt;margin-left:0cm'><a href="#_ftnref6" name="_ftn6" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[6]</span></span></span></a> <a
href="http://ec.europa.eu/environment/water/water-framework/objectives/pdf/strategy.pdf"><span
style='color:blue'>http://ec.europa.eu/environment/water/water-framework/objectives/pdf/strategy.pdf</span></a><a
href="http://ec.europa.eu/environment/water/water-framework/objectives/pdf/strategy.pdf"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn7>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref7" name="_ftn7" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[7]</span></span></span></a>
The SCHER is one of the Scientific Committees providing the Commission with
independent advice. It is made up of 17 scientists. More information at </p>

<p class=footnotedescription style='margin-left:78.55pt'><a
href="http://ec.europa.eu/health/scientific_committees/environmental_risks/index_en.htm"><span
style='color:blue'>http://ec.europa.eu/health/scientific_committees/environmental_risks/index_en.htm</span></a><a
href="http://ec.europa.eu/health/scientific_committees/environmental_risks/index_en.htm"><span
style='color:black;text-decoration:none'>  </span></a><a
href="http://ec.europa.eu/health/scientific_committees/environmental_risks/index_en.htm"><span
style='color:black;text-decoration:none'> </span></a></p>

</div>

<div id=ftn8>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref8"
name="_ftn8" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[8]</span></span></span></a> <a
href="http://ec.europa.eu/environment/working_en.htm"><span style='color:blue'>http://ec.europa.eu/environment/working_en.htm</span></a><a
href="http://ec.europa.eu/environment/working_en.htm"><span style='color:black;
text-decoration:none'>  </span></a></p>

</div>

<div id=ftn9>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref9" name="_ftn9" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[9]</span></span></span></a>
Biota refers to any groups of living aquatic organisms that can be analysed and
used as indicators of pollution such as fish, mussels, invertebrates, etc. </p>

</div>

<div id=ftn10>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.65pt;
margin-bottom:.5pt;margin-left:78.55pt;text-align:justify;text-justify:inter-ideograph;
text-indent:-36.0pt;line-height:105%'><a href="#_ftnref10" name="_ftn10"
title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[10]</span></span></span></a>
Decision No 2455/2001/EC of the European Parliament and of the Council of 20
November 2001 destablishing the list of priority substances in the field of
water policy and amending Directive 2000/60/EC [OJ L331 of 15.12.2001, p.1] </p>

</div>

<div id=ftn11>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
.6pt;margin-left:0cm'><a href="#_ftnref11" name="_ftn11" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[11]</span></span></span></a> <a
href="http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Chemicals_management_statistics"><span
style='color:blue'>http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Chemicals_management_statistics</span></a><a
href="http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Chemicals_management_statistics"><span
style='color:black;text-decoration:none'> </span></a></p>

</div>

<div id=ftn12>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.65pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:105%'><a
href="#_ftnref12" name="_ftn12" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[12]</span></span></span></a>
In the context of risk assessment exposure refers to the amount of
contaminant (dose) that an individual or the population will receive. This is
compared with the predicted no-effect concentration to perform the risk
assessment.  </p>

</div>

<div id=ftn13>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref13" name="_ftn13" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[13]</span></span></span></a>
Matrix refers to water, sediment or biota, the three compartments of the
aquatic environment in which contaminants can be measured.  </p>

</div>

<div id=ftn14>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref14"
name="_ftn14" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[14]</span></span></span></a><span
style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>             </span> 
              <a
href="http://www.scotland.gov.uk/Publications/2002/08/15170/9409"><span
style='color:blue'>http://www.scotland.gov.uk/Publications/2002/08/15170/94</span></a><u><span
style='color:blue'>09</span></u>  </p>

</div>

<div id=ftn15>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref15"
name="_ftn15" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[15]</span></span></span></a><span
style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>             </span> 
              <a
href="http://www.worldwildlife.org/what/globalmarkets/aquaculture/WWFBinaryitem8842.pdf"><span
style='color:blue'>http://www.worldwildlife.org/what/globalmarkets/aquaculture/WWFBinaryitem8842.pdf</span></a><a
href="http://www.worldwildlife.org/what/globalmarkets/aquaculture/WWFBinaryitem8842.pdf"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn16>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref16"
name="_ftn16" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[16]</span></span></span></a>             <a
href="http://www.cbc.ca/news/canada/new-brunswick/story/2010/02/18/nb-aquaculture-pesticide-bay-of-fundy-lobster-deaths-658.html"><span
style='color:blue'>http://www.cbc.ca/news/canada/new-brunswick/story/2010/02/18/nb-aquaculture-pesticide-bay-of</span></a><a
href="http://www.cbc.ca/news/canada/new-brunswick/story/2010/02/18/nb-aquaculture-pesticide-bay-of-fundy-lobster-deaths-658.html"><span
style='color:blue'>fundy-lobster-deaths-658.html</span></a><a
href="http://www.cbc.ca/news/canada/new-brunswick/story/2010/02/18/nb-aquaculture-pesticide-bay-of-fundy-lobster-deaths-658.html"><span
style='color:black;text-decoration:none'>  </span></a><a
href="http://quoddytides.com/salmon10-8-10.html"><span style='color:blue'>http://quoddytides.com/salmon10-8-10.html</span></a><a
href="http://quoddytides.com/salmon10-8-10.html"><span style='color:black;
text-decoration:none'>, </span></a><a
href="http://quoddytides.com/salmon10-8-10.html"><span style='color:black;
text-decoration:none'> </span></a></p>

</div>

<div id=ftn17>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.6pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:103%'><a
href="#_ftnref17" name="_ftn17" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[17]</span></span></span></a>
These substances are hydrophobic and bioaccumulative and therefore the
preferred matrix for monitoring is biota; their concentrations in water are so
low that are rarely measurable using state of the art analytical techniques.
The main exposure route posing a risk is secondary poisoning, i.e. risks to
human health via ingestion of contaminated fish or shellfish. </p>

</div>

<div id=ftn18>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref18"
name="_ftn18" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[18]</span></span></span></a> Former
Scientific Committee replaced by SCHER </p>

</div>

<div id=ftn19>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref19"
name="_ftn19" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[19]</span></span></span></a><span
style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>             </span> 
              <a
href="http://chm.pops.int/Convention/ThePOPs/tabid/673/language/en-GB/Default.aspx"><span
style='color:blue'>http</span></a><u><span style='color:blue'>://chm.pops.int/Convention/ThePOPs/tabid/673/language/en-GB/Default.aspx</span></u>; 
</p>

</div>

<div id=ftn20>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref20"
name="_ftn20" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[20]</span></span></span></a><span
style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>             </span> 
              <a href="http://www.unece.org/env/lrtap/pops_h1.htm"><span
style='color:blue'>http://www.unece.org/env/lrtap/pops_h1.htm</span></a><a
href="http://www.unece.org/env/lrtap/pops_h1.htm"><span style='color:black;
text-decoration:none'>  </span></a></p>

</div>

<div id=ftn21>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref21"
name="_ftn21" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[21]</span></span></span></a><span
style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>             </span><a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:229:0005:0022:EN:PDF"><span
style='color:black;text-decoration:none'>  </span></a>              <a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:229:0005:0022:EN:PDF"><span
style='color:blue'>http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:229:0005:0022:EN:PDF</span></a><a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:229:0005:0022:EN:PDF"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn22>

<p class=footnotedescription><a href="#_ftnref22" name="_ftn22" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[22]</span></span></span></a><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>          </span>                <a
href="http://ec.europa.eu/environment/waste/studies/pdf/POP_Waste_2011.pdf"><span
style='color:blue'>http://ec.europa.eu/environment/waste/studies/pdf/POP_Waste_2011.pd</span></a><u><span
style='color:blue'>f</span></u>  </p>

</div>

<div id=ftn23>

<p class=footnotedescription><a href="#_ftnref23" name="_ftn23" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[23]</span></span></span></a><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>          </span>                <a
href="http://www.pic.int/Procedures/PICProcedure/tabid/1364/language/en-US/Default.aspx"><span
style='color:blue'>http://www.pic.int/Procedures/PICProcedure/tabid/1364/language/en-US/Default.aspx</span></a><a
href="http://www.pic.int/Procedures/PICProcedure/tabid/1364/language/en-US/Default.aspx"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn24>

<p class=footnotedescription><a href="#_ftnref24" name="_ftn24" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[24]</span></span></span></a>  This is based on information
from 19 MS. Although it is early to extract conclusions from the RBMPs (their
assessment is on-going), it is clear that there is a wide diversity of
methodologies and likely an implementation gap in the identification of
substances of river basin importance in the context of ecological status.  </p>

</div>

<div id=ftn25>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref25"
name="_ftn25" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[25]</span></span></span></a> If
change is higher than one order of magnitude. </p>

</div>

<div id=ftn26>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref26" name="_ftn26" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[26]</span></span></span></a>
As explained in the problem definition section, options B3a and B3b are most
obviously relevant to ubiquitous PBTs but would apply to all PS. </p>

</div>

<div id=ftn27>

<p class=footnotedescription style='margin-top:0cm;margin-right:9.4pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-indent:-36.0pt;
line-height:125%'><a href="#_ftnref27" name="_ftn27" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[27]</span></span></span></a> <a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/implementation_documents/final_2010-2012/_EN_1.0_&amp;a=d"><span
style='color:blue'>http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/implementation_documents/fi
</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/implementation_documents/final_2010-2012/_EN_1.0_&amp;a=d"><span
style='color:blue'>nal_2010-2012/_EN_1.0_&amp;a=d</span></a><a
href="http://circa.europa.eu/Public/irc/env/wfd/library?l=/framework_directive/implementation_documents/final_2010-2012/_EN_1.0_&amp;a=d"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn28>

<p class=footnotedescription><a href="#_ftnref28" name="_ftn28" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[28]</span></span></span></a> European Commission, 2009b </p>

</div>

<div id=ftn29>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref29"
name="_ftn29" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[29]</span></span></span></a> <a
href="http://www.apvma.gov.au/products/review/docs/sheep_ectoparsiticide_prelim_report_vol_2.pdf"><span
style='color:blue'>http://www.apvma.gov.au/products/review/docs/sheep_ectoparsiticide_prelim_report_vol_2.pdf</span></a><a
href="http://www.apvma.gov.au/products/review/docs/sheep_ectoparsiticide_prelim_report_vol_2.pdf"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn30>

<p class=footnotedescription style='margin-bottom:5.05pt'><a href="#_ftnref30"
name="_ftn30" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[30]</span></span></span></a> <a
href="http://www.swrcb.ca.gov/rwqcb5/water_issues/tmdl/central_valley_projects/central_valley_pesticides/criteria_method/cypermethrin/2011mar_cypermethrin_draft.pdf"><span
style='color:blue'>http://www.swrcb.ca.gov/rwqcb5/water_issues/tmdl/central_valley_projects/central_valley_pesticides/c
</span></a><a
href="http://www.swrcb.ca.gov/rwqcb5/water_issues/tmdl/central_valley_projects/central_valley_pesticides/criteria_method/cypermethrin/2011mar_cypermethrin_draft.pdf"><span
style='color:blue'>riteria_method/cypermethrin/2011mar_cypermethrin_draft.pdf</span></a><a
href="http://www.swrcb.ca.gov/rwqcb5/water_issues/tmdl/central_valley_projects/central_valley_pesticides/criteria_method/cypermethrin/2011mar_cypermethrin_draft.pdf"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn31>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref31"
name="_ftn31" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[31]</span></span></span></a> <a
href="http://water.epa.gov/scitech/swguidance/ppcp/index.cfm"><span
style='color:blue'>http://water.epa.gov/scitech/swguidance/ppcp/index.cfm</span></a><a
href="http://water.epa.gov/scitech/swguidance/ppcp/index.cfm"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn32>

<p class=footnotedescription><a href="#_ftnref32" name="_ftn32" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[32]</span></span></span></a> European Commission, 2009b </p>

</div>

<div id=ftn33>

<p class=footnotedescription style='margin-left:78.55pt;text-indent:-36.0pt;
line-height:110%'><a href="#_ftnref33" name="_ftn33" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[33]</span></span></span></a> <a
href="http://www.imo.org/about/conventions/listofconventions/pages/international-convention-on-the-control-of-harmful-anti-fouling-systems-on-ships-(afs).aspx"><span
style='color:blue'>http://www.imo.org/about/conventions/listofconventions/pages/international-convention-on-the</span></a><a
href="http://www.imo.org/about/conventions/listofconventions/pages/international-convention-on-the-control-of-harmful-anti-fouling-systems-on-ships-(afs).aspx"><span
style='color:blue'>control-of-harmful-anti-fouling-systems-on-ships-(afs).aspx</span></a><a
href="http://www.imo.org/about/conventions/listofconventions/pages/international-convention-on-the-control-of-harmful-anti-fouling-systems-on-ships-(afs).aspx"><span
style='color:black;text-decoration:none'>  </span></a></p>

</div>

<div id=ftn34>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.6pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:100%'><a
href="#_ftnref34" name="_ftn34" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[34]</span></span></span></a>
To name a few aspirin, naproxen, ketorolac, ketoprofen, meloxicam, celecoxib,
mefenamic acid, etoricoxib, indometacin, ibuprofen. See for example information
at the National Health Service of England <a
href="http://www.nhs.uk/Conditions/Anti-inflammatories-non-steroidal/Pages/Introduction.aspx"><span
style='color:blue'>http://www.nhs.uk/Conditions/Anti-inflammatories-non-steroidal/Pages/Intro</span></a><u><span
style='color:blue'>duction.aspx</span></u> and <a
href="http://www.nhs.uk/Livewell/Pain/Pages/Whichpainkiller.aspx"><span
style='color:blue'>http://www.nhs.uk/Livewell/Pain/Pages/Whichpainkiller.aspx</span></a><a
href="http://www.nhs.uk/Livewell/Pain/Pages/Whichpainkiller.aspx"><span
style='color:black;text-decoration:none'> </span></a>which presents various
alternatives depending on the characteristics of the patient; the Prescription
Guide of the Spanish Medicament Agency <a
href="http://www.imedicinas.com/GPTage/Open.php?Y2ExMHNlMDFzYjAx"><span
style='color:blue'>http://www.imedicinas.com/GPTage/Open.php?Y2ExMHNlMDFzYjAx</span></a><a
href="http://www.imedicinas.com/GPTage/Open.php?Y2ExMHNlMDFzYjAx"><span
style='color:black;text-decoration:none'> </span></a>that indicates that
&quot;differences in anti-inflammatory activity of different NSAIDs are small,
but there is great variation in tolerance and response of each patient.
Approximately 60% of patients respond to any NSAID, and 40% respond to one or
another&quot;. </p>

</div>

<div id=ftn35>

<p class=footnotedescription style='margin-bottom:1.2pt'><a href="#_ftnref35"
name="_ftn35" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[35]</span></span></span></a>
European Commission, 2009b </p>

</div>

<div id=ftn36>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:119%'><a
href="#_ftnref36" name="_ftn36" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[36]</span></span></span></a>
See Entec 2011, report for E2, Appendix B. Per capita cost calculated on the
basis of average annual costs and 54 million inhabitants in England and Wales. </p>

</div>

<div id=ftn37>

<p class=footnotedescription style='margin-top:0cm;margin-right:0cm;margin-bottom:
1.15pt;margin-left:0cm'><a href="#_ftnref37" name="_ftn37" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[37]</span></span></span></a> OJ L3331, p 1, 15.12.2001 </p>

</div>

<div id=ftn38>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref38" name="_ftn38" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[38]</span></span></span></a>
Combined monitoring-based and modelling-based priority setting, developed for
the first prioritisation exercise:<a
href="http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm"><span
style='color:black;text-decoration:none'>  </span></a><a
href="http://ec.europa.eu/environment/water/water-dangersub/lib_pri_substances.htm"><span
style='color:blue'>http://ec.europa.eu/environment/water/water-dangersub/lib_pri_sub</span></a><u><span
style='color:blue'>stances.htm</span></u>  </p>

</div>

<div id=ftn39>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref39" name="_ftn39" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[39]</span></span></span></a>
Opinion on the revised proposal for a List of Priority Substances in the
Context of the Water <a
href="http://ec.europa.eu/health/ph_risk/committees/sct/docshtml/sct_out49_en.htm"><span
style='color:black;text-decoration:none'>Framework Directive (COMMPS Procedure)
prepared by the Fraunhofer-In</span></a><a
href="http://ec.europa.eu/health/ph_risk/committees/sct/docshtml/sct_out49_en.htm"><span
style='color:black;text-decoration:none'>s</span></a>titut (Germany) - Final </p>

</div>

<div id=ftn40>

<p class=footnotedescription><a href="#_ftnref40" name="_ftn40" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[40]</span></span></span></a><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>          </span>                OJ
L348, p.84-97, 24.12.2008 </p>

</div>

<div id=ftn41>

<p class=footnotedescription><a href="#_ftnref41" name="_ftn41" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[41]</span></span></span></a><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>          </span>                <a
href="http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:52006DC0398:EN:NOT"><span
style='color:blue'>htt</span></a><u><span style='color:blue'>p://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:52006DC0398:EN:NOT</span></u> 
</p>

</div>

<div id=ftn42>

<p class=footnotedescription><a href="#_ftnref42" name="_ftn42" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[42]</span></span></span></a><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif'>          </span>                Lepper,
2005.  </p>

</div>

<div id=ftn43>

<p class=footnotedescription style='margin-left:0cm'><a href="#_ftnref43"
name="_ftn43" title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[43]</span></span></span></a> European
Commission, 2011b </p>

</div>

<div id=ftn44>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.6pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:103%'><a
href="#_ftnref44" name="_ftn44" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[44]</span></span></span></a>
These substances are hydrophobic and bioaccumulative and therefore the
preferred matrix for monitoring is biota; their concentrations in water are so
low that are rarely measurable using state of the art analytical techniques.
The main exposure route causing risk is secondary poisoning, i.e. risks to
human health via ingestion of contaminated fish or shellfish. </p>

</div>

<div id=ftn45>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.65pt;
margin-bottom:0cm;margin-left:78.55pt;margin-bottom:.0001pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:103%'><a
href="#_ftnref45" name="_ftn45" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[45]</span></span></span></a>
The NORMAN network started its activities in September 2005 with the financial
support of the European Commission (NORMAN project - 6th Framework Programme)
and it is now established as a permanent self-sustaining network of more than
50 reference laboratories, research centres and related organisations for the
monitoring and biomonitoring of emerging environmental substances. </p>

<p class=footnotedescription style='margin-left:78.55pt'><a
href="http://www.norman-network.net/"><span style='color:blue'>http://www.norman-network.net/</span></a><a
href="http://www.norman-network.net/"><span style='color:black;text-decoration:
none'>  </span></a></p>

</div>

<div id=ftn46>

<p class=footnotedescription><a href="#_ftnref46" name="_ftn46" title=""><span
class=footnotemark><span class=footnotemark><span style='font-size:10.0pt;
line-height:103%'>[46]</span></span></span></a><span style='font-size:12.0pt;
line-height:107%'> </span>Main report: <a
href="http://ec.europa.eu/environment/water/water-framework/implrep2007/pdf/sec_2009_415_en.pdf"><span
style='color:blue'>http://ec.europa.eu/environment/water/water-framework/implrep2007/pdf/sec_2009_415_en.pdf</span></a>,
Annex: <a
href="http://ec.europa.eu/environment/water/water-framework/implrep2007/pdf/sec_2009_415_2_en.pdf"><span
style='color:blue'>http://ec.europa.eu/environment/water/water-framework/implrep2007/pdf/sec_2009_415_2_en.pdf</span></a><a
href="http://ec.europa.eu/environment/water/water-framework/implrep2007/pdf/sec_2009_415_2_en.pdf"><span
style='font-size:12.0pt;line-height:107%;color:black;text-decoration:none'> </span></a><sup>48</sup> 
            Assumes the average frequency of monitoring of 2 samples per year. </p>

</div>

<div id=ftn47>

<p class=footnotedescription style='margin-top:0cm;margin-right:5.7pt;
margin-bottom:.8pt;margin-left:78.55pt;text-align:justify;text-justify:inter-ideograph;
text-indent:-36.0pt;line-height:102%'><a href="#_ftnref47" name="_ftn47"
title=""><span class=footnotemark><span class=footnotemark><span
style='font-size:10.0pt;line-height:103%'>[47]</span></span></span></a> Global
Monitoring Plan for Persistent Organic Pollutants under the Stockholm
Convention Article 16 on effectiveness evaluation. First regional monitoring
report Western Europe and other groups Region (2008). <u><span
style='color:blue'>http://chm.pops.int/Portals/0/Repository/GMP/UNEP-POPS-GMP-RMR-WEOG.English.PDF</span></u>
and UN-ECE Convention on Long-Range Transboundary Air Pollution. Working Group
on Effects. POPs in the Freshwater environment: Effects of long-range
transboundary air pollution. </p>

<p class=footnotedescription style='margin-left:0cm'><span style='font-size:
11.0pt;line-height:107%;font-family:"Calibri",sans-serif'>                                   </span>EB.AIR/WG.1/2005/6
                                                                                                                                      (2005).
</p>

<p class=footnotedescription style='margin-left:78.55pt'><a
href="http://www.unece.org/env/documents/2005/eb/wg1/EB.AIR.WG.1.2005.6.e.pdf"><span
style='color:blue'>http://www.unece.org/env/documents/2005/eb/wg1/EB.AIR.WG.1.2005.6.e.pdf</span></a><a
href="http://www.unece.org/env/documents/2005/eb/wg1/EB.AIR.WG.1.2005.6.e.pdf"><span
style='color:black;text-decoration:none'>  </span></a><a
href="http://www.unece.org/env/documents/2005/eb/wg1/EB.AIR.WG.1.2005.6.e.pdf"><span
style='color:black;text-decoration:none'> </span></a></p>

</div>

<div id=ftn48>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:112%'><a
href="#_ftnref48" name="_ftn48" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[48]</span></span></span></a>
Roig B, 2010; EEA, 2010; SRU, 2007; Swedish Medical Products Agency, 2009;
Apoteket, 2006; CGEDD, 2010. </p>

</div>

<div id=ftn49>

<p class=footnotedescription style='margin-left:78.55pt;text-align:justify;
text-justify:inter-ideograph;text-indent:-36.0pt;line-height:105%'><a
href="#_ftnref49" name="_ftn49" title=""><span class=footnotemark><span
class=footnotemark><span style='font-size:10.0pt;line-height:103%'>[49]</span></span></span></a>
<a href="http://ec.europa.eu/transparency/regexpert/detailGroup.cfm?groupID=371"><span
style='color:blue'>http://ec.europa.eu/transparency/regexpert/detailGroup.cfm?groupID=371</span></a><a
href="http://ec.europa.eu/transparency/regexpert/detailGroup.cfm?groupID=371"><span
style='color:black;text-decoration:none'>, </span></a>under
&quot;Sub-groups&quot;, &quot;Priority Substances&quot;.  </p>

</div>

</div>

</body>

</html>
